WorldWideScience

Sample records for cancer current status

  1. Focal therapy for prostate cancer: The current status

    OpenAIRE

    Marshall, Susan; Taneja, Samir

    2015-01-01

    Purpose In an era of increasing prostate cancer incidence and earlier detection, the assessment of clinical significance of prostate cancer is critical. Minimally invasive therapies are increasingly being investigated in localized prostate cancer. Methods and results In this review, we discuss the current status of magnetic resonance imaging targeted fusion prostate biopsy and focal therapy for prostate cancer, its rationale, and techniques. Conclusion Focal therapy offers a promising outlook...

  2. Oral Cancer Chernoprevention: Current Status and Future Direction.

    Science.gov (United States)

    Messadi, Diana V; Sato, Kazumichi

    2016-02-01

    The aim of this study is to review the current status of cancer chemoprevention and its effectiveness in treatment of oral premalignant lesions and prevention of their progression to oral cancer. The challenges encountered in the different oral cancer chemoprevention clinical trials, including lack of surrogate endpoints, reversal of histologic premalignant changes as study endpoints, tobacco use, human papillomavirus, delivery system, adverse effects and risk of bias in clinical studies, are presented. PMID:26930753

  3. Chemoprevention of gastric cancer: current status

    Institute of Scientific and Technical Information of China (English)

    2003-01-01

    The development of gastric cancer is a multi-factor process. In addition to genetic factors, environmental factors including smoking, low gastric acidity, excessive intake of salt or salty food and low consumption of fresh fruits and vegetables all contribute to the development of gastric cancer. Of particular interest, epidemiological and experimental studies have demonstrated that Helicobacter pylori (H. pylori) infection is causally linked to gastric cancer. Most studies using micronutrient supplementation have failed to demonstrate any preventive effect against the development of gastric cancer. The use of non-steroidal anti-inflammatory drugs has been consistently observed to protect against the development of gastric cancer. Recently, eradication of H. pylori infection by a chemopreventative approach is being studied in a number of trials. Studies using precancerous lesions as an end point of the treatment have produced conflicting and mostly negative results. Trials using cancer as an end point are being cautiously carried out in high-risk populations, and will provide the definitive answer to this important question. In the end, vaccination may be proven to be the optimal strategy in human for the management of H. pylori infection and prevention of gastric cancer.

  4. Current Status and Challenges of Cancer Clinical Trials in Korea

    OpenAIRE

    Shim, Byoung Yong; Park, Se Hoon; Lee, Soonil; Kim, Jin-Soo; Lee, Kyoung Eun; Kang, Yoon-Koo; Ahn, Myung-Ju

    2015-01-01

    Purpose Cancer clinical trials in Korea have rapidly progressed in terms of quantity and quality during the last decade. This study evaluates the current status of cancer clinical trials in Korea and their associated problems. Materials and Methods We analyzed the clinical trials approved by the Korea Food and Drug Administration (KFDA) between 2007 and 2013. A nationwide on-line survey containing 22 questions was also performed with several cooperative study groups and individual researchers...

  5. Gastric Cancer: Current Status of Diagnosis and Treatment

    Energy Technology Data Exchange (ETDEWEB)

    Takahashi, Tsunehiro; Saikawa, Yoshiro, E-mail: saiky@z8.keio.jp; Kitagawa, Yuko [Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo 1608582 (Japan)

    2013-01-16

    Gastric cancer is the second leading cause of death from malignant disease worldwide and most frequently discovered in advanced stages. Because curative surgery is regarded as the only option for cure, early detection of resectable gastric cancer is extremely important for good patient outcomes. Therefore, noninvasive diagnostic modalities such as evolutionary endoscopy and positron emission tomography are utilized as screening tools for gastric cancer. To date, early gastric cancer is being treated using minimally invasive methods such as endoscopic treatment and laparoscopic surgery, while in advanced cancer it is necessary to consider multimodality treatment including chemotherapy, radiotherapy, and surgery. Because of the results of large clinical trials, surgery with extended lymphadenectomy could not be recommended as a standard therapy for advanced gastric cancer. Recent clinical trials had shown survival benefits of adjuvant chemotherapy after curative resection compared with surgery alone. In addition, recent advances of molecular targeted agents would play an important role as one of the modalities for advanced gastric cancer. In this review, we summarize the current status of diagnostic technology and treatment for gastric cancer.

  6. The current status of imaging diagnosis of breast cancer

    International Nuclear Information System (INIS)

    In recent years, the incidence and the mortality rate of female breast cancer in our country is increasing, Early diagnosis of breast cancer is particularly important. Precious preoperative staging in the breast cancer is advantageous for the treatment planning. Evaluating the efficacy of chemotherapy is beneficial for adjusting the follow-up plan. Imaging examination has become an important role in breast cancer management. At present, commonly used equipment include mammography, ultrasound, CT, and MRI, etc. This article reviews the present study status of these tools in diagnosis of breast cancer. A reasonable and effective choice of those tools can facilitate clinic diagnosis and treatment. (authors)

  7. Pathological examination of breast cancer biomarkers: current status in Japan.

    Science.gov (United States)

    Masuda, Shinobu

    2016-07-01

    This article reviews the current status of pathological evaluation for biomarkers in Japan. The introduced issues are the international trends for estimation of biomarkers considering diagnosis and treatment decision, and pathological issues under discussion, and how Japanese Breast Cancer Society (JBCS) members have addressed issues related to pathology and biomarkers evaluation. As topics of immunohistochemical study, (1) ASCO/CAP guidelines, (2) Ki67 and other markers, (3) quantification and image analysis, (4) application of cytologic samples, (5) pre-analytical process, and (6) Japan Pathology Quality Assurance System are introduced. Various phases of concepts, guidelines, and methodologies are co-existed in today's clinical practice. It is expected in near future that conventional methods and molecular procedures will be emerged, and Japanese Quality assurance/Quality control (QA/QC) system will work practically. What we have to do in the next generation are to validate novel procedures, to evaluate the relationship between traditional concepts and newly proposed ideas, to establish a well organized QA/QC system, and to standardize pre-analytical process that are the basis of all procedures using pathological tissues. PMID:25239167

  8. Prostate cancer chemoprevention: Current status and future prospects

    International Nuclear Information System (INIS)

    Chemoprevention is a strategy that aims to reduce the incidence and burden of cancer through the development of agents to prevent, reverse or delay the carcinogenic process. Prostate cancer is a suitable target for prevention because it has a high incidence and prevalence, as well as a long latency and disease-related mortality, and furthermore it is a disease in which lifestyle and environmental factors may play critical roles. The development of chemoprevention strategies against prostate cancer will have a huge impact, both medically and economically. Large-scale clinical trials suggest that some agents such as selenium, lycopene, soy, green tea, vitamins D and E, anti-inflammatory and inhibitors of 5α-reductase are effective in preventing prostate cancer. Although each agent has the potential to affect the natural history of the disease, it is important to develop strategies to strategically proceed for the design and selection of test agents in order to demonstrate clinical benefit with the minimum of adverse effects. Appropriate selection of agent(s), disease stage, trial design and endpoints is critical in selecting the most promising regimens to accomplish these goals. This review highlights the present status of prostate cancer chemoprevention and discusses future prospects for chemopreventive strategies that are safe and clinically beneficial

  9. Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme

    Directory of Open Access Journals (Sweden)

    Gilbert Bernier

    2011-03-01

    Full Text Available Glioblastoma multiforme (GBM, an aggressive brain tumor of astrocytic/neural stem cell origin, represents one of the most incurable cancers. GBM tumors are highly heterogeneous. However, most tumors contain a subpopulation of cells that display neural stem cell characteristics in vitro and that can generate a new brain tumor upon transplantation in mice. Hence, previously identified molecular pathways regulating neural stem cell biology were found to represent the cornerstone of GBM stem cell self-renewal mechanism. GBM tumors are also notorious for their resistance to radiation therapy. Notably, GBM “cancer stem cells” were also found to be responsible for this radioresistance. Herein, we will analyze the data supporting or not the cancer stem cell model in GBM, overview the current knowledge regarding GBM stem cell self-renewal and radioresistance molecular mechanisms, and discuss the potential therapeutic application of these findings.

  10. Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme

    Energy Technology Data Exchange (ETDEWEB)

    Facchino, Sabrina; Abdouh, Mohamed [Developmental Biology Laboratory, Hopital Maisonneuve-Rosemont, 5415 Boul. l' Assomption, Montreal, H1T 2M4 (Canada); Bernier, Gilbert, E-mail: gbernier.hmr@ssss.gouv.qc.ca [Developmental Biology Laboratory, Hopital Maisonneuve-Rosemont, 5415 Boul. l' Assomption, Montreal, H1T 2M4 (Canada); Faculté de Médecine, Université de Montréal, Montréal, H3T 1J4 (Canada)

    2011-03-30

    Glioblastoma multiforme (GBM), an aggressive brain tumor of astrocytic/neural stem cell origin, represents one of the most incurable cancers. GBM tumors are highly heterogeneous. However, most tumors contain a subpopulation of cells that display neural stem cell characteristics in vitro and that can generate a new brain tumor upon transplantation in mice. Hence, previously identified molecular pathways regulating neural stem cell biology were found to represent the cornerstone of GBM stem cell self-renewal mechanism. GBM tumors are also notorious for their resistance to radiation therapy. Notably, GBM “cancer stem cells” were also found to be responsible for this radioresistance. Herein, we will analyze the data supporting or not the cancer stem cell model in GBM, overview the current knowledge regarding GBM stem cell self-renewal and radioresistance molecular mechanisms, and discuss the potential therapeutic application of these findings.

  11. Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme

    International Nuclear Information System (INIS)

    Glioblastoma multiforme (GBM), an aggressive brain tumor of astrocytic/neural stem cell origin, represents one of the most incurable cancers. GBM tumors are highly heterogeneous. However, most tumors contain a subpopulation of cells that display neural stem cell characteristics in vitro and that can generate a new brain tumor upon transplantation in mice. Hence, previously identified molecular pathways regulating neural stem cell biology were found to represent the cornerstone of GBM stem cell self-renewal mechanism. GBM tumors are also notorious for their resistance to radiation therapy. Notably, GBM “cancer stem cells” were also found to be responsible for this radioresistance. Herein, we will analyze the data supporting or not the cancer stem cell model in GBM, overview the current knowledge regarding GBM stem cell self-renewal and radioresistance molecular mechanisms, and discuss the potential therapeutic application of these findings

  12. [18F]FDG-PET in lung cancer: current status

    OpenAIRE

    Jane Dobbs, H; Quint, Leslie Eisenbud; Miles, K A

    2005-01-01

    Increasingly, evidence of safety, effectiveness and cost-effectiveness is required to support funding of new diagnostic technologies. However, diagnostic imaging is a rapidly changing speciality with new data constantly being added to the evidence base. This article aims to review the evidence base for the application of fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) in lung cancer and to identify areas in which the evidence base is evolving. Currently, there is strong evidenc...

  13. Current status and perspectives of brachytherapy for cervical cancer.

    Science.gov (United States)

    Toita, Takafumi

    2009-02-01

    Standard definitive radiotherapy for cervical cancer consists of whole pelvic external beam radiotherapy (EBRT) and intracavitary brachytherapy (ICBT). In Japan, high-dose-rate ICBT (HDR-ICBT) has been utilized in clinical practice for more than 40 years. Several randomized clinical trials demonstrated that HDR-ICBT achieved comparative outcomes, both for pelvic control and incidences of late complications, to low-dose-rate (LDR) ICBT. In addition, HDR-ICBT has some potential advantages over LDR-ICBT, leading to further improvement in treatment results. Prior to the current computer planning systems, some excellent treatment planning concepts were established. At present, systems modified from these concepts, or novel approaches, such as image-guided brachytherapy (IGBT) are under investigation. One serious problem to be solved in HDR-ICBT for cervical cancer is that of the discrepancy in standard treatment schedules for combination HDR-ICBT and EBRT between the United States and Japan. Prospective studies are ongoing to assess the efficacy and toxicity of the Japanese schedule. PMID:19225920

  14. Current Status of Cryotherapy for Prostate and Kidney Cancer

    OpenAIRE

    Cho, Seok; Kang, Seok Ho

    2014-01-01

    In terms of treating diseases, minimally invasive treatment has become a key element in reducing perioperative complications. Among the various minimally invasive treatments, cryotherapy is often used in urology to treat various types of cancers, especially prostate cancer and renal cancer. In prostate cancer, the increased incidence of low-risk, localized prostate cancer has made minimally invasive treatment modalities an attractive option. Focal cryotherapy for localized unilateral disease ...

  15. Research on cancer diagnosis in Malaysia: current status.

    Science.gov (United States)

    Looi, L M; Zubaidah, Z; Cheah, P L; Cheong, S K; Gudum, H R; Iekhsan, O; Ikram, S I; Jamal, R; Mak, J W; Othman, N H; Puteri, J N; Rosline, H; Sabariah, A R; Seow, H F; Sharifah, N A

    2004-06-01

    Cancer is a major morbidity and mortality concern in Malaysia. Based on National Cancer Registry data, the Malaysian population is estimated to bear a cancer burden of about 40,000 new cases per year, and a cumulative lifetime risk of about 1:4. Cancer research in Malaysia has to consider needs relevant to our population, and resources constraints. Hence, funding bodies prioritise cancers of high prevalence, unique to our community and posing specific clinical problems. Cancer diagnosis is crucial to cancer management. While cancer diagnosis research largely aims at improvements in diagnostic information towards more appropriate therapy, it also impacts upon policy development and other areas of cancer management. The scope of cancer diagnosis upon which this paper is based, and their possible impact on other R&D areas, has been broadly categorized into: (1) identification of aetiological agents and their linkages to the development of precancer and cancer (impact on policy development, cancer prevention and treatment), (2) cancer biology and pathogenesis (impact on cancer prevention, treatment strategies and product development), (3) improvements in accuracy, sensitivity and specificity in cancer detection, monitoring and classification (impact on technology development) and (4) prognostic and predictive parameters (impact on treatment strategies). This paper is based on data collected by the Working Group on Cancer Diagnosis Research for the First National Conference on Cancer Research Coordination in April 2004. Data was collated from the databases of Institutions/Universities where the authors are employed, the Ministry of Science, Technology and Innovation (MOSTI) and targeted survey feedback from key cancer researchers. Under the 7th Malaysia Plan, 76 cancer projects were funded through the Intensified Research in Priority Areas (IRPA) scheme of MOSTI, amounting to almost RM15 million of grant money. 47(61.8%) of these projects were substantially in cancer

  16. Current Status and Future Perspectives in Differentiated Thyroid Cancer

    OpenAIRE

    Kim, Tae Yong; Kim, Won Gu; Kim, Won Bae; Shong, Young Kee

    2014-01-01

    Thyroid cancer is increasing all over the world. The exact cause of this increase is still debated and there are conflicting reports. Sophisticated molecular studies suggest that environmental chemicals may have effects of thyroid carcinogenesis. The development of powerful molecular biology techniques has enabled targeted next-generation sequencing for detection of mutations in thyroid cancer, and this technique can make a specific diagnosis of thyroid cancer in cytologically indeterminate c...

  17. Adjuvant Therapy of Colon Cancer: Current Status and Future Developments

    OpenAIRE

    Morse, Michael A.

    2005-01-01

    Options for the adjuvant therapy of resected stage III colon cancer have expanded beyond the previously well-accepted standard of 5-fluorouracil (5-FU) combined with leucovorin. The Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) study confirmed that capecitabine (Xeloda) is at least as effective and is less toxic than a bolus 5-FU and leucovorin regimen for patients with stage III colon cancer. This study, in addition to National Surgical Adjuvant Breast and Bowel Project (NSABP) C-06, which...

  18. Use of bisphosphonates in prostate cancer: Current status

    OpenAIRE

    Nayyar, Rishi; Gupta, Narmada P

    2007-01-01

    Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We hereby review the ongoing and some published randomized trials to define the role of bisphosphonates in various stages of prostate cancer.

  19. [Current Status and Perspective of Chemoradiotherapy for Uterine Cervical Cancer].

    Science.gov (United States)

    Toita, Takafumi; Ariga, Takuro; Kasuya, Goro; Hashimoto, Seiji; Maemoto, Hitoshi; Heianna, Joichi; Kakinohana, Yasumasa; Murayama, Sadayuki

    2015-10-01

    Fifteen years has passed since the NCI announced the clinical importance of concurrent chemoradiotherapy (CCRT) in radiotherapy for patients with locoregionally advanced uterine cervical cancer. Numerous clinical trials have been performed to further improve the outcomes of CCRT. In addition to investigations of chemotherapeutic regimens and schedules, adaptation of novel radiotherapy methods such as image-guided brachytherapy (IGBT) and intensity-modulated radiotherapy (IMRT) is encouraged in CCRT for cervical cancer. PMID:26489545

  20. Current status and prospect of therapy with advanced cancer

    International Nuclear Information System (INIS)

    Symtomatic or palliative therapy of the patients with advanced cancer must be directed to the relief of specific distressing symptoms caused by or associated with neoplasm. The radiotherapy must have a clear concepts of the potential accomplishments of other treatment modalities, such as neurosurgery, anesthesiology, chemotherapy, pharmacology and psychotherapy, so that he may use his own method in proper perspective. I discussed following is an list of contents in this papers. Relief of pain, Psychotherapy, SVC obstruction, Obstructive jaundice, Brain and lung metastasis, prevention of fracture, Skin metastasis, Liver metastasis and treatment of advanced pediaric tumor etc. For the future: 1) Establishment of Stage and Grade of advanced cancer. 2) Development of new chemotherapeutic drug and immunotherapy. 3) Combination of multidisciplinary team and multidisciplinary treatment. (author)

  1. Prostate Cancer Registries: Current Status and Future Directions

    OpenAIRE

    Gandaglia, G; Bray, F.; Cooperberg, MR; Karnes, RJ; Leveridge, MJ; Moretti, K; Murphy, DG; Penson, DF; Miller, DC

    2016-01-01

    © 2015 European Association of Urology. Context: Disease-specific registries that enroll a considerable number of patients play a major role in prostate cancer (PCa) research. Objective: To evaluate available registries, describe their strengths and limitations, and discuss the potential future role of PCa registries in outcomes research. Evidence acquisition: We performed a literature review of the Medline, Embase, and Web of Science databases. The search strategy included the terms prostate...

  2. Imaging in primary penile cancer: current status and future directions

    Energy Technology Data Exchange (ETDEWEB)

    Kochhar, Rohit; Taylor, Ben [Christie, NHS Foundation Trust, Department of Radiology, Manchester (United Kingdom); Sangar, Vijay [Christie, NHS Foundation Trust, Department of Urology, Manchester (United Kingdom)

    2010-01-15

    Penile cancer is a rare neoplasm in the developed world. Clinical assessment often results in inaccurate staging and radiological techniques have a key role in staging and postoperative assessment. Magnetic resonance imaging (MRI) depicts penile anatomy in detail and is the most accurate technique for local staging and postoperative follow-up. MRI and ultrasound (US), although helpful for assessment of lymph nodes, are not reliable enough for accurate nodal staging. US-guided fine needle aspiration cytology (FNAC), however, remains a valuable tool to confirm metastases in suspicious inguinal nodes. Lymphoscintigraphy with dynamic sentinel node biopsy (DSNB) is a promising technique used to predict occult lymph node metastases. Novel imaging techniques such as positron emission tomography/computed tomography (PET-CT) and nanoparticle enhanced MRI have high sensitivity and specificity for lymph node metastases but their availability is limited and clinical utility is not fully established. The radiologist needs to be familiar with the normal penile anatomy, imaging appearances of pre- and post-treatment penile cancer, and the advantages and limitations of the available imaging techniques. This review highlights the above points and presents a systematic approach to make the best use of imaging in the management of patients with penile cancer. (orig.)

  3. Radionuclide liver cancer therapies: from concept to current clinical status.

    Science.gov (United States)

    Vente, Maarten A D; Hobbelink, Monique G G; van Het Schip, Alfred D; Zonnenberg, Bernard A; Nijsen, Johannes F W

    2007-07-01

    Primary and secondary liver cancer have longtime been characterized by an overall poor prognosis since the majority of patients are not candidates for surgical resection with curative intent, systemic chemotherapy alone has rarely resulted in long-term survival, and the role of conventional external beam radiation therapy has traditionally been limited due to the relative sensitivity of the liver parenchyma to radiation. Therefore, a host of new treatment options have been developed and clinically introduced, including radioembolization techniques, which are the main topic of this paper. In these locoregional treatments liver malignancies are passively targeted because, unlike the normal liver, the blood supply of intrahepatic tumors is almost uniquely derived from the hepatic artery. These internal radiation techniques consist of injecting either yttrium-90 ((90)Y) microspheres, or iodine-131 ((131)I) or rhenium-188 ((188)Re) labeled lipiodol into the hepatic artery. Radioactive lipiodol is used exclusively for treatment of primary liver cancer, whereas (90)Y microsphere therapy is applied for treatment of both primary and metastatic liver cancers. Favorable clinical results have been achieved, particularly when (90)Y microspheres were used in conjunction with systemic chemotherapy. The main advantages of radiolabeled lipiodol treatment are that it is relatively inexpensive (especially (188)Re-HDD-lipiodol) and that the administration procedure is somewhat less complex than that of the microspheres. Holmium-166 ((166)Ho) loaded poly(L-lactic acid) microspheres have also been developed and are about to be clinically introduced. Since (166)Ho is a combined beta-gamma emitter and highly paramagnetic as well, it allows for both (quantitative) scintigraphic and magnetic resonance imaging. PMID:17630919

  4. [Current status of castration-resistant prostate cancer translational research].

    Science.gov (United States)

    Maeno, Atsushi; Habuchi, Tomonori

    2016-01-01

    Recently, new drugs including abiraterone and enzalutamide have been able to be used for castration resistant prostate cancer(CRPC) patients. However, a subset of these patients who receive the new drugs does not response to the therapies. Furthermore, most patients who initially response to the drugs, progress to secondary resistance eventually. Therefore, it is important to investigate a novel therapeutic target and a novel treatment-selection marker for CRPC. In this review, we focused on AR-V7, TMPRSS2-ERG fusion gene and EP4 antagonist as representative translational researches. PMID:26793877

  5. Focal therapy for prostate cancer: current status and future perspectives.

    Science.gov (United States)

    Miano, R; Asimakopoulos, A; Da Silva, R; Bove, P; Jones, S; De La Rosette, J; Kim, F

    2015-09-01

    Focal therapy is a relatively new and extremely attractive option of treatment for prostate cancer. It has been described as the "middle approach" between active surveillance and radical treatment, aiming to destroy the tumor itself or the region containing the tumor in order to preserve surrounding non-cancerous tissue. The goal is to maintain disease control at acceptable levels, while preserving erectile, urinary, and rectal function. While a lot of technologies have been described for delivering targeted therapy to the prostate, such as cryoablation, high intensity focused ultrasound, photodynamic therapy, irreversible electroporation and laser, the key point is the patient selection. Recent advances in mpMRI and the introduction of new biopsy techniques that use MR images as a guidance, have significantly improved localization of the tumor lesions and the detection rate, evolving prostate biopsy toward targeted rather than systematic biopsies. The future challenge to clinicians is to precisely risk-stratify patients to differentiate between those who would profit from focal treatment and who would not. Forthcoming research efforts should pursue to identify molecular, genetic, and imaging characteristics that distinguish aggressive prostate tumors from indolent lesions. PMID:26013953

  6. Berry fruits for cancer prevention: current status and future prospects.

    Science.gov (United States)

    Seeram, Navindra P

    2008-02-13

    Overwhelming evidence suggests that edible small and soft-fleshed berry fruits may have beneficial effects against several types of human cancers. The anticancer potential of berries has been related, at least in part, to a multitude of bioactive phytochemicals that these colorful fruits contain, including polyphenols (flavonoids, proanthocyanidins, ellagitannins, gallotannins, phenolic acids), stilbenoids, lignans, and triterpenoids. Studies show that the anticancer effects of berry bioactives are partially mediated through their abilities to counteract, reduce, and also repair damage resulting from oxidative stress and inflammation. In addition, berry bioactives also regulate carcinogen and xenobiotic metabolizing enzymes, various transcription and growth factors, inflammatory cytokines, and subcellular signaling pathways of cancer cell proliferation, apoptosis, and tumor angiogenesis. Berry phytochemicals may also potentially sensitize tumor cells to chemotherapeutic agents by inhibiting pathways that lead to treatment resistance, and berry fruit consumption may provide protection from therapy-associated toxicities. Although a wide variety of berry fruits are consumed worldwide, this paper focuses on those commonly consumed in North America, namely, blackberries, black raspberries, blueberries, cranberries, red raspberries, and strawberries. In addition, a large body of studies on singly purified berry bioactives is available, but this paper focuses on studies of "whole berries" per se, that is, as berry extracts and purified fractions, juices, and freeze-dried powders. Potential mechanisms of anticancer action and bioavailability of berry phenolics, as well as gaps in knowledge and recommendations for future berry research, are also briefly discussed. PMID:18211019

  7. Chemoprevention of prostate cancer: current status and future directions.

    Science.gov (United States)

    Lieberman, Ronald

    2002-01-01

    Prostate cancer chemoprevention can be described as the administration of natural products and pharmaceutical agents that inhibit one or more steps in the natural history of prostatic carcinogenesis. The principle components of the chemoprevention strategy are closely connected to this natural history and include: (a) agents and their molecular targets; (b) strategic intermediate endpoint biomarkers (IEBs) and their critical pathways; (c) cohorts identified by genetic and acquired risk factors and (d) efficient designs that combine these elements into a cohesive clinical trial. The primary goal is to find effective noncytotoxic agents that modulate the promotion and progression from normal epithelium to dysplasia to high-grade prostatic intraepithelial neoplasia (HGPIN) to locally invasive cancer and metastatic disease. Another important target for chemoprevention is to modulate progression to clinically aggressive disease and to maintain an androgen-sensitive clinical state and delay the emergence of androgen resistance. There is a rationale for use of antiandrogens as the lead class, e.g., 5 alpha receptor inhibitors (5ARI), for chemoprevention of prostate cancer. Nevertheless, the desire to improve the therapeutic index, achieve synergy (5ARI may have only modest anticancer effects) and prevent the emergence of drug (androgen) resistance provide incentives for developing other effective agents and combinations. The availability of more than a dozen classes of noncytotoxic pharmaceutical and natural products already in clinical development create many opportunities for rational combination therapy. Several agent classes have a pharmacodynamic basis for combination with antiandrogens including antiproliferatives, selective estrogen receptor modulators (SERMs), proapoptotic antioxidant micronutrients and selective cyclo-oxygenase (COX)-2 inhibitors. Many other rational pharmacodynamic combinations without antiandrogens are feasible. It is anticipated that in the

  8. Cytochrome P450-based cancer gene therapy: current status.

    Science.gov (United States)

    Kan, On; Kingsman, Susan; Naylor, Stuart

    2002-12-01

    Results from a number of preclinical studies have demonstrated that a P450-based gene-directed enzyme prodrug therapy (GDEPT) strategy for the treatment of cancer is both safe and efficacious. This strategy has now moved forward into the clinic. At least two different approaches using different delivery methods (retroviral vector MetXia [Oxford BioMedica] and encapsulated P450 expressing cells), different cytochrome P450 isoforms (human CYP2B6 versus rat CYP2B1) and different prodrugs (cyclophosphamide [CPA] versus ifosfamide [IFA]) have concluded Phase I/II clinical trial with encouraging results. In the future, P450-based GDEPT can potentially be further enhanced by improved vectors for P450 gene delivery and disease-targeted promoters for focused gene expression at the target site. In addition, there is scope for developing synthetic P450s and their respective prodrugs to improve both enzyme kinetics and the profile of the active moiety. PMID:12517265

  9. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies.

    Science.gov (United States)

    De Jager, R; Abdel-Nabi, H; Serafini, A; Pecking, A; Klein, J L; Hanna, M G

    1993-04-01

    The use of radiolabeled murine monoclonal antibodies (MoAbs) for cancer immunodetection has been limited by the development of human antimouse antibodies (HAMA). Human monoclonal antibodies do not elicit a significant human antihuman (HAHA) response. The generation and production of human monoclonal antibodies met with technical difficulties that resulted in delaying their clinical testing. Human monoclonal antibodies of all isotypes have been obtained. Most were immunoglobulin (Ig) M directed against intracellular antigens. Two antibodies, 16.88 (IgM) and 88BV59 (IgG3k), recognize different epitopes on a tumor-associated antigen, CTA 16.88, homologous to cytokeratins 8, 18, and 19. CTA 16.88 is expressed by most epithelial-derived tumors including carcinomas of the colon, pancreas, breast, ovary, and lung. The in vivo targeting by these antibodies is related to their localization in nonnecrotic areas of tumors. Repeated administration of 16.88 over 5 weeks to a cumulative dose of 1,000 mg did not elicit a HAHA response. Two of 53 patients developed a low titer of HAHA 1 to 3 months after a single administration of 88BV59. Planar imaging of colorectal cancer with Iodine-131 (131I)-16.88 was positive in two studies in 9 of 12 and 16 of 20 patients preselected by immunohistochemistry. Tumors less than 2 cm in diameter are usually not detected. The lack of immunogenicity and long tumor residence time (average = 17 days) makes 16.88 a good candidate for therapy. Radioimmunlymphoscintigraphy with indium-111 (111In)-LiLo-16.88 administered by an intramammary route was used in the presurgical staging of primary breast cancer. The negative predictive value of lymph node metastases for tumors less than 3 cm was 90.5%. Planar and single photon emission computed tomography imaging of colorectal carcinoma with technetium-99m (99mTc) 88BV59 was compared with computed tomography (CT) scan in 36 surgical patients. The antibody scan was more sensitive than the CT scan in detecting

  10. Gastric cancer: Current status of lymph node dissection.

    Science.gov (United States)

    Degiuli, Maurizio; De Manzoni, Giovanni; Di Leo, Alberto; D'Ugo, Domenico; Galasso, Erica; Marrelli, Daniele; Petrioli, Roberto; Polom, Karol; Roviello, Franco; Santullo, Francesco; Morino, Mario

    2016-03-14

    D2 procedure has been accepted in Far East as the standard treatment for both early (EGC) and advanced gastric cancer (AGC) for many decades. Recently EGC has been successfully treated with endoscopy by endoscopic mucosal resection or endoscopic submucosal dissection, when restricted or extended Gotoda's criteria can be applied and D1+ surgery is offered only to patients not fitted for less invasive treatment. Furthermore, two randomised controlled trials (RCTs) have been demonstrating the non inferiority of minimally invasive technique as compared to standard open surgery for the treatment of early cases and recently the feasibility of adequate D1+ dissection has been demonstrated also for the robot assisted technique. In case of AGC the debate on the extent of nodal dissection has been open for many decades. While D2 gastrectomy was performed as the standard procedure in eastern countries, mostly based on observational and retrospective studies, in the west the Medical Research Council (MRC), Dutch and Italian RCTs have been conducted to show a survival benefit of D2 over D1 with evidence based medicine. Unfortunately both the MRC and the Dutch trials failed to show a survival benefit after the D2 procedure, mostly due to the significant increase of postoperative morbidity and mortality, which was referred to splenopancreatectomy. Only 15 years after the conclusion of its accrual, the Dutch trial could report a significant decrease of recurrence after D2 procedure. Recently the long term survival analysis of the Italian RCT could demonstrate a benefit for patients with positive nodes treated with D2 gastrectomy without splenopancreatectomy. As nowadays also in western countries D2 procedure can be done safely with pancreas preserving technique and without preventive splenectomy, it has been suggested in several national guidelines as the recommended procedure for patients with AGC. PMID:26973384

  11. Current status and implications of microRNAs in ovarian cancer diagnosis and therapy

    Directory of Open Access Journals (Sweden)

    Zaman Mohd Saif

    2012-12-01

    Full Text Available Abstract Ovarian cancer is the fifth most common cancer among women and causes more deaths than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is based on the combination of surgery and chemotherapy. While recurrent ovarian cancer responds to additional chemotherapy treatments, the progression-free interval becomes shorter after each cycle, as chemo-resistance increases until the disease becomes incurable. There is, therefore, a strong need for prognostic and predictive markers to help optimize and personalize treatment in order to improve the outcome of ovarian cancer. An increasing number of studies indicate an essential role for microRNAs in ovarian cancer progression and chemo-resistance. MicroRNAs (miRNAs are small endogenous non-coding RNAs (~22bp which are frequently dysregulated in cancer. Typically, miRNAs are involved in crucial biological processes, including development, differentiation, apoptosis and proliferation. Two families of miRNAs, miR-200 and let-7, are frequently dysregulated in ovarian cancer and have been associated with poor prognosis. Both have been implicated in the regulation of epithelial-to-mesenchymal transition, a cellular transition associated with tumor aggressiveness, tumor invasion and chemo-resistance. Moreover, miRNAs also have possible implications for improving cancer diagnosis; for example miR-200 family, let-7 family, miR-21 and miR-214 may be useful in diagnostic tests to help detect ovarian cancer at an early stage. Additionally, the use of multiple target O-modified antagomirs (MTG-AMO to inhibit oncogenic miRNAs and miRNA replacement therapy for tumor suppressor miRNAs are essential tools for miRNA based cancer therapeutics. In this review we describe the current status of the role miRNAs play in ovarian cancer and focus on the possibilities of microRNA-based therapies and the use of microRNAs as diagnostic tools.

  12. Current status of methodology research on nuclear medicine on sentinel lymph node biopsy in breast cancer

    International Nuclear Information System (INIS)

    Breast cancer is the most common malignancy of the female,and axillary lymph node dissection has been considered as the basic method in breast cancer surgery. Sentinel lymph node biopsy (SLNB) in recent years is accepted gradually both at home and abroad because it not only can avoid complications but also has the advantages of safe and simple operation, high accuracy, and slight trauma. It has taken the place of axillary lymph node dissection in the treatment of axillary node-negative patients. Nuclear medicine inspection has played a crucial role in SLNB, and radiotracers, injecting techniques,detecting methods and standards have great influence upon the accuracy and false-negative rate of axillary lymph nodes and internal mammary lymph nodes detection. In this review, the current methodology status of nuclear medicine is summarized on SLNB in breast cancer at home and abroad. (authors)

  13. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fears

    Institute of Scientific and Technical Information of China (English)

    ME de Noo; RAEM Tollenaar; AM Deelder; LH Bouwman

    2006-01-01

    Colorectal adenocarcinoma (CRC) is the third most common type of cancer and the fourth most frequent cause of death due to cancer worldwide. Given the natural history of CRC, early diagnosis appears to be the most appropriate tool to reduce disease-related mortality. A field of recent interest is clinical proteomics, which was reported to lead to high sensitivity and specificities for early detection of several solid tumors. This emerging field uses mass spectrometry-based protein profiles/patterns of easy accessible body fluids to distinguish cancer from non-cancer patients. These discrepancies may be a result of: (1) proteins being abnormally produced or shed and added to the serum proteome, (2) proteins clipped or modified as a consequence of the disease process, or (3) proteins subtracted from the proteome owing to disease-related proteolytic degradation pathways. Therefore, protein pattern diagnostics would provide easy and reliable tools for detection of cancer. This paper focuses on the current status of clinical proteomics research in oncology and in colorectal cancer especially,and will reflect on pitfalls and fears in this relatively new area of clinical medicine, which are reproducibility issues and pre-analytical factors, statistical issues, and identification and nature of discriminating proteins/peptides.

  14. Targeted therapy for advanced gastric cancer: A review of current status and future prospects

    Institute of Scientific and Technical Information of China (English)

    Ozkan; Kanat; Bert; O’Neil; Safi; Shahda

    2015-01-01

    In the West in particular, the vast majority of gastric cancer(GC) patients present with advanced-stage disease. Although combination chemotherapy is stillthe most important component of treatment for these patients, it confers a modest survival advantage. Recently, increased knowledge of the key molecular signaling pathways involved in gastric carcinogenesis has led to the discovery of specific molecular-targeted therapeutic agents. Some of these agents such as trastuzumab and ramucirumab have changed the treatment paradigm for this disease. In this paper, we will summarize the current clinical status of targeted drug therapy in the management of GC.

  15. Current status and evolution of preclinical drug development models of epithelial ovarian cancer

    Directory of Open Access Journals (Sweden)

    Panagiotis A Konstantinopoulos

    2013-12-01

    Full Text Available Epithelial ovarian cancer (EOC is the most lethal gynecologic malignancy and the fifth most common cause of female cancer death in the United States. Although important advances in surgical and chemotherapeutic strategies over the last three decades have significantly improved the median survival of EOC patients, the plateau of the survival curve has not changed appreciably. Given that EOC is a genetically and biologically heterogeneous disease, identification of specific molecular abnormalities that can be targeted in each individual ovarian cancer on the basis of predictive biomarkers promises to be an effective strategy to improve outcome in this disease. However, for this promise to materialize, appropriate preclinical experimental platforms that recapitulate the complexity of these neoplasms and reliably predict antitumor activity in the clinic are critically important. In this review, we will present the current status and evolution of preclinical models of EOC, including cell lines, immortalized normal cells, xenograft models, patient-derived xenografts and animal models, and will discuss their potential for oncology drug development.

  16. Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges

    Institute of Scientific and Technical Information of China (English)

    Anil; Suri; Nirmala; Jagadish; Shikha; Saini; Namita; Gupta

    2015-01-01

    Colorectal cancer ranks third among the estimatedcancer cases and cancer related mortalities in United States in 2014. Early detection and efficient therapy remains a significant clinical challenge for this disease. Therefore, there is a need to identify novel tumor asso-ciated molecules to target for biomarker development and immunotherapy. In this regard, cancer testis antigens have emerged as a potential targets for developing novel clinical biomarkers and immunotherapy for various malignancies. These germ cell specific proteins exhibit aberrant expression in cancer cells and contribute in tumorigenesis. Owing to their unique expression profile and immunogenicity in cancer patients, cancer testis antigens are clinically referred as the most promising tumor associated antigens. Several cancer testis antigens have been studied in colorectal cancer but none of them could be used in clinical practice. This review is an attempt to address the promising cancer testis antigens in colorectal cancer and their possible clinical implications as biomarkers and immunotherapeutic targets with particular focus on challenges and future interventions.

  17. Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain

    Directory of Open Access Journals (Sweden)

    Prommer E

    2012-06-01

    Full Text Available Eric Prommer, Brandy FicekDivision of Hematology/Oncology, Mayo Clinic College of Medicine, Mayo Clinic Hospital, Scottsdale, AZ, USAAbstract: Breakthrough pain is a newly recognized pain category that was first described by Portenoy and Hagen in 1990. The term describes pain that increases in intensity to “break through” chronic pain that is being controlled by a scheduled opioid regimen. The development of fluctuations in pain intensity is challenging due to their unpredictable nature, rapid onset, and need for rapid treatment intervention. Breakthrough pain has been treated by using an extra opioid dose in addition to the scheduled opioid being used for pain. Recommendations for dose and frequency are based on expert opinion only, and have included dosing based on a percentage of the total opioid dose. Other recommendations include increasing the regularly scheduled opioid dose. Clinical trials have now focused on delivery of opioids that have both potency and a rapid onset of action. Lipophilic opioids have received a substantial amount of study due to their quick absorption and rapid onset of analgesia. Lipophilic opioids that have been studied to date include transmucosal fentanyl, sublingual fentanyl, intranasal sufentanil, and oral and sublingual methadone. Initial clinical trials have established the superiority of transmucosal fentanyl as a breakthrough analgesic when compared with immediate-release oral opioid formulations. Problems with bioavailability have led to a search for newer formulations of transmucosal delivery. Newer formulations, such as fentanyl transmucosal tablets, have been developed to ensure superior delivery for the patient suffering from breakthrough pain. The purpose of this paper is to discuss the current status of transmucosal tablet formulations for cancer breakthrough pain.Keywords: fentanyl, transmucosal, tablets, pain, breakthrough, cancer

  18. Current status of radiation therapy. Evidence-based medicine (EBM) of radiation therapy. Current management of patients with esophageal cancer

    International Nuclear Information System (INIS)

    The best management for small mucosal esophageal cancer is generally endoscopic mucosal resection. However, for submucosal cancer and extensive mucosal caner, either radical surgery or radiation seems to be an equally efficacious option. Radiation therapy concurrent with chemotherapy is more effective than radiation therapy alone for patients with unresectable esophageal cancer. The key drugs are cisplatin and 5-fluorouracil. However, for patients with poor performance status or for aged patients, radiation therapy alone is still a choice of treatment. Surgery has generally been indicated for patients with resectable esophageal cancer. However, outcomes of concurrent chemoradiation therapy may be comparable with those of surgery. Therefore, a prospective randomized study should be performed to determine the best management for patients with resectable esophageal cancer. The usefulness of intra-cavitary irradiation for esophageal cancer has not been clarified. A prospective randomized trial with a large number of patients is necessary to determine the effectiveness of intra-cavitary irradiation. The best management for patients with loco-regionally recurrent esophageal cancer after surgery has not been determined. Intensive therapy should be considered if the site of recurrence is limited and the time interval from surgery to recurrence is long. Chemotherapy is essential in the management of patients with small cell esophageal cancer. However, the best local therapy has not been determined. (author)

  19. [Current status and prospect of perioperative thrombus management in gastrointestinal cancer].

    Science.gov (United States)

    Qin, X Y

    2016-03-01

    Thanks to the progress of surgical theory and skills, as well as the application of modern medical devices in general surgery, both the occurrence of perioperative complications and mortality of gastrointestinal surgery have significantly reduced recently. However, it is still far from optimal in terms of the perioperative venous thromboembolism (VTE) management in gastrointestinal cancer, and what is responsible for that? This paper aims at finding out the reasons contributing to the current status, giving suggestions for how to make improvement at both disease level and hospital management level. At the same time, while paying attention for the prophylaxis of VTE, there have been more and more patients receiving antithrombotic treatment require elective or emergent surgery in clinical practice, due to aging and increased incidence of cardiovascular disease year by year. How to balance the bleeding and thrombosis risk for these patients during perioperative periods is also a question we are going to discuss. In conclusion, as to the issue of the management of perioperative thrombosis, there will be a long way for Chinese doctors to go. Our peers should pay more attention to this problem and take more efforts, so that the thrombotic complications in surgical patients can be reduced. PMID:26932880

  20. Current Status of Poly(ADP-ribose Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer

    Directory of Open Access Journals (Sweden)

    David J. Hiller

    2012-01-01

    Full Text Available Triple-negative breast cancer (TNBC is an aggressive type of breast cancer that is clinically defined as lacking estrogen and progesterone receptors, as well as being ERBB2 (HER-2 negative. Without specific therapeutic targets, TNBC carries a worse prognosis than other types of breast cancer in the absence of therapy. Research has now further differentiated breast cancer into subtypes based on genetic expression patterns. One of these subtypes, basal-like, frequently overlaps with the clinical picture of TNBC. Additionally, both TNBC and basal-like breast cancer link to BRCA mutations. Recent pharmaceutical advances have created a class of drugs, poly(ADP-ribose polymerase (PARP inhibitors, which are showing potential to effectively treat these patients. The aim of this paper is to summarize the basis behind PARP inhibitors and update the current status of their development in clinical trials for the treatment of TNBC.

  1. Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer

    Institute of Scientific and Technical Information of China (English)

    Norihisa; Uemura; Tadashi; Kondo

    2014-01-01

    Neoadjuvant therapy has been proven to be extremely valuable and is widely used for advanced esophageal cancer. However, a significant proportion of treated patients(60%-70%) does not respond well to neoadjuvant treatments and develop severe adverse effects. Therefore, predictive markers for individualization of multimodality treatments are urgently needed in esophageal cancer. Recently, molecular biomarkers that predict the response to neoadjuvant therapy have been explored in multimodal approaches in esophageal cancer and successful examples of biomarker identification have been reported. In this review, promising candidates for predictive molecular biomarkers developed by using multiple molecular approaches are reviewed. Moreover, treatment strategies based on the status of predicted biomarkers are discussed, while considering the international differences in the clinical background. However, in the absence of adequate treatment options related to the results of the biomarker test, the usefulness of these diagnostic tools is limited and new effective therapies for biomarker-identified nonresponders to cancer treatment should be concurrent with the progress of predictive technologies. Further improvement in the prognosis of esophageal cancer patients can be achieved through the introduction of novel therapeutic approaches in clinical practice.

  2. Current Status and Development of Traditional Chemotherapy in Non-small Cell Lung Cancer under the Background of Targeted Therapy

    OpenAIRE

    Zhang, Guowei; Wang, Huijuan; Mina ZHANG; Li, Peng; Ma, ZhiYong

    2015-01-01

    In recent years, along with rapid development of targeted therapy in non-small cell lung cancer, traditional chemotherapy get less and less attention. Yet it still can not be ignored in the current that how to locate and use traditional chemotherapy so patients could derive maximum benefit. For this purpose, through the literature review and analysis, we point out there are still many traditional chemotherapy irreplaceable places whatever patients’ driver gene status. And there are some new t...

  3. The status of current epidemiological knowledge of radiocarcinogenecity: other, miscellaneous cancers

    International Nuclear Information System (INIS)

    Currently available epidemiological data indicate low or intermediate levels of sensitivity for radiation-induced cancers of most tissues and organ systems other than lung, thyroid and female breast, and leukaemia. However, the estimated risks for these ''other, miscellaneous'' cancers may reflect deficiencies in the data as a result of small study populations, insufficient population dose to detect an effect, uncertainties in dosimetry or the confounding or modifying effects of unknown or unevaluated risk factors. Additional information is necessary to improve existing risk estimates for the malignancies in the other, miscellaneous category. This may be obtained by continued follow-up of the populations currently under study, application of new and developing molecular technologies to identify and quantify radiation exposures for individuals, and pooled or parallel analyses of multiple populations. Cancers of the following tissues are briefly discussed:- digestive system, genito-urinary system, brain or central nervous system, lymphoma, multiple myeloma, bone and skin. (Author)

  4. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer.

    Science.gov (United States)

    Shiota, Masaki; Eto, Masatoshi

    2016-05-01

    Since 1941, androgen deprivation therapy has been the primary treatment for metastatic hormone-sensitive prostate cancer. Androgen deprivation therapy consists of several regimens that vary according to therapeutic modality, as well as treatment schedule. Androgen deprivation therapy initially shows excellent antitumor effects, such as relief of cancer-related symptoms, tumor marker decline and tumor shrinking. However, most metastatic hormone-sensitive prostate cancer cases eventually develop castration resistance and become lethal. Taxanes, such as docetaxel and cabazitaxel, as well as novel androgen receptor-targeting agents, such as abiraterone acetate and enzalutamide, have emerged for metastatic castration-resistant prostate cancer. The concept and principle of primary therapy for metastatic hormone-sensitive prostate cancer has remained unchanged for decades. Recently, upfront docetaxel chemotherapy has been shown to prolong overall survival in men with metastatic hormone-sensitive prostate cancer, and would lead to a paradigm shift in primary pharmacotherapy for metastatic hormone-sensitive prostate cancer. This raises the possibility of upfront use of taxanes, as well as novel androgen receptor-targeting agents combined with androgen deprivation therapy. The present review summarizes the current status of primary pharmacotherapy for metastatic hormone-sensitive prostate cancer, and discusses future perspectives in this field. PMID:27062039

  5. Concurrent chemo-radiotherapy in the treatment of early breast cancer: Current status

    Directory of Open Access Journals (Sweden)

    Nabil Ismaili

    2013-01-01

    Full Text Available Concurrent chemo-radiotherapy (CCRT in early breast cancer was investigated by few authors and remains controversial. This treatment is more commonly used for locally advanced breast cancer and showed high rate of complete pathological response. A search of articles published in English literature, between 1980 and November 2012, was conducted on Medline using the following terms: "breast cancer", "chemotherapy", "concurrent radiotherapy", and "Trastuzumab". We identified five phase I/II trials and three randomized phase three trials evaluating concurrent chemoradiotherapy in the adjuvant of breast cancer. In patients with early breast cancer having positive lymph nodes, phases III clinical trials showed that CCRT improved local control after conservative breast surgery. However, these randomized trials used non-standard regimen: Cyclophosphamide, methotrexate and fluorouracil (CMF or fluorouracil, mitoxantrone and cyclophosphamide (FNC. In addition, in phases II clinical trials, concurrent use of taxanes and anthracycline with standard whole-breast irradiation showed high rate of toxicity: Pulmonary toxicity with taxane; and cardiac and skin toxicity with anthracycline. Consequentely, CCRT is not be used in practice because of concerns of toxicity with the standard drugs (anthracyclines and taxanes and radiation. Anthracyclines with partial breast irradiation (PBI was feasible according to one phase I clinical trial, and should be investigated in randomized clinical trials. Concurrent Trastuzumab plus radiotherapy is safe and can be used in HER2-positive breast cancer; in this case, cardiac volume sparing and patient selections for internal mammary chain irradiation are highly recommended. The present paper aimed to review the current data evaluating the efficacy and safety of CCRT in early breast cancer.

  6. Current status of ultrasound-guided surgery in the treatment of breast cancer.

    Science.gov (United States)

    Volders, José H; Haloua, Max H; Krekel, Nicole Ma; Meijer, Sybren; van den Tol, Petrousjka M

    2016-02-10

    The primary goal of breast-conserving surgery (BCS) is to obtain tumour-free resection margins. Margins positive or focally positive for tumour cells are associated with a high risk of local recurrence, and in the case of tumour-positive margins, re-excision or even mastectomy are sometimes needed to achieve definite clear margins. Unfortunately, tumour-involved margins and re-excisions after lumpectomy are still reported in up to 40% of patients and additionally, unnecessary large excision volumes are described. A secondary goal of BCS is the cosmetic outcome and one of the main determinants of worse cosmetic outcome is a large excision volume. Up to 30% of unsatisfied cosmetic outcome is reported. Therefore, the search for better surgical techniques to improve margin status, excision volume and consequently, cosmetic outcome has continued. Nowadays, the most commonly used localization methods for BCS of non-palpable breast cancers are wire-guided localization (WGL) and radio-guided localization (RGL). WGL and RGL are invasive procedures that need to be performed pre-operatively with technical and scheduling difficulties. For palpable breast cancer, tumour excision is usually guided by tactile skills of the surgeon performing "blind" surgery. One of the surgical techniques pursuing the aims of radicality and small excision volumes includes intra-operative ultrasound (IOUS). The best evidence available demonstrates benefits of IOUS with a significantly high proportion of negative margins compared with other localization techniques in palpable and non-palpable breast cancer. Additionally, IOUS is non-invasive, easy to learn and can centralize the tumour in the excised specimen with low amount of healthy breast tissue being excised. This could lead to better cosmetic results of BCS. Despite the advantages of IOUS, only a small amount of surgeons are performing this technique. This review aims to highlight the position of ultrasound-guided surgery for malignant breast

  7. Current status of immunotherapy for non-small-cell lung cancer.

    Science.gov (United States)

    Imbimbo, Martina; Lo Russo, Giuseppe; Blackhall, Fiona

    2016-08-01

    In the last few years, the introduction of novel immunotherapeutic agents has represented a treatment shift for a subset of patients with non-small-cell lung cancer (NSCLC). Checkpoint inhibitors have been demonstrated to improve survival in advanced stage disease with very good tolerability. This success follows many years of scientific effort to manipulate the human immune system to attack cancer cells. With a variety of approaches ranging from vaccines to administration of interleukin or interferon-γ, the results in NSCLC were unsuccessful, with the view that it is a scarcely immunogenic cancer, unlike melanoma or renal cell carcinoma. The step change has come from understanding of immune checkpoints-cell surface molecules that regulate immune system activation and mediate coinhibitory signaling pathways that physiologically protect the body from autoimmunity. These pathways play an important role in tumors, including NSCLC, and are a mechanism of escape from immune surveillance. Several monoclonal antibodies have been developed in order to inhibit these molecules and unleash the brakes of the immune system. Currently in NSCLC, 7 different checkpoint inhibitors are under investigation: 2 anti-cytotoxic T-lymphocyte-associated antigen 4, 2 anti-programmed death (PD)-1, and 3 anti-PD-ligand 1 antibodies. Here we review the progress to date in developing immunotherapy for NSCLC, summarize results from published trials, highlight ongoing trials, and discuss progress in the question of how best to select patients for this treatment. PMID:27443896

  8. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer

    Energy Technology Data Exchange (ETDEWEB)

    Raja, J. [Department of Radiology, St George' s Hospital, Tooting, London (United Kingdom)]. E-mail: jowadraja@gmail.com; Ramachandran, N. [Department of Radiology, St George' s Hospital, Tooting, London (United Kingdom); Munneke, G. [Department of Radiology, St George' s Hospital, Tooting, London (United Kingdom); Patel, U. [Department of Radiology, St George' s Hospital, Tooting, London (United Kingdom)

    2006-02-15

    In contemporary practice, most prostate cancers are either invisible on ultrasound or indistinguishable from concurrent benign prostatic hyperplasia. Diagnosis therefore rests on prostate biopsy. Biopsies are not simply directed at ultrasonically visible lesions, as these would miss many cancers; rather the whole gland is sampled. The sampling itself is systematic, using patterns based on prostate zonal anatomy and the geographical distribution and frequency of cancer. This review explains the evolution of the prostate biopsy technique, from the classical sextant biopsy method to the more recent extended biopsy protocols (8, 10, 12, >12 and saturation biopsy protocols). Extended protocols are increasingly being used to improve diagnostic accuracy, especially in those patients who require repeat biopsy. This trend has been facilitated by the ongoing improvement in safety and acceptability of the procedure, particularly with the use of antibiotic prophylaxis and local anaesthesia. The technical details of these extended protocols are discussed, as are the current data regarding procedure-related morbidity and how this may be minimized.

  9. Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects.

    Science.gov (United States)

    Liu, Chaoqun; Ho, Paul Chi-Lui; Wong, Fang Cheng; Sethi, Gautam; Wang, Ling Zhi; Goh, Boon Cher

    2015-06-28

    Garcinol is the main medicinal component of the dried fruit rind of Garcinia indica (G. indica), which has traditionally been extensively used to treat gastric ailments and skin irritation. In vitro studies of garcinol revealed its potential therapeutic effects, such as its anti-oxidative, anti-inflammatory and anti-cancer properties. Similarly, in vivo studies in animal models also demonstrated the efficacy of garcinol for the treatment of various inflammatory and cancerous conditions. Despite being well tolerated in preclinical studies, the toxicological profile of garcinol remains elusive. More importantly, systematic pharmacokinetics (PK) studies of garcinol to establish an appropriate route of administration and its effective concentration range under physiological conditions have not yet been performed. PK studies play an essential role in translating the preclinical findings of garcinol from cell line models and animal species to humans, thereby facilitating dose selection, the characterization of the therapeutic index, identification of a metabolic pathway, and the determination of garcinol's potency and tolerability. This paper reviews the current studies of garcinol as a potential anti-oxidant, anti-inflammatory and anti-cancer agent and highlights the importance of performing preclinical PK and toxicological studies on garcinol for its development pipeline. PMID:25796441

  10. Application of Quantum Dots-Based Biotechnology in Cancer Diagnosis: Current Status and Future Perspectives

    OpenAIRE

    Chun-Wei Peng; Yan Li

    2010-01-01

    The semiconductor nanocrystal quantum dots (QDs) have excellent photo-physical properties, and the QDs-based probes have achieved encouraging developments in cellular and in vivo molecular imaging. More and more researches showed that QDs-based technology may become a promising approach in cancer research. In this review, we focus on recent application of QDs in cancer diagnosis and treatment, including early detection of primary tumor such as ovarian cancer, breast cancer, prostate cancer an...

  11. Current Status of Targeted Therapy for Anaplastic Lymphoma Kinase in Non-small Cell Lung Cancer

    Directory of Open Access Journals (Sweden)

    Li MA

    2014-12-01

    Full Text Available The rate of the anaplastic lymphoma kinase (ALK gene rearrangements in non-small cell lung cancer (NSCLC tissues is 3%-5%. The first-in-class ALK tyrosine kinase inhibitor, crizotinib, can effectively target these tumors represent a significant advance in the evolution of personalized medicine for NSCLC. A randomized phase III clinical trial in which superiority of crizotinib over chemotherapy was seen in previously treated ALK-positive NSCLC patients demonstrated durable responses and well tolerance in the majority of ALK-positive NSCLC patients treated with crizotinib. However, despite the initial responses, most patients develop acquired resistance to crizotinib. Several novel therapeutic approaches targeting ALK-positive NSCLC are currently under evaluation in clinical trials, including second-generation ALK inhibitors, such as LDK378, CH5424802 (RO5424802, and AP26113, and new agents shock protein 90 inhibitors. This review aims to present the current knowledge on this fusion gene, the treatment advances, and novel drug clinical trials in ALK rearranged NSCLC.

  12. Teleradiology - current status

    International Nuclear Information System (INIS)

    Tele-radiology is a term becoming increasingly popular in the medical literature. Nevertheless, terminological definitions in this particular field are still rather vague. The scope of applications extend from simple image presenting via analogue telephone lines to transmission of 3-D medical images through a satellite. It is a matter of standards highly differing in terms of data transmission rates, safety, technical demands on the systems and the like. In this article new information technologies, technical aspects, as well as some major applications of tele-radiology are discussed. The current status of tele-medicine/tele-radiology in this country is likewise briefly outlined

  13. Current status on microRNAs as biomarkers for ovarian cancer.

    Science.gov (United States)

    Prahm, Kira Philipsen; Novotny, Guy Wayne; Høgdall, Claus; Høgdall, Estrid

    2016-05-01

    Ovarian cancer (OC) is the most lethal gynecological malignancy in the Western world, and has a very poor prognosis, often due to late diagnosis and emergence of chemotherapy resistance. Therefore, there is an essential need for new diagnostic and prognostic markers that can improve and initiate more personalized treatment, eventually improving survival of the patients. MicroRNAs are small, non-coding RNA molecules, that post-transcriptionally regulate gene expression. Several studies have within the last decade shown that microRNAs are deregulated in OC and have potential as diagnostic and prognostic biomarkers for OC. Recently studies have also focused on microRNAs as predictors of chemotherapy responses and their potential as therapeutic targets. However, many of the published studies are difficult to interpret as a whole due to various methods of analysis. Future focus should be aimed at developing a general standardized analytical method, which can limit differences between studies thus allowing easier comparison across them. In addition, validation of studies in independent series that ideally should be histotype-specific is essential to determine the clinical role of microRNAs in different types of OC. In this review we summarize the current knowledge of microRNAs as potential biomarkers for OC, with focus on their clinical relevance. PMID:26809719

  14. Application of Quantum Dots-Based Biotechnology in Cancer Diagnosis: Current Status and Future Perspectives

    Directory of Open Access Journals (Sweden)

    Chun-Wei Peng

    2010-01-01

    Full Text Available The semiconductor nanocrystal quantum dots (QDs have excellent photo-physical properties, and the QDs-based probes have achieved encouraging developments in cellular and in vivo molecular imaging. More and more researches showed that QDs-based technology may become a promising approach in cancer research. In this review, we focus on recent application of QDs in cancer diagnosis and treatment, including early detection of primary tumor such as ovarian cancer, breast cancer, prostate cancer and pancreatic cancer, as well as regional lymph nodes and distant metastases. With the development of QDs synthesis and modification, the effect of QDs on tumor metastasis investigation will become more and more important in the future.

  15. Stem cell technology in breast cancer: current status and potential applications

    Directory of Open Access Journals (Sweden)

    Chiotaki R

    2016-04-01

    Full Text Available Rena Chiotaki, Hara Polioudaki, Panayiotis A Theodoropoulos Department of Biochemistry, School of Medicine, University of Crete, Heraklion, Greece Abstract: Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the tumor, identified as breast cancer stem cells (BCSCs. BCSCs underlie the mechanisms of tumor initiation and sustenance and are implicated in the dissemination of the primary tumor to metastatic sites, as they have been found circulating in the blood of breast cancer patients. The discovery of BCSCs has generated a great amount of interest among the scientific community toward their isolation, molecular characterization, and therapeutic targeting. In this review, after summarizing the literature on molecular characterization of BCSCs and methodologies used for their isolation, we will focus on recent data supporting their molecular and functional heterogeneity. Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings challenging their safety. Keywords: breast cancer stem cells, cancer stem cell heterogeneity, targeting cancer stem cells, circulating tumor cells, stem cell technology

  16. Current status of gene therapy for breast cancer: progress and challenges

    Directory of Open Access Journals (Sweden)

    McCrudden CM

    2014-11-01

    Full Text Available Cian M McCrudden, Helen O McCarthySchool of Pharmacy, Queen’s University Belfast, Belfast, UKAbstract: Breast cancer is characterized by a series of genetic mutations and is therefore ideally placed for gene therapy intervention. The aim of gene therapy is to deliver a nucleic acid-based drug to either correct or destroy the cells harboring the genetic aberration. More recently, cancer gene therapy has evolved to also encompass delivery of RNA interference technologies, as well as cancer DNA vaccines. However, the bottleneck in creating such nucleic acid pharmaceuticals lies in the delivery. Deliverability of DNA is limited as it is prone to circulating nucleases; therefore, numerous strategies have been employed to aid with biological transport. This review will discuss some of the viral and nonviral approaches to breast cancer gene therapy, and present the findings of clinical trials of these therapies in breast cancer patients. Also detailed are some of the most recent developments in nonviral approaches to targeting in breast cancer gene therapy, including transcriptional control, and the development of recombinant, multifunctional bio-inspired systems. Lastly, DNA vaccines for breast cancer are documented, with comment on requirements for successful pharmaceutical product development.Keywords: breast cancer, gene therapy, nonviral, clinical trial

  17. Stem cell technology in breast cancer: current status and potential applications.

    Science.gov (United States)

    Chiotaki, Rena; Polioudaki, Hara; Theodoropoulos, Panayiotis A

    2016-01-01

    Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the tumor, identified as breast cancer stem cells (BCSCs). BCSCs underlie the mechanisms of tumor initiation and sustenance and are implicated in the dissemination of the primary tumor to metastatic sites, as they have been found circulating in the blood of breast cancer patients. The discovery of BCSCs has generated a great amount of interest among the scientific community toward their isolation, molecular characterization, and therapeutic targeting. In this review, after summarizing the literature on molecular characterization of BCSCs and methodologies used for their isolation, we will focus on recent data supporting their molecular and functional heterogeneity. Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings challenging their safety. PMID:27217783

  18. Quantum Dots for Cancer Research: Current Status, Remaining Issues, and Future Perspectives

    International Nuclear Information System (INIS)

    Cancer is a major threat to public health in the 21st century because it is one of the leading causes of death worldwide. The mechanisms of carcinogenesis, cancer invasion, and metastasis remain unclear. Thus, the development of a novel approach for cancer detection is urgent, and real-time monitoring is crucial in revealing its underlying biological mechanisms. With the optical and chemical advantages of quantum dots (QDs), QD-based nanotechnology is helpful in constructing a biomedical imaging platform for cancer behavior study. This review mainly focuses on the application of QD-based nanotechnology in cancer cell imaging and tumor microenvironment studies both in vivo and in vitro, as well as the remaining issues and future perspectives

  19. The current status and issues of the screening for colorectal cancer with CT colonography

    International Nuclear Information System (INIS)

    In recent years, CTC (CT colonography) has been clinically applied in the screaning of colorectal cancers, and is regarded highly for its diagnostic accuracy. This has become possible because of widespread use of multi-slice CT and increased use of analysis software. In addition, CTC, which yields objective and reproducible results, is a high-potential screening method, in that it is a low-invasive test associated with only mild distress, and can be easily normalized. In this center, screening for colorectal cancers with CTC is being conducted, with its accuracy being proved by statisical data: sensitivity (91.4%), specificity (92.4%), positive predictive value (PPV) (69.6%), negative predictive value (NPV) (98.3%), proper diagnosis rate (92.3%), and rate of detecting cancer (0.21%). CTC is considered to have the potential to become a 'new test for colorectal cancers', and can play an important role in screening for such cancers. (author)

  20. Current status and future perspectives of multimodality treatment for esophageal cancer in Japan

    International Nuclear Information System (INIS)

    History, current state and future perspectives of the treatment of the cancer in the title (EC) are explained. Japan Clinical Oncology Group (JCOG) EC group (JEOG) has conducted various multicenter randomized controlled trials of adjuvant therapy for surgery of EC, involving chemo- (CT) and radio-therapy (RT) since 1978. The meta-analysis of 24 foreign trials has recently revealed the significantly high efficacy for survival rate of preoperative CRT with the hazard ratio (HR) 0.78 vs CT with HR 0.87. In Japan, esophageal squamous cell carcinoma is predominant (90%) whereas in US, adenocarcinoma amounts to 70-80% and surgical procedure is slightly different. This suggests the necessity of confirmation of the results above and JCOG is comparing the foreign standard of preoperative CRT with preoperative CT. JCOG already established the definitive CRT using the concurrent treatment with 60 Gy and CT by their phase II study (JCOG9516). For stage II/III EC, the phase II study (JCOG9906) for the definitive CRT gave results of complete response (CR) 68% (50/74 cases) with 3-y survival 45%, which are essentially agreeable with 2 European trials'. Other JEOG phase II study with the similar CRT to above showed the complete response 88% (63/72 cases) and 5-y survival 75% in EC of the stage I (T1bN0), comparable to surgical outcome, and thus comparison with surgery (209 cases vs CRT 159) was made, of which results are in analysis. Now a large scale comparative phase III trial of preoperative CT and CRT with 41.4 Gy is in progress. (T.T.)

  1. Development and Current Status of National Cancer Center for Chinese Medicine

    Institute of Scientific and Technical Information of China (English)

    LI Jie; LIN Hong-sheng; HOU Wei; ZHANG Pei-tong; HUA Bao-jin

    2011-01-01

    @@ Chinese medicine (CM) is an important feature of cancer treatment in China.Especially in the last 10years, the effect of CM in cancer treatment has been of high concern and has been accepted by experts and patients locally and overseas.The oncology department (OD) of Guang'anmen Hospital (GAMH) of China Academy of Chinese Medical Sciences (CATCM),which will mark its 50th anniversary in 2013, is one of China's most-respected centers devoted exclusively to cancer patient care, research, education, and prevention through CM.It is located at the campus of GAMH,central Beijing.

  2. Current Status and Development of Traditional Chemotherapy in Non-small Cell Lung Cancer under the Background of Targeted Therapy

    Directory of Open Access Journals (Sweden)

    Guowei ZHANG

    2015-09-01

    Full Text Available In recent years, along with rapid development of targeted therapy in non-small cell lung cancer, traditional chemotherapy get less and less attention. Yet it still can not be ignored in the current that how to locate and use traditional chemotherapy so patients could derive maximum benefit. For this purpose, through the literature review and analysis, we point out there are still many traditional chemotherapy irreplaceable places whatever patients’ driver gene status. And there are some new treatment modalities of traditional chemotherapy which have been developed to further improve patients’ survival. At the same time, through exposition of predictive bio-markers development in chemotherapy, we pointed out that the future of traditional chemotherapy must be part of “targeted therapy”.

  3. Intensity-modulated radiotherapy for lung cancer: current status and future developments

    OpenAIRE

    Chan, C; Lang, S.; Rowbottom, C; Guckenberger, M.; Faivre-Finn, C

    2014-01-01

    Radiotherapy plays an important role in the management of lung cancer, with over 50% of patients receiving this modality at some point during their treatment. Intensity-modulated radiotherapy (IMRT) is a technique that adds fluence modulation to beam shaping, which improves radiotherapy dose conformity around the tumor and spares surrounding normal structures. Treatment with IMRT is becoming more widely available for the treatment of lung cancer, despite the paucity of high level evidence sup...

  4. Current status of gene therapy for breast cancer: progress and challenges

    OpenAIRE

    McCrudden CM; McCarthy HO

    2014-01-01

    Cian M McCrudden, Helen O McCarthySchool of Pharmacy, Queen’s University Belfast, Belfast, UKAbstract: Breast cancer is characterized by a series of genetic mutations and is therefore ideally placed for gene therapy intervention. The aim of gene therapy is to deliver a nucleic acid-based drug to either correct or destroy the cells harboring the genetic aberration. More recently, cancer gene therapy has evolved to also encompass delivery of RNA interference technologies, as well as c...

  5. Breast cancer screening in the working population. Current status and future issues in Tokyo

    International Nuclear Information System (INIS)

    We conducted a comparative study of breast cancer mass screening by the Tokyo Health Service Association for the regional and working population. The mammographic screening rate has been over 90% for all examinees since 2004, and the rate of inspection and palpation has been almost 0% in the regional population, although the rate was still 24% of all screenings among the working population even in 2006. In the working population the average age at which breast cancer screening was done was younger than in the regional population. The proportion of the population under 40 was 38.4% in 2003 and 35.7% in 2006, and in this population the rates of mammography, ultrasonography, and inspection and palpation were almost the same. This suggests a degree of confusion about breast cancer screening among younger women. The breast cancer detection rate was significantly better in the regional than in the working population. However, there was no significant difference in the rate between the two populations in the 40- to 59- year age range. In conclusion, the breast cancer screening system for the regional population has been improved as a result of the official notices of the Ministry of Health, Labour and Welfare. On the other hand, the data for the working population have not been favorable because of age-related factors and the methods used for screening. It will be necessary to refine the screening system for the working population to improve not only screening efficacy but also the breast cancer mortality rate. (author)

  6. Tasquinimod in the treatment of castrate-resistant prostate cancercurrent status and future prospects

    Science.gov (United States)

    Mehta, Amit R.; Armstrong, Andrew J.

    2016-01-01

    Treatment options have significantly expanded in recent years for men with metastatic castration-resistant prostate cancer (mCRPC), with the routine use of immunotherapy (sipuleucel-T) and novel hormonal agents such as enzalutamide and abiraterone acetate prior to taxane-based chemotherapy or radium-223 radiotherapy. A number of immune checkpoints limit the immune response of the host to metastatic tumor progression in prostate cancer, one of which is an immunosuppressive and pro-angiogenic cell called the myeloid-derived suppressor cell (MDSC). Tasquinimod is a small molecular oral inhibitor of S100A9, a key cell surface regulator of MDSC function, and has shown anti-angiogenic, antitumor and immune-modulatory properties in preclinical models of prostate cancer and other solid tumors. A large randomized phase II trial of tasquinimod in men with chemotherapy-naïve mCRPC demonstrated a significant prolongation in radiographic and symptomatic progression-free survival compared with placebo, which was also associated with improvements in overall survival. Tasquinimod was studied in a global phase III randomized trial in men with bone mCRPC and, while it significantly improved radiographic progression-free survival, this did not result in an overall survival benefit. However, tasquinimod is under evaluation as well as a combination therapy with other systemic agents in prostate cancer and as a single agent in other solid tumors. This review encompasses the preclinical and clinical development of tasquinimod as a therapy for men with prostate cancer. PMID:26834836

  7. The current status and future prospects of breast cancer screening using ultrasonography at our facility

    International Nuclear Information System (INIS)

    We report the results obtained by breast cancer screening of the general population using both ultrasonography and mammography conducted by the Tochigi Public Health Service Association. An investigation of breast cancer screening carried out on approximately 140,000 participants between 2000 and 2007 showed that ultrasonography and mammography are remarkably complementary for detection of breast cancer, particularly for women in their 40s and 50s, and that each modality improves the sensitivity of breast cancer detection by approximately 20%. The following issues are pivotal for establishing a breast cancer ultrasonography screening system that is able to maintain high precision and adequate efficiency: technical training of sonographers and physicians who must interpret the sonographic images, quality control of equipment, and an interpretation system that allows previous sonographs to be used as a reference. In independent combined screening systems using ultrasonography and mammography, the high recall rate becomes an issue. Comparative interpretation of sonographic images with previous sonographs is effective for resolving this. However, hopes abound for a comprehensive assessment system that allows simultaneous imaging and interpretation of both ultrasonography and mammography. (author)

  8. Tasquinimod in the treatment of castrate-resistant prostate cancer - current status and future prospects.

    Science.gov (United States)

    Mehta, Amit R; Armstrong, Andrew J

    2016-02-01

    Treatment options have significantly expanded in recent years for men with metastatic castration-resistant prostate cancer (mCRPC), with the routine use of immunotherapy (sipuleucel-T) and novel hormonal agents such as enzalutamide and abiraterone acetate prior to taxane-based chemotherapy or radium-223 radiotherapy. A number of immune checkpoints limit the immune response of the host to metastatic tumor progression in prostate cancer, one of which is an immunosuppressive and pro-angiogenic cell called the myeloid-derived suppressor cell (MDSC). Tasquinimod is a small molecular oral inhibitor of S100A9, a key cell surface regulator of MDSC function, and has shown anti-angiogenic, antitumor and immune-modulatory properties in preclinical models of prostate cancer and other solid tumors. A large randomized phase II trial of tasquinimod in men with chemotherapy-naïve mCRPC demonstrated a significant prolongation in radiographic and symptomatic progression-free survival compared with placebo, which was also associated with improvements in overall survival. Tasquinimod was studied in a global phase III randomized trial in men with bone mCRPC and, while it significantly improved radiographic progression-free survival, this did not result in an overall survival benefit. However, tasquinimod is under evaluation as well as a combination therapy with other systemic agents in prostate cancer and as a single agent in other solid tumors. This review encompasses the preclinical and clinical development of tasquinimod as a therapy for men with prostate cancer. PMID:26834836

  9. Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance

    Directory of Open Access Journals (Sweden)

    Huiqin Guo

    2012-10-01

    Full Text Available The resistance of tumor cells to a broad range of anticancer agents continues to be a problem for the success of cancer chemotherapy. Multidrug resistance (MDR is due in part to three drug transporter proteins: ABCB1/P-glycoprotein (P-gp, ABCC1/multidrug resistance protein 1 (MRP1 and ABCG2/breast cancer resistance protein (BCRP. These transporters are part of the ATP-binding cassette (ABC superfamily, whose members function as ATP-dependent drug-efflux pumps. Their activity can be blocked by various drugs such as verapamil (calcium channel blocker and cyclosporin A (immunosuppressive agent, etc. These compounds are called MDR modulators or reversals. This review highlights several marine natural products with reversal effect on multidrug resistance in cancer, including agosterol A, ecteinascidin 743, sipholane triterpenoids, bryostatin 1, and welwitindolinones.

  10. Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance

    OpenAIRE

    Huiqin Guo; Zhe-Sheng Chen; Khalid El Sayed; Ioana Abraham

    2012-01-01

    The resistance of tumor cells to a broad range of anticancer agents continues to be a problem for the success of cancer chemotherapy. Multidrug resistance (MDR) is due in part to three drug transporter proteins: ABCB1/P-glycoprotein (P-gp), ABCC1/multidrug resistance protein 1 (MRP1) and ABCG2/breast cancer resistance protein (BCRP). These transporters are part of the ATP-binding cassette (ABC) superfamily, whose members function as ATP-dependent drug-efflux pumps. Their activity can be block...

  11. Adeno-Associated Virus-Mediated Cancer Gene Therapy: Current Status

    OpenAIRE

    Luo, Jingfeng; Luo, Yuxuan; Sun, Jihong; Zhou, Yurong; Zhang, Yajing; Yang, Xiaoming

    2014-01-01

    Gene therapy is one of the frontiers of modern medicine. Adeno-associated virus (AAV)-mediated gene therapy is becoming a promising approach to treat a variety of diseases and cancers. AAV-mediated cancer gene therapies have rapidly advanced due to their superiority to other gene-carrying vectors, such as the lack of pathogenicity, the ability to transfect both dividing and non-dividing cells, low host immune response, and long-term expression. This article reviews and provides up to date kno...

  12. Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients

    Directory of Open Access Journals (Sweden)

    Per Pfeiffer

    2008-12-01

    Full Text Available Per Pfeiffer, Camilla Qvortrup, Jon K BjerregaardDepartment of Oncology, Odense University Hospital. Institute of Clinical Research, University of Southern Denmark. Odense C, DenmarkPurpose: Elderly cancer patients often have co-morbidities and other characteristics that make the selection of optimal treatment more complex. The introduction of targeted therapies in colorectal cancer has further complicated this problem. This review will focus on the role of the EGFR antibody cetuximab in elderly patients.Methods: We have reviewed the available evidence in the literature to evaluate the results of therapy with cetuximab, alone or in combination with chemotherapy, with a focus on elderly patients with metastatic colorectal cancer (mCRC.Results: In patients with mCRC, combination chemotherapy prolongs median survival to more than 18 months and even around 24 months in combination with cetuximab in selected patients. No prospective studies have evaluated cetuximab in elderly patients. However, subgroup analyses from randomized trials and retrospective analysis suggest that the efficacy of chemotherapy and cetuximab is maintained in fit elderly patients, but with slightly increased but acceptable toxicity.Conclusion: No prospective cetuximab studies have been conducted solely in a population of elderly patients. However, available data suggest that outcomes in the fit elderly mirror results observed in younger patients.Keywords: metastatic colorectal cancer, cetuximab, elderly patients

  13. Current status of high dose rate brachytherapy in cervical cancer in Korea and optimal treatment schedule

    Energy Technology Data Exchange (ETDEWEB)

    Huh, Seung Jae [College of Medicine, Sungkyunkwan Univ., Seoul (Korea, Republic of)

    1998-12-01

    Brachytherapy is an essential part of radiotherapy for uterine cervical cancer. The low dose rate (LDR) regimen has been the major technique of intracavitary therapy for cervical cancer. However, there has been an expansion in the last 20 years of high dose rate (HDR) machines using Ir-192 sources. Since 1979, HDR brachytherapy has been used for the treatment of uterine cervical cancer in Korea. The number of institutions employing HDR has been increasing, while the number of low dose rate system has been constant. In 1995, there was a total 27 HDR brachytherapy units installed and 1258 cases of patients with cervical cancer were treated with HDR. Most common regimens of HDR brachytherapy are total dose of 30-39 Gy at point A with 10-13 fractions in three fractions per week, 24-32 Gy with 6-8 fractions in two fractions per week, and 30-35 Gy with 6-7 fractions in two fractions per week. The average fractionation regimen of HDR brachytherapy is about 8 fractions of 4. 1 Gy each to point A. In Korea, treatment results for HDR brachytherapy are comparable with the LDR series and appears to be a safe and effective alternative to LDR therapy for the treatment of cervical carcinoma. Studies from the major centers report the five-year survival rate of cervical cancer as, 78-86% for Stage I, 68-85% for stage II, and 38-56% for Stage III. World-wide questionnaire study and Japanese questionnaire survey of multiple institutions showed no survival difference in any stages and dose-rate effect ratio (HDR/LDR) was calculated to be 0.54 to 0.58. However, the optimum treatment doses and fractionation schemes appropriate to generate clinical results comparable to conventional LDR schemes have yet to be standardized. In conclusion, HDR intracavitary radiotherapy is increasingly practiced in Korea and an effective treatment modality for cervical cancer. To determine the optimum radiotherapy dose and fractionation schedule, a nation-wide prospective study is necessary in Korea. In

  14. The Role of VATS in Lung Cancer Surgery: Current Status and Prospects for Development

    Directory of Open Access Journals (Sweden)

    Dariusz Dziedzic

    2015-01-01

    Full Text Available Since the introduction of anatomic lung resection by video-assisted thoracoscopic surgery (VATS 20 years ago, VATS has experienced major advances in both equipment and technique, introducing a technical challenge in the surgical treatment of both benign and malignant lung disease. The demonstrated safety, decreased morbidity, and equivalent efficacy of this minimally invasive technique have led to the acceptance of VATS as a standard surgical modality for early-stage lung cancer and increasing application to more advanced disease. Formerly there was much debate about the feasibility of the technique in cancer surgery and proper lymph node handling. Although there is a lack of proper randomized studies, it is now generally accepted that the outcome of a VATS procedure is at least not inferior to a resection via a traditional thoracotomy.

  15. Proton beam therapy and localised prostate cancer: current status and controversies

    OpenAIRE

    Efstathiou, J. A.; Gray, P. J.; Zietman, A L

    2013-01-01

    Proton therapy is a promising, but costly, treatment for prostate cancer. Theoretical physical advantages exist; yet to date, it has been shown only to be comparably safe and effective when compared with the alternatives and not necessarily superior. If clinically meaningful benefits do exist for patients, more rigorous study will be needed to detect them and society will require this to justify the investment of time and money. New technical advances in proton beam delivery coupled with shor...

  16. Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives

    OpenAIRE

    Biondi, Alberto; Lirosi, Maria C; D’Ugo, Domenico; Fico, Valeria; Ricci, Riccardo; Santullo, Francesco; Rizzuto, Antonia; Cananzi, Ferdinando CM; Persiani, Roberto

    2015-01-01

    In the last 20 years, several clinical trials on neoadjuvant chemotherapy and chemo-radiotherapy as a therapeutic approach for locally advanced gastric cancer have been performed. Even if more data are necessary to define the roles of these approaches, the results of preoperative treatments in the combined treatment of gastric adenocarcinoma are encouraging because this approach has led to a higher rate of curative surgical resection. Owing to the results of most recent randomized phase III s...

  17. Current status of endoscopic submucosal dissection for the management of early gastric cancer: A Korean perspective

    Institute of Scientific and Technical Information of China (English)

    Hoon Jai Chun; Bora Keum; Ji Hyun Kim; Sang Young Seol

    2011-01-01

    The early diagnosis of gastric cancer allows patients and physicians to pursue the option of endoscopic resection, which is significantly less invasive than conventional surgical resection. In Korea, the use of endoscopic submucosal dissection (ESD) has been increasing, and many reports on ESD have been published. In addition, Korean gastroenterologists from several hospitals performing ESD have conducted formal meetings to discuss useful information regarding ESD. Here, we discuss the Korean experience with ESD, including outcomes and prospects of endoscopic treatments.

  18. The Role of VATS in Lung Cancer Surgery: Current Status and Prospects for Development

    OpenAIRE

    Dariusz Dziedzic; Tadeusz Orlowski

    2015-01-01

    Since the introduction of anatomic lung resection by video-assisted thoracoscopic surgery (VATS) 20 years ago, VATS has experienced major advances in both equipment and technique, introducing a technical challenge in the surgical treatment of both benign and malignant lung disease. The demonstrated safety, decreased morbidity, and equivalent efficacy of this minimally invasive technique have led to the acceptance of VATS as a standard surgical modality for early-stage lung cancer and increasi...

  19. [Current Status of Perioperative Rehabilitation in Patients who Undergo Esophagectomy for Cancer].

    Science.gov (United States)

    Oikawa, Masato; Hanada, Masatoshi; Hidaka, Shigekazu; Nagayasu, Takeshi; Kozu, Ryo

    2016-01-01

    The esophagectomy for esophageal cancer is major surgery and has the highest rate of postoperative pulmonary complications. Respiratory physiotherapy in patients undergoing esophagectomy has been applied to improve oxygenation and airway secretion clearance. Recently, the utility and effectiveness of enhanced recovery after surgery for gastroenterological surgery have been reported in Japan, and patients should be encouraged to participate in early mobilization. Perioperative rehabilitation which includes early mobilization reduces postoperative complications and improves fast-track recovery after esophagectomy. These interventions play important role in postoperative care. PMID:26975645

  20. Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals

    International Nuclear Information System (INIS)

    Although the prognosis of differentiated thyroid cancer (DTC) is favorable, some histotypes show worst clinical outcome and higher risk of recurrence. Serum thyroglobulin (Tg) levels and 131I-whole-body-scan (WBS), together with neck ultrasound (US), represent the golden standard for DTC follow-up. Nevertheless, the relatively high frequency of patients with high Tg levels and negative WBS requires further investigations by using new imaging modalities. The availability of whole body positron emission tomography (PET) methods, in parallel with the advances in radiochemistry, offer a wide substrate for many solutions. To this day 18F-fluoro-deoxy-glucose (18F-FDG) PET/CT still represents the imaging of choice in follow-up of patients with high serum Tg and negative 131I-WBS but in the last decades the research has focused on finding “second generation” radiopharmaceuticals for PET imaging, with both diagnostic and prognostic purposes, aiming to change the way to image thyroid cancer. Moreover, the use of various PET radiopharmaceuticals, that offer the possibility to explore different pathways involved in thyroid cancer, could find important applications in the near future for clinical decision making in order to program tailored treatments and follow-up. It would be desirable to use the same radiopharmaceutical for both imaging and dosimetric purpose to achieve a tailored therapy. Many efforts are focused in this direction and 124I-PET/CT is now emerging as a valid tool in restaging and therapy management of DTC with promising results. Although the preliminary data available in literature require a confirmation in larger studies with longer follow-up, we think that in next future 124-PET/CT could gain an important role for management of DTC. The aim of this review was to perform a systematic analysis of literature describing the state of art of “second generation” PET-radiopharmaceuticals for imaging DTC. Discussion is focused on the utility of 124I

  1. Biosimilar drugs: Current status.

    Science.gov (United States)

    Kumar, Rajiv; Singh, Jagjit

    2014-07-01

    Biologic products are being developed over the past three decades. The expiry of patent protection for many biological medicines has led to the development of biosimilars in UK or follow on biologics in USA. This article reviews the literature on biosimilar drugs that covers the therapeutic status and regulatory guidelines. Appraisal of published articles from peer reviewed journals for English language publications, search from PubMed, and guidelines from European Medicines Agency, US Food Drug Administration (FDA) and India were used to identify data for review. Literature suggest that biosimilars are similar biological products, i.e., comparable but not identical to the reference product, are not generic version of innovator product and do not ensure therapeutic equivalence. Biosimilars present more challenges than conventional generics and marketing approval is also more complicated. To improve access, US Congress passed the Biologics Price Competition and Innovation act 2009 and US FDA allowed "abbreviated pathway" for their approval. U.S law has defined new standards and terms and EMA scientific guidelines have also set detailed approval standards. India being one of the most preferred manufacturing destinations of biosimilars, there is a need for stringent safety and regulatory guidelines. The New India Guidelines "Draft Guidelines on Similar Biologics were announced in June 2012, by Department of Biotechnology at Boston bio and available online. PMID:25143877

  2. The bivariate current status model

    OpenAIRE

    Groeneboom, P.

    2013-01-01

    For the univariate current status and, more generally, the interval censoring model, distribution theory has been developed for the maximum likelihood estimator (MLE) and smoothed maximum likelihood estimator (SMLE) of the unknown distribution function, see, e.g., [12], [7], [4], [5], [6], [10], [11] and [8]. For the bivariate current status and interval censoring models distribution theory of this type is still absent and even the rate at which we can expect reasonable estimators to converge...

  3. Current status of the use of antiadhesive agents for gastric cancer surgery: a questionnaire survey in South Korea

    OpenAIRE

    Park, Ji-Ho; Jeong, Sang-Ho; Lee, Young-Joon; Choi, Sang-Kyung; Hong, Soon-Chan; Jung, Eun-Jung; Jeong, Chi-Young; Ju, Young-Tae; Ha, Woo-Song

    2013-01-01

    Purpose The aim of this study was to investigate the current status of the use of antiadhesive agents (AAdAs) via a questionnaire and to discuss the availability of AAdAs. Methods The survey was sent to a list of members that was approved by the Korean Gastric Association. The survey included questions on AAdA use by surgeons, the type of AAdAs used, and the reasons for not using AAdAs. Surgeons were also asked to describe complications related to AAdAs, and the reliability of its use. Result...

  4. [Current status of p53 tumor suppressor gene as a possible molecular marker of cancer of the prostate].

    Science.gov (United States)

    Peña González, J A; Morote Robles, J; de Torres Ramírez, I M; Martínez Cuenca, E

    1998-04-01

    Diagnosis of prostate cancer has increased over the last few years both in localized and in more advanced stages. At present, several groups are working in the search and evaluation of alternative tumoral markers as the current ones do not cover all the Urologist's needs. In this context, a number of studies on the mutation of the tumour suppressor gen p53 in both localized and metastatic prostate cancer are being carried out. When a noxa acts on the DNA, protein p53 inhibits the cell cycle allowing the repair systems to operate and, if the damage is significant enough, cell apoptosis. The loss of this control mechanism secondary to the synthesis of anomalous proteins can result in the proliferation of neoplastic cells. A revision of the most representative papers in the literature is presented here, addressing the surrounding controversy and the resulting future possibilities. PMID:9658641

  5. Current Status of Graphene Transistors

    OpenAIRE

    Lemme, Max. C.

    2009-01-01

    This paper reviews the current status of graphene transistors as potential supplement to silicon CMOS technology. A short overview of graphene manufacturing and metrology methods is followed by an introduction of macroscopic graphene field effect transistors (FETs). The absence of an energy band gap is shown to result in severe shortcomings for logic applications. Possibilities to engineer a band gap in graphene FETs including quantum confinement in graphene Nanoribbons (GNRs) and electricall...

  6. Epidermal growth factor receptor inhibitors in non-small cell lung cancer: current status and future perspectives

    Directory of Open Access Journals (Sweden)

    Mauro Zükin

    2012-04-01

    Full Text Available Two classes of epidermal growth factor receptor (EGFR inhibitors are currently available for clinical use: tyrosine-kinase inhibitors (TKIs and monoclonal antibodies. The introduction of pharmacological agents that are able to inhibit EGFR represents an important step in the management of patients with advanced non-small cell lung cancer (NSCLC, the leading cause of cancer death worldwide. The use of EGFR inhibitors has not only led to meaningful therapeutic gains for patients, but has also expanded our knowledge about the disease itself, as it is now recognized that activating mutations of EGFR play a pathogenetic role in NSCLC, especially in adenocarcinoma, patients who never smoked or former light smokers, females, and Asian individuals. Patients with NSCLC and one or more of these features are more likely to harbor tumors with EGFR mutations, and hence to respond to TKIs, than individuals without these features. Currently, TKIs are considered by many as the treatment of first choice in both the first- and second-line treatment of patients with clinical or molecular predictors of therapeutic benefit, and chemotherapy is a second option in these cases, especially when activating mutations of EGFR are present. Moreover, TKIs and anti-EGFR antibodies may be used in other settings, and their therapeutic role in NSCLC is clearly expanding. However, despite an initially successful treatment course, patients with advanced NSCLC eventually develop resistance to TKIs; and novel agents that hold promise for the future include irreversible EGFR inhibitors with activity against resistance-conferring EGFR mutations.

  7. Management of Cancer Survivors in Clinical and Public Health Perspectives: Current Status and Future Challenges in Korea

    OpenAIRE

    Shin, Dong Wook; Cho, BeLong; Kim, So Young; Jung, Je Hyuck; Park, Jong Hyock

    2013-01-01

    The number of cancer survivors is increasing dramatically. Many cancer survivors face lifetime risks associated with their cancer therapy, with a significant proportion at risk for serious morbidity and premature mortality. Concerns regarding the long-term physical, psychosocial, and economic effects of cancer treatment on cancer survivors and their families are increasingly being recognized and addressed by public and private sector. This article summarizes economic burden of cancer survivor...

  8. Deep brain stimulation: Current status

    Directory of Open Access Journals (Sweden)

    Sanjay Pandey

    2015-01-01

    Full Text Available In the last two decades, applications of deep brain stimulation (DBS have expanded rapidly in the field of neurosciences. The most common indications for DBS are Parkinson′s disease, medically refractory seizures, essential tremors, and primary dystonia. This device has also been used as an investigational tool in patients having Tourette′s syndrome, tardive dyskinesia, and refractory seizures. In the field of psychiatry, DBS has been used for the treatment of refractory obsessive compulsive disorder and depression. The complications are mainly related to surgery, the device, and its stimulation. This article provides an overview of the current status and recent advances in the field of DBS.

  9. Management of cancer survivors in clinical and public health perspectives: current status and future challenges in Korea.

    Science.gov (United States)

    Shin, Dong Wook; Cho, BeLong; Kim, So Young; Jung, Je Hyuck; Park, Jong Hyock

    2013-05-01

    The number of cancer survivors is increasing dramatically. Many cancer survivors face lifetime risks associated with their cancer therapy, with a significant proportion at risk for serious morbidity and premature mortality. Concerns regarding the long-term physical, psychosocial, and economic effects of cancer treatment on cancer survivors and their families are increasingly being recognized and addressed by public and private sector. This article summarizes economic burden of cancer survivors, main post-treatment health problems including secondary primary cancer and comorbidities, health behaviors such as smoking, exercise and physical activity, nutrition, and psychosocial problems. Faced with various health and psychosocial problems specific to this population, several healthcare and policy models are being suggested to address these issues, including 'shared care model' and 'integrative supportive care service delivery system for cancer survivors'. More effort is needed to make the cancer survivorship agenda a reality, attended by a wide variety of stakeholders including researchers, patients, providers, and policy makers. PMID:23678254

  10. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: Current status of vaginal brachytherapy

    International Nuclear Information System (INIS)

    Purpose: To survey the current postoperative recommendations for radiotherapy (RT) in patients with endometrial cancer, with an emphasis on vaginal brachytherapy (VBT). Methods and Materials: In August 2003, a 32-item questionnaire was mailed to a random sample of 2396 members of the American Society for Therapeutic Radiology and Oncology and the American Brachytherapy Society. The sample excluded members-in-training, physicists, and non-U.S. members. A follow-up mailing was conducted in November 2003. Those who had not treated any patient in the previous year for endometrial carcinoma were instructed to indicate so at the beginning of the questionnaire and return it without responding to any other item. Responses were tabulated to determine the relative frequency distribution. Results: of the 2396 surveys sent out, 757 were returned, for a response rate of 31.6%. Of those who responded, 551 (72.8%) had performed postoperative irradiation for endometrial cancer and were included in this study. Of the 551 respondents, 99.8% had delivered external beam RT to some endometrial cancer patients. An increasing trend was found toward referrals for VBT; 91.5% of those who treated endometrial cancer performed VBT. The vaginal target most often irradiated was the upper vagina in 40.7%, upper 4-5 cm in 54.5%, and the entire vagina in 4.9%; 21.3% placed clips at the vaginal apex for applicator verification. The maximal dose to the bladder and rectum was recorded in 78.3% and 80.2% of patients, respectively. Of the respondents, 40% did not use low-dose-rate (LDR) VBT. The two most common LDR applicators were Delclos cylinders (29.7%) and Fletcher colpostats (29.3%). The mean boost dose delivered with LDR VBT when prescribed to the surface was 29.9 Gy and when prescribed to 0.5 cm was 23.8 Gy. When LDR therapy was used without external beam RT, the mean dose when prescribed to the surface was 56.8 Gy and when prescribed to 0.5 cm was 47.9 Gy. In 2002, 69.1% of respondents treated

  11. Questionnaire survey of current status and reserve for breast cancer screening in Mie prefecture. Achievement of a 50% participation rate

    International Nuclear Information System (INIS)

    Mie Medical Network of Breast Cancer Screening, a NPO, was assigned the task of breast cancer screening in Mie prefecture in April, 2010. For breast cancer screening in Mie prefecture in 2009, a questionnaire survey was performed toward both consigner and consignee. Consigners were local public offices managing breast cancer screening for local inhabitants, and consignees were facilities offering breast cancer screening. The number of breast cancer screening was investigated toward all 29 of consigners in Mie prefecture. The questionnaire survey was conducted toward all 52 of the facilities possessing mammography systems (breast cancer screening being performed at 48 of them) in Mie prefecture in 2009. We investigated the predictive additional number of breast cancer screening and also investigated the requisite number of staff to achieve the predictive maximum number of breast cancer screening. As a result, the total number of breast cancer screenings was 93,525, and the participation rate was 27.5% which was calculated by reduction of continuator in Mie prefecture in 2009. The continuator accounted for over 30% of all breast cancer screenings. The predictive additional number was 126,950, this indicates that a possible participation rate of 75.2% after 2011. To achieve this high participation rate, active support is essential for short-handed facilities, and about 20% increase of medical staff is necessary. To achieve a participation rate of over 50% as a goal, new screenees should be recruited and breast cancer screening of every other year should be enlightened. (author)

  12. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

    Directory of Open Access Journals (Sweden)

    Barth Rolf F

    2012-08-01

    Full Text Available Abstract Boron neutron capture therapy (BNCT is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Clinical interest in BNCT has focused primarily on the treatment of high grade gliomas, recurrent cancers of the head and neck region and either primary or metastatic melanoma. Neutron sources for BNCT currently have been limited to specially modified nuclear reactors, which are or until the recent Japanese natural disaster, were available in Japan, United States, Finland and several other European countries, Argentina and Taiwan. Accelerators producing epithermal neutron beams also could be used for BNCT and these are being developed in several countries. It is anticipated that the first Japanese accelerator will be available for therapeutic use in 2013. The major hurdle for the design and synthesis of boron delivery agents has been the requirement for selective tumor targeting to achieve boron concentrations in the range of 20 μg/g. This would be sufficient to deliver therapeutic doses of radiation with minimal normal tissue toxicity. Two boron drugs have been used clinically, a dihydroxyboryl derivative of phenylalanine, referred to as boronophenylalanine or “BPA”, and sodium borocaptate or “BSH” (Na2B12H11SH. In this report we will provide an overview of other boron delivery agents that currently are under evaluation, neutron sources in use or under development for BNCT, clinical dosimetry, treatment planning, and finally a summary of previous and on-going clinical studies for high grade gliomas and recurrent tumors of the head and neck region. Promising results have been obtained with both groups of patients but these outcomes must be more rigorously evaluated in larger

  13. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

    International Nuclear Information System (INIS)

    Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Clinical interest in BNCT has focused primarily on the treatment of high grade gliomas, recurrent cancers of the head and neck region and either primary or metastatic melanoma. Neutron sources for BNCT currently have been limited to specially modified nuclear reactors, which are or until the recent Japanese natural disaster, were available in Japan, the United States, Finland and several other European countries, Argentina and Taiwan. Accelerators producing epithermal neutron beams also could be used for BNCT and these are being developed in several countries. It is anticipated that the first Japanese accelerator will be available for therapeutic use in 2013. The major hurdle for the design and synthesis of boron delivery agents has been the requirement for selective tumor targeting to achieve boron concentrations in the range of 20 μg/g. This would be sufficient to deliver therapeutic doses of radiation with minimal normal tissue toxicity. Two boron drugs have been used clinically, a dihydroxyboryl derivative of phenylalanine, referred to as boronophenylalanine or “BPA”, and sodium borocaptate or “BSH” (Na2B12H11SH). In this report we will provide an overview of other boron delivery agents that currently are under evaluation, neutron sources in use or under development for BNCT, clinical dosimetry, treatment planning, and finally a summary of previous and on-going clinical studies for high grade gliomas and recurrent tumors of the head and neck region. Promising results have been obtained with both groups of patients but these outcomes must be more rigorously evaluated in larger, possibly randomized clinical

  14. The OPERA experiment: current status

    International Nuclear Information System (INIS)

    Full text: The neutrino flavour oscillations hypothesis has been confirmed by several experiments, all are based on the observation of the disappearance of a given neutrino flavour. The long baseline neutrino experiment OPERA (Oscillation Project with Emulsion tRacking Apparatus) aims to give the first direct proof of the tau neutrino appearance in a pure muon neutrino beam (CERN neutrinos to Gran Sasso beam). The neutrino interactions in the detector are recorded by Emulsion Cloud Chambers (ECC), stacks of 57 nuclear emulsions interleaved with 1 mm thick lead plates. In 2008 the OPERA experiment has started full data taking in the CNGS beam and around 1700 interactions in the detector have been recorded. After a description of the experiment and the data taking procedure, a review of the current status and preliminary results from 2008 run will be presented. (author)

  15. Sinoprobe Datacenter Development: Current Status

    Science.gov (United States)

    Guan, Y.; Dong, S.; Chen, Z.; Chen, G.; Cheng, M.

    2011-12-01

    The project of the Sinoprobe datacenter development is to build new IT infrastructures needed to store, visualize and manage all the data acquired by SinoProbe program.The SinoProbe data center is designed using service-oriented architecture (SOA) principles. More specifically, service component architecture (SCA) is used to implement sinoprobe data services. It also uses various advanced technologies such as Java/JEE for the platform, PostgresSQL/PostGIS for the data storage, ApacheDS for LDAP, CoachDB for the medadata storage, GeoServer for the GIS services, ExtJs and OpenLayer for the Ajax framework, and Apache Shiro for the security framework. Through the integration and development of various technologies used, the major services of the datacenter system are implemented including the security infrastructure services (user authentication and authorization), metadata services, data warehouse stores, data services, GIS services, and web portal. There are also visualization components including the development of a virtual globe to replace the currently used Google Earth. This poster presents the current status of the SinoProbe data center development, and the detailed discussion of the system.

  16. Current status of surgical treatment of gastric cancer in the era of minimally invasive surgery in China: Opportunity and challenge.

    Science.gov (United States)

    Zhao, En-Hao; Ling, Tian-Long; Cao, Hui

    2016-04-01

    Gastric cancer is one of the most common cancers in China. In the past decade, with the developments in surgical instruments and technologies, minimally invasive surgery has rapidly become an accepted treatment for gastric cancer in China. Many Chinese surgeons and researchers have contributed to the rapid evolution of minimally invasive surgery for gastric cancer. Their efforts have transformed into unique laparoscopic technique, workshops, academic communications, education and international communications in China. Meanwhile, many retrospective comparative trials and randomized controlled trials have revealed the advantages in minimally invasive surgery for gastric cancer. However, multicenter randomized controlled trials are still needed to delineate significantly quantifiable differences between laparoscopic and open gastrectomy. With more and more experience has accumulated, laparoscopic gastrectomy has been performed on older and overweight patients. Moreover, advanced minimally invasive techniques, such as modified laparoscopic spleen-preserving splenic hilum lymphadenectomy, various laparoscopic gastric reconstruction methods and robotic gastrectomy have been developed. It seems that China owns the potential to keep up with her neighbor, Japan and Korea, to become one of leading countries utilizing minimally invasive surgery for gastric cancer. PMID:26889972

  17. Current status of converter steelmaking

    Energy Technology Data Exchange (ETDEWEB)

    Oghbasialasie, H.; Holappa, L.

    1995-12-31

    This literature work is mainly focusing on the mechanisms of modern converter steelmaking and related with the evaluation of converter technology applied during the last decades and further to the future. The history of steelmaking has been briefly reviewed from bloomeries and early-steelmaking processes to the progress of modern converter process. The pneumatic converter processes were developed in the 1850`s and thereafter the basis for the rapid growth of steel industries was established for the next 100 years. The world production of steel has not continuously grown but fluctuating quite much. It reached 723 Mt in 1994. The production is believed to grow the forecast for the year 2003 being approximately 800 Mt. Electric arc furnace production is estimated to reach 280 Mt by 2003, and BOFIOH will reach 520 Mt by 2003. The current status of the converter steelmaking process is briefly described both on its theoretical bases and practical technological progresses. Developments which significantly improve the process are briefly discussed. Several more recent developments such as combined oxygen blowing process, increased scrap melting, post combustion and hot metal pretreatment are discussed. The future progress will be in further development of these process characteristics as well as in eventual emerging of the continuous converter process. (author)

  18. PET/CT - Current status

    International Nuclear Information System (INIS)

    From autoradiography to planar X rays, computed tomography (CT) and Magnetic Resonance (MR), morphology and structure has been the mainstay of biological and medical imaging for over a century. While structural changes may suggest the presence of disease, functional changes are more sensitive indicators of early-stage pathology, and with cancer, early detection is the key to a favorable prognosis. Since molecular imaging offers the potential to quantitatively image functional changes in vivo, it is assuming an increasingly important role in the identification, staging and re-staging of human disease. Specifically, Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) are sensitive techniques to map human physiology non-invasively through the use of high-resolution imaging devices and appropriate radioactively-labeled biomarkers. However, such metabolic maps do not offer the structural detail associated with anatomical imaging techniques such as CT and MR and therefore dual modality devices such as PET/CT, SPECT/CT or PET/MR that combine both structural and functional information offer a more complete and accurate assessment of the status of disease. PET/CT instrumentation, for example, was first introduced into the clinic in 2001 and since then, progress has been rapid. Technological advances in each modality, CT and PET, have been consistently incorporated into the combined device ensuring state-of-the-art performance for PET/CT. Recent advances in CT include an increase in the number of detector rows or slices (from 1 to 64), a reduction in rotation times (to less than 0.5 s), and the emergence of the first CT scanner incorporating dual X ray sources. Paralleling these advances, PET instrumentation has witnessed the introduction of new faster scintillators, higher resolution detectors, increased sensitivity through extended axial coverage, and the resurgence of time-of-flight information to improve image signal-to-noise. A

  19. The Current Status of Tumor Markers in Lung Cancer%肿瘤标志物在肺癌诊疗中的研究进展

    Institute of Scientific and Technical Information of China (English)

    郑名华; 孙国栋; 张郧樊; 杨建新

    2016-01-01

    肿瘤标志物的检测,对肺癌的早期诊断、临床分期、组织学分型、预后判断和疗效监测都具有重要价值。本文对癌胚抗原(CEA)、胃泌素释放肽前体(ProGRP)、细胞角蛋白19片段(CYFRA21-1)、神经元特异性烯醇化酶(NSE)、鳞状上皮细胞癌抗原(SCC)等肺癌肿瘤标志物的研究现状进行概述。%The determination of tumor markers is of great value for early diagnosis. It is not only helpful in clinical staging and classification of pathological types in patients with lung cancer, but also useful in evaluation of prognosis and response to treatment.This article reviews the current status of tumor markers in lung cancer,such as CEA,ProGRP,CYFRA21-1,NSE,SCC,and so on.

  20. [Current status and new applications of sentinel lymph node mapping in non-small cell lung cancer].

    Science.gov (United States)

    Minamiya, Yoshihiro; Ogawa, Jun-Ichi

    2009-03-01

    Sentinel lymph node (SLN) mapping has become a common procedure in the treatment of breast cancer and malignant melanoma. Its primary benefit is that it enables surgeons to avoid nontherapeutic lymph node dissection and the complications that may follow. All present evidence demonstrates the existence of SLNs in non-small cell lung cancer (NSCLC). However, SLN mapping is not widely used in the treatment of NSCLC for several reasons: first, special precautions are required to minimize exposure to radioisotopes; second, it is difficult to detect a dye within anthoracotic thoracic lymph nodes; and third, major complications comparable to the arm edema seen in breast cancer or the lymphedema and nerve injury seen in melanoma are not seen with mediastinal lymph node dissection. However, if the SLN mapping procedure were simplified, it could be used to avoid nontherapeutic mediastinal lymph node dissection in NSCLC. Recently, new applications of SLN mapping have been reported, such as the detection of lymph node micrometastases and segmentectomy for NSCLC. We expect SLN mapping to become a common clinical practice in the treatment of NSCLC in the near future PMID:19348199

  1. Current status of diuretic renography

    International Nuclear Information System (INIS)

    Percutaneous antegrade perfusion studies constitute a valuable contribution to the investigation of obstructive uropathy. In 1978, the first report of application of diuretic renogram techniques to this problem appeared in the literature. This was the first systematic report of a standardized protocol to be applied to a specific surgical problem. The purpose of the procedure, as with perfusion pressure-flow studies, is to help distinguish between a dilated urinary tract that is obstructed and requires surgery and a nonobstructed system in which urographic dilation and stasis mimic obstruction, but no genuine impedance to urine flow exists, and surgery is not required. The technique provides dual information. It gives quantitative data on individual renal function that perfusion pressure-flow studies do not, and it gives time-activity curves reflecting the urodynamics through the individual upper urinary tracts at normal and high urinary flow rates. In the early days, this information was obtained from probe studies, but the procedure is now almost exclusively performed using the gamma camera, images from which give additional information on the site of any suspected obstruction. In some ways, the development of diuretic renography and that of perfusion pressure-flow studies have proceeded in a competitive fashion, both attempting to answer the same questions by different means. In practice, however, the two tests would be regarded as complementary, as will be shown later in this chapter. The following sections describe the technique of diuretic renography, its current clinical application and status in surgical and nuclear medicine practice, and its role in comparison with other available tests for management of the dilated upper urinary tract

  2. Current status of zirconia restoration.

    Science.gov (United States)

    Miyazaki, Takashi; Nakamura, Takashi; Matsumura, Hideo; Ban, Seiji; Kobayashi, Taira

    2013-10-01

    During the past decade, zirconia-based ceramics have been successfully introduced into the clinic to fabricate fixed dental prostheses (FDPs), along with a dental computer-aided/computer-aided manufacturing (CAD/CAM) system. In this article (1) development of dental ceramics, (2) the current status of dental CAD/CAM systems, (3) CAD/CAM and zirconia restoration, (4) bond between zirconia and veneering ceramics, (5) bond of zirconia with resin-based luting agents, (6) surface finish of zirconia restoration and antagonist enamel wear, and (7) clinical evaluation of zirconia restoration are reviewed. Yttria partially stabilized tetragonal zirconia polycrystalline (Y-TZP) showed better mechanical properties and superior resistance to fracture than other conventional dental ceramics. Furthermore, ceria-stabilized tetragonal zirconia polycrystalline and alumina nanocomposites (Ce-TZP/A) had the highest fracture toughness and had resistance to low-temperature aging degradation. Both zirconia-based ceramics have been clinically available as an alternative to the metal framework for fixed dental prostheses (FDPs). Marginal adaptation of zirconia-based FDPs is acceptable for clinical application. The most frequent clinical complication with zirconia-based FDPs was chipping of the veneering porcelain that was affected by many factors. The mechanism for the bonding between zirconia and veneering ceramics remains unknown. There was no clear evidence of chemical bonding and the bond strength between zirconia and porcelain was lower than that between metal and porcelain. There were two alternatives proposed that might avoid chipping of veneering porcelains. One was hybrid-structured FDPs comprising CAD/CAM-fabricated porcelain parts adhering to a CAD/CAM fabricated zirconia framework. Another option was full-contour zirconia FDPs using high translucent zirconia. Combined application of silica coating and/or silane coupler, and 10-methacryloyloxydecyl dihydrogen phosphate is

  3. Quimioprevenção do câncer de mama Current status of breast cancer chemoprevention

    Directory of Open Access Journals (Sweden)

    Vilmar Marques de Oliveira

    2006-12-01

    defined as the use of natural or synthetic chemical agents to reverse, suppress or prevent carcinogenic progression of invasive cancer. Drugs that act as chemoprevention agents for breast cancer are divided into two major groups: drugs that prevent Estrogen Receptor (ER - positive breast cancers [selective estrogen receptor modulators (SERM, aromatase inhibitors GnKH agonists and phytoestrogens] and drugs that prevent ER - negative breast cancers [cyclooxygenase-2 (COX-2 inhibitors, retinoids, statins, receptor tyrosine, kinase inhibitors, monoclonal antibody against HER-2 and telomerase inhibitors]. Results from the NSABP Study of Tamoxifen and Raloxifene (STAR, which compared the risk-reducing efficacy as well as toxicity of these two SERMs in a similar high-risk for breast cancer population, showed that Raloxifene is as effective as Tamoxifen in reducing the risk of non-invasive breast cancer (p=.83. It has a statistically significant lower risk of thromboembolic events and cataracts, however a non- statistically significant higher risk of noninvasive breast cancer. Based on promising data involving reduction of contralateral breast cancer risk in adjuvant studies, several aromatase inhibitors, including letrozole, anastrozole and exemestane, are being included in trials to evaluate their efficacy in breast cancer prevention in both case-control and cohort studies As such randomized studies to confirm this efficacy are needed. Positive results of several recent clinical trials for preventing breast cancer in high-risk populations suggest that chemoprevention is a rational and attractive strategy.

  4. Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects

    Energy Technology Data Exchange (ETDEWEB)

    Bharali, Dhruba J. [The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144 (United States); Siddiqui, Imtiaz A.; Adhami, Vaqar M.; Chamcheu, Jean Christopher [Department of Dermatology, University of Wisconsin, Madison, WI 53706 (United States); Aldahmash, Abdullah M. [Stem Cell Unit, College of Medicine, King Saud University, Riyadh, 11461 (Saudi Arabia); University Hospital of Odense & Medical Biotechnology Center, Winslowsparken 25, DK-5000, Odense (Denmark); Mukhtar, Hasan [Department of Dermatology, University of Wisconsin, Madison, WI 53706 (United States); Mousa, Shaker A., E-mail: shaker.mousa@acphs.edu [The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144 (United States); Stem Cell Unit, College of Medicine, King Saud University, Riyadh, 11461 (Saudi Arabia)

    2011-10-26

    The advent of nanotechnology has had a revolutionary impact on many aspects of 21{sup st} century life. Nanotechnology has provided an opportunity to explore new avenues that conventional technologies have been unable to make an impact on for diagnosis, prevention, and therapy of different diseases, and of cancer in particular. Entities in nanometer sizes are excellent platforms to incorporate various drugs or active materials that can be delivered effectively to the desired action site without compromising the activity of the incorporated drug or material. In particular, nanotechnology entities can be used to deliver conventional natural products that have poor solubility or a short half life. Conventional natural products used with entities in nanometer sizes enable us to solve many of the inherent problems (stability, solubility, toxicity) associated with natural products, and also provide a platform for targeted delivery to tumor sites. We recently introduced the novel concept of using nanotechnology for enhancing the outcome of chemoprevention, which we called ‘nanochemoprevention’. This idea was subsequently exploited by several laboratories worldwide and has now become an advancing field in chemoprevention research. This review examines some of the applications of nanotechnology for cancer prevention and therapy using natural products.

  5. Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects

    Directory of Open Access Journals (Sweden)

    Hasan Mukhtar

    2011-10-01

    Full Text Available The advent of nanotechnology has had a revolutionary impact on many aspects of 21st century life. Nanotechnology has provided an opportunity to explore new avenues that conventional technologies have been unable to make an impact on for diagnosis, prevention, and therapy of different diseases, and of cancer in particular. Entities in nanometer sizes are excellent platforms to incorporate various drugs or active materials that can be delivered effectively to the desired action site without compromising the activity of the incorporated drug or material. In particular, nanotechnology entities can be used to deliver conventional natural products that have poor solubility or a short half life. Conventional natural products used with entities in nanometer sizes enable us to solve many of the inherent problems (stability, solubility, toxicity associated with natural products, and also provide a platform for targeted delivery to tumor sites. We recently introduced the novel concept of using nanotechnology for enhancing the outcome of chemoprevention, which we called ‘nanochemoprevention’. This idea was subsequently exploited by several laboratories worldwide and has now become an advancing field in chemoprevention research. This review examines some of the applications of nanotechnology for cancer prevention and therapy using natural products.

  6. Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects

    International Nuclear Information System (INIS)

    The advent of nanotechnology has had a revolutionary impact on many aspects of 21st century life. Nanotechnology has provided an opportunity to explore new avenues that conventional technologies have been unable to make an impact on for diagnosis, prevention, and therapy of different diseases, and of cancer in particular. Entities in nanometer sizes are excellent platforms to incorporate various drugs or active materials that can be delivered effectively to the desired action site without compromising the activity of the incorporated drug or material. In particular, nanotechnology entities can be used to deliver conventional natural products that have poor solubility or a short half life. Conventional natural products used with entities in nanometer sizes enable us to solve many of the inherent problems (stability, solubility, toxicity) associated with natural products, and also provide a platform for targeted delivery to tumor sites. We recently introduced the novel concept of using nanotechnology for enhancing the outcome of chemoprevention, which we called ‘nanochemoprevention’. This idea was subsequently exploited by several laboratories worldwide and has now become an advancing field in chemoprevention research. This review examines some of the applications of nanotechnology for cancer prevention and therapy using natural products

  7. [Current status of autism studies].

    Science.gov (United States)

    Kurita, H

    2001-01-01

    The current status of autism studies was reviewed based on English articles published during the 1990s. Although the concepts of autism and pervasive developmental disorders (PDD) are established, diagnostic criteria of PDDNOS or atypical autism, which is frequently difficult to differentiate from autism, need to be established. The prevalence of autism has been estimated as about 0.05% in the U.S and many European countries, while it was reported to be 0.1% or higher in Japan and some European countries, though the reasons for this difference are unclear. High-functioning (IQ > or = 70) autism may not be as rare a condition as previously thought and both its difference from and similarity to Asperger's syndrome, the highest functioning PDD subtype, need clarification. About 20 to 40% of children with autism lose meaningful words by the age of 2 years and display autistic symptoms thereafter. Such autism, called the setback type in Japan, has been demonstrated to have a poorer adolescent/adult outcome compared to autism without setback and its relationship with childhood disintegrative disorder, which displays a clearer regression after normal development for at least the first 2 years of life, needs to be addressed. The etiology of autism is now considered mostly genetic for reasons, such as the significantly higher concordance rate of autism in identical twin pairs (60-80%) than in fraternal twin pairs (0-10%) and an 3-5% incidence of autism among sibs of an autism proband, 30 to 100 times higher than that in the general population. The involvement of several genes is implicated to create susceptibility for autism, yet the responsible genes have not been identified. Although there is no medication to cure autism, some psychotropic drugs, such as antipsychotics and SSRIs, seem effective for behavior problems in autism patients. Psychosocial treatments are the main therapeutic approach to autism, though they are yet to be well systematized. It is important to

  8. Current status of MR colonography.

    LENUS (Irish Health Repository)

    Thornton, Eavan

    2010-01-01

    The search for an acceptable colorectal cancer screening examination has led to the development of virtual colonoscopy, which includes both computed tomographic (CT) colonography and magnetic resonance (MR) colonography. As indicated by the much larger number of published studies on CT colonography than on MR colonography, multidetector CT appears to be more suitable for colorectal screening than does MR colonography, in part reflecting the ease and speed of performing CT, as well as the increased spatial resolution, decreased cost, and wider availability of CT colonography. The main advantage of MR colonography over CT colonography is that it does not use ionizing radiation, which has important implications for colorectal cancer screening. The use of dark-lumen MR colonography to screen patients for colorectal cancer as well as other abdominopelvic disease could make it more attractive than CT. With the integration of 3.0-T MR colonography, fecal tagging, and parallel imaging into research and clinical settings, new MR colonography protocols must be optimized. Future MR colonography research should address issues such as image characteristics, presence of artifacts, management of specific absorption rate, and hardware-related modifications.

  9. Current status and prospect of 125I production

    International Nuclear Information System (INIS)

    125I nuclide is widely applied in many fields such as medical and biological research, radioimmunoassay, brachytherapy of cancers, etc. The processes and current status of 125I production, domestic market demand, and the prospect of 125I nuclide production with the existing reactors in China were briefly introduced. (author)

  10. Edible vaccines: Current status and future

    Directory of Open Access Journals (Sweden)

    Lal P

    2007-01-01

    Full Text Available Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and socioculturally readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins. Introduced as a concept about a decade ago, it has become a reality today. A variety of delivery systems have been developed. Initially thought to be useful only for preventing infectious diseases, it has also found application in prevention of autoimmune diseases, birth control, cancer therapy, etc. Edible vaccines are currently being developed for a number of human and animal diseases. There is growing acceptance of transgenic crops in both industrial and developing countries. Resistance to genetically modified foods may affect the future of edible vaccines. They have passed the major hurdles in the path of an emerging vaccine technology. Various technical obstacles, regulatory and non-scientific challenges, though all seem surmountable, need to be overcome. This review attempts to discuss the current status and future of this new preventive modality.

  11. Status of current IPH applications

    Energy Technology Data Exchange (ETDEWEB)

    Kearney, D. W.

    1981-03-01

    The US Department of Energy has funded a series of field tests since 1977 to gain operational experience in the application of solar energy to industrial process heat requirements. To date, 34 design studies or actual installations have been funded utilizing technologies ranging from flat plates to line-focus concentrators to central receiver industrial systems. The types of solar systems include hot air, hot water, and steam production applied to a broad spectrum of industrial processes. The program elements are identified and put in perspective relative to transport fluid, temperature level, and size of the solar field. The status of these programs ranges from design studies to operational systems. Solar enhanced oil recovery and repowering have been studied. The chronological history of each program is tabulated. (LEW)

  12. Current status of pulmonary metastasectomy

    DEFF Research Database (Denmark)

    Hornbech, Kåre; Ravn, Jesper; Steinbrüchel, Daniel Andreas

    2011-01-01

    Malignant disease's ability to metastasize remains one of the major obstacles when treating patients with cancer. The change from loco-regional to systemic disease usually renders the patient beyond surgical treatment, as local treatment with surgery in a systemic disease is usually considered...... without benefit. However, numerous retrospective studies have demonstrated that resection of metastases limited to the lungs may be associated with prolonged survival. No prospective, randomized studies have been published, and most series compare highly selected patients with historical data for...... surgery are discussed. Finally, we review some of the common tumors that metastasize to the lungs, the role of metastasectomy in their treatment and the prognostic factors with impact on survival....

  13. Transungual drug delivery: current status.

    Science.gov (United States)

    Elkeeb, Rania; AliKhan, Ali; Elkeeb, Laila; Hui, Xiaoying; Maibach, Howard I

    2010-01-15

    Topical therapy is highly desirable in treating nail disorders due to its localized effects, which results in minimal adverse systemic events and possibly improved adherence. However, the effectiveness of topical therapies is limited by minimal drug permeability through the nail plate. Current research on nail permeation that focuses on altering the nail plate barrier by means of chemical treatments, penetration enhancers as well as physical and mechanical methods is reviewed. A new method of nail sampling is examined. Finally limitations of current ungual drug permeability studies are briefly discussed. PMID:19819318

  14. Current status of RENO experiment

    International Nuclear Information System (INIS)

    The RENO (Reactor Experiment for Neutrino Oscillation) experiment is completed in February of 2011, to measure the value of the smallest and unknown neutrino mixing angle θ13. Data-taking is expected to start from july 2011 after all the liquids are filled. It will compare the measured fluxes of electron antineutrinos at two detectors located at 290 m and 1.4 km distances from the centre of the Yonggwang nuclear reactors in Korea. An expected number of observed antineutrino is roughly 1280 and 115 per day in the near and far detectors, respectively. An estimated systematic uncertainty associated with the measurement is less than 0.5%, and an expected statistical error is about 0.3%. With three years of data, the experiment will search for the mixing angle values of sin 22θ13 down to 0.02 in the 90% C.L. limit. In this talk, we report completion of detector construction and the status of liquid scintillator production.

  15. Current Status of RENO Experiment

    International Nuclear Information System (INIS)

    The RENO (Reactor Experiment for Neutrino Oscillation) is under construction to measure the value of the smallest and unknown neutrino mixing angle θ13. The experiment will compare the measured fluxes of electron antineutrinos at two detectors located at 290 m and 1.4 km distances from the center of the Yonggwang nuclear reactors in Korea, with world-second largest thermal power output of 16.4 GW. Construction of experimental halls and access tunnels for both near and far detector sites was completed in early 2009. The detectors are near completion, and data-taking is planned to start in mid 2010. An expected number of observed antineutrino is roughly 510 and 80 per day in the near detector and far detector, respectively. An estimated systematic uncertainty associated with the measurement is less than 0.6%, and an expected statistical error is about 0.3%. With three years of data, the experiment will search for the mixing angle values of sin2(2θ13) down to 0.02 in 90% C.L. limit. In this talk, the construction status will be presented. (author)

  16. The Current Status of Galaxy Formation

    OpenAIRE

    Silk, Joe; Mamon, Gary A.

    2012-01-01

    Understanding galaxy formation is one of the most pressing issues in cosmology. We review the current status of galaxy formation from both an observational and a theoretical perspective, and summarise the prospects for future advances.

  17. Current status of transarterial radioembolization.

    Science.gov (United States)

    Mahnken, Andreas H

    2016-05-28

    Unresectable primary and secondary liver malignancies present a major problem in the treatment of solid tumors. Transarterial radioembolization (TARE) is an increasingly used technique for treating various types of malignant liver tumors. This approach is appealing, as the mechanism of action is independent from other loco-regional treatments and potentially complementary to systemic therapies. There are two commercially available products in use for TARE: (90)Y-resin and (90)Y-glass microspheres. Currently available data indicates TARE so be safe and effective in hepatocellular carcinoma (HCC) and metastatic liver disease. In HCC the results compare well with chemoembolization, while the role of TARE in combination with kinase inhibitors has yet to be established. Current data on TARE in metastatic liver disease is promising, but there is a strong need for prospective randomized trials comparing TARE and modern chemotherapeutic regimen to support the growing role of TARE in metastatic liver disease. PMID:27247711

  18. Current status of rotavirus vaccines

    Institute of Scientific and Technical Information of China (English)

    Ching-Min Wang; Shou-Chien Chen; Kow-Tong Chen

    2015-01-01

    Background: Rotaviruses remain the major cause of childhood diarrheal disease worldwide and of diarrheal deaths of infants and children in developing countries. The huge burden of childhood rotavirus-related diarrhea in the world continues to drive the remarkable pace of vaccine development. Data sources: Research articles were searched using terms "rotavirus" and "rotavirus vaccine" in MEDLINE and PubMed. Articles not published in the English language, articles without abstracts, and opinion articles were excluded from the review. After preliminary screening, all articles were reviewed and synthesized to provide an overview of current vaccines and vaccination programs. Results: In this review of the global rotavirus vaccines and vaccination programs, the principles of rotavirus vaccine development and the efficacy of the currently licensed vaccines from both developed and developing countries were summarized. Conclusions: Rotavirus is a common cause of diarrhea in children in both developed and developing countries. Rotavirus vaccination is a cost-effective measure to prevent rotavirus diarrhea.

  19. Current status of viroid taxonomy.

    Science.gov (United States)

    Di Serio, F; Flores, R; Verhoeven, J Th J; Li, S-F; Pallás, V; Randles, J W; Sano, T; Vidalakis, G; Owens, R A

    2014-12-01

    Viroids are the smallest autonomous infectious nucleic acids known so far. With a small circular RNA genome of about 250-400 nt, which apparently does not code for any protein, viroids replicate and move systemically in host plants. Since the discovery of the first viroid almost forty-five years ago, many different viroids have been isolated, characterized and, frequently, identified as the causal agents of plant diseases. The first viroid classification scheme was proposed in the early 1990s and adopted by the International Committee on Taxonomy of Viruses (ICTV) a few years later. Here, the current viroid taxonomy scheme and the criteria for viroid species demarcation are discussed, highlighting the main taxonomic questions currently under consideration by the ICTV Viroid Study Group. The impact of correct taxonomic annotation of viroid sequence variants is also addressed, taking into consideration the increasing application of next-generation sequencing and bioinformatics for known and previously unrecognized viroids. PMID:25216773

  20. Engineered barriers: current status 1989

    International Nuclear Information System (INIS)

    This report summarises the current state of research relevant to assessing the performance of engineered barriers made of steel and concrete in radioactive waste repositories. The objective of these barriers is to contain substantially the radionuclides within them by providing both physical and chemical impediment to their release. The physical barriers are of most value for highly soluble isotopes with relatively short half-lives (eg 137Cs), since they can provide a measure of containment until a large fraction of the activity has decayed. In addition they can facilitate retrievability for some period after disposal. The chemical barriers operate by beneficial conditioning of the near field groundwater and providing sites for sorption of radionuclides. Both of these reduce the aqueous concentration of radionuclides in the near field. (author)

  1. REACH and nanomaterials: current status

    International Nuclear Information System (INIS)

    New challenges for regulators are emerging about a specific assessment and appropriate management of the potential risks of nanomaterials. In the framework of European legislation on chemicals, Regulation (EC) No. 1907/2006 REACH aims to ensure the safety of human health and the environment through the collection of information on the physico-chemical characteristics of the substances and on their profile (eco) toxicological and the identification of appropriate risk management linked to 'exposure to these substances without impeding scientific progress and the competitiveness of industry. In order to cover the current shortage of information on the safety of nanomaterials and tackle the acknowledged legal vacuum, are being a rich activities, carried out both by regulators both by stake holders, and discussions on the proposals for adapting the European regulatory framework for chemicals . The European Commission is geared to strengthen the REACH Regulation by means of updates of its annexes. The importance of responding to the regulatory requirements has highlighted the need for cooperation between European organizations, scientists and industries to promote and ensure the safe use of nanomaterials.

  2. Nanodosimetry: Principle and Current Status

    Science.gov (United States)

    Schulte, Reinhard W.

    2011-05-01

    Due to the success of theoretical track structure Monte Carlo simulations, showing that features of ionization patterns on the nanometer level are important for the biological effectiveness of ionizing radiation, several new methods for experimental track structure investigations have been developed in recent years. These methods all use the principle of density scaling in low-pressure gas to probe track structure in macroscopic dimensions, ideally with single-ionization resolution. The new field of experimental track structure investigation, which has been called nanodosimetry, can be approached in two ways: (1) the number of ionizations in a defined, ideally wall-less, sensitive volume is registered per single primary particle and cluster size distributions are obtained, or (2) the full track structure of an ion track segment is "imaged". Existing nanodosimetric methods are based on the first approach, but a track structure imaging detector is currently under development at Loma Linda University. This contribution will review the principle and existing technical approaches to nanodosimetry and will give an outlook on future developments and applications.

  3. Nanodosimetry: Principle and Current Status

    International Nuclear Information System (INIS)

    Due to the success of theoretical track structure Monte Carlo simulations, showing that features of ionization patterns on the nanometer level are important for the biological effectiveness of ionizing radiation, several new methods for experimental track structure investigations have been developed in recent years. These methods all use the principle of density scaling in low-pressure gas to probe track structure in macroscopic dimensions, ideally with single-ionization resolution. The new field of experimental track structure investigation, which has been called nanodosimetry, can be approached in two ways: (1) the number of ionizations in a defined, ideally wall-less, sensitive volume is registered per single primary particle and cluster size distributions are obtained, or (2) the full track structure of an ion track segment is 'imaged'. Existing nanodosimetric methods are based on the first approach, but a track structure imaging detector is currently under development at Loma Linda University. This contribution will review the principle and existing technical approaches to nanodosimetry and will give an outlook on future developments and applications.

  4. rasdaman Array Database: current status

    Science.gov (United States)

    Merticariu, George; Toader, Alexandru

    2015-04-01

    rasdaman (Raster Data Manager) is a Free Open Source Array Database Management System which provides functionality for storing and processing massive amounts of raster data in the form of multidimensional arrays. The user can access, process and delete the data using SQL. The key features of rasdaman are: flexibility (datasets of any dimensionality can be processed with the help of SQL queries), scalability (rasdaman's distributed architecture enables it to seamlessly run on cloud infrastructures while offering an increase in performance with the increase of computation resources), performance (real-time access, processing, mixing and filtering of arrays of any dimensionality) and reliability (legacy communication protocol replaced with a new one based on cutting edge technology - Google Protocol Buffers and ZeroMQ). Among the data with which the system works, we can count 1D time series, 2D remote sensing imagery, 3D image time series, 3D geophysical data, and 4D atmospheric and climate data. Most of these representations cannot be stored only in the form of raw arrays, as the location information of the contents is also important for having a correct geoposition on Earth. This is defined by ISO 19123 as coverage data. rasdaman provides coverage data support through the Petascope service. Extensions were added on top of rasdaman in order to provide support for the Geoscience community. The following OGC standards are currently supported: Web Map Service (WMS), Web Coverage Service (WCS), and Web Coverage Processing Service (WCPS). The Web Map Service is an extension which provides zoom and pan navigation over images provided by a map server. Starting with version 9.1, rasdaman supports WMS version 1.3. The Web Coverage Service provides capabilities for downloading multi-dimensional coverage data. Support is also provided for several extensions of this service: Subsetting Extension, Scaling Extension, and, starting with version 9.1, Transaction Extension, which

  5. Current research status of radioimmunotherapy monoclonal antibody drug

    International Nuclear Information System (INIS)

    Radioimmunotherapy (RIT) was one of the most important progresses in the field of cancer therapy over the past 20 years. It has been successfully applied in the treatment of blood system tumors such as NHL. For the utilization of RIT in therapy of solid tumors, however, development of more effective monoclonal antibodies, labeling methods and so on are needed. The current status of radionuclides, monoclonal antibodies and drugs commonly used in the RIT were briefly reviewed. (authors)

  6. Current status of the AUSTRON project

    International Nuclear Information System (INIS)

    The current status of the AUSTRON spallation source project is described with reference to the need for neutrons in Europe and - due to a certain West-East imbalance of large research facilities - especially in Central Europe. A short overview about technical aspects of proton accelerator, rapid cycling synchrotron, storage ring, target and instrumentation is presented. (author)

  7. Current Status of Radioisotope Applications in Defence

    Directory of Open Access Journals (Sweden)

    P. K. Bhatnagar

    1987-07-01

    Full Text Available Reviews the current status of radioisotope applications in Defence- R&D Establishments, Defence Inspectorates, Ordnance Factories, Public Sector Undertakings under the Defence Ministry, Army, Navy and Air Force Establishments and Military Hospitals. It also lists the users of film badge service in Defence. Training programmes in radioisotope applications in Defence conducted by DRDO organisations have also been highlighted.

  8. ATM in Europe: analysis of current status

    DEFF Research Database (Denmark)

    1999-01-01

    This deliverable provides an overview of the current status of the European market for ATM services. The offer of ATM services by principal operators in Belgium, Denmark, Finland, France, Germany, Greece, Italy, Norway, Portugal, Spain, Sweden and United Kingdom is described. In addition, a number...... of international providers of ATM in Europe are presented....

  9. Anal cancer: current and future treatment strategies

    Directory of Open Access Journals (Sweden)

    Chin JY

    2013-01-01

    Full Text Available Joanna Y Chin, Theodore S Hong, Jennifer Y WoDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USAAbstract: Anal cancer is a relatively rare malignancy, accounting for approximately 2% of gastrointestinal cancers. Concurrent chemoradiation with 5-fluorouracil/mitomycin remains the standard of care for the treatment of anal cancer. There is currently no proven role for platinum-based induction or adjuvant chemotherapy in anal cancer, even in cases of bulky disease. Multiple trials have shown that radiosensitization with concurrent chemotherapy is beneficial over radiation alone, and in particular, efforts to remove or substitute mitomycin from the chemoradiation regimen have been unsuccessful. Because local-regional control remains a challenge in the management of anal cancer, future studies will need to focus on radiation dose-escalation and/or addition of further chemotherapy or targeted agents. Patient selection, eg, with PET-CT or with biomarkers including HPV status, may be necessary to define patients who need more aggressive local treatment, ie, for patients with bulky disease, or to de-escalate treatment in others, ie, patients with early-stage, localized cancer.Keywords: anal cancer, chemoradiation, IMRT

  10. Current status of neutron scattering in Thailand

    International Nuclear Information System (INIS)

    The current neutron powder diffractometer at the Thai Research Reactor-1/Modification 1 (TRR-1/M1) has been modified from the obsolete neutron diffractometer which had been used during 1968-1975. The upgraded diffractometer has medium resolution and is appropriate for studying samples with small unit cell dimensions and training university students in the field of neutron scattering. This paper describes the current activities of neutron scattering research in Thailand, the current status of a new research reactor project at Ongkarak for enlarging the perspectives of its utilization in the future as well as the organizational reformation of the Office of Atomic Energy for Peace (OAEP). (author)

  11. Current management of oral cancer

    Institute of Scientific and Technical Information of China (English)

    Robert Ord

    2008-01-01

    @@ This presentation will summarize some of the current areas of interest in the management of oral cancer. The presentation will be divided into a brief review of epidemiology and diagnosis, with a more extensive discussion regarding the controversial areas in surgery and a review of the adjuvant roles of radiation and chemotherapy.

  12. Current status of the DARPA Quantum Network

    OpenAIRE

    Elliott, Chip; Colvin, Alexander; Pearson, David; Pikalo, Oleksiy; Schlafer, John; Yeh, Henry

    2005-01-01

    This paper reports the current status of the DARPA Quantum Network, which became fully operational in BBN's laboratory in October 2003, and has been continuously running in 6 nodes operating through telecommunications fiber between Harvard University, Boston University, and BBN since June 2004. The DARPA Quantum Network is the world's first quantum cryptography network, and perhaps also the first QKD systems providing continuous operation across a metropolitan area. Four more nodes are now be...

  13. Current status of the DARPA Quantum Network

    CERN Document Server

    Elliott, C; Pearson, D; Pikalo, O; Schlafer, J; Yeh, H; Elliott, Chip; Colvin, Alexander; Pearson, David; Pikalo, Oleksiy; Schlafer, John; Yeh, Henry

    2005-01-01

    This paper reports the current status of the DARPA Quantum Network, which became fully operational in BBN's laboratory in October 2003, and has been continuously running in 6 nodes operating through telecommunications fiber between Harvard University, Boston University, and BBN since June 2004. The DARPA Quantum Network is the world's first quantum cryptography network, and perhaps also the first QKD systems providing continuous operation across a metropolitan area. Four more nodes are now being added to bring the total to 10 QKD nodes. This network supports a variety of QKD technologies, including phase-modulated lasers through fiber, entanglement through fiber, and freespace QKD. We provide a basic introduction and rational for this network, discuss the February 2005 status of the various QKD hardware suites and software systems in the network, and describe our operational experience with the DARPA Quantum Network to date. We conclude with a discussion of our ongoing work.

  14. Gravitational wave astronomy: the current status

    CERN Document Server

    Blair, David; Zhao, Chunnong; Wen, Linqing; Chu, Qi; Fang, Qi; Cai, RongGen; Gao, JiangRui; Lin, XueChun; Liu, Dong; Wu, Ling-An; Zhu, ZongHong; Reitze, David H; Arai, Koji; Zhang, Fan; Flaminio, Raffaele; Zhu, Xingjiang; Hobbs, George; Manchester, Richard N; Shannon, Ryan M; Baccigalupi, Carlo; Xu, Peng; Bian, Xing; Cao, Zhoujian; Chang, ZiJing; Dong, Peng; Gong, XueFei; Huang, ShuangLin; Ju, Peng; Luo, ZiRen; Qiang, Li'E; Tang, WenLin; Wan, XiaoYun; Wang, Yue; Xu, ShengNian; Zhang, YunLong; Zhang, HaiPeng; Lau, Yun-Kau; Ni, Wei-Tou

    2016-01-01

    In the centenary year of Einstein's General Theory of Relativity, this paper reviews the current status of gravitational wave astronomy across a spectrum which stretches from attohertz to kilohertz frequencies. Sect. 1 of this paper reviews the historical development of gravitational wave astronomy from Einstein's first prediction to our current understanding the spectrum. It is shown that detection of signals in the audio frequency spectrum can be expected very soon, and that a north-south pair of next generation detectors would provide large scientific benefits. Sect. 2 reviews the theory of gravitational waves and the principles of detection using laser interferometry. The state of the art Advanced LIGO detectors are then described. These detectors have a high chance of detecting the first events in the near future. Sect. 3 reviews the KAGRA detector currently under development in Japan, which will be the first laser interferometer detector to use cryogenic test masses. Sect. 4 of this paper reviews gravit...

  15. Current status of robot-assisted gastric surgery

    Directory of Open Access Journals (Sweden)

    Se-Jin Baek

    2011-01-01

    Full Text Available In an effort to minimize the limitations of laparoscopy, a robotic surgery system was introduced, but its role for gastric cancer is still unclear. The objective of this article is to assess the current status of robotic surgery for gastric cancer and to predict future prospects. Although the current study was limited by its small number of patients and retrospective nature, robot-assisted gastrectomy with lymphadenectomy for the treatment of gastric cancer is a feasible and safe procedure for experienced laparoscopic surgeons. Most studies have reported satisfactory results for postoperative short-term coutcomes, such as: postoperative oral feeding, gas out, hospital stay and complications, compared with laparoscopic surgery; the difference is a longer operation time. However, robotic surgery showed a shallow learning curve compared with the familarity of conventional open surgery; after the accumulation of several cases, robotic surgery could be expected to result in a similar operation time. Robotic-assisted gastrectomy can expand the indications of minimally invasive surgery to include advanced gastric cancer by improving the ability to perform lymphadenectomy. Moreover, ”total” robotic gastrectomy can be facilitated using a robot-sewing technique and gastric submucosal tumors near the gastroesophageal junction or pylorus can be resected safely by this novel technique. In conclusion, robot-assisted gastrectomy may offer a good alternative to conventional open or laparoscopic surgery for gastric cancer, provided that long-term oncologic outcomes can be confirmed.

  16. Current status and installation of dental PACS

    International Nuclear Information System (INIS)

    Picture Archiving and Communication System (PACS) is difficult to implement in the best of situations, but evidence is growing that the benefits are significant. The aims of this study are to analyze the current status of full PACS and establish successful installation standard of dental PACS. Materials and Methods were based on the investigation of current working status and installation standard of PACS, and observation of variable issues to installation of dental PACS. By September 30, 2004, full PACS implementations in their facilities were 88.1% in specialized general hospitals (37 installations out of total 42 hospitals), 59.8% in general hospitals (144 installations out of total 241 hospitals), 12.3% in medical hospitals (116 installations out of total 941 hospitals) and 3.6% in dental hospitals (4 installations out of total 110 hospitals). Only 4 university dental hospitals currently have installed and are operating full PACS. Major obstacle to wide spread of dental PACS is initial high investments. Clinical environments of dental PACS differed from medical situation. Because of characteristic dental practice, the initial investments for dental PACS are generally much greater than those of medical PACS. Also new economic crisis makes users scruple. The best way to overcome these limitations is to establish an economic installation standard for dental PACS. Also the clear technical communication between the customer and the supplier before both sides are committed to the obstacles are critical to its success.

  17. Current Status of Nuclear Physics Research

    OpenAIRE

    Bertulani, C.A.; Hussein, M. S.

    2015-01-01

    In this review we discuss the current status of research in nuclear physics which is being carried out in different centers in the World. For this purpose we supply a short account of the development in the area which evolved over the last 9 decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data become available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such a...

  18. Current status of neutron scattering in Thailand

    Energy Technology Data Exchange (ETDEWEB)

    Ampornrat, Pantip [Nuclear Material Sciences Section, Physics Division, Office of Atomic Energy for Peace, Bangkok (Thailand)

    2000-10-01

    The neutron scattering experiments in Thailand have been done continuously since the start up of the reactor. In 1977, Thai research reactor was modified into TRIGA MARK III core. After that, the neutron spectrometer was installed again under a development program. Installation of upgrading spectrometer was delayed because of some problems involving the neutron intensity and instruments. However, these problems were solved and the setup is almost completed. The paper reports the current status of neutron spectrometer, the problems and plans for the experiments. (author)

  19. The current status of observational cosmology

    Indian Academy of Sciences (India)

    Jeremiah P Ostriker; Tarun Souradeep

    2004-10-01

    Observational cosmology has indeed made very rapid progress in recent years. The ability to quantify the universe has largely improved due to observational constraints coming from structure formation. The transition to precision cosmology has been spearheaded by measurements of the anisotropy in the cosmic microwave background (CMB) over the past decade. Observations of the large scale structure in the distribution of galaxies, high red-shift supernova, have provided the required complementary information. We review the current status of cosmological parameter estimates from joint analysis of CMB anisotropy and large scale structure (LSS) data. We also sound a note of caution on overstating the successes achieved thus far.

  20. Current status of neutron scattering in Thailand

    International Nuclear Information System (INIS)

    The neutron scattering experiments in Thailand have been done continuously since the start up of the reactor. In 1977, Thai research reactor was modified into TRIGA MARK III core. After that, the neutron spectrometer was installed again under a development program. Installation of upgrading spectrometer was delayed because of some problems involving the neutron intensity and instruments. However, these problems were solved and the setup is almost completed. The paper reports the current status of neutron spectrometer, the problems and plans for the experiments. (author)

  1. The ENIQ pilot study: current status

    Energy Technology Data Exchange (ETDEWEB)

    Lemaitre, P.; Eriksen, B.; Crutzen, S. [European Commission, DG Joint Research Centre, Petten (Netherlands); Hansch, M. [Preussische Elektrizitaets-AG (Preussenelektra), Hannover (Germany); Whittle, J. [AEA Technology, Warrington (United Kingdom)

    1998-11-01

    A pilot study is currently being carried out by ENIQ (European Network for Inspection Qualification) in order to explore the issues involved in inspection qualification applied along the general principles of the European methodology. The components selected for the pilot study are austenitic pipe to pipe and pipe to elbows welds typical of those in BWR recirculation loops. A range of defect parameters has been defined. A suitable inspection procedure designed to find the designated defects will be applied to geometrically representative test pieces. The procedure/equipment will be qualified through open trials and technical justification. The personnel qualification will be done in a blind way. Once all features of the inspection system will have been qualified an in-service inspection will be simulated in order to test the feasibility of the qualification approach followed. In this paper the current status of this pilot study is discussed. (orig.)

  2. The ENIQ pilot study: current status

    International Nuclear Information System (INIS)

    A pilot study is currently being carried out by ENIQ (European Network for Inspection Qualification) in order to explore the issues involved in inspection qualification applied along the general principles of the European methodology. The components selected for the pilot study are austenitic pipe to pipe and pipe to elbows welds typical of those in BWR recirculation loops. A range of defect parameters has been defined. A suitable inspection procedure designed to find the designated defects will be applied to geometrically representative test pieces. The procedure/equipment will be qualified through open trials and technical justification. The personnel qualification will be done in a blind way. Once all features of the inspection system will have been qualified an in-service inspection will be simulated in order to test the feasibility of the qualification approach followed. In this paper the current status of this pilot study is discussed. (orig.)

  3. Current status of respiratory nuclear medicine

    International Nuclear Information System (INIS)

    Multimodality image fusion is now becoming popular in respiratory nuclear medical field, since scintigraphic diagnosis, based on functional image interpretation, becomes more accurate and meaningful when supported by corresponding anatomical data. Although SPECT/PET scanner-mounted X-ray tomographic systems are now being introduced for an accurate image fusion in the chest, the use of a fully automatic multi-modality image fusion algorithm may be an alternative method. Our initial attempt of this algorithm for fusion imaging of Tc-99m MAA perfusion or thallium-201 SPECT and helical CT scan has contributed to accurate interpretation of the results without user interaction, and has facilitated the understanding of the functional basis of lung parenchymal CT attenuation changes. Three-dimensional displays with functional mapping are also now being increasingly introduced to various respiratory nuclear studies. A fractal analysis has shown successful results in the analysis of technegas and 99mTc-MAA perfusion images, which will be increasingly applied for more objective assessment of the results. The feasibility of 18F-FDG PET scan in accurate staging of lung cancer and the good cost performance of this method in lung cancer strategy are repeatedly stressed by the recent studies. The feasibility of 99mTc-MAA perfusion scan in the evaluation of right-to-left shunt in patients with hepatopulmonary syndrome, and the potential of 123I-MIBG scan in the evaluation of the function status of pulmonary neuroadrenergic system are new aspects for these well established tracers. There is the first attempt of intraoperative 99mTc-colloid sentinel lymph node mapping in patients with resectable non-small cell lung cancer. This may improve the precision of pathologic staging and limit the need for mediastinal node dissection in selected patients. Radiolabeled aerosol lung scintigraphy is being increasingly applied to evaluate lung deposition of various aerosolized, therapeutic drugs

  4. Nutritional status assessment in colorectal cancer patients

    OpenAIRE

    Joana Pedro Lopes; Paula Manuela de Castro Cardoso Pereira; Ana Filipa dos Reis Baltazar Vicente; Alexandra Bernardo; María Fernanda de Mesquita

    2013-01-01

    The present study intended to evaluate the nutritional status of Portuguese colorectal patients and associated it with surgery type as well as quality of life outcomes. Malnutrition can affect up to 85% of cancer patients and specifically 30-60% in colorectal cancer and can significantly influence health outcomes. A sample of 50 colorectal cancer patients was evaluated in what refers to several anthropometric measures, food intake, clinical history, complications rate before and after surgery...

  5. Gravitational wave astronomy: the current status

    Science.gov (United States)

    Blair, David; Ju, Li; Zhao, ChunNong; Wen, LinQing; Chu, Qi; Fang, Qi; Cai, RongGen; Gao, JiangRui; Lin, XueChun; Liu, Dong; Wu, Ling-An; Zhu, ZongHong; Reitze, David H.; Arai, Koji; Zhang, Fan; Flaminio, Raffaele; Zhu, XingJiang; Hobbs, George; Manchester, Richard N.; Shannon, Ryan M.; Baccigalupi, Carlo; Gao, Wei; Xu, Peng; Bian, Xing; Cao, ZhouJian; Chang, ZiJing; Dong, Peng; Gong, XueFei; Huang, ShuangLin; Ju, Peng; Luo, ZiRen; Qiang, Li'E.; Tang, WenLin; Wan, XiaoYun; Wang, Yue; Xu, ShengNian; Zang, YunLong; Zhang, HaiPeng; Lau, Yun-Kau; Ni, Wei-Tou

    2015-12-01

    In the centenary year of Einstein's General Theory of Relativity, this paper reviews the current status of gravitational wave astronomy across a spectrum which stretches from attohertz to kilohertz frequencies. Sect. 1 of this paper reviews the historical development of gravitational wave astronomy from Einstein's first prediction to our current understanding the spectrum. It is shown that detection of signals in the audio frequency spectrum can be expected very soon, and that a north-south pair of next generation detectors would provide large scientific benefits. Sect. 2 reviews the theory of gravitational waves and the principles of detection using laser interferometry. The state of the art Advanced LIGO detectors are then described. These detectors have a high chance of detecting the first events in the near future. Sect. 3 reviews the KAGRA detector currently under development in Japan, which will be the first laser interferometer detector to use cryogenic test masses. Sect. 4 of this paper reviews gravitational wave detection in the nanohertz frequency band using the technique of pulsar timing. Sect. 5 reviews the status of gravitational wave detection in the attohertz frequency band, detectable in the polarisation of the cosmic microwave background, and discusses the prospects for detection of primordial waves from the big bang. The techniques described in sects. 1-5 have already placed significant limits on the strength of gravitational wave sources. Sects. 6 and 7 review ambitious plans for future space based gravitational wave detectors in the millihertz frequency band. Sect. 6 presents a roadmap for development of space based gravitational wave detectors by China while sect. 7 discusses a key enabling technology for space interferometry known as time delay interferometry.

  6. The current status of the treatment for T4 maxillary sinus cancer in Japan. A multi-institutional retrospective observation study

    International Nuclear Information System (INIS)

    The purpose of this study was to assess the current status in Japan of the treatment for squamous cell carcinoma of the T4 maxillary sinus (MS-SCC) and its use to plan clinical trials in the future. The data for 128 patients with previously untreated MS-SCC were obtained from 28 institutions from 2006 to 2007. Of the 128 patients, 118 patients with curative intent were included in an analysis of the treatment and its results. Of the 118 patients, 73 patients had T4a disease, and 45 with T4b. Thirty-nine patients (33.1%) were treated with total maxillectomy, 25 (21.2%) with partial maxillectomy, 22 patients (18.6%) with RADPLAT, 19 patients (16.1%) with IV-CRT, and 13 patients (11.0%) with others. The 5-year overall survival rate and local control rate for 118 patients were 49.8% and 48.9%, respectively. The 5-year overall survival rates for patients with T4aN0M0 and T4bN0M0 were 67.5% and 29.8%, respectively. This study was retrospective, but we could understand the tendency of treatment choice and treatment results. It will be useful information to plan clinical trials in the future. (author)

  7. Current status of neutron capture therapy

    International Nuclear Information System (INIS)

    There are about 6000 new glioblastoma multiform brain tumours diagnosed each year in the United States of America alone. This cancer is usually fatal within six months of diagnosis even with current standard treatments. Research on boron neutron capture therapy (BNCT) has been considered as a method of potentially curing such cancers. There is a great interest at under-utilised research reactors institutions to identify new medical utilization, attractive to the general public. Neutron capture therapy is a true multidisciplinary topic with a large variety of individuals involved. This publication attempts to provide current information for all those thinking about being involved with NCT, based on the knowledge and experience of those who have pioneered the treatment. It covers the whole range of NCT from designing reactor conversions or new facilities, through to clinical trials and their effectiveness. However, since most work has been done with boron capture therapy for brain tumours using modified thermal research reactors, this tends to be the focus of the report. One of the factors which need to be addressed at the beginning is the timing of the further development of NCT facilities. It should be emphasised that all current work is still at the research stage. Many of those now involved believe that there is little need for many more research facilities until such time as the treatment shows more promising results. For this and other reasons discussed in the report, very serious consideration should be given by research reactor owners and operators before spending large sums of money converting their facilities for NCT

  8. Current status of NDC fuel hot laboratory

    Energy Technology Data Exchange (ETDEWEB)

    Yamaguchi, Youichirou; Matsuoka, Takanori; Shiraishi, Satoshi [Nuclear Development Corp., Tokai, Ibaraki (Japan); Sugano, Mitsuteru

    1999-09-01

    Nuclear Development Corporation (NDC) fuel hot laboratory was established to investigate the causes for leaked rods and to confirm the integrity of the precedence irradiation fuels, in 1986. After that, it obtained a license to conduct PIE of the structural materials, such as stainless steels, inside the reactor in addition to fuels. So far we have conducted PIE of fuels and metallic materials including fuel assembly components and reactor internal components irradiated in Japanese PWR plants or some test reactors. To meet these PIE needs, we are making efforts to improve facilities and to install high advanced equipments. This paper describes current status of the facilities and PIE techniques in NDC fuel hot laboratory. (author)

  9. Current status of Pohang Neutron Facility

    Energy Technology Data Exchange (ETDEWEB)

    Kim, G.N.; Lee, Y.S.; Cho, M.H. [Pohang Accelerator Laboratory, POSTECH, Pohang (KR)] [and others

    2000-03-01

    We present the current status of Pohang Neutron Facility, which is the pulsed neutron facility, based on the 70-MeV electron linear accelerator completed on Dec.1997. We have prepared the 15-m time-of-flight path, a Ta-target system, and the Data Acquisition System. Meanwhile we have measured the total cross-sections of Dy and Hf samples at the Research Reactor Institute, Kyoto University and the neutron capture cross-sections of {sup 164}Dy isotope at Research Laboratory for Nuclear Reactors, Tokyo Institute of Technology both in Japan. We also were participated the experiment at the 122-m flight path of the IBR-30 pulsed neutron source of Joint Institute of Nuclear Research in Dubna, Russia. (author)

  10. Interventional Radiology of Male Varicocele: Current Status

    Energy Technology Data Exchange (ETDEWEB)

    Iaccarino, Vittorio, E-mail: vittorio.iaccarino@unina.it; Venetucci, Pietro [University of Naples ' Federico II' , Diagnostic Imaging Department-Cardiovascular and Interventional Radiology, School of Medicine (Italy)

    2012-12-15

    Varicocele is a fairly common condition in male individuals. Although a minor disease, it may cause infertility and testicular pain. Consequently, it has high health and social impact. Here we review the current status of interventional radiology of male varicocele. We describe the radiological anatomy of gonadal veins and the clinical aspects of male varicocele, particularly the physical examination, which includes a new clinical and ultrasound Doppler maneuver. The surgical and radiological treatment options are also described with the focus on retrograde and antegrade sclerotherapy, together with our long experience with these procedures. Last, we compare the outcomes, recurrence and persistence rates, complications, procedure time and cost-effectiveness of each method. It clearly emerges from this analysis that there is a need for randomized multicentre trials designed to compare the various surgical and percutaneous techniques, all of which are aimed at occlusion of the anterior pampiniform plexus.

  11. Current surgical status of thyroid diseases.

    Science.gov (United States)

    Touzopoulos, Panagiotis; Karanikas, Michael; Zarogoulidis, Paul; Mitrakas, Alexandros; Porpodis, Konstantinos; Katsikogiannis, Nikolaos; Zervas, Vasilis; Kouroumichakis, Ioannis; Constantinidis, Theodoros C; Mikroulis, Dimitrios; Tsimogiannis, Konstantinos E

    2011-01-01

    Thyroid nodules are a common clinical problem for surgeons. The clinical importance of nodules is the need to exclude thyroid cancer, which occurs in 5%-15% of patients. If fine needle aspiration cytology is positive, or suspicious for malignancy, surgery is recommended. During the past decade, with the tendency to develop smaller incisions, an endoscopic approach has been applied to thyroid surgery, called minimally invasive video-assisted thyroidectomy. This approach was immediately followed by other minimally invasive or scarless neck techniques, such as the breast approach, axillary-breast approach, and robot-assisted method. All these techniques follow the same principles of surgery and oncology. This review presents the current surgical management of the thyroid gland, including the surgical techniques and compares them by describing benefits and drawbacks of each one. PMID:22247619

  12. Current surgical status of thyroid diseases

    Directory of Open Access Journals (Sweden)

    Touzopoulos P

    2011-12-01

    Full Text Available Panagiotis Touzopoulos1, Michael Karanikas1, Paul Zarogoulidis2, Alexandros Mitrakas1, Konstantinos Porpodis2, Nikolaos Katsikogiannis3, Vasilis Zervas2, Ioannis Kouroumichakis4, Theodoros C Constantinidis5, Dimitrios Mikroulis6, Konstantinos E Tsimogiannis71First Surgery Department, University General Hospital of Alexandroupolis, Democritus University of Alexandroupolis, Greece; 2Pulmonary Department, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Greece; 3Surgery Department (NHS, University General Hospital of Alexandroupolis, Greece; 4Second Internal Medicine Department, University General Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece; 5Medical School, Laboratory of Hygiene and Environmental Protection, Democritus University of Thrace, Regional Laboratory of Public Health, Eastern Macedonia-Thrace, Greece; 6Cardiothoracic Surgery Department, General University Hospital of Alexandroupolis, Democritus University of Thrace, Greece; 7Surgery Department, "G. Hatzikosta" General Hospital of Ioannina, GreeceAbstract: Thyroid nodules are a common clinical problem for surgeons. The clinical importance of nodules is the need to exclude thyroid cancer, which occurs in 5%–15% of patients. If fine needle aspiration cytology is positive, or suspicious for malignancy, surgery is recommended. During the past decade, with the tendency to develop smaller incisions, an endoscopic approach has been applied to thyroid surgery, called minimally invasive video-assisted thyroidectomy. This approach was immediately followed by other minimally invasive or scarless neck techniques, such as the breast approach, axillary-breast approach, and robot-assisted method. All these techniques follow the same principles of surgery and oncology. This review presents the current surgical management of the thyroid gland, including the surgical techniques and compares them by describing benefits and drawbacks of

  13. Current Status of Nuclear Physics Research

    CERN Document Server

    Bertulani, C A

    2015-01-01

    In this review we discuss the current status of research in nuclear physics which is being carried out in different centers in the World. For this purpose we supply a short account of the development in the area which evolved over the last 9 decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data become available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such as the shell model, the collective model, the statistical model, the interacting boson model, etc., some of these models may be seemingly in conflict with each other, but this was shown to be only apparent. The richness of the ideas and abundance of theoretical models attests to the important fact that the nucleus is a really singular system in the sense that it evolves from two-body bound states such as the deuteron, to few-body bound states, such as $^4$He, $^7$Li, $^9$Be etc. and up the ladder to heavier bound nuclei co...

  14. Chinese Soybean Industry: Current Status and Outlook

    Institute of Scientific and Technical Information of China (English)

    Dachuan Liu; Shaojun Tian

    2002-01-01

    This paper focus on the soybeanresources and their industry development inChina. Due to the high demand in domesticmarket, it is necessary to expand the cultivationarea and improve the production yields.Meanwhile, to inc e the export of soybeansfrom overseas is also important. China has along history in producing traditional soyfoods. After recent fifty years, the developmentof Chinese soybean industry has reached to areasonable level. The current status of Chinesesoybean industry has been included in thepaper. It has been expected that in next fiveyears, there will be a rapid increase in theprocessing of soybeans; it will become morereasonable in the scale and distribution ofsoybean oil factories. Emphasis will be put onthe improvement of the functionalities ofsoybean products. Different kinds of functionalsoybean foods, especially the soybean proteinsfor particular uses will be developed by the useof modification technologies. Concern is alsogiven to the multi -utilizn of soybeanresources, which not only the extractionof oil from soybean and the processingof protein products from the meal; but alsoincludes the recovery of the naturalchemicals from soybeans which could then beexploited to novel products with more profits.

  15. Current status in diabetic macular edema treatments.

    Science.gov (United States)

    Romero-Aroca, Pedro

    2013-10-15

    Diabetes is a serious chronic condition, which increase the risk of cardiovascular diseases, kidney failure and nerve damage leading to amputation. Furthermore the ocular complications include diabetic macular edema, is the leading cause of blindness among adults in the industrialized countries. Today, blindness from diabetic macular edema is largely preventable with timely detection and appropriate interventional therapy. The treatment should include an optimized control of glycemia, arterial tension, lipids and renal status. The photocoagulation laser is currently restricted to focal macular edema in some countries, but due the high cost of intravitreal drugs, the use of laser treatment for focal and diffuse diabetic macular edema (DME), can be valid as gold standard in many countries. The intravitreal anti vascular endothelial growth factor drugs (ranibizumab and bevacizumab), are indicated in the treatment of all types of DME, but the correct protocol for administration should be defined for the different Retina Scientific Societies. The corticosteroids for diffuse DME, has a place in pseudophakic patients, but its complications restricted the use of these drugs for some patients. Finally the intravitreal interface plays an important role and its exploration is mandatory in all DME patients. PMID:24147200

  16. Radiopharmaceuticals in China. Current status and prospects

    Energy Technology Data Exchange (ETDEWEB)

    Jia, Hong-Mei; Liu, Bo-Li [Beijing Normal Univ. (China). Key Laboratory of Radiopharmaceuticals

    2014-04-01

    The review provides an overview of the current status of radiopharmaceuticals in China for in vivo clinical use and also describes some important advances in the past three decades. Development of the diagnostic and therapeutic radiopharmaceuticals as well as basic research on radiopharmaceutical chemistry are being introduced. The radiotracers developed in China include: (1) Brain perfusion imaging agents and CNS radiotracers for β-amyloid plaques, σ{sub 1} receptors, and dopamine D{sub 2} or D{sub 4} receptors; (2) {sup 99m}Tc- and {sup 18}F-labeled myocardial perfusion imaging agents; (3) tumor imaging agents including integrin-targeting radiotracer, novel sentinel lymph node imaging agents, hypoxia imaging agents, {sup 99m}Tc-labeled glucose derivatives, σ{sub 2} receptor imaging agents, folate receptor imaging agents, and potential radiotracers for imaging of human telomerase reverse transcriptase expression; (4) Potential infection imaging agents; (5) Potential asialoglycoprotein receptor imaging agents; (6) Other imaging agents. Moreover, some prospects of research and development of radiopharmaceuticals in the near future are discussed. (orig.)

  17. Current status of ITER EC design

    International Nuclear Information System (INIS)

    The ITER-FEAT Electron Cyclotron System employs one equatorial launcher and three upper port launchers to inject 20 + 20 MW of mm-wave power at 170 GHz through slots in the plasma-facing neutron and radiation shield. The equatorial launcher includes 3 sets of toroidally steer-able mirrors, each collecting 8 RF beams from 24 circular cross-section corrugated wave-guides. In the upper-port launcher, eight beams, reflected in pairs by four toroidally angled (∼30 angle) and poloidally steer-able (∼ 10 angle) mirrors focus of the RF power on the plasma m = 2 and m = 3/2 plasma flux rational surfaces, for neo-classical tearing mode(s) (NTM) control. Conceptual studies of remote steering that would possibly allow removing the beam- steering equipment from the vacuum vessel and locating them in more protected positions have been carried out. All EC wave transmission is based on low losses circular cross section corrugated and evacuated wave guides each connected to a 170 GHz, 1 MW CW Gyrotron tube oscillator featuring an overall efficiency of ∼ 50%, obtained by depressed-collector energy recovery. In the paper, requirements, issues and the current status of the design is reviewed. (authors)

  18. Current status in diabetic macular edema treatments

    Institute of Scientific and Technical Information of China (English)

    Pedro; Romero-Aroca

    2013-01-01

    Diabetes is a serious chronic condition,which increase the risk of cardiovascular diseases,kidney failure and nerve damage leading to amputation.Furthermore the ocular complications include diabetic macular edema,is the leading cause of blindness among adults in the industrialized countries.Today,blindness from diabetic macular edema is largely preventable with timely detection and appropriate interventional therapy.The treatment should include an optimized control of glycemia,arterial tension,lipids and renal status.The photocoagulation laser is currently restricted to focal macular edema in some countries,but due the high cost of intravitreal drugs,the use of laser treatment for focal and diffuse diabetic macular edema(DME),can be valid as gold standard in many countries.The intravitreal anti vascular endothelial growth factor drugs(ranibizumab and bevacizumab),are indicated in the treatment of all types of DME,but the correct protocol for administration should be defined for the different Retina Scientific Societies.The corticosteroids for diffuse DME,has a place in pseudophakic patients,but its complications restricted the use of these drugs for some patients.Finally the intravitreal interface plays an important role and its exploration is mandatory in all DME patients.

  19. IAEA occupational radiation protection programme: current status

    International Nuclear Information System (INIS)

    As stated in Art.III.A.6 of its Statute, the International Atomic Energy Agency (commonly referred to as the Agency) is authorized to establish or adopt, in consultation and, where appropriate, in collaboration with the competent organs of the United Nations and with the specialized agencies concerned, standards of safety for protection of health and minimization of danger to life and property (including such standards for labour conditions), and to provide for the application of these standards to its own operation as well as to the operations making use of materials, services, equipment, facilities, and information made available by the Agency or at its request or under its control or supervision. The Agency s Occupational Radiation Protection Programme aims at harmonizing infrastructures for the control of radiation exposure of workers and for optimizing radiation protection in situation s of exposures due to external radiation and intakes of radionuclides from both artificial and natural sources of radiation. Under its regular and technical cooperation programmes, the Agency has been assigning high priority to both the establishment of safety standards for labour conditions and for the application of these standards through, Interalia, direct assistance under its technical cooperation (TC) programme, the rendering of services, the promotion of education and training, the fostering of information exchange and the coordination of research and development. The purpose of this paper is to present the current status and future IAEA activities in support of occupational radiation protection. (authors)

  20. Current status of neutron scattering in Thailand

    International Nuclear Information System (INIS)

    The first double-axis neutron spectrometer in Thailand was installed at the Thai Research Reactor (TRR-1) in 1968. It was about a decade that this diffractometer had supported a number of the magnetic materials researches. During 1975-1977, the reactor was modified into a TRIGA MARK III type with nominal power of 2 MW. Meanwhile the diffractometer was dismantled, since then neutron scattering activities had ceased for many years. As the Office of Atomic Energy for Peace recognized the important role of neutron scattering techniques in materials research, therefore in 1992, a spectrometer upgrade program has been setup in order to improve the performance of the obsolete diffractometer. At present, installation and alignment of the diffractometer have been completed. This report gives brief description about the past activities as well as current status of the upgraded diffractometer. Additionally, the Office of Atomic Energy is in process of establishing a new Nuclear Research Center. Its main facility is a multipurpose 10 MW TRIGA reactor. The reactor will be equipped with a High Resolution Powder Diffractometer. The HRPD is anticipated to be ready for operation soon after the commission of the reactor. Feature of the HRPD including its potential utilization are also presented in this report. (author)

  1. Current Status of TRR-1/M1

    Energy Technology Data Exchange (ETDEWEB)

    Sittichai, Chaiyut [Reactor Operation Division, Office of Atomic Energy for Peace, Bangkok (Thailand)

    2000-10-01

    In 1961, the first Thai Research Reactor, TRR-1, having power of 1 MW was established. It was located at Office of Atomic Energy for Peace (OAEP) in Bangkok. TRR-1 was completely commissioned in June 1962. Plate typed high-enriched uranium (HEU) and U{sub 3}O{sub 8}-Al were used as fuel. Light water used as moderator and coolant. During 1975-1977, TRR-1 was shut down for modification. The reactor core and control system were disassembled and replaced by TRIGA Mark III. It is a circular hexagonal core typed reactor designed by General Atomics Company (GA). Afterwards, TRR-1 was officially renamed to Thai Research Reactor 1/Modification 1 (TRR-1/M1). TRR-1/M1 is a multipurpose reactor with nominal power of 2 MW. This swimming pool typed reactor uses low-enriched uranium (LEU) as fuel and light water as coolant and moderator. To date, the reactor has been operated with core No.12 that released power 1135 MWD to serve the user. The reactor has been serving for various kinds of utilization, for example, to produce radioisotope, neutron beam experiments and reactor physics experiments. This report explains in detail regarding operational experience and current status of this reactor, for example, reactor operation and reactor utilization. (author)

  2. Current Status of TRR-1/M1

    International Nuclear Information System (INIS)

    In 1961, the first Thai Research Reactor, TRR-1, having power of 1 MW was established. It was located at Office of Atomic Energy for Peace (OAEP) in Bangkok. TRR-1 was completely commissioned in June 1962. Plate typed high-enriched uranium (HEU) and U3O8-Al were used as fuel. Light water used as moderator and coolant. During 1975-1977, TRR-1 was shut down for modification. The reactor core and control system were disassembled and replaced by TRIGA Mark III. It is a circular hexagonal core typed reactor designed by General Atomics Company (GA). Afterwards, TRR-1 was officially renamed to Thai Research Reactor 1/Modification 1 (TRR-1/M1). TRR-1/M1 is a multipurpose reactor with nominal power of 2 MW. This swimming pool typed reactor uses low-enriched uranium (LEU) as fuel and light water as coolant and moderator. To date, the reactor has been operated with core No.12 that released power 1135 MWD to serve the user. The reactor has been serving for various kinds of utilization, for example, to produce radioisotope, neutron beam experiments and reactor physics experiments. This report explains in detail regarding operational experience and current status of this reactor, for example, reactor operation and reactor utilization. (author)

  3. Current status of JENDL-3.3

    Energy Technology Data Exchange (ETDEWEB)

    Hasegawa, Akira [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    1998-03-01

    Current status of JENDL-3.3 is presented. Reevaluation work toward JENDL-3.3 has started last April for three years project to supply a consolidated new versions of JENDL by JAERI NDC (Nuclear Data center) with the cooperation of JNDC (Japanese Nuclear Data Committee). The working schedule has been fixed by the careful review of the summary report, `The problems of JENDL-3.2`, submitted to JNDC last March after one year discussions by a small advisory group: `Identifying the problems of JENDL-3.2`. To cope with the problems, two new subgroups are set up in the Subcommittee of Nuclear Data of JNDC. One is Heavy Mass Elements Evaluation Working Group for the re-evaluation of major actinides (Th-232, U-233,235,236,238, Pu-236,239,241,242). The other is Intermediate Mass Elements Evaluation Working Group for solving the inconsistencies between calculations and integral experiments relating to the fields of fusion neutronics and shielding applications as well as new evaluations such as Er elements. Supplying covariance data for important nuclides are one of the main feature of JENDL-3.3. Re-evaluated data will be released as JENDL-3.3 in the individual bases after the reviewing process by the experts. (author)

  4. Current status of the SNO+ experiment

    Energy Technology Data Exchange (ETDEWEB)

    Lozza, Valentina; Krosigk, Belina von; Krueger, Felix; Schrock, Philipp; Zuber, Kai [TU Dresden, IKTP, Dresden (Germany)

    2011-07-01

    The SNO+ (Sudbury Neutrino Observatory plus scintillator) experiment is the follow up of the SNO experiment, replacing the heavy water volume with about 1000 tons of liquid scintillator (LAB) in order to shift the sensitive threshold to the low energy range. It is located in one of the mines near Sudbury at a depth of 6000 m.w.e., presently the deepest underground laboratory in the world. The natural rock shielding which reduces the cosmic muon flux to about 3 muon per hour, and the use of ultra-clean materials makes the detector suitable for neutrinos studies. The main physical goals are the detection of pep and CNO solar neutrinos, geo-neutrinos originated from radioactivity in the earth, the possible observation of neutrinos from supernova, the study of reactor oscillation. Complementing this neutrino program, SNO+ will also search for neutrinoless double beta decay. In this phase the liquid scintillator will be loaded with 0.1% natural Neodymium allowing the study of {sup 150}Nd (5.6% abundance) neutrinoless double beta decay. A review of the general SNO+ setup, the physics goals and the current status will be presented.

  5. Radiopharmaceuticals in China. Current status and prospects

    International Nuclear Information System (INIS)

    The review provides an overview of the current status of radiopharmaceuticals in China for in vivo clinical use and also describes some important advances in the past three decades. Development of the diagnostic and therapeutic radiopharmaceuticals as well as basic research on radiopharmaceutical chemistry are being introduced. The radiotracers developed in China include: (1) Brain perfusion imaging agents and CNS radiotracers for β-amyloid plaques, σ1 receptors, and dopamine D2 or D4 receptors; (2) 99mTc- and 18F-labeled myocardial perfusion imaging agents; (3) tumor imaging agents including integrin-targeting radiotracer, novel sentinel lymph node imaging agents, hypoxia imaging agents, 99mTc-labeled glucose derivatives, σ2 receptor imaging agents, folate receptor imaging agents, and potential radiotracers for imaging of human telomerase reverse transcriptase expression; (4) Potential infection imaging agents; (5) Potential asialoglycoprotein receptor imaging agents; (6) Other imaging agents. Moreover, some prospects of research and development of radiopharmaceuticals in the near future are discussed. (orig.)

  6. Current status of the SNO+ experiment

    International Nuclear Information System (INIS)

    The SNO+ (Sudbury Neutrino Observatory plus scintillator) experiment is the follow up of the SNO experiment, replacing the heavy water volume with about 1000 tons of liquid scintillator (LAB) in order to shift the sensitive threshold to the low energy range. It is located in one of the mines near Sudbury at a depth of 6000 m.w.e., presently the deepest underground laboratory in the world. The natural rock shielding which reduces the cosmic muon flux to about 3 muon per hour, and the use of ultra-clean materials makes the detector suitable for neutrinos studies. The main physical goals are the detection of pep and CNO solar neutrinos, geo-neutrinos originated from radioactivity in the earth, the possible observation of neutrinos from supernova, the study of reactor oscillation. Complementing this neutrino program, SNO+ will also search for neutrinoless double beta decay. In this phase the liquid scintillator will be loaded with 0.1% natural Neodymium allowing the study of 150Nd (5.6% abundance) neutrinoless double beta decay. A review of the general SNO+ setup, the physics goals and the current status will be presented.

  7. Current status and future perspective of PET

    International Nuclear Information System (INIS)

    Positron Emission Tomography (PET) is a nuclear medicine imaging modality that consists of systemic administration to a subject of a radiopharmaceutical labeled with a positron-emitting radionuclide. Following administration, its distribution in the organ or structure under study can be assessed as a function of time and space by (1) detecting the annihilation radiation resulting from the interaction of the positrons with matter, and (2) reconstructing the distribution of the radioactivity from a series of that used in computed tomography (CT). The nuclides most generally exhibit chemical properties that render them particularly desirable in physiological studies. The radionuclides most widely used in PET are F-18, C-11, O-15 and N-13. Regarding to the number of the current PET Centers worldwide (based on ICP data), more than 300 PET Centers were in operation in 2000. The use of PET technology grew rapidly compared to that in 1992 and 1996, particularly in the USA, which demonstrates a three-fold rise in PET installations. In 2001, 194 PET Centers were operating in the USA. In 1994, two clinical and research-oriented PET Centers at Seoul National University Hospital and Samsung Medical Center, was established as the first dedicated PET and Cyclotron machines in Korea, followed by two more PET facilities at the Korea Cancer Center Hospital, Ajou Medical Center, Yonsei University Medical Center, National Cancer Center and established their PET Center. Catholic Medical School and Pusan National University Hospital have finalized a plan to install PET machine in 2002, which results in total of nine PET Centers in Korea. Considering annual trends of PET application in four major PET centers in Korea in Asan Medical Center recent six years (from 1995 to 2000), a total of 11,564 patients have been studied every year and the number of PET studies has shown steep growth year upon year. We had, 1,020 PET patients in 1995. This number increased to 1,196, 1,756, 2,379, 3

  8. Current status of JMTR refurbishment project

    International Nuclear Information System (INIS)

    The JMTR is a light water moderated and cooled, beryllium reflected tank- type reactor using LUE silicide plate-type fuels. Its thermal power is 50 MW, maximum thermal and fast neutron flux is 4x1018 m-2s-1. First criticality was achieved in March 1968, and its operation was stopped from August, 2006 for the refurbishment. The refurbishment is scheduled from the beginning of FY2007 to the end of FY2010. The renewed and upgraded JMTR will be re-started from FY2011. An investigation on aged components (aged-investigation) was carried out for concrete structures of the JMTR reactor building, exhaust stack, etc., and for tanks in the primary cooling system, heat exchangers, pipes in the secondary cooling system, cooling tower, emergency generators and so on, in order to identify their integrity. The aged-investigation was carried out at the beginning of FY2007. As a result, some components were decided to replace from viewpoints of future maintenance and improvement of reliability, and some components or structures were decided to repair. A visual inspection of inner side of the pressure vessel was carried out using an underwater camera in FY2008, and no serious damage was observed. Up to now, refurbishment works are in progress according to the planned schedule. In FY2009, motors of primary cooling pumps, secondary cooling pumps, motors of drain pumps, pump in the primary water transfer line to the water purification system, beryllium reflector frame, low-voltage motor control centers are to be replaced. A nuclear instrumentation system, process control system, safety protection system and so on are to be replaced in FY2010. In this paper, current status of JMTR refurbishment project is presented. (author)

  9. Counseling in Turkey: Current Status and Future Challenges

    OpenAIRE

    Suleyman Dogan

    1998-01-01

    In this article a special emphasis is placed on the current status and the future challenges of counseling in Turkey. A brief history of counseling in Turkey, current developments, and the basic issues in this field are pointed out. Finally, the future challenges and recommendations to improve the current status of counseling are discussed.

  10. Torque teno virus (TTV): current status.

    Science.gov (United States)

    Hino, Shigeo; Miyata, Hironori

    2007-01-01

    Torque teno virus (TTV), currently classified into the family Circoviridae, genus Anellovirus, was first found in a patient with non-A-E hepatitis. TTV has a single stranded circular DNA of approximately 3.8 kb. TTVs are extraordinarily diverse, spanning five groups including SANBAN and SEN viruses. Torque teno mini virus (TTMV) with approximately 2.9 kb genome also has wide variants. Recently, two related 2.2- and 2.6-kb species joined this community. Recombinations between variants are frequent. This extensive TTV diversity remains unexplained; it is unclear how TTVs could be viable, and why they require such genetic variation. An unequivocal culture system is still not available. TTVs are ubiquitous in > 90% of adults worldwide but no human pathogenicity of TTV has been fully established. Epidemiological surveys need to specify the variants being studied and clinical targets, and must calibrate the sensitivity of the assay used. Potentially interesting observations include a higher viral load in patients with severe idiopathic inflammatory myopathies, cancer and lupus. Active replication was also found in infants with acute respiratory diseases. TTV/TTMV-related viruses were found in chimpanzees, apes, African monkeys and tupaias, and also in chickens, pigs, cows, sheep and dogs. Experimentally, rhesus monkeys were persistently infected by TTV, but only 1/53 chimpanzees. TTV transcribes three species of mRNAs, 3.0-, 1.2- and 1.0-kb in the ratio of 60:5:35. Recently, at least three mRNAs were shown in chicken anaemia virus. The genomic region -154/-76 contains a critical promoter. TTV seems to have at least three proteins; however, the definite functions of these proteins await further research work. PMID:17146841

  11. Cancer immunotherapy: moving beyond current vaccines

    OpenAIRE

    Rosenberg, Steven A.; Yang, James C.; Restifo, Nicholas P

    2004-01-01

    Great progress has been made in the field of tumor immunology in the past decade, but optimism about the clinical application of currently available cancer vaccine approaches is based more on surrogate endpoints than on clinical tumor regression. In our cancer vaccine trials of 440 patients, the objective response rate was low (2.6%), and comparable to the results obtained by others. We consider here results in cancer vaccine trials and highlight alternate strategies that mediate cancer regre...

  12. Current status of nuclear physics research

    International Nuclear Information System (INIS)

    In this review, we discuss the current status of research in nuclear physics which is being carried out in different centers in the world. For this purpose, we supply a short account of the development in the area which evolved over the last nine decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data became available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such as the shell model, the collective model, the statistical model, the interacting boson model, etc., some of these models may be seemingly in conflict with each other, but this was shown to be only apparent. The richness of the ideas and abundance of theoretical models attests to the important fact that the nucleus is a really singular system in the sense that it evolves from two-body bound states such as the deuteron, to few-body bound states, such as 4He, 7Li, 9Be, etc. and up the ladder to heavier bound nuclei containing up to more than 200 nucleons. Clearly, statistical mechanics, usually employed in systems with very large number of particles, would seemingly not work for such finite systems as the nuclei, neither do other theories which are applicable to condensed matter. The richness of nuclear physics stems from these restrictions. New theories and models are presently being developed. Theories of the structure and reactions of neutron-rich and proton-rich nuclei, called exotic nuclei, halo nuclei, or Borromean nuclei, deal with the wealth of experimental data that became available in the last 35 years. Furthermore, nuclear astrophysics and stellar and Big Bang nucleosynthesis have become a more mature subject. Due to limited space, this review only covers a few selected topics, mainly those with which the authors have worked on. Our aimed potential readers of this review are nuclear physicists and physicists in other areas, as well as graduate students interested in

  13. Current Status of Nuclear Physics Research

    Science.gov (United States)

    Bertulani, Carlos A.; Hussein, Mahir S.

    2015-12-01

    In this review, we discuss the current status of research in nuclear physics which is being carried out in different centers in the world. For this purpose, we supply a short account of the development in the area which evolved over the last nine decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data became available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such as the shell model, the collective model, the statistical model, the interacting boson model, etc., some of these models may be seemingly in conflict with each other, but this was shown to be only apparent. The richness of the ideas and abundance of theoretical models attests to the important fact that the nucleus is a really singular system in the sense that it evolves from two-body bound states such as the deuteron, to few-body bound states, such as 4He, 7Li, 9Be, etc. and up the ladder to heavier bound nuclei containing up to more than 200 nucleons. Clearly, statistical mechanics, usually employed in systems with very large number of particles, would seemingly not work for such finite systems as the nuclei, neither do other theories which are applicable to condensed matter. The richness of nuclear physics stems from these restrictions. New theories and models are presently being developed. Theories of the structure and reactions of neutron-rich and proton-rich nuclei, called exotic nuclei, halo nuclei, or Borromean nuclei, deal with the wealth of experimental data that became available in the last 35 years. Furthermore, nuclear astrophysics and stellar and Big Bang nucleosynthesis have become a more mature subject. Due to limited space, this review only covers a few selected topics, mainly those with which the authors have worked on. Our aimed potential readers of this review are nuclear physicists and physicists in other areas, as well as graduate students interested in

  14. Current status of nuclear physics research

    Energy Technology Data Exchange (ETDEWEB)

    Bertulani, Carlos A. [Department of Physics and Astronomy, Texas A and M University-Commerce (United States); Hussein, Mahir S., E-mail: hussein@if.usp.br [Instituto Tecnologico de Aeronautica (ITA), Sao Jose dos Campos, SP (Brazil). Dept. de Fisica

    2015-12-15

    In this review, we discuss the current status of research in nuclear physics which is being carried out in different centers in the world. For this purpose, we supply a short account of the development in the area which evolved over the last nine decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data became available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such as the shell model, the collective model, the statistical model, the interacting boson model, etc., some of these models may be seemingly in conflict with each other, but this was shown to be only apparent. The richness of the ideas and abundance of theoretical models attests to the important fact that the nucleus is a really singular system in the sense that it evolves from two-body bound states such as the deuteron, to few-body bound states, such as {sup 4}He, {sup 7}Li, {sup 9}Be, etc. and up the ladder to heavier bound nuclei containing up to more than 200 nucleons. Clearly, statistical mechanics, usually employed in systems with very large number of particles, would seemingly not work for such finite systems as the nuclei, neither do other theories which are applicable to condensed matter. The richness of nuclear physics stems from these restrictions. New theories and models are presently being developed. Theories of the structure and reactions of neutron-rich and proton-rich nuclei, called exotic nuclei, halo nuclei, or Borromean nuclei, deal with the wealth of experimental data that became available in the last 35 years. Furthermore, nuclear astrophysics and stellar and Big Bang nucleosynthesis have become a more mature subject. Due to limited space, this review only covers a few selected topics, mainly those with which the authors have worked on. Our aimed potential readers of this review are nuclear physicists and physicists in other areas, as well as graduate

  15. Non-small cell lung cancer: current status of chemoradiation for locally advanced disease and an update on susceptibility and prevention

    International Nuclear Information System (INIS)

    Locally advanced, inoperable non-small cell lung cancer (NSCLC) afflicts 40,000 patients yearly. The traditional treatment has been radiation therapy (RT) alone with 5 year survival rates averaging around 5%. Recent reports of randomized clinical trials using combined radiochemotherapy suggest significant improvement in survival compared to RT alone. These trials are difficult to evaluate because of differences in dose, timing and sequencing of both the chemotherapy (CT) and the RT. Dr. Byhardt will give an overview of the significant chemoradiation trials, especially with respect to the factors associated with reduction of local failure and distant metastasis. Dr. Tishler will review the biologic rationale of these regimens and make some prognostications about the potential role of new chemotherapy agents, new developments in RT dose-time-fractionation, and new RT technology in future radiochemotherapy trials. While progress continues to be made using the more traditional cancer treatment modalities, investigations in NSCLC epidemiology and prevention are providing new insights regarding susceptibility, etiology, failure risk stratification, and potential avenues of therapeutic intervention. Dr. Spitz will discuss NSCLC as a paradigm of an environmentally induced disease in which host susceptibility may be determined by genetically determined modulation of environmental exposures. A mutagen sensitivity assay can determine individuals at high risk for developing NSCLC if exposed to carcinogens such as those in cigarette smoke. This susceptibility may have prognostic implications that could influence choice of therapy. Highly susceptible individuals can also be selected for special counseling, smoking cessation, with consideration given to chemoprevention. Dr. Gritz will review major work done in this area

  16. A balanced review of the status T cell-based therapy against cancer

    Directory of Open Access Journals (Sweden)

    Marincola Francesco M

    2005-04-01

    Full Text Available Abstract A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach involving the adoptive transfer of in vitro expanded tumor antigen-specific T cells. Although the same authors clarified their position in response to others' rebuttal more discussion needs to be devoted to the current status of T cell-based anti-cancer therapy. The accompanying publications review the status of adoptive transfer of cancer vaccines on one hand and active-specific immunization on the other. Hopefully, reading these articles will offer a balanced view of the current status of antigen-specific ant-cancer therapies and suggest future strategies to foster unified efforts to complement either approach with the other according to specific biological principles.

  17. Current status of the world's research reactors

    International Nuclear Information System (INIS)

    Data from the IAEA's Research Reactor Database (RRDB) provides information with respect to the status of the world's research reactors. Some summary data are given. Recent initiatives by the IAEA regarding communications and information flow with respect to research reactors are discussed. Future plans and perspectives are also introduced. (author)

  18. Qualitative Study of Current Status and Needs of Caregivers of Terminal Cancer Patient%晚期癌症患者照顾者照护现状和需求的质性研究

    Institute of Scientific and Technical Information of China (English)

    许君; 叶文琴; 江萍

    2014-01-01

    目的:了解晚期癌症患者照顾者的照护现状和需求,为提供适合照顾者需求的护理服务提供依据。方法采用目的抽样法,选择2013年8-12月上海市浦东新区人民医院收治的晚期癌症患者的照顾者10名,对其进行面对面、半结构式的深入访谈,并采用内容分析法对资料进行分析。结果分析出关于照顾者照护现状和需求的主要主题共8个。结论晚期癌症患者照顾者承担着一定的压力,面临着不同程度的问题,护理人员应为照顾者提供专业和个性化的培训,同时建议医院联动社会资源,为患者提供全方位服务。此外,对照顾者适时进行临终辅导,提供有效的情感支持。%Objective To understand the current status and needs of caregivers of terminal cancer patient , in order to provide evidence for fulfilling the caregiver’s needs and nursing service .Methods By using pur‐pose sampling method ,10 participants were applied face to face ,semi‐structured in‐depth interview ,and use content analyze method to analysis the material .Results Eight themes were analyzed about caregiver’s care current status and needs .Conclusion Caregivers of terminal cancer patients are under the pressure , and facing the different kinds of problem .Nursing staff should provide caregivers with professional and personalized training ,and hospital should alliance with social resources to provide all around service for pa‐tients .Besides ,it is important to offer caregivers end of life assistant with effective emotional support .

  19. Current status and prospects of research reactors

    International Nuclear Information System (INIS)

    Full text: The first nuclear research reactors (RR) appeared in the 1940s. Their initial purpose was to provide knowledge of the main processes associated with neutron-induced nuclear reactions. Later, the rang of problems addressed expanded substantially. Besides fundamental research in the properties of matter, such reactors are successfully used for dealing with problems in the fields of materials science, nuclear engineering, medicine, isotope production, education, etc. Over the whole period of RR fleet growth, more than six hundred nuclear research facilities were built in 70 countries of the world. As of the end of 2008, the number of Russian research reactors in service was about 20% of the globally operating RR fleet. This paper discusses the current status of the world's RR fleet and describes the capabilities of the experimental reactor facilities existing in Russia. In the 21st century, research reactors will remain in demand to solve scientific and technological problems for innovative development of society. The emerging renaissance of nuclear power, the expanding RR uses for production of isotopes and other applications, the increase in the number of countries willing to use nuclear technologies in energy production, industry and science - all contribute to a rebirth of interest in research reactors. One of the ways to improve the experimental capabilities lies in radical upgrading of the reactor facilities with qualitative changes in the main neutronic characteristics of the core. The associated design approaches are illustrated with the example of the IBR-2M reactor at the JNRI in Dubna. The imperative need restricting the spread of nuclear threat leads us to give up using highly enriched uranium in most research reactors. Development of RR fuel with reduced enrichment in uranium has been one of the priority objectives of NIKIET for many years. This paper presents the latest results obtained along these lines, as applied to pool-type research

  20. Current status and prospects of research reactors

    International Nuclear Information System (INIS)

    Full text: The first nuclear research reactors (RR) appeared in the 1940s. Their initial purpose was to provide knowledge of the main processes associated with neutron-induced nuclear reactions. Later, the range of problems addressed expanded substantially. Besides fundamental research in the properties of matter, such reactors are successfully used for dealing with problems in the fields of materials science, nuclear engineering, medicine, isotope production, education, etc. Over the whole period of RR fleet growth, more than six hundred nuclear research facilities were built in 70 countries of the world. As of the end of 2008, the number of Russian research reactors in service was about 20% of the globally operating RR fleet. This paper discusses the current status of the world's RR fleet and describes the capabilities of the experimental reactor facilities existing in Russia. In the 21st century, research reactors will remain in demand to solve scientific and technological problems for innovative development of society. The emerging renaissance of nuclear power, the expanding RR uses for production of isotopes and other applications, the increase in the number of countries willing to use nuclear technologies in energy production, industry and science - all contribute to a rebirth of interest in research reactors. One of the ways to improve the experimental capabilities lies in radical upgrading of the reactor facilities with qualitative changes in the main neutronic characteristics of the core. The associated design approaches are illustrated with the example of the IBR-2M reactor at the JNRI in Dubna. The imperative need for restricting the spread of nuclear threat leads us to give up using highly enriched uranium in most research reactors. Development of RR fuel with reduced enrichment in uranium has been one of the priority objectives of NIKIET for many years. This paper presents the latest results obtained along these lines, as applied to pool-type research

  1. Effects of Cognitive Status on Life Participation of Cancer Survivors

    Directory of Open Access Journals (Sweden)

    Mary F. Baxter PhD, OT, FAOTA

    2014-04-01

    Full Text Available The purposes of this study were to identify the cognitive status of cancer survivors, determine the effect of cognitive status on function and participation in daily activities, and explore how cancer survivors perceive changes in their cognition. The study used a quantitative nonexperimental cross-sectional design. The participants included 35 cancer survivors from two different sites. Instruments included the Montreal Cognitive Assessment (MoCA and the Reintegration to Normal Index-Postal Version (RNLI-P in the measurement of cognitive impairment and functional performance respectively. Data were also collected with a supplemental questionnaire to explore participants’ perspectives on their cognitive difficulties and current function. The participant scores on the MoCA indicated cognitive impairment (μ= 25 and their scores on the RNLI-P demonstrated subpar reintegration (μ=9.64. Twenty-one participants answered the supplemental questionnaire. In content analysis of questionnaire responses, 17/21 participants reported some level of cognitive change related to cancer and cancer treatment. Data from an open-ended question were organized into four categories: decreased participation, more selective in activities, balance in activities, and cognitive changes. Study results indicate a large percentage of cancer survivors demonstrate mild cognitive impairment as well as changes in participation in instrumental activities of daily living.

  2. The Current Status of STEM Education Research

    Science.gov (United States)

    Brown, Josh

    2012-01-01

    This paper explores the current Science, Technology, Engineering and Mathematics (STEM) education research base through an analysis of articles from eight journals focused on the STEM disciplines. Analyzed are both practitioner and research publications to determine the current scope of STEM education research, where current STEM education…

  3. Palliative radiotherapy: current status and future directions.

    Science.gov (United States)

    Sharma, Sonam; Hertan, Lauren; Jones, Joshua

    2014-12-01

    For nearly 100 years, palliative radiotherapy has been a time-efficient, effective treatment for patients with metastatic or advanced cancer in any area where local tumors are causing symptoms. Short courses including a single fraction of radiotherapy may be effective for symptom relief with minimal side effects and maximization of convenience for patient and family. With recent advances in imaging, surgery, and other local therapies as well as systemic cancer therapies, palliative radiotherapy has been used frequently in patients who may not yet have symptoms of advanced or metastatic cancer. In this setting, more prolonged radiotherapy courses and advanced radiotherapy techniques including intensity-modulated radiotherapy (IMRT) or stereotactic radiotherapy (SRT) may be useful in obtaining local control and durable palliative responses. This review will explore the use of radiotherapy across the spectrum of patients with advanced and metastatic cancer and delineate an updated, rational approach for the use of palliative radiotherapy that incorporates symptoms, prognosis, and other factors into the delivery of palliative radiotherapy. PMID:25499634

  4. Current status of VHTR development in Japan

    International Nuclear Information System (INIS)

    The status of the program at the beginning of fiscal 1982 is reviewed. Special emphasis is placed on the altering of the output helium temperature of the experimental VHTR to 9500. The modification is aimed at establishing the technical basis for post-experimental VHTR output helium temperature of 10000C. Notes are given on the design of the VHTR as well as various research and development efforts in Japan on multi-purpose nuclear heat applications and HTGR technology

  5. Current status of neutron scattering in Thailand

    International Nuclear Information System (INIS)

    Thailand's neutron spectrometer has been installed soon after the startup of the reactor. The neutron scattering experiments have been done continuously, although there were some problems involving the neutron intensity and instruments. Development program has been planned for better experimental result. This paper reports the past and present status of neutron scattering equipment and experiments in Thailand. In addition, installation of a HRPD (High Resolution Powder Diffraction) system is included within the scope of the Ongkharak Nuclear Research Center project. (author)

  6. Current status of the RERTR Program

    Energy Technology Data Exchange (ETDEWEB)

    Travelli, A.

    1980-01-01

    The main purpose of this paper is to review the progress which has been accomplished by the RERTR Program during the past year, the present status of the program, the activities which are now in progress, and the program plans for the coming years. The changes that have taken place in the overall program plan are, in themselves, not very significant. Some activities were found to be somewhat more difficult than expected and required a longer time to complete; others were found to be less difficult than expected and caused opposite readjustments of the program plan. These effects tend to balance each other when the program is considered as a whole.

  7. Current status of neutron scattering in Thailand

    Energy Technology Data Exchange (ETDEWEB)

    Ampornrat, Pantip [Physics Division, Office of Atomic Energy for Peace, Chatuchak, Bangkok (Thailand)

    1999-10-01

    Thailand's neutron spectrometer has been installed soon after the startup of the reactor. The neutron scattering experiments have been done continuously, although there were some problems involving the neutron intensity and instruments. Development program has been planned for better experimental result. This paper reports the past and present status of neutron scattering equipment and experiments in Thailand. In addition, installation of a HRPD (High Resolution Powder Diffraction) system is included within the scope of the Ongkharak Nuclear Research Center project. (author)

  8. Current status of photovoltaic research at SERI

    Science.gov (United States)

    Deb, S. K.

    1987-02-01

    The purpose of the Solar Energy Research Institute's photovoltaic cell development program is to conduct high risk, potentially high-payoff R&D leading to a more substantial knowledge base for exploitation by private concerns interested in the electrical energy market. Attention is presently given to the status of research and development for crystalline and amorphous silicon, polycrystalline CuInSe2 and CdTe thin-film, and high efficiency III-V compound solar cells. Comparative efficiencies and economies are presented in tabular form, together with schematics of promising solar cell layer structures.

  9. Spent fuel management: Current status and prospects

    International Nuclear Information System (INIS)

    The main objective of the Advisory Group on Spent Fuel Management is to review the world-wide situation in Spent Fuel Management, to define the most important directions of national efforts and international cooperation in this area, to exchange information on the present status and progress in performing the back-end of Nuclear Fuel Cycle and to elaborate the general recommendations for future Agency programmes in the field of spent fuel management. This report which is a result of the third IAEA Advisory Group Meeting (the first and second were held in 1984 and 1986) is intended to provide the reader with an overview of the status of spent fuel management programmes in a number of leading countries, with a description of the past and present IAEA activities in this field of Nuclear Fuel Cycle and with the Agency's plans for the next years, based on the proposals and recommendations of Member States. A separate abstract was prepared for each of 14 papers presented at the advisory group meeting. Refs, figs and tabs

  10. Current Status and Future of Sports Food

    Directory of Open Access Journals (Sweden)

    Hailong Zhang

    2015-06-01

    Full Text Available According to the need of the popularization of sports nutrition knowledge and promoting of our country sports nutrition needs, the study expounds the new concept of sports nutrition food, the development of sports nutrition food abroad, the prospect of the domestic market and the status quo of cultivate. Sports nutrition food system which has been basically in more than a decade in domestic is made a detailed elaboration and an introduction of product research and development has been made. The evolved industry standards, sports nutrition food industry, sports nutrition knowledge popularization, academic exchange domestic and overseas and sports nutrition training of our sport nutrition food industry in the past two years are all expounded in this study. These big good situations indicate the better future of our country's sports nutrition food market.

  11. 乳腺癌术后上肢淋巴水肿危险因素的研究现状%Current status of research on the risk of breast cancer-related lymphedema

    Institute of Scientific and Technical Information of China (English)

    王玲; 李惠萍; 王本忠

    2012-01-01

    OBJECTIVE: To sump up current status of research on the risk of breast cancer-related lymphedema. METHODS: "breast cancer, lymphedema, risk factor" were searched as key words in the database of PubMed, CNKI and CBM. A total of 216 literatures were obtained from PubMed, 6 literatures from CNKI and 2 literatures from CBM during the period of 2005 to 2012. Including criteria; 1. the features of breast cancer-related lymphedema; 2. risks reported risk ratioCRR or OR) estimates. By extraction according to the inclusion criteria, 114 literatures were finaly analyzed. RESULTS: The risk factors for breast cancer-related lymphedema including four aspects : physiological factors, disease factors, treatment factors, and behavioral factors. Physiological factors include: age, weight, whether the surgical side of the main hand, history of hypertension; Disease factors: tumor stage and location, local tumor recurrence and metastasis, the number of axillary lymph nodes; Therapeutic factors include: surgical method, incision type, postoperative complications, axillary lymph node dissection and postoperative adjuvant therapy; Behavioral factors include: the exercise of limb function, limb activity frequency and intensity, and limb infection and injury. CONCLUSIONS: Breast cancer-related lymphedema is a chronic, incurable sick ness. Prevention should focus on major risk factors and to avoid or reduce exposure to risk factors, in order to reduce the incidence of lymphedema.%目的:总结国内外关于乳腺癌术后淋巴水肿危险因素的研究现状.方法:以“乳腺癌或乳腺肿瘤(breast cancer)、淋巴水肿(lymphedema)、危险因素(risk factor)”为关键词,检索PubMed、CNK1期刊全文数据库和CBM数据库中2005-01-2011-12的相关文献,共检索216篇英文文献,8篇中文文献.纳入标准:1)乳腺癌术后淋巴水肿;2)危险因素中报告RR或OR值.根据纳入标准,共纳入114篇文献.结果:乳腺癌术后淋巴水肿的危险因素包括4个

  12. Nutritional status assessment in colorectal cancer patients

    Directory of Open Access Journals (Sweden)

    Joana Pedro Lopes

    2013-04-01

    Full Text Available The present study intended to evaluate the nutritional status of Portuguese colorectal patients and associated it with surgery type as well as quality of life outcomes. Malnutrition can affect up to 85% of cancer patients and specifically 30-60% in colorectal cancer and can significantly influence health outcomes. A sample of 50 colorectal cancer patients was evaluated in what refers to several anthropometric measures, food intake, clinical history, complications rate before and after surgery procedure. The sample was divided between convention and fast-track procedures. Most of the individuals were overweight or obese but had lost weight on the past six months. Despite mild, there were signs of malnutrition in this sample with high losses of fat free mass, weight and also fat mass during the hospitalization period. These results reinforce the importance of malnutrition assessment in colorectal patients as well as consider weight loss on the past months and body composition in order to complement nutritional status evaluation.

  13. Current status of flexible ureteroscopy in urology.

    Science.gov (United States)

    Cho, Sung Yong

    2015-10-01

    Retrograde intrarenal surgery (RIRS) is being performed for the surgical management of upper urinary tract pathology. With the development of surgical instruments with improved deflection mechanisms, visuality, and durability, the role of RIRS has expanded to the treatment of urinary calculi located in the upper urinary tract, which compensates for the shortcomings of shock wave lithotripsy and percutaneous nephrolithotomy. RIRS can be considered a conservative treatment of upper urinary tract urothelial cancer (UTUC) or for postoperative surveillance after radical treatment of UTUC under an intensive surveillance program. RIRS has a steep learning curve and various surgical techniques can be used. The choice of instruments during RIRS should be based on increased surgical efficiency, decreased complications, and improved cost-benefit ratio. PMID:26495068

  14. Current status of tumor radiogenic therapy

    Institute of Scientific and Technical Information of China (English)

    Feng-Ling Min; Hong Zhang; Wen-Jian Li

    2005-01-01

    Although tumor gene therapy falls behind its clinical use, the combination of irradiation and gene therapy is full ofpromise in cancer therapy based on traditional radiotherapy, chemotherapy and surgery. We have termed it as radiogenic therapy. This review focuses on the following aspects of radiogenic therapy in recent years: improvement of gene transfer efficiency by irradiation, radiotherapy combined with cytokine gene delivery or enhancement of the immunity of tumor cells by transgene, direct stimulation by radiation toproduce cytotoxic agents, increase of tumor cell radiosensitivity in gene therapy by controlling the radiosensitivity genes and adjusting the fraction dose and interval of radiation so as to achieve the optimum antitumor effect while reducing the normal tissue damage, radioprotective gene therapy enhancing radiation tumor killing effect while protecting the normal tissue and organs with transgene using transfer vectors.

  15. Current status of neutron scattering in Thailand

    International Nuclear Information System (INIS)

    The current neutron powder diffractometer at the Thai Research Reactor-1/M1 (TRR-1/M1) has been modified from the obsolete neutron diffractometer which had been used during 1968-1975. The upgraded diffractometer has medium resolution and is appropriate for studying samples with small unit cell dimensions and training university students in the field of neutron scattering. This paper describes the current activities of neutron scattering research in Thailand as well as a new research reactor for enlarging the perspectives of its utilization in the future. (author)

  16. Current status of neutron scattering in Thailand

    Energy Technology Data Exchange (ETDEWEB)

    Kornduangkaeo, Areeratt; Pongkasem, Somchai; Putchar, Suriya; Ampornrat, Pantip; Kajornrith, Varavuth; Sangariyavanich, Archara [Office of Atomic Energy for Peace, Bangkok (Thailand)

    2003-03-01

    The current neutron powder diffractometer at the Thai Research Reactor-1/M1 (TRR-1/M1) has been modified from the obsolete neutron diffractometer which had been used during 1968-1975. The upgraded diffractometer has medium resolution and is appropriate for studying samples with small unit cell dimensions and training university students in the field of neutron scattering. This paper describes the current activities of neutron scattering research in Thailand as well as a new research reactor for enlarging the perspectives of its utilization in the future. (author)

  17. Energy sector in Ecuador: Current status

    International Nuclear Information System (INIS)

    This paper describes the current energy sector in Ecuador, its present structure, the oil industry, subsidies, and renewable energy, focusing on the evolution and reform of the electricity sector. Currently, 86% of the primary energy originates from nonrenewable sources. In 2005, the gross electricity generation was 15 127 GWh (45.5% hydropower, 43.11% thermal, and 11.39% imported). Ecuador is the fifth largest oil producer in South America but lacks sufficient oil refining capacity. Reserves of natural gas (NG) are small, and most of NG is produced from oil fields without energy recovery. Several projects are underway to increase the utilization of NG and renewable energies to meet Ecuador commitments to the Kyoto Protocol

  18. Energy sector in Ecuador: Current status

    Energy Technology Data Exchange (ETDEWEB)

    Pelaez-Samaniego, M.R. [University of Cuenca (Ecuador). Faculty of Chemical Sciences; Energy Systems Planning, FEM, UNICAMP (Brazil); Garcia-Perez, M. [Monash University, Melbourne (Australia); Cortez, L.A.B. [Energy Systems Planning, FEM, UNICAMP (Brazil); Oscullo, J. [National Center for Energy Control - CENACE (Ecuador); Olmedo, G. [Polytechnic School of the Army - ESPE (Ecuador)

    2007-08-15

    This paper describes the current energy sector in Ecuador, its present structure, the oil industry, subsidies, and renewable energy, focusing on the evolution and reform of the electricity sector. Currently, 86% of the primary energy originates from nonrenewable sources. In 2005, the gross electricity generation was 15 127 GWh (45.5% hydropower, 43.11% thermal, and 11.39% imported). Ecuador is the fifth largest oil producer in South America but lacks sufficient oil refining capacity. Reserves of natural gas (NG) are small, and most of NG is produced from oil fields without energy recovery. Several projects are underway to increase the utilization of NG and renewable energies to meet Ecuador commitments to the Kyoto Protocol. (author)

  19. Pharmacotherapy of Sexual Dysfunctions : Current Status

    OpenAIRE

    Avasthi, Ajith; Biswas, Parthasarathy

    2004-01-01

    The sexual dysfunctions are one of the most prevalent conditions. Sexual dysfunctions can have profound effect on the psychological well-being of an individual and the psychosexual relationship of a couple. Management of the sexual dysfunction should be preceded by an accurate diagnosis reached after a complete medical and sexual history and physical examination. Current focus of researchers has been on understanding the pathophysiology of erectile dysfunction, premature ejaculation and other...

  20. The current status of grazing incidence optics

    International Nuclear Information System (INIS)

    The developments in the area of grazing incidence optics with emphasis on telescopes for use in X-ray astronomy are reviewed. The performance of existing high-resolution telescopes is outlined and compared with those expected from future missions like ROSAT and AXAF. Starting from the basic principles of X-ray reflection and scattering, an attempt is made to highlight the current understanding of X-ray mirror physics using new theoretical ideas as well as experimental laboratory results. (author)

  1. Canadian hydrogen : current status and future prospects

    International Nuclear Information System (INIS)

    A summary of hydrogen technology and details of current production and use of hydrogen in Canada were presented. Future demand for hydrogen was discussed. The aim of the report was to enable readers to better understand the significant size of the hydrogen industry. Canada is the largest per capita producer of hydrogen in the OECD, with production currently at 3.09 million tonnes per year. The current hydrogen surplus was attributed to a combination of short-term reductions in demand and excess capacity built in anticipation of growing demand. Mechanical and chemical processes that create hydrogen were reviewed, and details of prospective emerging technologies in hydrogen production, purification, transportation and storage were presented. Technical opportunities for hydrogen were explored. A regionalized inventory of hydrogen production in Canada was provided. Projected demands for 3 scenarios of hydrogen production were presented: (1) a business as usual perspective with no dramatic political or climatic impacts; (2) a carbon conscious agenda where major disturbances due to climate change have resulted in a focus on greenhouse gas (GHG) reduction and fuel efficiency; and (3) a hydrogen priority path that promotes North American energy self-sufficiency and concerted actions by government to adopt the hydrogen economy. The production consequences of hydrogen demand under each scenario emphasized the potential size and location of Canada's hydrogen needs. It was concluded that Canadian companies and research facilities have established a strong technical and commercial presence in hydrogen production over the last 10 years. tabs., figs

  2. Avian influenza in Croatia - Current status

    International Nuclear Information System (INIS)

    Full text: Wild birds can carry a wide range of viral and other zoonotic agents, which may be transmitted to humans. From October 2005 to March 2006 HPAI H5N1 virus was isolated from wild birds (mute swans, black-headed gulls and a mallard duck) in Croatia at five locations. After isolation of H5N1 virus at 2006 from mallard duck near City of Zagreb (capital of Croatia) Department of Poultry Diseases with Clinic at the Faculty of Veterinary Medicine, has conducted monitoring of avian viruses that could endanger human health. Samples (999 pharyngeal and cloacal swabs) from 23 wild bird species were taken. After year 2006 Croatia has regular monitoring for avian influenza in wild birds and poultry (especially in the backyard flocks). During 2007 (6,928 wild birds and 18,000 blood samples from poultry) and 2008 (2,486 wild birds; 20,000 blood samples and 1,500 cloacal swabs from poultry) were taken. Isolation was performed with classical virus detection method by inoculation of 10 day old chicken embryos, and molecular methods by conventional PCR and Real Time PCR (M gene, H5, H7 and N1 genes), and serological methods by antibody detection from blood samples (inhibition hemagglutination and ELISA). All samples were HPAI virus negative but investigators from the Poultry Centre of the Croatian Veterinary Institute isolated from wild birds LPAI viruses: H2N3, H3N8, H5N3 and H10N7. The results obtained by these investigations and monitoring revealed the need for permanent monitoring of wild bird's health status, especially the water birds species. Vaccination against AI is never practiced in Croatia. Quick and accurate detection of wild migratory birds infected with the H5N1 virus prevented the spread of the virus to the domestic poultry in Croatia which would have had enormous consequences. (author)

  3. The current status and influencing factors of quality of life in patients with cervical cancer%宫颈癌患者生存质量状况及其影响因素研究

    Institute of Scientific and Technical Information of China (English)

    徐昊; 丁焱

    2011-01-01

    Objective To investigate the status and influencing factors of quality of life(QOL) in patients with cervical cancer. Methods A total of 473 patients with cervical cancer were investigated with the Functional Assessment of Cancer Therapy scale-Cervix (FACT-Cx). Results The mean score.of QOL was 118.65±19.72. Marital status,perceived family relationship, performance status and perceived financial burden were influencing factors of patients' QOL. Conclusions The quality of life in patients with cervical cancer is in middle to high level. It is suggested to provide interventions to improve the quality of life for patients with heavy financial burden,poor family relationship,worse performance status and single.%目的 调查宫颈癌患者生存质量状况,分析其影响因素。方法 采用宫颈癌生存质量评估量表(FACT-Cx)对473例宫颈癌患者进行调查。结果 患者生存质量总分均值为(118.65±19.72)分。单身、家庭关系一般、活动状况较差和经济负担重是生存质量的影响因素。结论 宫颈癌患者生存质量得分处于较好水平。应加强对经济负担较量、家庭关系较差、单身和活动状态较差患者的干预,以提高其生存质量。

  4. Family therapy in Brazil: current status.

    Science.gov (United States)

    Picon, Felipe

    2012-04-01

    In the last three decades there has been a noticeable trend in the redefinition of the nuclear family in Brazil. A recent increase in the rates of divorces and paradoxically also in the rates of marriages, the legalization of same-sex unions and adoption by these couples, and the phenomenon of teenage pregnancy are some of the aspects that reflect on the current Brazilian family. This review highlights these changes and describes how family therapists in Brazil are facing the challenge of assisting these families, in a continental-sized country with uneven distribution of training courses and healthcare assistance. PMID:22515454

  5. RBMK fuel assemblies: Current status and perspectives

    International Nuclear Information System (INIS)

    The safety enhancement measures implemented since 1986 have led to substantial burnup reduction in the RBMK fuel assemblies and consequently to economical losses. With the purpose to compensate the losses, computer analysis and experiments were performed during the last decade. The works were aimed at the RBMK fuel charge perfection to reduce void reactivity effect and to increase fuel burnup. The paper presents principle results of the studies which are currently under implementation or are supposed to be implemented in the nearest future. (author)

  6. Current status of nanotechnology in urology

    Directory of Open Access Journals (Sweden)

    Suresh K. Goyal

    2016-08-01

    Full Text Available Nanotechnology has been investigated for its applications in medicine. The objective of this review was to summarize the current applications of nanotechnology in Urology. A systematic search of literature was performed and relevant articles were analyzed with specific reference to applications in Urology. Nanotechnology has applications in diagnostic urology like in uroimaging using nanoparticles and nanosensors. It has therapeutic applications in infections, malignancies, genetic disease using targeted drug delivery, gene transfers, nano device-based manipulations etc. Nanotechnology has many applications in Urology. More efforts are required to make these applications practically feasible and affordable. [Int J Res Med Sci 2016; 4(8.000: 3114-3120

  7. The STIS MAMA status: Current detector performance

    Science.gov (United States)

    Danks, A. C.; Joseph, C.; Bybee, R.; Argebright, V.; Abraham, J.; Kimble, R.; Woodgate, B.

    1992-01-01

    The STIS (Space Telescope Imaging Spectrograph) is a second generation Hubble instrument scheduled to fly in 1997. Through a variety of modes, the instrument will provide spectral resolutions from R approximately 50 in the objective spectroscopy mode to 100,000 in the high resolution echelle mode in the wavelength region from 115 to 1000 nm. In the UV the instrument employs two MAMA (Multimode Anode Microchannel plate Arrays) 1024 by 1024 pixel detectors, which provide high DQE (Detective Quantum Efficiency), and good dynamic range and resolution. The current progress and performance of these detectors are reported, illustrating that the technology is mature and that the performance is very close to flight requirements.

  8. Current status of the implantable LVAD.

    Science.gov (United States)

    Kadakia, Sagar; Moore, Ryan; Ambur, Vishnu; Toyoda, Yoshiya

    2016-09-01

    With the ongoing shortage of available organs for heart transplantation, mechanical circulatory support devices have been increasingly utilized for managing acute and chronic heart failure that is refractory to medical therapy. In particular, the introduction of the left ventricular assist devices (LVAD) has revolutionized the field. In this review, we will discuss a brief history of the LVAD, available devices, current indications, patient selection, complications, and outcomes. In addition, we will discuss recent outcomes and advancements in the field of noncardiac surgery in the LVAD patient. Finally, we will discuss several topics for surgical consideration during LVAD implantation. PMID:27270581

  9. Sensing technology current status and future trends

    CERN Document Server

    Mukhopadhyay, Subhas; Jayasundera, Krishanthi; Bhattacharyya, Nabarun

    2014-01-01

    This book is written for academic and industry professionals working in the field of sensing, instrumentation and related fields, and is positioned to give a snapshot of the current state of the art in sensing technology, particularly from the applied perspective.  The book is intended to give a broad overview of the latest developments, in addition to discussing the process through which researchers go through in order to develop sensors, or related systems, which will become more widespread in the future.  

  10. Current status and trends of radiation technology

    International Nuclear Information System (INIS)

    Radiation technology(RT) is more intimate than the other nuclear technologies and closely related to the public. The present conditions of radiation and radioisotope utilization and economic scales of radiation and radioisotope application in USA, Japan and Korea were examined, and the current trends and prospects of radiation technology were investigated. For planning of extended uses of the technology, the programs of the USA Office of Isotope for Medicine and Science, and the privatization activities of commercial isotopes of DOE were observed. The 2nd 'Comprehensive Nuclear Energy Promotion Plan(CNEPP)' of MOST includes utilization of radiation and radioisotopes, the suggestions for the practice of it were made

  11. Current status of the HIBMC and results of representative diseases

    Science.gov (United States)

    Murakami, Masao; Demizu, Yusuke; Niwa, Yasue; Miyawaki, Daisuke; Terashima, Kazuki; Arimura, Takeshi; Mima, Masayuki; Nagayama, Shinichi; Maeda, Takuya; Baba, Masashi; Akagi, Takashi; Hishikawa, Yoshio; Abe, Mitsuyuki

    2009-07-01

    The proton radiotherapy (PRT) has been spreading, since 1990 when 250 MeV proton beams with rotation gantry was developed for medical use. On the other hand, carbon-ion radiotherapy (CRT) that has both physical and biological features is available at 4 facilities in the world. HIBMC is the only facility to be able to use both particles. From Apr 2001 to Dec 2008, 2486 patients were treated with PRT in 2030 patients or with CRT in 456. Treatment to the Head and Neck (H&N: in 405 patients), the lung (245), the liver (371), and the prostatic carcinoma (1059) was a major subject. The 2-year local control rates is 72% in H&N (n = 163, T1:9, T2:18, T3:36, T4:79, malignant melanoma 48, adenoid cystic carcinoma 35, squamous cell carcinoma (SCC) 32, adenocarcinoma 14, others 34), 88% in lung (n = 116, T1:59, T2:42, T3:4, T4:6, SCC 30, adenocarcinoma 59, others 27), and 89% in liver cancer (n = 153, Proton: 130, carbon: 23). Biochemical disease free 3-year survival of 291 prostate cancer is 100% in 9 patients with initial prostate-specific antigen (PSA) level 20 ng/ml. These results are excellent comparable or superior to those of surgery. Thus, particle therapy is sophisticated radiotherapy, however the only problem to prohibit the progress is high costs for construction and maintenance. Facilities at which both proton and carbon ion beams can be used, including the HIBMC, have to investigate the differential use. We started clinical randomized trial to compare both ion beams, and started biological examinations in a project aiming at the development of a laser driven proton radiotherapy. We stated about the current status of the HIBMC and the results of representative diseases.

  12. Current status of the RERTR program

    International Nuclear Information System (INIS)

    The main purpose of this paper is to review the progress which has been accomplished by the RERTR Program during the past year, the present status of the program, the activities which are now in progress, and the program plans for the coming years. The main program objectives have not changed during the past year. The primary goal of the RERTR Program is still to reduce the amount of HEU which is shipped and used around the world in research reactors and, with it, the nuclear proliferation potential which it creates. Also unchanged is the program objective to reduce HEU use without significant penalty to the reactors involved. This means that for every possible conversion, our technical goal is to achieve good experiment capabilities and the economic advantages that come from a long core lifetime and from relatively economical fuels. We also intend to limit as much as possible the modifications which may have to be made to the reactor in order to achieve conversion and, last but not least, we intend to avoid any significant problems that might appear in the safety and licensing areas. Other important goals are the sharing of information about reduced-enrichment technology and providing technical assistance to the U.S. Government on special problems that may affect implementation of its policies. The timetable of the RERTR Program has stretched slightly. At the time of the previous ANL Conference, a long range goal was set which was anticipated to require about five or six years. This happened in 1978 and, therefore, the long range goal was considered to be achievable by 1984. This final deadline, the time when the long term goal of technical convertibility of all research reactors can be achieved, has now been moved to 1986. In the meantime, good progress has been made towards the near-term goals. Much more detailed knowledge is available about what lies ahead from a technical point of view. In addition, the general level of confidence in the achievability of the

  13. Esophageal tissue engineering: Current status and perspectives.

    Science.gov (United States)

    Poghosyan, T; Catry, J; Luong-Nguyen, M; Bruneval, P; Domet, T; Arakelian, L; Sfeir, R; Michaud, L; Vanneaux, V; Gottrand, F; Larghero, J; Cattan, P

    2016-02-01

    Tissue engineering, which consists of the combination and in vivo implantation of elements required for tissue remodeling toward a specific organ phenotype, could be an alternative for classical techniques of esophageal replacement. The current hybrid approach entails creation of an esophageal substitute composed of an acellular matrix and autologous epithelial and muscle cells provides the most successful results. Current research is based on the use of mesenchymal stem cells, whose potential for differentiation and proangioogenic, immune-modulator and anti-inflammatory properties are important assets. In the near future, esophageal substitutes could be constructed from acellular "intelligent matrices" that contain the molecules necessary for tissue regeneration; this should allow circumvention of the implantation step and still obtain standardized in vivo biological responses. At present, tissue engineering applications to esophageal replacement are limited to enlargement plasties with absorbable, non-cellular matrices. Nevertheless, the application of existing clinical techniques for replacement of other organs by tissue engineering in combination with a multiplication of translational research protocols for esophageal replacement in large animals should soon pave the way for health agencies to authorize clinical trials. PMID:26711880

  14. Anaerobic biorefinery: Current status, challenges, and opportunities.

    Science.gov (United States)

    Sawatdeenarunat, Chayanon; Nguyen, Duc; Surendra, K C; Shrestha, Shilva; Rajendran, Karthik; Oechsner, Hans; Xie, Li; Khanal, Samir Kumar

    2016-09-01

    Anaerobic digestion (AD) has been in use for many decades. To date, it has been primarily aimed at treating organic wastes, mainly manures and wastewater sludge, and industrial wastewaters. However, with the current advancements, a more open mind is required to look beyond these somewhat restricted original applications of AD. Biorefineries are such concepts, where multiple products including chemicals, fuels, polymers etc. are produced from organic feedstocks. The anaerobic biorefinery concept is now gaining increased attention, utilizing AD as the final disposal step. This review aims at evaluating the potential significance of anaerobic biorefineries, including types of feedstocks, uses for the produced energy, as well as sustainable applications of the generated residual digestate. A comprehensive analysis of various types of anaerobic biorefineries has been developed, including both large-scale and household level applications. Finally, future directives are highlighted showing how anaerobic biorefinery concept could impact the bioeconomy in the near future. PMID:27005786

  15. Current Status of Biliary Metal Stents.

    Science.gov (United States)

    Nam, Hyeong Seok; Kang, Dae Hwan

    2016-03-01

    Many advances have been achieved in biliary stenting over the past 30 years. Endoscopic stent placement has become the primary management therapy to relieve obstruction in patients with benign or malignant biliary tract diseases. Compared with plastic stents, a self-expandable metallic stent (SEMS) has been used for management in patients with malignant strictures because of a larger lumen and longer stent patency. Recently, SEMS has been used for various benign biliary strictures and leaks. In this article, we briefly review the characteristics of SEMS as well as complications of stent placement. We review the current guidelines for managing malignant and benign biliary obstructions. Recent developments in biliary stenting are also discussed. PMID:26911896

  16. Current Status of Biliary Metal Stents

    Science.gov (United States)

    Nam, Hyeong Seok; Kang, Dae Hwan

    2016-01-01

    Many advances have been achieved in biliary stenting over the past 30 years. Endoscopic stent placement has become the primary management therapy to relieve obstruction in patients with benign or malignant biliary tract diseases. Compared with plastic stents, a self-expandable metallic stent (SEMS) has been used for management in patients with malignant strictures because of a larger lumen and longer stent patency. Recently, SEMS has been used for various benign biliary strictures and leaks. In this article, we briefly review the characteristics of SEMS as well as complications of stent placement. We review the current guidelines for managing malignant and benign biliary obstructions. Recent developments in biliary stenting are also discussed. PMID:26911896

  17. Current status of optical coherence tomography.

    Science.gov (United States)

    Inami, Shigenobu; Wang, Zuoyan; Ming-Juan, Zhang; Takano, Masamichi; Mizuno, Kyoichi

    2011-09-01

    Optical coherence tomography (OCT) is a novel imaging technology based on low-coherence interferometry that use near-infrared light in real-time, and allows cross-sectional in-situ visualization of the vessel wall at the microscopic level. OCT provides 10-fold higher resolution than intravascular ultrasound which is currently the most used modality for intra-coronary imaging. OCT offers the obvious advantages when characterizing precise plaque microstructure and distinguishing various type of plaques. OCT is also being assessed for its potential role in the understanding of neointimal coverage, vascular healing and the progression of atherosclerosis in coronary vasculature after stenting on the micron scale. These unique capabilities could be helpful in guiding coronary management and interventions. Recent improvement in next generation OCT technology, such as frequency-domain OCT, will allow for a simple imaging procedure, providing more useful information and complementing other modalities on both clinical and research applications for the cardiologists. PMID:24122583

  18. Current Status of Biosimilar Growth Hormone

    Directory of Open Access Journals (Sweden)

    Saenger Paul

    2009-08-01

    Full Text Available As the first wave of biopharmaceuticals is set to expire, biosimilars or follow-on protein products (FOPPs have emerged. The regulatory foundation for these products is more advanced and better codified in Europe than in the US. Recent approval of biosimilar Somatropin (growth hormone in Europe and the US prompted this paper. The scientific viability of biosimilar growth hormone is reviewed. Efficacy and safety data (growth rates, IGF-1 generation for up to 7 years for pediatric indications measure up favorably to previously approved growth hormones as reference comparators. While the approval in the US is currently only for treatment of growth hormone deficiency (GHD in children and adults, the commercial use of approved biosimilar growth hormones will allow in the future for in-depth estimation of their efficacy and safety in non-GH deficient states as well.

  19. Current Status of Biosimilar Growth Hormone

    Directory of Open Access Journals (Sweden)

    Paul Saenger

    2009-01-01

    Full Text Available As the first wave of biopharmaceuticals is set to expire, biosimilars or follow-on protein products (FOPPs have emerged. The regulatory foundation for these products is more advanced and better codified in Europe than in the US. Recent approval of biosimilar Somatropin (growth hormone in Europe and the US prompted this paper. The scientific viability of biosimilar growth hormone is reviewed. Efficacy and safety data (growth rates, IGF-1 generation for up to 7 years for pediatric indications measure up favorably to previously approved growth hormones as reference comparators. While the approval in the US is currently only for treatment of growth hormone deficiency (GHD in children and adults, the commercial use of approved biosimilar growth hormones will allow in the future for in-depth estimation of their efficacy and safety in non-GH deficient states as well.

  20. [Evaluating the current status of anthropologic psychiatry].

    Science.gov (United States)

    Schmidt-Degenhard, M

    1997-10-01

    Phenomenological psychiatry examines the variety of psychiatric diseases as regular modifications of human feeling tone experience and behaviour, which can be derived approximately from the nature of man as defined philosophically, Interdisciplinary self-conception of phenomenological psychiatry as a science calls for a constant critical dialogue with the philosophy of man and other disciplines of the humanities. The point of departure of phenomenological psychiatry is the mental or affective illness of the individual patient, with which the psychiatrist is acquainted, and reflects in interpersonal encounters in such a way that individual case studies are of central importance in this area of studies. From a methodological point of view two approaches are to be differentiated within the field of research in phenomenological psychiatry: 1. The phenomenological approach is concerned with the analysis of specific patterns of disturbance of the transcendental organisation of psychotic subjectivity. 2. The interpretative approaches are again divided into the so called "Daseinsanalyse" as a hermeneutic access to the inner biography and "Weltanschauung" of the psychiatric patient as well as the attempts of understanding the meaning of psychotic forms of experience. In this context a survey of the current fields of research of phenomenological psychiatry is given which aims at a deeper understanding of the situation of psychiatric patients and which claims to have a strong relevance for therapy. The relevance of such a phenomenological approach for current psychiatry lies in a broadening and sophistication of our experience in clinic and practice. Its main interest lies in the concentration on the patient as an individual and on the existential dimension of forms of mental and emotional diseases. PMID:9445840

  1. Advanced radiation chemistry research: Current status

    International Nuclear Information System (INIS)

    Radiation chemistry is a branch of chemistry that studies chemical transformations in materials exposed to high-energy radiations. It is based on the use of ionizing radiation as the initiator or catalyst in chemical reactions. The most significant advantage of radiation chemistry lies in its ability to be used in the production and study of almost any reactive atomic and molecular species playing a part in chemical reaction, synthesis, industrial processes, or in biological systems. Over the the last few years a number of meetings have taken place, under the auspices of the IAEA, in order to evaluate recent developments in radiation chemistry as well as the trends indicated by the results obtained. Radiation chemists from different countries have participated at these meetings. The present publication, a companion to the previous publication - New Trends and Development in Radiation Chemistry, IAEA-TECDOC-527 (1989) - includes some of the important contributions presented at these meetings. It is hoped that it will provide a useful overview of current activities and of emerging trends in this field, thus promoting better understanding of potential contributions of radiation chemistry to other fields of knowledge as well as to practical applications in industry, medicine and agriculture. Refs, figs and tabs

  2. Photoacoustic imaging: current status and future development

    Science.gov (United States)

    Lu, Tao; Jiang, Jingying; Su, Yixiong; Wang, Ruikang K.; Zhang, Fan; Yao, Jianquan

    2006-09-01

    Photo-acoustic tomography(PAT) is a new ultrasound-mediated biomedical imaging technology which combines the advantages of high optical contrast and high ultrasonic resolution. In theory, PAT can image object embedded several centimeters under the surface of sample with the resolution of tens of microns. In this paper, several representative image reconstruction algorithms are discussed. Because the PA signal is wide band signal, it is hard to get the whole frequency spectrum due to the tremendous calculation needed. Therefore, the most applicable reconstruction algorithms are all performed in time domain such as "delay-and-sum" and "back projection". The current research methods have been focused on optical detecting and piezoelectric detecting. The optical method has the advantage of high spatial sensitivity due to the short wavelength of the probe laser beam. PA signal detecting using piezoelectric sensor has two main modes i.e. using unfocused transducer or transducer array or using focused transducer array or linear transducer array. When a focused transducer array is used, the "delay-and-sum" method is often used for image reconstruction. The advantage of the method is that its data acquisition time can be reduced to several minutes or even several seconds by employing the phase control linear scan technique. The future development in PAT research and its potential clinic application is also presented.

  3. Current status of adrenalectomy for Cushing's disease

    International Nuclear Information System (INIS)

    To evaluate the current use of adrenalectomy in the treatment of Cushing's disease, we reviewed seven consecutive patients who have undergone adrenalectomy for Cushing's disease at this medical center during 1983 to 1984. Seventy-one percent (5/7) had pituitary, or type I, Cushing's disease, while 29% (2/7) had adrenal, or type II, Cushing's disease from either an adenoma or an adrenocortical carcinoma. Presenting signs and symptoms, either initially or at the time of recurrence, were typical of Cushing's syndrome. Four of five patients with type I disease had recurrent disease after transphenoidal hypophysectomy, bilateral adrenalectomy, or unilateral adrenalectomy. In three of five patients, medical therapy of hypercortisolism was abandoned because of adverse side effects. Preoperative evaluation in all patients included cortisol and ACTH levels, dexamethasone suppression tests, and computerized tomography (both abdominal and head). In patients with a prior history of adrenalectomy, radiocholesterol scans were also performed and were useful. Angiographic procedures were not required in these patients. In patients with type I disease, posterior operative approaches were used. In patients with type II disease, an anterolateral approach was used. Posterolateral incisions are preferred over Hugh-Young incisions and provide better exposure with a reduced risk of poor wound healing. Morbidity and mortality included one death and three nonhealing wounds. In the six surviving patients, symptoms resolved with variable frequency. Findings suggestive of Nelson's syndrome (hyperpigmentation) have occurred in two patients; serial computerized tomographic scans fail to reveal evidence of pituitary tumors

  4. Current Status of VHTR Technology Development

    International Nuclear Information System (INIS)

    High Temperature Gas-cooled Reactors (HTGRs) featuring particle fuel reached the stage of commercial deployment in the mid-1980s with the Fort St.Vrain and Thorium HochTemperatur Reaktor feeding electricity to the grids in the United States and West Germany, respectively. The technology was then adopted by Japan and China with the operation of the High Temperature Test Reactor in Oarai, Japan and the High Temperature Reactor (HTR-10) in China. Increasing the outlet temperature of the HTGR to even higher temperatures above 900 C will improve the thermodynamic efficiency of the system and enable application of a new class of gas reactor, the very high temperature reactor, to provide process heat, electricity, and hydrogen to chemical industries with the attendant benefits of improved energy security and reduced CO2 emissions. However, the increase in coolant outlet temperature presents a number of technical challenges associated with fuel, materials, power conversion, and analysis methods for the reactor and hydrogen production. The U.S. Department of Energy is sponsoring a broad program of research and development with a goal of addressing the technical challenges over a broad range of outlet temperatures as part of the Next Generation Nuclear Plant Project. This paper describes the research and development activities that are currently underway to realize the technologies needed for an HTGR that features outlet temperatures of 750 to 950 C.

  5. Current status of the LBNE neutrino beam

    CERN Document Server

    Moore, Craig Damon; Crowley, Cory Francis; Hurh, Patrick; Hylen, James; Lundberg, Byron; Marchionni, Alberto; McGee, Mike; Mokhov, Nikolai V; Papadimitriou, Vaia; Plunkett, Rob; Reitzner, Sarah Diane; Stefanik, Andrew M; Velev, Gueorgui; Williams, Karlton; Zwaska, Robert Miles

    2015-01-01

    The Long Baseline Neutrino Experiment (LBNE) will utilize a neutrino beamline facility located at Fermilab. The facility is designed to aim a beam of neutrinos toward a detector placed in South Dakota. The neutrinos are produced in a three-step process. First, protons from the Main Injector hit a solid target and produce mesons. Then, the charged mesons are focused by a set of focusing horns into the decay pipe, towards the far detector. Finally, the mesons that enter the decay pipe decay into neutrinos. The parameters of the facility were determined by an amalgam of the physics goals, the Monte Carlo modeling of the facility, and the experience gained by operating the NuMI facility at Fermilab. The initial beam power is expected to be ~700 kW, however some of the parameters were chosen to be able to deal with a beam power of 2.3 MW. The LBNE Neutrino Beam has made significant changes to the initial design through consideration of numerous Value Engineering proposals and the current design is described.

  6. Current Status of VHTR Technology Development

    Energy Technology Data Exchange (ETDEWEB)

    David Petti; Hans Gougar; Richard Wright; William Windes; Steve Herring; Richard Schultz; Paul Humrickhouse

    2010-10-01

    Abstract – High Temperature Gas-cooled Reactors (HTGRs) featuring particle fuel reached the stage of commercial deployment in the mid-1980s with the Fort St.Vrain and Thorium HochTemperatur Reaktor feeding electricity to the grids in the United States and West Germany, respectively. The technology was then adopted by Japan and China with the operation of the High Temperature Test Reactor in Oarai, Japan and the High Temperature Reactor (HTR-10) in China. Increasing the outlet temperature of the HTGR to even higher temperatures above 900°C will improve the thermodynamic efficiency of the system and enable application of a new class of gas reactor, the very high temperature reactor, to provide process heat, electricity, and hydrogen to chemical industries with the attendant benefits of improved energy security and reduced CO2 emissions. However, the increase in coolant outlet temperature presents a number of technical challenges associated with fuel, materials, power conversion, and analysis methods for the reactor and hydrogen production. The U.S. Department of Energy is sponsoring a broad program of research and development with a goal of addressing the technical challenges over a broad range of outlet temperatures as part of the Next Generation Nuclear Plant Project. This paper describes the research and development activities that are currently underway to realize the technologies needed for an HTGR that features outlet temperatures of 750 to 950°C.

  7. Current status of laser applications in urology

    Science.gov (United States)

    Knipper, Ansgar; Thomas, Stephen; Durek, C.; Jocham, Dieter

    1993-05-01

    The overall development of laser use in urology is recessing. The reasons are the refinement of methods of radical surgery and the continuing development of alternative technologies involving electric current. Taking the cost factor into account, are lasers still opportune in medicine? The answer is definitely yes. Cost reduction in medical practice without quality loss is only possible with effective methods of minimally invasive surgery. Continuing investigation of cutting, welding, coagulating and ablating instruments is justified. Competition of lasers to other technologies can only be beneficial to the cause. But where are the highlights of laser applications? The unsurpassed utilization of optical properties of lasers lie in the concept of photodynamic therapies and in optical feedback mechanisms for laser applications. The combination of lasers with three dimensional visualization of the treatment area by ultrasound (TULIP-procedure for benign prostatic hyperplasia) is a novel approach in laser application. The further development of these treatment modalities will reveal the true benefit of laser technology in urological applications.

  8. Current status of fusion reactor blanket thermodynamics

    International Nuclear Information System (INIS)

    Recent studies of liquid lithium have concentrated on its sorption characteristics for hydrogen isotopes and its interaction with common impurity elements. Hydrogen isotope sorption data (P-C-T relations, activity coefficients, Sieverts' constants, plateau pressures, isotope effects, free energies of formation, phase boundaries etc.) are presented in a tabular form that can be conveniently used to extract thermodynamic information for the α-phase of the Li-LiH, Li-LiD, and Li-LiT systems and to construct complete phase diagrams. Recent solubility data for Li3N, Li2O, and Li2C2 in liquid lithium are discussed with emphasis on the prospects for removing these species by cold-trapping methods. Current studies on the sorption of hydrogen in solid lithium alloys (e.g., Li--Al and Li--Pb), made using a new technique (the hydrogen titration method), have shown that these alloys should lead to smaller blanket-tritium inventories than are attainable with liquid lithium and that the P-C-T relationships for hydrogen in Li--M alloys can be estimated from lithium activity data for these alloys

  9. Current status of permanent total artificial hearts.

    Science.gov (United States)

    Davis, P K; Rosenberg, G; Snyder, A J; Pierce, W S

    1989-01-01

    Pneumatic total artificial heats, although demonstrating utility as temporary mechanical circulatory support devices, have not demonstrated a great deal of promise as permanent cardiac replacements. The increasing number of patients who would be candidates for total heart replacement suggests a large role for a permanent implantable total artificial heart. To that end, the Pennsylvania State University is developing an electric motor-driven total artificial heart; the results with implants in calves are encouraging. In this device, a roller-screw mechanism is used to translate the rotation of a brushless direct-current motor into rectilinear motion of a pusher-plate assembly, which in turn empties the blood sacs. The total artificial heart of the future will function under automatic control without percutaneous leads, and this should provide the patient with a nearly normal life-style. Although further experimental efforts are necessary to prepare the device for clinical trials, the technology to provide a safe and reliable electric blood-pump system is at hand. PMID:2912392

  10. Current status of the PBMR licensing project

    International Nuclear Information System (INIS)

    The CNS is currently reviewing the PBMR conceptual design from a licensibility point of view. The PBMR concept is based on a High Temperature Gas Cooled Reactor - pebble bed reactor type. It is anticipated that the PBMR design will rely on inherent safety characteristics to contain fission products within fuel over the full range of design basis events. This feature combined with the high temperature integrity of the fuel and structural graphite, allows the safe use of a high coolant temperature, which allows consideration of the future development of this reactor for non-electrical applications of nuclear heat for industrial use. The CNS licensing approach requires that the licensing and design basis of the plant should respect prevailing international norms and practices and that a quantitative risk assessment should demonstrate compliance with the CNS fundamental safety standards. The first stage of the licensing process is now ongoing; this is a pre-application phase, which will result in a statement on licensibility being issued. Identification of the specific documentation requirements and information needed is required across every step of the licensing process. Top level regulatory requirements have been established for the PBMR. They include the CNS fundamental safety standard and basic licensing criteria, which describes requirements on licensees of nuclear installations regarding risk assessment and compliance with the safety criteria and define classification of licensing basis events. (author)

  11. Current status of tritium calorimetry at TLK

    International Nuclear Information System (INIS)

    Inside a tritium facility, calorimetry is an important analytical method as it is the only reference method for accountancy (it is based on the measurement of the heat generated by the radioactive decay). Presently, at Tritium Laboratory Karlsruhe (TLK), 4 calorimeters are in operation, one of isothermal type and three of inertial guidance control type (IGC). The volume of the calorimeters varies between 0.5 and 20.6 liters. About two years ago we started an extensive work to improve our calorimeters with regard to reliability and precision. We were forced to upgrade 3 of our 4 calorimeters due to the outdated interfaces and software. This work involved creating new LabView programs driving the devices, re-tuning control loops and replacing obsolete hardware components. In this paper we give a review on the current performance of our calorimeters, comparing it to recently available devices from the market and in the literature. We also show some ideas for a next generation calorimeter based on experiences with our IGC calorimeters and other devices reported in the literature. (authors)

  12. [Current MRI staging of rectal cancer].

    Science.gov (United States)

    Wietek, B M; Kratt, T

    2012-11-01

    Colorectal carcinoma is the second most prevalent cause for cancer, and has very variable outcomes. Advancements in surgery, the change from adjuvant to neo-adjuvant radio-chemo-therapies as well as in clinical diagnostics have improved the prognosis for patients in a multi-modal therapy concept. An accurate primary staging including a reliable prediction of the circumferential resection margin (CRM) has established MR Imaging (MRI) beside intraluminal endoscopic ultrasound (EUS). MRI facilitates the selection of patients likely to benefit from a preoperative therapy, especially in cases of unfavorable factors. Currently the relationship of the tumor to the mesorectal fascia has become a more important prognostic factor than the T-staging, particularly for surgical therapy. In addition further prognostic factors like the depth of infiltration into the perirectal fat and the extramural venous infiltration (EMVI) have important impact on therapy and prognosis. High resolution MRI has proved useful in clarifying the relationship between the tumor and the mesorectal fascia, which represents the CRM at the total mesorectal excision (TME) especially in the upper and middle third. Preoperative evaluation of the other prognostic factors as well as the nodal status is still difficult. It is used increasingly not only for primary staging but also progressively for the monitoring of neoadjuvant therapy. The addition of diffusion weighted imaging (DWI) is an interesting option for the improvement of response evaluation. The following overview provides an introduction of MRI diagnosis as well as its importance for the evaluation of the clinically relevant prognostic factors leading to an improvement of therapy and prognosis of patients with rectal carcinoma. PMID:22893486

  13. Prostate Cancer: Current Treatment and Prevention Strategies

    OpenAIRE

    Chen, Fang-zhi; Zhao, Xiao-kun

    2013-01-01

    Abstract Prostate cancer is one of the life threatening disorders of male. Although, over the last two decades, a high rate of overdiagnosis, and overtreatment has lowered the incidence rate of prostate cancer, the treatment or prevention strategies are not enough to control the high rate of disease related mortality. Current medical treatment approaches include surgery, radiation therapy, chemotherapy, hormonal therapy, cryosurgery and other methods. These approaches are more or less effecti...

  14. International Shock-Wave Database: Current Status

    Science.gov (United States)

    Levashov, Pavel

    2013-06-01

    Shock-wave and related dynamic material response data serve for calibrating, validating, and improving material models over very broad regions of the pressure-temperature-density phase space. Since the middle of the 20th century vast amount of shock-wave experimental information has been obtained. To systemize it a number of compendiums of shock-wave data has been issued by LLNL, LANL (USA), CEA (France), IPCP and VNIIEF (Russia). In mid-90th the drawbacks of the paper handbooks became obvious, so the first version of the online shock-wave database appeared in 1997 (http://www.ficp.ac.ru/rusbank). It includes approximately 20000 experimental points on shock compression, adiabatic expansion, measurements of sound velocity behind the shock front and free-surface-velocity for more than 650 substances. This is still a useful tool for the shock-wave community, but it has a number of serious disadvantages which can't be easily eliminated: (i) very simple data format for points and references; (ii) minimalistic user interface for data addition; (iii) absence of history of changes; (iv) bad feedback from users. The new International Shock-Wave database (ISWdb) is intended to solve these and some other problems. The ISWdb project objectives are: (i) to develop a database on thermodynamic and mechanical properties of materials under conditions of shock-wave and other dynamic loadings, selected related quantities of interest, and the meta-data that describes the provenance of the measurements and material models; and (ii) to make this database available internationally through the Internet, in an interactive form. The development and operation of the ISWdb is guided by an advisory committee. The database will be installed on two mirrored web-servers, one in Russia and the other in USA (currently only one server is available). The database provides access to original experimental data on shock compression, non-shock dynamic loadings, isentropic expansion, measurements of sound

  15. [Headache. Current status of research and treatment].

    Science.gov (United States)

    Straube, A; Gaul, C

    2015-10-01

    The starting point for German headache research and clinical education was the engagement of D. Soyka in the 1970s, which enabled the foundation of the German Headache Society (DMKG) on 28 June 1979 and, some years later, the founding congress of the International Headache Society (IHS) in Munich 1982. As a result of these activities, in 1988 the first international classification of headache disorders was published. This classification was one of the major milestones in the development of basic as well as clinical headache research. In the following years, epidemiological studies all over the world showed a 1-year prevalence for headache of approximately 60%, making headaches one of the most frequent medical complaints. Basic research showed an involvement of serotonergic mechanisms in migraine pain and triptans were one of the first drugs designed to influence these mechanisms. Functional brain imaging studies in migraine patients further showed a cyclic modulation of the activity of brainstem areas independent of the current pain state. Various research groups were involved in the clarification of the role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache. A specific development in the German headache scene is the establishment of integrated headache centers and reflects the primarily multimodal treatment approach in Germany which contrasts with the settings in other countries. These successful developments are increasingly being undermined by the fact that the low financial support of headache research, for example, by the German science council is causing a decreasing interest in headache research, with the consequence that the clinical education of students as well as young medical doctors shows increasing deficits. The consequence for the future will be a deficit in the clinical care of the population. PMID:26264901

  16. Current Status on Biochip and Detection Technology

    International Nuclear Information System (INIS)

    The recent biotechnology technique has been miniaturized and it features a fusion of electricity, electronics and mechanics in the existing biology. As an example, biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput and speed. Like a computer chip that can perform millions of mathematical operations in a second, the biochip can perform thousands of biological reactions, such as decoding genes, in a few seconds. The biochip is being used in toxicological, protein, and biochemical research and it can also be used to rapidly detect chemical agents used in biological warfare so that defensive measures can be taken. These biochip technologies incorporate elements of microfluidics, micromachining, synthetic chemistry, separation technologies, and detection technologies of biological molecules. Basically, biochips can be divided into two types: microarray and lab-on-a-chip system. Microarrays use planted probes to catch and identify target biological molecules while lab-on-a-chips actively process loaded samples. The biochips are becoming more diverse and customers are appearing all over the world. The products from the biochip market are being used to help accelerating the research processes and capabilities of bio-pharmaceutical drug discovery and basic academic bioresearch. To fully take advantages of the attributes of biochip technologies such as miniaturization, parallelism, automation and integration, there are some problems to overcome. The major problem is to reduce the cost. Currently the prices of biochip products are too expensive to replace traditional products and processes. As a method to solve the problem, a radioisotope can be used as a detecting sensor by appling on the biochip, as it were, radio-biochip that will further bring the cost down. The originality using the radioisotope on the biochip technology will be able

  17. Current Status of NASA's Heavy Lift Plans

    Science.gov (United States)

    Creech, Steve

    2010-01-01

    Numerous studies since the Apollo Program of the 1960s have highlighted the benefits of - and the need for - a national heavy lift launch capability to support human exploration, science, national security, and commercial development of space. NASA's most recent and most refined effort to develop that heavy lift capability is the Ares V. Ares V is a key element of NASA's Constellation Program. It s overall goal s part of approved national space policy is to retire the Space Shuttle and develop its successor, complete the International Space Station, and resume human exploration beyond low Earth orbit (LEO), beginning with exploration of the Moon as a step to other destinations in the Solar System. Ares V s first role is that of cargo vehicle to carry a lunar lander into Earth orbit, rendezvous with astronauts launched on the smaller Ares I crew launch vehicle, and perform the trans lunar injection (TLI) mission to send the mated crew and lander vehicles to the Moon. The design reference missions (DRMs) envisioned for it also include direct lunar cargo flights and a human Mars mission. Although NASA's priority from the start of the Constellation Program to the present has been development of the Ares I and Orion crew vehicle to replace the retiring Shuttle fleet, the Ares team has made significant progress in understanding the performance, design trades, technology needs, mission scenarios, ground and flight operations, cost, and other factors associated with heavy lift development. The current reference configuration was selected during the Lunar Capabilities Concept Review (LCCR) in fall 2008. That design has served since then as a point of departure for further refinements and trades among five participating NASA field centers. Ares V development to date has benefited from progress on the Ares I due to commonality between the vehicles. The Ares I first stage completed a successful firing of a 5-segment solid rocket motor. The Ares I-X launch Numerous studies

  18. Status of particle therapy for lung cancer

    International Nuclear Information System (INIS)

    The current standard treatment for lung cancer, the most common type of cancer worldwide, depends on disease stage. Surgery is the treatment of choice for early-stage tumors, but radiotherapy is a good option for those with early-stage tumors who cannot undergo surgery, and radiotherapy in conjunction with chemotherapy is the standard of care for locally advanced tumors. Although advances in photon (x-ray)-based radiotherapy involving three-dimensional conformal radiotherapy and intensity-modulated radiotherapy allow radiation doses to be escalated beyond the traditional limit of 60 Gy, this dose is not considered to be sufficient for tumor eradication. Moreover, the improvements in local control and survival conferred by concurrent chemotherapy come at the cost of considerable toxicity owing to inadvertent irradiation of surrounding normal tissues, and this toxicity often limits the radiation dose that can be delivered. Unfortunately for patients with locally advanced lung cancer, local control and survival remain poor. Attempts to improve clinical outcomes for patients with lung cancer have led to the use of charged particle therapy in an effort to exploit the physical properties of such particles to escalate the dose to the tumor while simultaneously limiting the dose to nearby structures, thereby enhancing the therapeutic ratio and potentially improving cancer cure rates. This review summarizes the rationale for and challenges associated with the use of charged particles for lung cancer therapy and reviews the clinical experience to date with using protons and carbon ions for early-stage and locally advanced stage non-small cell lung cancer

  19. An overview of the current status of CMB observations

    CERN Document Server

    Barreiro, R B

    2009-01-01

    In this paper we briefly review the current status of the Cosmic Microwave Background (CMB) observations, summarising the latest results obtained from CMB experiments, both in intensity and polarization, and the constraints imposed on the cosmological parameters. We also present a summary of current and future CMB experiments, with a special focus on the quest for the CMB B-mode polarization.

  20. Helicopter Rotor Noise Prediction: Background, Current Status, and Future Direction

    Science.gov (United States)

    Brentner, Kenneth S.

    1997-01-01

    Helicopter noise prediction is increasingly important. The purpose of this viewgraph presentation is to: 1) Put into perspective the recent progress; 2) Outline current prediction capabilities; 3) Forecast direction of future prediction research; 4) Identify rotorcraft noise prediction needs. The presentation includes an historical perspective, a description of governing equations, and the current status of source noise prediction.

  1. Impact of Job Status on Accessibility of Cancer Screening

    OpenAIRE

    Kim, Seung Ju; Han, Kyu-Tae; Park, Eun-Cheol

    2015-01-01

    Purpose Cancer is a leading cause of death worldwide with approximately 75,000 cancer deaths in Korea alone in 2013. Cancer screening is an important method of prevention; however, only 63.4% of Koreans sought cancer screening in 2012 even though it was widely offered at no cost. We focused on part time workers because they often experience job instability and relative discrimination. Therefore, we investigated the correlation between job status and cancer screening. Materials and Methods Dat...

  2. Exercise after breast cancer treatment: current perspectives

    Directory of Open Access Journals (Sweden)

    Dieli-Conwright CM

    2015-10-01

    Full Text Available Christina M Dieli-Conwright, Breanna Z Orozco Division of Biokinesiology and Physical Therapy, Women's Health and Exercise Laboratory, University of Southern California, Los Angeles, CA, USA Abstract: Over the past 2 decades, great strides have been made in the field of exercise-oncology research, particularly with breast cancer. This area of research is particularly important since there are >2.8 million breast cancer survivors who are in need of an intervention that can offset treatment-related side effects. Noticeable reductions in physical fitness (ie, cardiopulmonary fitness and muscular strength, negative changes in body composition (ie, increase in body mass, decrease in lean body mass, and increase in fat mass, increased fatigue, depression, or anxiety are some of the common side effects of cancer treatments that negatively impact overall quality of life and increase the risk for the development of comorbidities. Exercise plays a vital role in improving cardiopulmonary function, psychological events, muscular strength, and endurance in breast cancer survivors, and thus should be considered as a key factor of lifestyle intervention to reverse negative treatment-related side effects. The purpose of this review is to address current perspectives on the benefits of aerobic and resistance exercise after breast cancer treatments. This review is focused on the well-established benefits of exercise on physical and emotional well-being, bone health, lymphedema management, and the postulated benefits of exercise on risk reduction for recurrence of breast cancer. Keywords: breast cancer, exercise, physical well-being

  3. Current Status of Nuclear Fuel Irradiation Test at HANARO

    Energy Technology Data Exchange (ETDEWEB)

    Yang, Seong Woo; Park, Seung Jae; Shin, Yoon Taeg; Choo, Kee Nam; Cho, Man Soon [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

    2014-05-15

    The in-pile testing of HANARO demand of not only the reactor core and structure material but also the nuclear fuel is recently increased to verify its irradiation performance, some fuel irradiation tests were planned and conducted using the irradiation test capsule in OR irradiation hole at HANARO. In this paper, the current status of irradiation test for the nuclear fuels at HANARO is reported. The current status of nuclear fuel irradiation test was reported. The irradiation test for plate, particle, pellet and metallic fuel for the development of research reactor, VHTR, LWR, SFR was planned and conducted at HANARO.

  4. Current status of endoscopic ultrasound for the upper gastrointestinal tract in Asia.

    Science.gov (United States)

    Yoshinaga, Shigetaka; Hilmi, Ida Normiha; Kwek, Boon Eu Andrew; Hara, Kazuo; Goda, Kenichi

    2015-04-01

    We summarize the current status of endoscopic ultrasound (EUS) for the upper gastrointestinal (GI) tract solely in Asia, focusing on the staging of superficial cancers and the diagnosis of submucosal tumors (SMT), by analysis of questionnaire responses and a literature review. EUS for assessing the depth of superficial cancers of the upper GI tract is useful; however, evidence is lacking to support that EUS is superior to other modalities. The current status of EUS varies across different Asian countries, and standardization of the methods used both during the procedure and for depth subclassification is necessary to evaluate the diagnostic accuracy. Although EUS alone is limited in the diagnosis of SMT, EUS-guided fine-needle aspiration is an effective and safe diagnostic tool. Although there is a role for EUS, there are still many limitations both technically and in terms of accessibility. PMID:25537645

  5. Exercise after breast cancer treatment: current perspectives.

    Science.gov (United States)

    Dieli-Conwright, Christina M; Orozco, Breanna Z

    2015-01-01

    Over the past 2 decades, great strides have been made in the field of exercise-oncology research, particularly with breast cancer. This area of research is particularly important since there are >2.8 million breast cancer survivors who are in need of an intervention that can offset treatment-related side effects. Noticeable reductions in physical fitness (ie, cardiopulmonary fitness and muscular strength), negative changes in body composition (ie, increase in body mass, decrease in lean body mass, and increase in fat mass), increased fatigue, depression, or anxiety are some of the common side effects of cancer treatments that negatively impact overall quality of life and increase the risk for the development of comorbidities. Exercise plays a vital role in improving cardiopulmonary function, psychological events, muscular strength, and endurance in breast cancer survivors, and thus should be considered as a key factor of lifestyle intervention to reverse negative treatment-related side effects. The purpose of this review is to address current perspectives on the benefits of aerobic and resistance exercise after breast cancer treatments. This review is focused on the well-established benefits of exercise on physical and emotional well-being, bone health, lymphedema management, and the postulated benefits of exercise on risk reduction for recurrence of breast cancer. PMID:26543382

  6. Current status and future direction of the MONK software package

    International Nuclear Information System (INIS)

    The current status of the MONK criticality software package is summarized in terms of recent and current developments and envisaged directions for the future. The areas of the discussion are physics modeling, geometry modeling, source modeling, nuclear data, validation, supporting tools and customer services. In future development plan, MONK continues to be focused on meeting the short and long-term needs of the code user community. (J.P.N.)

  7. Nuclear Power for Sustainable Development : Current Status and Future Prospects

    OpenAIRE

    Adamantiades, A.; Kessides, I.

    2009-01-01

    Interest in nuclear power has been revived as a result of volatile fossil fuel prices, concerns about the security of energy supplies, and global climate change. This paper describes the current status and future plans for expansion of nuclear power, the advances in nuclear reactor technology, and their impacts on the associated risks and performance of nuclear power. Advanced nuclear reactors have been designed to be simpler and safer, and to have lower costs than currently operating reactor...

  8. Special Education History, Current Status and Future: India

    Science.gov (United States)

    Antony, Pavan John

    2013-01-01

    Education of all children in public schools, including those with disabilities, continues to be an unresolved issue in many countries around the globe. While education of all children is mandated by law and considered a basic human right in many countries, the current status of implementation varies. India, for example, is an ancient country that…

  9. Corporate Blended Learning in Portugal: Current Status and Future Directions

    Science.gov (United States)

    Marcal, Julia; Caetano, Antonio

    2010-01-01

    The aim of this study is to characterize the current status of blended learning in Portugal, given that b-learning has grown exponentially in the Portuguese market over recent years. 38 organizations (representing 68% of all institutions certified to provide distance training by the Government Labour Office--DGERT-) participated in this study. The…

  10. Current status of studies on temperature fluctuation phenomena in LMFRs

    International Nuclear Information System (INIS)

    This paper describes the current status of studies being performed in PNC on temperature fluctuation phenomena occurring in fast reactors. The studies concentrate on four problems: thermal stratification, thermal striping, core-plenum interaction and free surface sloshing. Both experimental and analytical approaches to reveal these phenomena and to establish design and safety evaluation methods are presented together with future works. (author)

  11. Current status of quantitative rotational spectroscopy for atmospheric research

    Science.gov (United States)

    Drouin, Brian J.; Wlodarczak, Georges; Colmont, Jean-Marcel; Rohart, Francois

    2004-01-01

    Remote sensing of rotational transitions in the Earth's atmosphere has become an important method for the retrieval of geophysical temperatures, pressures and chemical composition profiles that requires accurate spectral information. This paper highlights the current status of rotational data that are useful for atmospheric measurements, with a discussion of the types the rotational lineshape measurements that are not generally available in either online repository.

  12. Current status and future research in motion planning

    Energy Technology Data Exchange (ETDEWEB)

    Hwang, Y.K.

    1995-07-01

    There have been numerous research efforts in the field of motion planning, resulting in many theoretical and practical results. We review the current status of existing motion planning algorithms, evaluate their completeness and efficiencies on modern computers, and suggest fruitful future research directions.

  13. Refugee Issues: Current Status and Directions for the Future.

    Science.gov (United States)

    Rubin, Gary; And Others

    A comprehensive review of current refugee policy and program issues is provided in this paper, which is intended to serve both as a status report and a guide to developing an agenda for the future. Chapter I deals with early warning as to potential refugee movements, mass asylum, and interim assistance. Chapter II discusses and analyzes four types…

  14. Current status of radiation treatment of water and wastewater

    International Nuclear Information System (INIS)

    This is a brief review of the current status of radiation treatment of surface water, groundwater, wastewaters, and sewage sludges. Sources of ionizing radiation, and combination radiation methods for purification are described in some detail. Special attention is paid to pilot and industrial facilities. (author)

  15. Current status and key issues of nuclear liability regime

    International Nuclear Information System (INIS)

    Nuclear liability regime has been established from the beginning of the nuclear power industry. The first nuclear accident with major transboundary consequences occurred at Chernobyl, and led to reexamination of the nuclear liability regime. Current status and key issues of the national and international nuclear liability regime are reviewed. (author)

  16. Colonography: current status, research directions and challenges. Update 2002

    International Nuclear Information System (INIS)

    With the introduction of multislice CT technology and faster gradients in MRI, CT and MR colonography are increasingly becoming attractive alternatives for colorectal mass screening. In this article we summarise the current status, research directions, and challenges in CT and MR colonography. (orig.)

  17. Counseling in Malaysia: History, Current Status, and Future Trends

    Science.gov (United States)

    See, Ching Mey; Ng, Kok-Mun

    2010-01-01

    This article presents an overview of the history of counseling in Malaysia, provides an update of its current status, and discusses some anticipated future trends for the profession in light of recent developments in the country. Counseling in Malaysia began with school guidance in the 1960s and has now achieved recognition as a profession in…

  18. Epidermal growth factor receptor inhibition in lung cancer: status 2012.

    Science.gov (United States)

    Hirsch, Fred R; Jänne, Pasi A; Eberhardt, Wilfried E; Cappuzzo, Federico; Thatcher, Nick; Pirker, Robert; Choy, Hak; Kim, Edward S; Paz-Ares, Luis; Gandara, David R; Wu, Yi-Long; Ahn, Myung-Ju; Mitsudomi, Tetsuya; Shepherd, Frances A; Mok, Tony S

    2013-03-01

    Lung cancer is the most common cause of cancer deaths. Most patients present with advanced-stage disease, and the prognosis is generally poor. However, with the understanding of lung cancer biology, and development of molecular targeted agents, there have been improvements in treatment outcomes for selected subsets of patients with non-small-cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have demonstrated significantly improved tumor responses and progression-free survival in subsets of patients with advanced NSCLC, particularly those with tumors harboring activating EGFR mutations. Testing for EGFR mutations is a standard procedure for identification of patients who will benefit from first-line EGFR TKIs. For patients with advanced NSCLC and no activating EGFR mutations (EGFR wild-type) or no other driving oncogenes such as ALK-gene rearrangement, chemotherapy is still the standard of care. A new generation of EGFR TKIs, targeting multiple receptors and with irreversible bindings to the receptors, are in clinical trials and have shown encouraging effects. Research on primary and acquired resistant mechanisms to EGFR TKIs are ongoing. Monoclonal antibodies (e.g. cetuximab), in combination with chemotherapy, have demonstrated improved outcomes, particularly for subsets of NSCLC patients, but further validations are needed. Novel monoclonal antibodies are combined with chemotherapy, and randomized comparative studies are ongoing. This review summarizes the current status of EGFR inhibitors in NSCLC in 2012 and some of the major challenges we are facing. PMID:23370315

  19. Image-Guided Hydrodynamic Gene Delivery: Current Status and Future Directions

    Directory of Open Access Journals (Sweden)

    Kenya Kamimura

    2015-08-01

    Full Text Available Hydrodynamics-based delivery has been used as an experimental tool to express transgene in small animals. This in vivo gene transfer method is useful for functional analysis of genetic elements, therapeutic effect of oligonucleotides, and cancer cells to establish the metastatic cancer animal model for experimental research. Recent progress in the development of image-guided procedure for hydrodynamics-based gene delivery in large animals directly supports the clinical applicability of this technique. This review summarizes the current status and recent progress in the development of hydrodynamics-based gene delivery and discusses the future directions for its clinical application.

  20. Research status and funding trends of lung cancer biomarkers

    OpenAIRE

    Li, Cui; Hong, Wei

    2013-01-01

    Lung cancer is one of malignant tumors with the highest morbidity and mortality in the world. At present, research of early diagnosis, treatment, prognosis, and metastasis associated biomarkers is most active. This article reviewed the research status of lung cancer biomarkers and analyzed the funding situation in the field of lung cancer markers in recent 10 years in China and abroad, to provide a reference for the future basic and clinical translational research of lung cancer biomarkers.

  1. CMS Data Analysis: Current Status and Future Strategy

    CERN Document Server

    Innocente, V

    2003-01-01

    We present the current status of CMS data analysis architecture and describe work on future Grid-based distributed analysis prototypes. CMS has two main software frameworks related to data analysis: COBRA, the main framework, and IGUANA, the interactive visualisation framework. Software using these frameworks is used today in the world-wide production and analysis of CMS data. We describe their overall design and present examples of their current use with emphasis on interactive analysis. CMS is currently developing remote analysis prototypes, including one based on Clarens, a Grid-enabled client-server tool. Use of the prototypes by CMS physicists will guide us in forming a Grid-enriched analysis strategy. The status of this work is presented, as is an outline of how we plan to leverage the power of our existing frameworks in the migration of CMS software to the Grid.

  2. Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.

    Science.gov (United States)

    Mayor, Marissa; Yang, Neng; Sterman, Daniel; Jones, David R; Adusumilli, Prasad S

    2016-05-01

    Recent successes in immunotherapeutic strategies are being investigated to combat cancers that have less than ideal responses to standard of care treatment, such as non-small-cell lung cancer. In this paper, we summarize concepts and the current status of immunotherapy for non-small cell lung cancer, including salient features of the major categories of immunotherapy-monoclonal antibody therapy, immune checkpoint blockade, immunotoxins, anticancer vaccines, and adoptive cell therapy. PMID:26516195

  3. Macromolecular contrast agents for MR mammography: current status

    International Nuclear Information System (INIS)

    Macromolecular contrast media (MMCM) encompass a new class of diagnostic drugs that can be applied with dynamic MRI to extract both physiologic and morphologic information in breast lesions. Kinetic analysis of dynamic MMCM-enhanced MR data in breast tumor patients provides useful estimates of tumor blood volume and microvascular permeability, typically increased in cancer. These tumor characteristics can be applied to differentiate benign from malignant lesions, to define the angiogenesis status of cancers, and to monitor tumor response to therapy. The most immediate challenge to the development of MMCM-enhanced mammography is the identification of those candidate compounds that demonstrate the requisite long intravascular distribution and have the high tolerance necessary for clinical use. Potential mammographic applications and limitations of various MMCM, defined by either experimental animal testing or clinical testing in patients, are reviewed in this article. (orig.)

  4. Current status of sentinel node biopsy in urological malignancies

    Directory of Open Access Journals (Sweden)

    Friedhelm Wawroschek

    2010-08-01

    Full Text Available Like in most other malignancies the lymph node status is of outstanding prognostic relevance and an important tool for the determination of adjuvant strategies for urological tumor entities, too. Even in the era of PET/CT and MRI with iron oxid nano-particles the radiological imaging technology is strongly limited in cases of metastases smaller than 5 mm. Therefore only the operative lymph node exploration is suitable for an exact lymph node staging. The dilemma, however, is that the extended lymphadenectomy techniques feature a high morbidity and that any limitation of the dissection area results in a reduced detection rate of metastases in penile and prostate cancer. In contrast the sentinel- guided lymphadenectomy (SLND offers a short operation time and a low morbidity without the risk of a significantly reduced detection of lymph node positive patients. As a consequence of many published papers dealing with a few thousands of patients the European Association of Urology (EAU guidelines recommend the SLND in penile cancer (tumor stages ≥ T1G2 and as an option in prostate cancer. The latest studies of bladder, renal cell and testicular cancer promise the feasibility for these tumor entities, too. Up to which extend these thera- peutic concepts are able to replace or at least complement the default therapeutic procedures has to be shown in further studies.

  5. Health Insurance Status May Affect Cancer Patients' Survival

    Science.gov (United States)

    ... https://medlineplus.gov/news/fullstory_160304.html Health Insurance Status May Affect Cancer Patients' Survival 2 studies highlight disparities in outcomes for uninsured and Medicaid patients To use the sharing features on this ...

  6. Corporate blended learning in Portugal: current status and future directions

    OpenAIRE

    Marçal, J.; Caetano, A.

    2010-01-01

    The aim of this study is to characterize the current status of blended learning in Portugal, given that b-learning has grown exponentially in the Portuguese market over recent years. 38 organizations (representing 68% of all institutions certified to provide distance training by the Government Labour Office – DGERT -) participated in this study. The results revealed that in 2007, although the predominant instructional format in Portugal was still face-to-face training (65%), e-learning at 15%...

  7. Corporate Social Responsibility : Benefit, Current Status and Future Trend

    OpenAIRE

    Ahmed, Sarwar U.; Uchida, Shigeru

    2006-01-01

    The objective of this paper is to review the current status and future trend of corporate social responsibility concept practiced by companies. In doing so, the term corporate social responsibility is defined with the regulations governing it. Then the benefits of performing such responsibilities are elaborated. Finally, the role of the public sector is discussed in assisting the business firms for practicing social responsibility. The examination of various available literatures revealed tha...

  8. Current Status of Laparoscopic Liver Resection in Korea

    OpenAIRE

    Park, Joon Seong; Han, Ho-Seong; Hwang, Dae Wook; Yoon, Yoo-Seok; Cho, Jai Young; Koh, Yang-Seok; Kwon, Choon Hyuck David; Kim, Kyung Sik; Kim, Sang Bum; Kim, Young Hoon; Kim, Hyung Chul; Chu, Chong Woo; Lee, Dong Shik; Kim, Hong-Jin; Park, Sang Jae

    2012-01-01

    Since laparoscopic liver resection was first introduced in 2001, Korean surgeons have chosen a laparoscopic procedure as one of the treatment options for benign or malignant liver disease. We distributed and analyzed a nationwide questionnaire to members of the Korean Laparoscopic Liver Surgery Study Group (KLLSG) in order to evaluate the current status of laparoscopic liver resection in Korea. Questionnaires were sent to 24 centers of KLLSG. The questionnaire consisted of operative procedure...

  9. Current Status and Prospects of Biodiesel Production from Microalgae

    Directory of Open Access Journals (Sweden)

    Yuhuan Liu

    2012-07-01

    Full Text Available Microalgae represent a sustainable energy source because of their high biomass productivity and ability to remove air and water born pollutants. This paper reviews the current status of production and conversion of microalgae, including the advantages of microalgae biodiesel, high density cultivation of microalgae, high-lipid content microalgae selection and metabolic control, and innovative harvesting and processing technologies. The key barriers to commercial production of microalgae biodiesel and future perspective of the technologies are also discussed.

  10. Current Status and Prospects of Biodiesel Production from Microalgae

    OpenAIRE

    Yuhuan Liu; Rongsheng Ruan; Zhenyi Du; Xiaodan Wu

    2012-01-01

    Microalgae represent a sustainable energy source because of their high biomass productivity and ability to remove air and water born pollutants. This paper reviews the current status of production and conversion of microalgae, including the advantages of microalgae biodiesel, high density cultivation of microalgae, high-lipid content microalgae selection and metabolic control, and innovative harvesting and processing technologies. The key barriers to commercial production of microalgae biodie...

  11. Current status of acupuncture and moxibustion in China

    OpenAIRE

    Lim, Min Yee; Huang, Jian; Zhao, Baixiao; Ha, Lue

    2015-01-01

    Acupuncture and moxibustion are more integrated in the Chinese healthcare system than in the national healthcare systems of other countries. Development of acupuncture and moxibustion in China is making progress in this field. For overseas researchers, this commentary offers perspectives on the current status of acupuncture and moxibustion in China and examines relevant opportunities and challenges in healthcare reforms. There has been a steady increase in the number of undergraduates and pos...

  12. Review of the current status of radiation risk estimates

    International Nuclear Information System (INIS)

    This report reviews the current status of radiation risk estimation for low linear energy transfer radiation. Recent statements by various national and international organisations regarding risk estimates are critically discussed. The recently published revised population risk estimates from the study of Japanese bomb survivors are also reviewed and used with some unpublished data from Japan to calculate risk figures for a general work force. (author)

  13. Current Status of Deltabaculoviruses, Cypoviruses and Chloriridoviruses Pathogenic for Mosquitoes

    Institute of Scientific and Technical Information of China (English)

    James J. Becnel

    2007-01-01

    There are a variety of viral pathogens that cause disease in mosquitoes with most belonging to three major groups. The most common viruses of mosquitoes are the baculoviruses (DBVs) (Baculoviridae: Deltabaculovirus), cytoplasmic polyhedrosis viruses (CPVs) (Reoviridae: Cypovirus) and the iridoviruses (MIVs) (Iridoviridae: Chloriridovirus). Baculoviruses and iridoviruses are DNA viruses while cypoviruses are the main RNA viruses in mosquitoes. This review presents an overview of the current status and recent advancements in understanding the biology and molecular features of mosquito pathogenic viruses.

  14. Current Status of Protein Force Fields for Molecular Dynamics

    Science.gov (United States)

    Lopes, Pedro E.M.; Guvench, Olgun

    2015-01-01

    Summary The current status of classical force fields for proteins is reviewed. These include additive force fields as well as the latest developments in the Drude and AMOEBA polarizable force fields. Parametrization strategies developed specifically for the Drude force field are described and compared with the additive CHARMM36 force field. Results from molecular simulations of proteins and small peptides are summarized to illustrate the performance of the Drude and AMOEBA force fields. PMID:25330958

  15. Current Status of Protein Force Fields for Molecular Dynamics

    OpenAIRE

    Lopes, Pedro E. M.; Guvench, Olgun; MacKerell, Alexander D.

    2015-01-01

    The current status of classical force fields for proteins is reviewed. These include additive force fields as well as the latest developments in the Drude and AMOEBA polarizable force fields. Parametrization strategies developed specifically for the Drude force field are described and compared with the additive CHARMM36 force field. Results from molecular simulations of proteins and small peptides are summarized to illustrate the performance of the Drude and AMOEBA force fields.

  16. Current status of protein force fields for molecular dynamics simulations.

    Science.gov (United States)

    Lopes, Pedro E M; Guvench, Olgun; MacKerell, Alexander D

    2015-01-01

    The current status of classical force fields for proteins is reviewed. These include additive force fields as well as the latest developments in the Drude and AMOEBA polarizable force fields. Parametrization strategies developed specifically for the Drude force field are described and compared with the additive CHARMM36 force field. Results from molecular simulations of proteins and small peptides are summarized to illustrate the performance of the Drude and AMOEBA force fields. PMID:25330958

  17. Nuclear liability legislation in Russia - current status and expected developments

    International Nuclear Information System (INIS)

    Present report is provided by the experts of the Russian insurance business, a company member of the Russian Nuclear Pool, and not the experts of the Ministry of Atomic Energy of Russian Federation (RF Minatom). Considering the above, the following document will outline the current status of nuclear liability legislation and insurance in Russia from a viewpoint of the insurance companies and not RF Minatom. (author)

  18. Marine renewable energy in China: Current status and perspectives

    OpenAIRE

    Zhang, Yong-Liang; Lin, Zheng; Qiu-lin LIU

    2014-01-01

    Based on a general review of marine renewable energy in China, an assessment of the development status and amount of various marine renewable energy resources, including tidal energy, tidal current energy, wave energy, ocean thermal energy, and salinity gradient energy in China’s coastal seas, such as the Bohai Sea, the Yellow Sea, the East China Sea, and the South China Sea, is presented. We have found that these kinds of marine renewable energy resources will play an important role in meeti...

  19. Current status of fire protection regulations for German nuclear facilities

    International Nuclear Information System (INIS)

    Operating nuclear power plants in Germany have been designed and constructed in different plant generations resulting in differences in the design and layout of fire protection features. Thus, it was necessary to assess the current fire safety status of the NPP. The systematic assessment of existing plants regarding the adequacy of their implemented fire protection features has been performed by deterministic and probabilistic methods. (author)

  20. The lion in Ghana: its historical and current status

    OpenAIRE

    Angelici, F. M.; Mahama, A.; Rossi, L.

    2015-01-01

    Historically, the lion (Panthera leo) population in Ghana has been little studied and its status is poorly documented. Currently, after recent unsuccessful attempts to find signs of the presence of the species, many authors believe that the Ghanaian lion population is most likely extinct. In an attempt to gather more data, since 2005 we have been carrying out lion surveys in the most important parks and other protected areas of Ghana, mainly focusing on Mole National Park (MNP). We have also ...

  1. The current status of Zika virus in Southeast Asia

    Science.gov (United States)

    2016-01-01

    OBJECTIVES: Zika virus currently poses a global threat and is a major public health issue throughout Latin America and the Caribbean. However, Zika virus infections in humans have also been observed in other regions, including Southeast Asia, where arboviral diseases are very common. In this study, we summarize the current status of Zika virus in Southeast Asia. This review aims to provide an overview of the current situation and also to suggest ways of adequately managing the emergence of Zika virus in Southeast Asia. METHODS: The literature searching for the reports on Zika virus in Southeast Asia was done using standard database PubMed and the re-analysis and summarization on the reports was done. RESULTS: A limited number of reports have addressed Zika virus disease in Southeast Asia, but it is has been confirmed that a problem already exists. Individual case reports and outbreaks of Zika virus have been confirmed in Southeast Asia. Several reports have also described patients becoming infected after visiting Southeast Asia. In addition, the concurrent circulation of Zika virus with other arboviruses has been confirmed. CONCLUSIONS: As a tropical region with a high prevalence of arboviral diseases, the emergence of Zika virus in Southeast Asia is a major concern. It is essential for local medical personnel to recognize this disease. Given the status of Southeast Asia as a globally important tourist destination, continuous updates on the status of Zika virus in Southeast Asia are required and should be incorporated into global health advisories regarding travel. PMID:27336445

  2. Ukrainian network of permanent geodynamic stations: Current status and perspective

    Science.gov (United States)

    Yatskiv, Y.; Bolotin, S.; Bolotina, O.; Khoda, O.; Medvedsky, M.; Sydorenko, G.; Stopkhay, Y.; Volvach, O.

    Current status and perspective of establishing the Ukrainian network of permanent geodynamic stations (UKRGEONETWORK) is reviewed in connection with Integrated Space Geodetic Systems project. The UKRGEONETWORK consists of several stations which form GPS, SLR, and VLBI subnetworks as well as Gravimetry subsystem. Some information concerned with current activity of the UKRGEONETWORK in particular precise orbit determination in software complex Kiev-Geodynamic, ionospheric modelling in Klio program, and EOP determination on SteelBreeze software is given. Plan for upgrading the hardware of stations and for increasing the number of collocation sites is considered.

  3. Current status of percutaneous coronary intervention of chronic total occlusion

    Institute of Scientific and Technical Information of China (English)

    Jun-bo GE

    2012-01-01

    This paper describes the current status of percutaneous coronary intervention (PCI) for totally occluded coronary arteries.Chronic total occlusion is associated with 10%-20% of all PCI procedures.Results show that opening an occluded vessel,especially one supplying a considerable area of myocardium,may be beneficial for a patient's angina relief and heart function.We describe the devices used currently in re-canalization such as new wires,microcatheters (including Tonus and Cosair) and intravascular ultrasound guidance.Different techniques to improve the success rate and reduce complications are discussed in detail.

  4. The Current Status, Evolution and Future of Facial Reconstruction

    Directory of Open Access Journals (Sweden)

    Fu-Chan Wei

    2008-10-01

    Full Text Available Facial reconstructive surgery aims to establish anatomicnormality as closely as possible following disfigurement tooptimize functional and esthetic outcomes and the potential fornormal psychosocial patient reintegration. The purposes of thisarticle are to outline the current status of facial reconstructionand reflect upon possibilities for its future development.Current reconstructive methods include the use of non-vascularizedgrafts, non-microsurgical vascularized flap transfers,microvascular free tissue transplantation, and their combinations.Whatever the method chosen, the principles of reconstructionfor each facial region or esthetic subunit should berespected.Most facial defects can be addressed satisfactorily withthe described techniques. Reconstructions for total or subtotalfacial defects, however, remain disappointing. Current reconstructivetechniques and principles continue to become more refined, providing improvedoutcomes. In the future, composite tissue allotransplantation and tissue engineering of vascularizedcomposite tissue constructs may also be applicable for facial reconstruction, inparticular for total or subtotal facial defects that appear outside the limits of current reconstructivemethods.

  5. Total antioxidant status (TAS in childhood cancer survivors Total antioxidant status (TAS in childhood cancer survivors

    Directory of Open Access Journals (Sweden)

    Maryna Krawczuk-Rybak

    2012-10-01

    Full Text Available Total antioxidant status (TAS, and the influence of treatment and correlation between TAS and parameters
    involved in metabolic syndrome (MS in pediatric cancer survivors were evaluated. One hundred children
    and adolescents were studied. Twenty-five survivors received radiotherapy, 12 were obese or overweight.
    Additionally, we analyzed TAS in eight children with acute lymphoblastic leukemia (ALL at diagnosis and
    during treatment after remission induction. The control group consisted of 22 healthy children. Serum concentrations
    of TAS, glucose, cholesterol, HDL-cholesterol, triglycerides, fibrinogen and insulin were measured. In
    cancer survivors, independently of diagnosis and kind of treatment (radiotherapy anthracyclines administration,
    the mean serum TAS did not differ significantly from the control group. No correlations were observed
    with age at the time of diagnosis or interval after the end of treatment. TAS values did not correlate with traits of
    the metabolic syndrome. In a group of eight patients with ALL at diagnosis and after induction of remission,
    TAS values were lower than in the control and cancer survivor groups. Antioxidant status was not found to be
    deteriorated in children after anticancer treatment, irrespective of diagnosis or kind of treatment, which might
    indicate sufficient antioxidant prevention. However, the possibility of the development of MS and cardiovascular
    disease in adulthood indicates the need for future studies.Total antioxidant status (TAS, and the influence of treatment and correlation between TAS and parameters
    involved in metabolic syndrome (MS in pediatric cancer survivors were evaluated. One hundred children
    and adolescents were studied. Twenty-five survivors received radiotherapy, 12 were obese or overweight.
    Additionally, we analyzed TAS in eight children with acute lymphoblastic leukemia (ALL at diagnosis and
    during

  6. MRI for breast cancer: Current indications

    International Nuclear Information System (INIS)

    Mammography is the only imaging study that has been proven in multiple large randomized trials to decrease breast cancer mortality. Mammography, however, has its limitations and, as such, other modalities that can complement it are being studied. One of these is dynamic contrast-enhanced breast MRI, which has emerged as an important adjunctive modality and is at present the most sensitive modality that we have to evaluate the breast. The American College of Radiology, in its 2004 practice guidelines, has outlined the 12 current indications for breast MRI. This manuscript reviews and provides examples of each of these

  7. 癌因性疲乏患者运动现状及障碍因素的调查分析%Investigation analysis of current exercise status and its obstacle factors in patients with cancer-related fatigue

    Institute of Scientific and Technical Information of China (English)

    王晓庆; 段培蓓; 杨丽华; 梅思娟

    2015-01-01

    目的 了解患有癌因性疲乏的胃肠道肿瘤患者的运动情况,分析其障碍因素,为临床护理工作提供依据. 方法 采用自行设计的一般资料调查问卷及肿瘤患者运动障碍问卷对江苏省中医院消化肿瘤外科的216例胃肠道肿瘤并具有不同程度癌因性疲乏的患者进行问卷调查. 结果 216例患者中有155例进行运动,但只有66例运动强度达到了美国肿瘤学会2012年发布的运动指南推荐的标准."不知道运动能够减轻疲乏程度""害怕运动对疾病及治疗带来负面影响""疲乏""缺乏运动技能"及"无运动习惯"等是影响癌因性疲乏患者实施运动疗法的主要障碍因素. 结论 医护人员应意识到癌因性疲乏对肿瘤患者生活质量的严重影响,规范化评估和管理疲乏,进行睡眠干预和行为指导,科学地评价疲乏的管理效果.%Objective To probe into the exercise status of digestive tumor patients in cancer-related fatigue, analyze its obstacle factors, in order to provide evidence for clinical nursing care. Methods Self designed general information questionnaire and tumor patient′s cinesipathy questionnaire in 216 digestive tumor patients of Digestive Tumor Surgery Department in Jiangsu Chinese Medicine Hospital for investigation of different degree cancer-related fatigue. Results A total of 155 of 216 patients had excises, but 66 cases reached the excises intensity of American Cancer Society in 2012 published guidelines recommend movement standards;"do not know that exercise can reduce fatigue degree", "fear campaign negative impact on disease and treatment","tired", "lack of motor skills" and "no exercise habits" were the obstacle factors for cancer-related fatigue carrying out exercise therapy. Conclusions Medical personnel should be aware of the impact of cancer-related fatigue on the quality of life in the cancer patients, regulate assessment and manage fatigue, carry out sleep interventions and guide

  8. Current status of the PSG Monte Carlo neutron transport code

    International Nuclear Information System (INIS)

    PSG is a new Monte Carlo neutron transport code, developed at the Technical Research Centre of Finland (VTT). The code is mainly intended for fuel assembly-level reactor physics calculations, such as group constant generation for deterministic reactor simulator codes. This paper presents the current status of the project and the essential capabilities of the code. Although the main application of PSG is in lattice calculations, the geometry is not restricted in two dimensions. This paper presents the validation of PSG against the experimental results of the three-dimensional MOX fuelled VENUS-2 reactor dosimetry benchmark. (authors)

  9. Current research status of immunology in the genomic era

    Institute of Scientific and Technical Information of China (English)

    LI HaoWen; LI dinZhi; ZHAO GuoPing; WANG Ying

    2009-01-01

    This review updates the current status of immunology research under the influence of genomics, both conceptually and technologically. It particularly highlights the advantages of employing the high-throughput and large-scale technology, the large genomic database, and bioinformatic power in the immunology research. The fast development in the fields of basic immunology, clinical immunology (tumor and infectious immunology) and vaccine designing is illustrated with respect to the successful usage of genomic strategy. We also speculate the future research directions of immunology in the era of genomics and post-genomics.

  10. On the current status of Phakopsora pachyrhizi genome sequencing

    Directory of Open Access Journals (Sweden)

    Marco eLoehrer

    2014-08-01

    Full Text Available Recent advances in the field of sequencing technologies and bioinformatics allow a more rapid access to genomes of non-model organisms at sinking costs. Accordingly, draft genomes of several economically important cereal rust fungi have been released in the last three years. Aside from the very recent flax rust and poplar rust draft assemblies there are no genomic data available for other dicot-infecting rust fungi. In this article we outline rust fungus sequencing efforts and comment on the current status of Phakopsora pachyrhizi (Asian soybean rust genome sequencing.

  11. The current status of women in physics in Tanzania

    Science.gov (United States)

    Mohammed, Najat K.; Kazmili, Brenda

    2015-12-01

    Women's representation in physics in Tanzania is generally low. Various studies have shown that Tanzanian girls face obstacles to realizing their educational and intellectual capabilities. The situation is even worse in the field of physics because of the perception that the subject is too difficult. The number of women in physics at the university level is highly associated with their number in secondary school level as well as their performance. This paper analyzes the current status of women engaged in physics in Tanzania in the academic and research institutions.

  12. Current Status of Integral Medical Study on Endometriosis

    Institute of Scientific and Technical Information of China (English)

    YU Chao-qin (俞超芹); YU Jin (俞瑾)

    2003-01-01

    @@ Endometriosis (EM), an estrogen dependent disease that comes from the planting of endometrial gland and stroma outside the uterine cavity, is characterized by invasiveness, wide planting and liability to relapse. It has been proved by recent studies that the pathogenesis of EM has its genetic background and is closely related with neuro-, endocrino- and immuno-factors. There has been great progress in the treatment of EM, but the clinical effect is not yet satisfactory. Traditional Chinese medicine (TCM) has definitely played its role in EM treatment. In this article, the current status of integral medical study on EM is reviewed.

  13. Current status and some aspects of the future energy strategy

    International Nuclear Information System (INIS)

    Current status of the energy production and of the energy sources in the world, European Union, Serbia and Montenegro and the Balkan states is analyzed. Some trends in the energy consumption and productions in some European states are analyzed. Some problems of the Serbia and Montenegro energy production system are compared with situation in neighbor states, Germany, and European Union. At present, anywhere in the world, the nuclear power in on the defensive. In some countries it has been even outlawed. Some parameters show that nuclear power, on the global scale and during this century at least, is absolutely essential and reasons for revival of nuclear energy are realistic. (author)

  14. Current status of examinations and investigations in oxide-pyroprocess

    International Nuclear Information System (INIS)

    Oxide pyroprocess includes the treatment of the spent oxide fuels from LWR or FBR in high temperature molten salts using chlorine gas, followed by recovery of uranium and plutonium as the form of oxides by electro-deposition or precipitation methods. The process does not use water, this relaxing the criticality requirements resulting in compact equipment and low decontamination factor. Nuclear Power R and D Center, Tokyo Electric Power Co. has been working on oxide-pyroprocess these ten years in collaboration with RIAR for the development of the next generation reprocessing technology. The current status on the research will be presented. (S. Ohno)

  15. Current status and future of Mo-99 supply

    Energy Technology Data Exchange (ETDEWEB)

    Ponsard, Bernard [Belgian Nuclear Research Center (SCK.CEN), Mol (Belgium). AIPES Reactors and Isotopes Working Group

    2016-01-15

    The global supply of Mo-99 relies on a limited number of research reactors and processing facilities. Its production is essential as medical diagnostic imaging techniques using Tc-99m account for approximately 80% of all nuclear medicine procedures worldwide. The short half-life's of the radioisotopes requires a continuous supply. Several severe disruptions have been experienced over the past decade. Fortunately, the situation encouraged the industry to develop new projects and new production routes. The current status of Mo-99 supply is described and the efforts made to achieve a reliable Tc-99m availability for nuclear medicine is summarized.

  16. Current Status and Prospects of Natural Gas Utilization in China

    Institute of Scientific and Technical Information of China (English)

    Shi Xin

    2002-01-01

    @@ 1 Overview and Current Status of Utilization of China's Natural Gas Resources Natural gas as a green fuel with low carbon content can comply with the trend in the epoch for development of non carbonaceous energy source, and has a lot of advantages such as its abundance in resources, convenience in applica tion and cost competitiveness. The application of natural gas as a premium fuel has become a focus pursued aggres sively by international players, and the perspectives for gas demand growth will be better than that for oil globally.

  17. ZnO growth technologies: current status and perspectives

    International Nuclear Information System (INIS)

    Development of new technologies for ZnO nano materials and thin films is of critical importance for further fundamental investigations and practical applications. We discuss on the main technical control of the synthesis of zinc oxide and its properties, which are of significance in understanding the growth mechanism and further developing ZnO-based devices. Next, we present a brief summary of recent research activities, current status and progress in developing improved control of technological processes for zinc oxide as advanced material.

  18. Current research status of immunology in the genomic era

    Institute of Scientific and Technical Information of China (English)

    2009-01-01

    This review updates the current status of immunology research under the influence of genomics,both conceptually and technologically.It particularly highlights the advantages of employing the high-throughput and large-scale technology,the large genomic database,and bioinformatic power in the immunology research.The fast development in the fields of basic immunology,clinical immunology(tumor and infectious immunology) and vaccine designing is illustrated with respect to the successful usage of genomic strategy.We also speculate the future research directions of immunology in the era of genomics and post-genomics.

  19. Mobile Ad Hoc Networks Current Status and Future Trends

    CERN Document Server

    Loo, Jonathan

    2011-01-01

    Guiding readers through the basics of these rapidly emerging networks to more advanced concepts and future expectations, Mobile Ad hoc Networks: Current Status and Future Trends identifies and examines the most pressing research issues in Mobile Ad hoc Networks (MANETs). Containing the contributions of leading researchers, industry professionals, and academics, this forward-looking reference provides an authoritative perspective of the state of the art in MANETs. The book includes surveys of recent publications that investigate key areas of interest such as limited resources and the mobility o

  20. Current role of surgical therapy in gastric cancer

    Institute of Scientific and Technical Information of China (English)

    Ryan Swan; Thomas J Miner

    2006-01-01

    Surgery is currently the only potentially curative treatment for gastric cancer. Since the inception of the gastrectomy for cancer of the stomach, there has been debate over the bounds of surgical therapy, balancing potential long-term survival with perioperative morbidity and mortality. This review delineates the current role of surgery in preoperative staging, curative resection, and palliative treatment for gastric cancer.

  1. MONK and MCBEND: Current status and recent developments

    International Nuclear Information System (INIS)

    Highlights: • We describe recent developments to the Monte Carlo codes MONK and MCBEND. • MONK is a Monte Carlo code for nuclear criticality and reactor physics analyses. • MCBEND is a Monte Carlo code for radiation shielding and dosimetry analyses. • Improvements include input; physics; scoring; variance reduction; and visualisation. • Parallelisation of MONK and multi-physics coupling are described. - Abstract: MONK® and MCBEND are Monte Carlo software packages for: nuclear criticality and reactor physics; and radiation shielding and dosimetry applications, respectively. The codes are actively developed, maintained and supported by AMEC’s ANSWERS® Software Service in line with the ANSWERS vision of providing easy-to-use software that meets the current and emerging needs of the user community. This paper summarises the current status of MONK and MCBEND and the recent developments which have been carried out to the codes, and their supporting nuclear data libraries and visualisation package

  2. Review of the current status of linear hybrid reactor concepts

    International Nuclear Information System (INIS)

    A review was made of the current status of linear fusion-fission hybrid reactor design studies in the USA. The linear hybrid reactor concepts reviewed include the linear theta-pinch hybrid reactor being studied at Los Alamos Scientific Laboratory, the electron beam-heated solenoid hybrid reactor under development at Physics International Co., the laser-heated solenoid hybrid reactor being investigated at Mathematical Sciences Northwest, Inc., and the linear fusion waste burning reactor being studied at General Atomic Company. The discussion addresses confinement and heating mechanisms for each concept, as well as the hybrid blanket designs. The current state of the four reactor designs is summarized and the performance of the various concepts compared

  3. Current status of surrogacy in Japan and uterine transplantation research.

    Science.gov (United States)

    Kisu, Iori; Banno, Kouji; Mihara, Makoto; Iida, Takuya; Yoshimura, Yasunori

    2011-10-01

    Recent advances in assisted reproductive technology (ART) have made it possible to circumvent many causes of male and female infertility. The right to have a child by ART has been respected for infertile couples. However, there are currently no legal regulations concerning ART in Japan, and this has resulted in social and ethical problems. Surrogacy involves particularly complex medical, ethical, social, and legal issues, and is frequently focused on as a major social concern. Uterine transplantation (UTx) is a potential alternative for young women with uterine factor infertility due to hysterectomy for treatment of a malignant uterine tumor or massive blood loss after delivery, or because of a congenital disease such as Mayer-Rokitansky-Küster syndrome. UTx has been examined in experimental animals as a basis for establishment of fecundity for young women with uterine factor infertility. In this review, we focus on surrogacy in Japan and UTx research, and discuss the current status and concerns in this field. PMID:21632170

  4. Elementary particle physics and cosmology: current status and prospects

    International Nuclear Information System (INIS)

    The current status of elementary particle physics can be briefly summarized as follows: the Standard Model of elementary particles is perfectly (at the level of radiation effects!) adequate in describing all the available experimental data except for the recent indications of neutrino oscillations. At the same time, much (and possibly most) of today's cosmology is not encompassed by the Standard Model - a fact which, together with intrinsic theoretical difficulties and the neutrino oscillation challenge, strongly indicates that the Standard Model is incomplete. It is expected that in the current decade a 'new physics', i.e. particles and interactions beyond the Standard Model, will emerge. Major advances in cosmology, both in terms of qualitatively improved observations and theoretical analysis of the structure and evolution of the Universe, are expected as well. (special issue)

  5. Current status of Paragonimus and paragonimiasis in Ecuador

    Directory of Open Access Journals (Sweden)

    Manuel Calvopiña

    2014-11-01

    Full Text Available A review of national and international publications on paragonimiasis in Ecuador, epidemiological records from the Ministry of Public Health and unpublished research data was conducted to summarise the current status of the parasite/disease. The purpose of the review is to educate physicians, policy-makers and health providers on the status of the disease and to stimulate scientific investigators to conduct further research. Paragonimiasis was first diagnosed in Ecuador 94 years ago and it is endemic to both tropical and subtropical regions in 19 of 24 provinces in the Pacific Coast and Amazon regions. Paragonimus mexicanus is the only known species in the country, with the mollusc Aroapyrgus colombiensis and the crabs Moreirocarcinus emarginatus, Hypolobocera chilensis and Hypolobocera aequatorialis being the primary and secondary intermediate hosts, respectively. Recent studies found P. mexicanus metacercariae in Trichodactylus faxoni crabs of the northern Amazon. Chronic pulmonary paragonimiasis is commonly misdiagnosed and treated as tuberculosis and although studies have demonstrated the efficacy of praziquantel and triclabendazole for the treatment of human infections, neither drug is available in Ecuador. Official data recorded from 1978-2007 indicate an annual incidence of 85.5 cases throughout the 19 provinces, with an estimated 17.2% of the population at risk of infection. There are no current data on the incidence/prevalence of infection, nor is there a national control programme.

  6. Current Status: Site-Specific Antibody Drug Conjugates.

    Science.gov (United States)

    Schumacher, Dominik; Hackenberger, Christian P R; Leonhardt, Heinrich; Helma, Jonas

    2016-05-01

    Antibody drug conjugates (ADCs), a promising class of cancer biopharmaceuticals, combine the specificity of therapeutic antibodies with the pharmacological potency of chemical, cytotoxic drugs. Ever since the first ADCs on the market, a plethora of novel ADC technologies has emerged, covering as diverse aspects as antibody engineering, chemical linker optimization and novel conjugation strategies, together aiming at constantly widening the therapeutic window for ADCs. This review primarily focuses on novel chemical and biotechnological strategies for the site-directed attachment of drugs that are currently validated for 2nd generation ADCs to promote conjugate homogeneity and overall stability. PMID:27003914

  7. Active Debris Removal: Current Status of Activities in CNES

    Science.gov (United States)

    Bonnal, Christophe; Ruault, Jean-Marc; Desjean, Marie-Christine

    2013-08-01

    Most of the ongoing studies led at worldwide level, mainly through IADC Actions, conclude that in order to keep a stable Low Earth Orbit environment in the coming decades, it may be necessary to retrieve some 5 to 10 large objects annually. These operations, known as Active Debris Removal (ADR), raise a huge amount of difficulties in numerous domains: political, legal, insurance, defense, financing and, last but not least, technical questions. The current paper aims at reviewing the current status of the ADR activities led by CNES both at National and Multi-lateral level. The first question which is raised is that of the high level requirements to be applied. What are the requirements coming from the operators; do we want to stabilize the environment, decrease it or could we accept some increase over the years; when do we have to act; can we baseline random reentry of such large objects or do we have to stick to controlled destructive reentries?… There may not yet be clear answers to these points, so efforts at international level are required. The second part of the paper deals with the potential solutions at system level. Numerous possibilities can be identified, depending on the size of the launcher and of the strategy selected to de-orbit the debris. Large space tugs visiting some 10 debris or small dedicated chasers launched as piggyback are among the solutions which have been traded. The currently preferred solution is described in details. The third part of the paper is devoted to the chaser-debris operations themselves, following five key functions; - the long range rendezvous, - the short range rendezvous up to contact, - the mechanical interfacing of the debris, - its control by the chaser, when required, - the de-orbiting maneuver itself. For each of these functions, the current status of available technologies is described, enabling the identification of the most critical ones requiring additional R&T effort and subsequent demonstrations. Among them

  8. Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary

    International Nuclear Information System (INIS)

    In early 2011, a dialogue was initiated within the Board of Directors (BOD) of the American Society for Radiation Oncology (ASTRO) regarding the future of the basic sciences of the specialty, primarily focused on the current state and potential future direction of basic research within radiation oncology. After consideration of the complexity of the issues involved and the precise nature of the undertaking, in August 2011, the BOD empanelled a Cancer Biology/Radiation Biology Task Force (TF). The TF was charged with developing an accurate snapshot of the current state of basic (preclinical) research in radiation oncology from the perspective of relevance to the modern clinical practice of radiation oncology as well as the education of our trainees and attending physicians in the biological sciences. The TF was further charged with making suggestions as to critical areas of biological basic research investigation that might be most likely to maintain and build further the scientific foundation and vitality of radiation oncology as an independent and vibrant medical specialty. It was not within the scope of service of the TF to consider the quality of ongoing research efforts within the broader radiation oncology space, to presume to consider their future potential, or to discourage in any way the investigators committed to areas of interest other than those targeted. The TF charge specifically precluded consideration of research issues related to technology, physics, or clinical investigations. This document represents an Executive Summary of the Task Force report

  9. Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary

    Energy Technology Data Exchange (ETDEWEB)

    Wallner, Paul E., E-mail: pwallner@theabr.org [21st Century Oncology, LLC, and the American Board of Radiology, Bethesda, Maryland (United States); Anscher, Mitchell S. [Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia (United States); Barker, Christopher A. [Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York (United States); Bassetti, Michael [Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin (United States); Bristow, Robert G. [Departments of Radiation Oncology and Medical Biophysics, Princess Margaret Cancer Center/University of Toronto, Toronto, Ontario (Canada); Cha, Yong I. [Department of Radiation Oncology, Norton Cancer Center, Louisville, Kentucky (United States); Dicker, Adam P. [Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania (United States); Formenti, Silvia C. [Department of Radiation Oncology, New York University, New York, New York (United States); Graves, Edward E. [Departments of Radiation Oncology and Radiology, Stanford University, Stanford, California (United States); Hahn, Stephen M. [Department of Radiation Oncology, University of Pennsylvania (United States); Hei, Tom K. [Center for Radiation Research, Columbia University, New York, New York (United States); Kimmelman, Alec C. [Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (United States); Kirsch, David G. [Department of Radiation Oncology, Duke University, Durham, North Carolina (United States); Kozak, Kevin R. [Department of Human Oncology, University of Wisconsin (United States); Lawrence, Theodore S. [Department of Radiation Oncology, University of Michigan (United States); Marples, Brian [Department of Radiation Oncology, Oakland University, Oakland, California (United States); and others

    2014-01-01

    In early 2011, a dialogue was initiated within the Board of Directors (BOD) of the American Society for Radiation Oncology (ASTRO) regarding the future of the basic sciences of the specialty, primarily focused on the current state and potential future direction of basic research within radiation oncology. After consideration of the complexity of the issues involved and the precise nature of the undertaking, in August 2011, the BOD empanelled a Cancer Biology/Radiation Biology Task Force (TF). The TF was charged with developing an accurate snapshot of the current state of basic (preclinical) research in radiation oncology from the perspective of relevance to the modern clinical practice of radiation oncology as well as the education of our trainees and attending physicians in the biological sciences. The TF was further charged with making suggestions as to critical areas of biological basic research investigation that might be most likely to maintain and build further the scientific foundation and vitality of radiation oncology as an independent and vibrant medical specialty. It was not within the scope of service of the TF to consider the quality of ongoing research efforts within the broader radiation oncology space, to presume to consider their future potential, or to discourage in any way the investigators committed to areas of interest other than those targeted. The TF charge specifically precluded consideration of research issues related to technology, physics, or clinical investigations. This document represents an Executive Summary of the Task Force report.

  10. ESTIMATION OF ORAL STATUS IN PATIENTS WITH OROPHARYNGEAL AREA CANCER

    OpenAIRE

    Julia KOLENKO

    2013-01-01

    Summary. Objectives. In the general structure of onco‑ logical morbidity, malignant tumors of head and neck rep‑ resent 20%. The aim of this study was to investigate the oral status of patients with malignant tumors in the oro‑ pharyngeal area. Methods: Clinical observations were car‑ ried out at the National Cancer Institute (Kiev) in 2012 to 2013. The study involved 120 patients with head and neck cancer, with ages between 21 and 82 years. Clinical exam‑ ination of t...

  11. Photodynamic therapy using 5-aminolevulinic acid-induced photosensitization: current clinical status

    Science.gov (United States)

    Marcus, Stuart L.; Golub, Allyn L.; Shulman, D. Geoffrey

    1995-03-01

    Photodynamic therapy using 5-aminolevulinic acid-induced photosensitization (ALA PDT) via endogenous protoporphyrin IX (PpIX) synthesis has been reported as efficacious, using topical formulations, in the treatment of a variety of dermatologic diseases including superficial basal cell carcinoma, Bowen's disease, and actinic (solar) keratoses. Application of ALA PDT to the detection and treatment of both malignant and non-malignant diseases of internal organs has recently been reported. Local internal application of ALA has been used for the detection, via PpIX fluorescence, of pathological conditions of the human urinary bladder and for selective endometrial ablation in animal model systems. Systemic, oral administration of ALA has been used for ALA PDT of superficial head and neck cancer and of colorectal cancer. This paper reviews the current clinical status of ALA PDT.

  12. [Current and future status of haploidentical hematopoietic stem cell transplantation].

    Science.gov (United States)

    Ikegame, Kazuhiro; Ogawa, Hiroyasu

    2015-03-01

    Stem cell transplantation from HLA-haploidentical related donors (haploSCT) has been highlighted as an alternative donor source. The regimen consisting of post-transplant cyclophosphamide (PTCY) has been highly prevalent in the US, Europe, and Japan. Considering the status overseas and the current status in Japan, we aim to show our efforts in haploSCT. We initially established the "haplo-full (original)" regimen, which was found to be excessively toxic for general use. Thus, we added ATG to diminish the GVH reaction (haplo-full with ATG). Unfortunately, "haplo-mini (original)" was found to be relatively weak against refractory diseases. Thus, we intensified the preconditioning regimen, which has enabled us to deal with refractory and post-transplant relapse (FAMC-T). One of the characteristics in haploSCT in Hyogo is the use of steroids from the beginning of SCT. The aim of this strategy is to diminish the inflammation affecting GVHD-target organs, and to suppress chemokine release. Since chemokines produced by the preconditioning regimen are well known to induce GVHD, chemokine suppression should effectively suppress GVHD development. The dependency of the GVL effect on chemokines is unclear, possibly serving as a therapeutic window to separate GVHD from the GVL effect. PMID:25876782

  13. Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

    Directory of Open Access Journals (Sweden)

    Chanan-Khan Asher A

    2010-01-01

    Full Text Available Abstract Background Survivin is known playing a role in drug resistance. However, its role in bortezomib-mediated inhibition of growth and induction of apoptosis is unclear. There are conflicting reports for the effect of bortezomib on survivin expression, which lacks of a plausible explanation. Methods: In this study, we tested cancer cells with both p53 wild type and mutant/null background for the relationship of bortezomib resistance with survivin expression and p53 status using MTT assay, flow cytometry, DNA fragmentation, caspase activation, western blots and RNAi technology. Results We found that cancer cells with wild type p53 show a low level expression of survivin and are sensitive to treatment with bortezomib, while cancer cells with a mutant or null p53 show a high level expression of survivin and are resistant to bortezomib-mediated apoptosis induction. However, silencing of survivin expression utilizing survivin mRNA-specific siRNA/shRNA in p53 mutant or null cells sensitized cancer cells to bortezomib mediated apoptosis induction, suggesting a role for survivin in bortezomib resistance. We further noted that modulation of survivin expression by bortezomib is dependent on p53 status but independent of cancer cell types. In cancer cells with mutated p53 or p53 null, bortezomib appears to induce survivin expression, while in cancer cells with wild type p53, bortezomib downregulates or shows no significant effect on survivin expression, which is dependent on the drug concentration, cell line and exposure time. Conclusions Our findings, for the first time, unify the current inconsistent findings for bortezomib treatment and survivin expression, and linked the effect of bortezomib on survivin expression, apoptosis induction and bortezomib resistance in the relationship with p53 status, which is independent of cancer cell types. Further mechanistic studies along with this line may impact the optimal clinical application of bortezomib in

  14. Current status of severe acute respiratory syndrome in China

    Institute of Scientific and Technical Information of China (English)

    Qing-He Nie; Xin-Dong Luo; Jian-Zhong Zhang; Qin Su

    2003-01-01

    Severe acute respiratory syndrome (SARS), also called infectious atypical pneumonia, is an emerging infectious disease caused by a novel variant of coronavirus (SARS associated coronavirus, SARS-CoV). It is mainly characterized by pulmonary infection with a high infectivity and fatality.SARS is swept across almost all the continents of the globe, and has currently involved 33 countries and regions, including the mainland China, Hong Kong, Taiwan, North America and Europe. On June 30, 2003, an acumulative total reached 8450 cases with 810 deaths. SARS epidemic was very rampant in March, April and May 2003 in the mainland of China and Hong Kong. Chinese scientists and healthcare workers cooperated closely with other scientists from all over the world to fight the disease. On April 16, 2003, World Health Organization (WHO) formally declared that SARSCoV was an etiological agent of SARS. Currently, there is no specific and effective therapy and prevention method for SARS. The main treatments include corticosteroid therapy,antiviralagents, anti-infection, mechanical ventilation and isolation. This disease can be prevented and controlled, and it is also curable. Under the endeavor of the Chinese Government, medical staffs and other related professionals,SARS has been under control in China, and Chinese scientists have also made a great contribution to SARS research.Otherstudies in developing new detection assays and therapies, and discovering new drugs and vaccines are in progress. In this paper, we briefly review the current status of SARS in China.

  15. Immunomonitoring in glioma immunotherapy: current status and future perspectives.

    Science.gov (United States)

    Lamano, Jonathan B; Ampie, Leonel; Choy, Winward; Kesavabhotla, Kartik; DiDomenico, Joseph D; Oyon, Daniel E; Parsa, Andrew T; Bloch, Orin

    2016-03-01

    Given the continued poor clinical outcomes and refractory nature of glioblastoma multiforme to traditional interventions, immunotherapy is gaining traction due to its potential for specific tumor-targeting and long-term antitumor protective surveillance. Currently, development of glioma immunotherapy relies on overall survival as an endpoint in clinical trials. However, the identification of surrogate immunologic biomarkers can accelerate the development of successful immunotherapeutic strategies. Immunomonitoring techniques possess the potential to elucidate immunological mechanisms of antitumor responses, monitor disease progression, evaluate therapeutic effect, identify candidates for immunotherapy, and serve as prognostic markers of clinical outcome. Current immunomonitoring assays assess delayed-type hypersensitivity, T cell proliferation, cytotoxic T-lymphocyte function, cytokine secretion profiles, antibody titers, and lymphocyte phenotypes. Yet, no single immunomonitoring technique can reliably predict outcomes, relegating immunological markers to exploratory endpoints. In response, the most recent immunomonitoring assays are incorporating emerging technologies and novel analysis techniques to approach the goal of identifying a competent immunological biomarker which predicts therapy responsiveness and clinical outcome. This review addresses the current status of immunomonitoring in glioma vaccine clinical trials with emphasis on correlations with clinical response. PMID:26638171

  16. Current Soil Nutrient Status of Intensively Managed Greenhouses

    Institute of Scientific and Technical Information of China (English)

    HU Yun-Cai; SONG Zhi-Wen; LU Wen-Long; C.POSCHENRIEDER; U.SCHMIDHALTER

    2012-01-01

    Nine districts covering the main greenhouse vegetable areas in Tianjin Municipality of the North China Plain were selected for the soil investigation in 2010 to survey the current soil nutrient status (soil available N,P and K),acidification and salinization due to excessive input of fertilizers in greenhouses in Tianjin. The study showed that,in particular,soil available P content increased with the age of greenhouses.In contrast,our results did not reveal higher K accumulation and lowered pH in the greenhouse soils compared with cultivation in open fields.Over-fertilization,causing high NO3- accumulation,most likely resulted in salinity problems in the greenhouses.Ninety percent of the investigated greenhouse soils had electrical conductivity values of saturated paste extracts of 2-10 d S m-1,which might affect the yields of vegetable crops like green bean,pepper,cabbage,carrot,eggplant,lettuce,spinach,celery,cucumber and tomato. The findings of our survey of the current fertility and salinity problems in greenhouse soils suggest that there is an urgent need to improve the farmers' practices and strategies in fertilization management in greenhouses of China.Because education and the agricultural technical extension services may play a more important role in avoiding overuse of fertilizers,we suggest that current nutrient management practices should be improved in the near future through training of local farmers in farmers' schools and through strengthening the agricultural extension services with practical techniques.

  17. Current status of minimally invasive endoscopicmanagement for Zenker diverticulum

    Institute of Scientific and Technical Information of China (English)

    Alberto Aiolfi; Federica Scolari; Greta Saino; Luigi Bonavina

    2015-01-01

    Surgical resection has been the mainstay of treatment ofpharyngoesophageal (Zenker) diverticula over the pastcentury. Developments in minimally invasive surgeryand new endoscopic devices have led to a paradigmchange. The concept of dividing the septum betweenthe esophagus and the pouch rather than resecting thepouch itself has been revisited during the last threedecades and new technologies have been investigatedto make the transoral operation safe and effective. Theinternal pharyngoesophageal myotomy accomplished through the transoral stapling approach has been shown to effectively relieve outflow obstruction and restore physiological bolus transit in patients with medium size diverticula. Transoral techniques, either through a rigid device or by flexible endoscopy, are gaining popularity over the open surgical approach due the low morbidity, the fast recovery time and the fact that the procedure can be safely repeated. We provide an analysis of the the current status of minimally invasive endoscopic management of Zenker diverticulum.

  18. Current status of high energy nucleon-meson transport code

    Energy Technology Data Exchange (ETDEWEB)

    Takada, Hiroshi; Sasa, Toshinobu [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    1998-03-01

    Current status of design code of accelerator (NMTC/JAERI code), outline of physical model and evaluation of accuracy of code were reported. To evaluate the nuclear performance of accelerator and strong spallation neutron origin, the nuclear reaction between high energy proton and target nuclide and behaviors of various produced particles are necessary. The nuclear design of spallation neutron system used a calculation code system connected the high energy nucleon{center_dot}meson transport code and the neutron{center_dot}photon transport code. NMTC/JAERI is described by the particle evaporation process under consideration of competition reaction of intranuclear cascade and fission process. Particle transport calculation was carried out for proton, neutron, {pi}- and {mu}-meson. To verify and improve accuracy of high energy nucleon-meson transport code, data of spallation and spallation neutron fragment by the integral experiment were collected. (S.Y.)

  19. Advanced Gas Tungsten Arc Weld Surfacing Current Status and Application

    Directory of Open Access Journals (Sweden)

    Stephan Egerland

    2015-09-01

    Full Text Available Abstract Gas Shielded Tungsten Arc Welding (GTAW – a process well-known providing highest quality weld results joined though by lower performance. Gas Metal Arc Welding (GMAW is frequently chosen to increase productivity along with broadly accepted quality. Those industry segments, especially required to produce high quality corrosion resistant weld surfacing e.g. applying nickel base filler materials, are regularly in consistent demand to comply with "zero defect" criteria. In this conjunction weld performance limitations are overcome employing advanced 'hot-wire' GTAW systems. This paper, from a Welding Automation perspective, describes the technology of such devices and deals with the current status is this field – namely the application of dual-cathode hot-wire electrode GTAW cladding; considerably broadening achievable limits.

  20. Cognitive behavioral therapy: current status and future research directions.

    Science.gov (United States)

    McMain, Shelley; Newman, Michelle G; Segal, Zindel V; DeRubeis, Robert J

    2015-01-01

    Cognitive behavioral therapy (CBT), an umbrella term that includes a diverse group of treatments, is defined by a strong commitment to empiricism. While CBT has a robust empirical base, areas for improvement remain. This article reviews the status of the current empirical base and its limitations, and presents future directions for advancement of the field. Ultimately, studies are needed that will identify the predictors, mediators, and moderators of treatment response in order to increase knowledge on how to personalize interventions for each client and to strengthen the impact of CBT. Efforts to advance the dissemination and implementation of CBT, innovative approaches such as practice-oriented research, and the advantages of incorporating new and existing technologies, are discussed as well. PMID:25689506

  1. Indian fast reactor technology: Current status and future programme

    Indian Academy of Sciences (India)

    S C Chetal; P Chellapandi

    2013-10-01

    The paper brings out the advantages of fast breeder reactor and importance of developing closed nuclear fuel cycle for the large scale energy production, which is followed by its salient safety features. Further, the current status and future strategy of the fast reactor programme since the inception through 40 MWt/13 MWe Fast Breeder Test Reactor (FBTR), is highlighted. The challenges and achievements in science and technology of FBRs focusing on safety are described with the particular reference to 500 MWe capacity Prototype Fast Breeder Reactor (PFBR), being commissioned at Kalpakkam. Roadmap with comprehensive R&D for the large scale deployment of Sodium Cooled Fast Reactor (SFRs) and timely introduction of metallic fuel reactors with emphasis on breeding gain and enhanced safety are being brought out in this paper.

  2. Marine renewable energy in China: Current status and perspectives

    Directory of Open Access Journals (Sweden)

    Yong-liang ZHANG

    2014-07-01

    Full Text Available Based on a general review of marine renewable energy in China, an assessment of the development status and amount of various marine renewable energy resources, including tidal energy, tidal current energy, wave energy, ocean thermal energy, and salinity gradient energy in China’s coastal seas, such as the Bohai Sea, the Yellow Sea, the East China Sea, and the South China Sea, is presented. We have found that these kinds of marine renewable energy resources will play an important role in meeting China’s future energy needs. Additionally, considering the uneven distribution of China’s marine renewable energy and the influences of its exploitation on the environment, we have suggested several sites with great potential for each kind of marine energy. Furthermore, perspectives on and challenges related with marine renewable energy in China are addressed.

  3. Current status of SK-Gd project and EGADS

    Science.gov (United States)

    Xu, Chenyuan; Super-Kamiokande Collaboration

    2016-05-01

    Supernova Relic Neutrino (SRN) has not been observed yet because of its low event rate and high background. By adding gadolinium into water Cherenkov detector, inverse beta decay will have two signals, the prompt one is positron signal and the delayed one is a ~8 MeV gamma cascade from neutron capture on gadolinium. By this way, background for SRN can be largely reduced by detecting prompt and delayed signals coincidently, and Super-K will also have the ability to distinguish neutrino and anti-neutrino. SK-Gd is a R&D project proposed to dissolve gadolinium into Super-K. As a part of it, EGADS, a 200 ton water Cherenkov detector was built in Kamioka mine. Current status of SK-Gd project and the physics work being performed in EGADS will be presented here.

  4. The current status of the Korean student health examination

    Directory of Open Access Journals (Sweden)

    Hye-Jung Shin

    2013-08-01

    Full Text Available Recent trends place an emphasis on school health care, the ultimate goal of which is to protect,maintain, and promote students’ health. School health care is a program that integrates health careservices, health education, health counseling, and local social health services. The student healthexamination (SHE system is a part of school health care and schools and communities must beavailable to provide professional health services. Pediatricians also have important roles as experts inboth school health care and the SHE system. In this article, the history of school health care, its legalbasis, and the current status of the SHE system in Korea are reviewed. Furthermore, sample surveysfrom the past few years are reviewed. Through this holistic approach, future directions are proposed forthe improvement of SHE and school health care.

  5. Development of Structural Materials for JSFR - Overview and Current Status

    International Nuclear Information System (INIS)

    This paper summarized the ongoing efforts regarding new core and structural materials that are to applied to the Japanese sodium cooled fast breeder reactors (JSFR) of which demonstration plant's operation is envisioned in around 2025. For core materials, oxide dispersed strengthened steel (ODS) and precipitation hardened (PH) ferritic steels will be applied. For structural materials, 316FR stainless steel and Modified 9Cr-1Mo steel are applied. The current status alloy design, acquisition of data necessary to establish material strength standard, fabrication techniques to meet the requirements of the design of JSFR both in terms of quality and quantity, and codification of the material strength standards regarding the new materials are overviewed. Further described is path forward to the application of the materials to the JSFR. (author)

  6. Current Backpack Weight Status for Primary Schoolchildren in Colima, Mexico.

    Science.gov (United States)

    Olmedo-Buenrostro, Bertha Alicia; Delgado-Enciso, Iván; Sánchez-Ramírez, Carmen Alicia; Cruz, Sergio Adrián Montero; Vásquez, Clemente; Mora-Brambila, Ana Bertha; Rodríguez-Sánchez, Iram P; Martínez-Fierro, Margarita L

    2016-06-01

    The purpose of the study was to identify the current status of backpack weight in primary schoolchildren in Colima, Mexico, in relation to gender, school grade level, and body mass index. A cross-sectional study was conducted on 240 randomly selected children from 20 primary schools. The participating children's parents signed statements of informed consent. Descriptive statistics, the χ(2) test, Student's t-test, and Kruskal-Wallis test were used. The mean age was 8.55 ± 2 years (range: 5-12 years). Seventy-eight percent of the schoolchildren presented with a backpack overload that was greater than 10% of their body weight. No significant differences were found in relation to gender. Four out of every five schoolchildren presented with backpack overload, exposing them to a potential health problem. Education and public policy prevention strategies for this situation should be implemented in Mexico and other regions of the world with the same problem. PMID:26416767

  7. Current Status and Future Regulatory Direction on Sump Clogging Issue

    International Nuclear Information System (INIS)

    A significant progress in resolving the sump clogging issue has been achieved since the USNRC Generic Letter 2004-01 was issued. In Korea, the issue was begun to be discussed in regulatory framework through safety review and plant inspection since 2005. KINS has performed the licensing review for several plants including Kori Unit 1 and SKN Units 3, 4, according to the technical requirement of USNRC. Due to the efforts from the industry side and regulatory side, the newly designed improved strainer can be installed at some plants. However, some challengeable concerns such as chemical effect and downstream effect still need a further research. The present paper is to discuss the current status of issue resolution and the related regulation based on the up-to-date achievements and review findings. Also the future regulatory direction on the new concerns related to the issue is discussed

  8. The Current Status of World Protection for Mangrove Forest

    Institute of Scientific and Technical Information of China (English)

    张征云; 苏智先; 张桥英; 申爱英

    2003-01-01

    Mangrove forests occur extensively in the tropic areas rich in wildlife and other non-forestry resources and provide a wide array of raw materials for livelihood and production processes and have been a major source of income generation and subsistence for the local people.Exploitation of timber, fuel wood, poles, industrial raw material, and many other non-wood products from the nangrove forests give rise to large scale economic activity and income generation. At present, mangrove forests are facing great peril. Reckless exploitation and swampland reclamation result in their gradual degradation. This article deals with the world's mangrove forest resources and their benefit to people; describes the current status, points out the main causes of the destruction of these forests, presents proposals for protecting mangrove forests, and discusses international cooperation in protecting the world's mangrove forests.

  9. The current status of TRR-II project

    International Nuclear Information System (INIS)

    The TRR-II organization has been reorganized to enhance the project management and to minimize the interfaces among decommissioning, reactor reconstruction, and experimental facilities design. Several modifications suggested by the reviewing committee members to upgrade our reactor had been actualized in the present design. An extension of one year of the schedule due to the delay of old TRR removal engineering bid process was proposed by the project and approved by the authorities. The duration of the project will then be July 1998 - Dec. 2006. In the mean time, the project is able to spend more time exploring the design and construction techniques of reactor system, and training of personnel for neutron application research. The progresses of the project in the past 18 months and the current technical status of the project are described in the order of integral planning and management, TRR dismantling, TRR-II reconstruction, and TRR-II experimental facility. (orig.)

  10. Colorectal tissue engineering: prerequisites, current status and perspectives.

    Science.gov (United States)

    Denost, Quentin; Adam, Jean-Philippe; Rullier, Eric; Bareille, Reine; Montembault, Alexandra; David, Laurent; Bordenave, Laurence

    2013-07-01

    Gastrointestinal tissue engineering has emerged over the past 20 years and was often focused on esophagus, stomach or small intestine, whereas bioengineering researches of colorectal tissue are scarce. However, some promising results have been obtained in animal models. Refinements should be performed in scaffold and cell source selection to allow smooth muscle layer regeneration. Indeed, synthetic and natural polymers such as small intestinal submucosa and collagen sponge seeded with organoid units or smooth muscle cells did not allow smooth muscle regeneration. Mesenchymal stem cells derived from adipose tissue seeded on composite scaffold could represent an interesting way to achieve this goal. This article reviews potential indications, current status and perspectives of tissue engineering in the area of colorectal surgery. PMID:23895077

  11. The current status and future of granular media

    International Nuclear Information System (INIS)

    The current status of CoPtCr-SiO2 granular media is briefly reviewed, and challenges relative to media technology exceeding 1 Tb/in2 are discussed. It is effective to enhance grain isolation using oxide materials that easily precipitate at the grain boundary, and this technique is adopted in commercially available perpendicular recording media. Although some difficulties such as reduction of the grain size retaining the switching field remain, 1 Tb/in2 could be achieved by using granular exchange-coupled composite-type media or related technologies. Discrete track media could be used for more than 1 Tb/in2 recording. It could also take several years to further develop nano-processing technology and establish a cost-effective infrastructure. BPM offers great potential in achieving high recording density, although some necessary technologies are still too primitive to consider commercial production

  12. Contrast-enhanced endoscopic ultrasonography: advance and current status

    Directory of Open Access Journals (Sweden)

    Sung Ill Jang

    2014-07-01

    Full Text Available Endoscopic ultrasonography (EUS technology has undergone a great deal of progress along with the color and power Doppler imaging, three-dimensional imaging, electronic scanning, tissue harmonic imaging, and elastography, and one of the most important developments is the ability to acquire contrast-enhanced images. The blood flow in small vessels and the parenchymal microvasculature of the target lesion can be observed non-invasively by contrast-enhanced EUS (CE-EUS. Through a hemodynamic analysis, CE-EUS permits the diagnosis of various gastrointestinal diseases and differential diagnoses between benign and malignant tumors. Recently, mechanical innovations and the development of contrast agents have increased the use of CE-EUS in the diagnostic field, as well as for the assessment of the efficacy of therapeutic agents. The advances in and the current status of CE-EUS are discussed in this review.

  13. Running Vacuum in the Universe: current phenomenological status

    CERN Document Server

    Sola, Joan

    2016-01-01

    I review the excellent phenomenological status of a class of dynamical vacuum models in which the vacuum energy density, $\\rho_{\\Lambda}=\\rho_{\\Lambda}(H)$, as a function of the Hubble rate, evolves through its interaction with dark matter and/or through the accompanying running of the gravitational coupling $G$, including the possibility of being self-conserved with a nontrivial effective equation of state. Some of these models have been used to incorporate into a single vacuum structure the rapid stage of inflation, followed by the standard radiation and cold dark matter epochs all the way down until the dark energy era. Remarkably, the running vacuum models (RVM's) render an outstanding phenomenological description of the main cosmological data at a level that is currently challenging the concordance $\\Lambda$CDM model, thereby implying that present observations seem to point to a running vacuum rather than to a rigid cosmological constant $\\Lambda$ in our Universe.

  14. Contrast-enhanced endoscopic ultrasonography: advance and current status

    Energy Technology Data Exchange (ETDEWEB)

    Jang, Sung Il [Dept. of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul (Korea, Republic of); Lee, Dong Ki [Dept. of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul (Korea, Republic of)

    2014-10-15

    Endoscopic ultrasonography (EUS) technology has undergone a great deal of progress along with the color and power Doppler imaging, three-dimensional imaging, electronic scanning, tissue harmonic imaging, and elastography, and one of the most important developments is the ability to acquire contrast-enhanced images. The blood flow in small vessels and the parenchymal microvasculature of the target lesion can be observed non-invasively by contrast-enhanced EUS (CE-EUS). Through a hemodynamic analysis, CE-EUS permits the diagnosis of various gastrointestinal diseases and differential diagnoses between benign and malignant tumors. Recently, mechanical innovations and the development of contrast agents have increased the use of CE-EUS in the diagnostic field, as well as for the assessment of the efficacy of therapeutic agents. The advances in and the current status of CE-EUS are discussed in this review.

  15. Current status of thermoluminescence studies on minerals and rocks

    International Nuclear Information System (INIS)

    The usefulness of thermoluminescence (TL) in geological studies is being increasingly recognized, as may be judged from the considerable volume of literature accumulated over the past couple of decades; besides, a number of seminars, conferences and specialists' meetings have also been held on the subject of applied TL. However, these publications lie scattered over several periodicals and conference proceedings and an interested worker finds it difficult to obtain the gist of the contributions in one place. The present authors felt a need for this and have, therefore, attempted to bring together in this Report the current status of TL research about different minerals; applications in the fields of geochronology, ore-prospecting, stratigraphic correlation, geothermometry and other useful areas are also included. (author)

  16. Current research status, databases and application of single nucleotide polymorphism.

    Science.gov (United States)

    Javed, R; Mukesh

    2010-07-01

    Single Nucleotide Polymorphisms (SNPs) are the most frequent form of DNA variation in the genome. SNPs are genetic markers which are bi-allelic in nature and grow at a very fast rate. Current genomic databases contain information on several million SNPs. More than 6 million SNPs have been identified and the information is publicly available through the efforts of the SNP Consortium and others data bases. The NCBI plays a major role in facillating the identification and cataloging of SNPs through creation and maintenance of the public SNP database (dbSNP) by the biomedical community worldwide and stimulate many areas of biological research including the identification of the genetic components of disease. In this review article, we are compiling the existing SNP databases, research status and their application. PMID:21717869

  17. Current status and future tendency of lake eutrophication in China

    Institute of Scientific and Technical Information of China (English)

    JIN Xiangcan; XU Qiujin; HUANG Changzhu

    2005-01-01

    Current trophic status and trend of Chinese freshwater lakes were investigated in this study. The results showed that all lakes studied were commonly undergoing the eutrophication process, water quality decreased and lake's ecosystem is being declined. Most of the urban lakes are facing serious eutrophication. Many medium-sized lakes are in metrophic or eutrophic status, some local water are even approaching the hypertrophic level. The famous five freshwater lakes in China have entered into eutrophication in the condition of higher nutrient load. Lake Taihu, Hongze and Caohu are already in eutrophic state. Eutrophic lakes are mainly distributed in the middle and lower reaches of Yangtze River and Yungui plateau. Lake eutrophication developed rapidly. Among the 34 lakes studied in 1970's, most of lakes were in the mesotrophic status,mesotrophic water area accounted for 91.8%. With the nine year of 1978-1987 the area percentage of oligotrophic lakes decreased from 3.2% to 0.53%, and that of eutrophic lakes increased from 5.0% to 55.01%. Recent data showed 57.5% lakes were in eutrophic and hypertrophic status of the 40 surveyed lakes.Eutrophic trend of Lake Taihu, Chaohu and Xuanwu in the region of the middle and lower reaches of Yangtze River was predicated using the ecological stress model. The results showed that in 2008 Lake Taihu, Chaohu and Xuanwu might be of eutrophication, eutrophication and hypertrophication, respectively if no control measurement is taken. Provided the pollution water treatment rate is 60% in 2030, approximately 30 billion ton pollution water would still be discharged directly in the lakes. Therefore, in 2030 the urban lakes in China might be eutrophication or hypertrophication, and most of the medium-sized lakes at the urban-rural fringe might be in eutrophication or hypertrophication. The famous five biggest freshwater lakes in China might be eutrophication if control countermeasures are taken as now.Lake eutrophication has become a

  18. Smoking behaviours of current cancer patients in Canada

    Science.gov (United States)

    Liu, J.; Chadder, J.; Fung, S.; Lockwood, G.; Rahal, R.; Halligan, M.; Mowat, D.; Bryant, H.

    2016-01-01

    Evidence shows that continued smoking by cancer patients leads to adverse treatment outcomes and affects survival. Smoking diminishes treatment effectiveness, exacerbates side effects, and increases the risk of developing additional complications. Patients who continue to smoke also have a higher risk of developing a second primary cancer or experiencing a cancer recurrence, both of which ultimately contribute to poorer quality of life and poorer survival. Here, we present a snapshot of smoking behaviours of current cancer patients compared with the non-cancer patient population in Canada. Minimal differences in smoking behaviours were noted between current cancer patients and the rest of the population. Based on 2011–2014 data from the Canadian Community Health Survey, 1 in 5 current cancer patients (20.1%) reported daily or occasional smoking. That estimate is comparable to findings in the surveyed non-cancer patient population, of whom 19.3% reported smoking daily or occasionally. Slightly more male cancer patients than female cancer patients identified as current smokers. A similar distribution was observed in the non-cancer patient population. There is an urgent need across Canada to better support cancer patients in quitting smoking. As a result, the quality of patient care will improve, as will cancer treatment and survival outcomes, and quality of life for these patients.

  19. Husband's smoking status and breast cancer risk in Japan: From the Takayama study.

    Science.gov (United States)

    Wada, Keiko; Kawachi, Toshiaki; Hori, Akihiro; Takeyama, Naoharu; Tanabashi, Shinobu; Matsushita, Shogen; Tokimitsu, Naoki; Nagata, Chisato

    2015-04-01

    The effects of smoking on breast cancer remain unclear. We assessed the associations of subjects' or husbands' smoking status with breast cancer incidence in a population-based prospective study in Japan. The subjects were 15 719 women aged 35 years or older. The follow up was conducted from September 1992 to March 2008. Cancer incidence was mainly confirmed through regional population-based cancer registries. Breast cancer was defined as code C50 according to the International Classification of Diseases and Health Related Problems, 10th Revision. Lifestyle, including smoking status, was assessed with a self-administered questionnaire. Alcohol consumption was assessed with a validated food-frequency questionnaire. After multivariate adjustments for age, body mass index, alcohol consumption, physical activity, education, age at menarche, age at first delivery, menopausal status, number of children and history of hormone replacement therapy, active smoking was not associated with the risk of breast cancer. Compared with never smokers whose husband had never smoked, the risks of breast cancer were 1.98 (95% CI: 1.03-3.84) among never smokers whose husband was a current smoker of 21 cigarettes per day or more. The increased risk of breast cancer among women having a smoking husband was pronounced among those who did not habitually consume alcohol. These results suggest that exposure to smoke from husbands is a potential risk factor for breast cancer. The impact of alcohol consumption on the increased breast cancer risk from passive smoking needs to be addressed in further studies. PMID:25645582

  20. Sunscreens in the United States: current status and future outlook.

    Science.gov (United States)

    Jou, Paul C; Tomecki, Kenneth J

    2014-01-01

    Incidence rates of nonmelanoma skin cancer and melanoma has been on the rise in the United States for the past 20 years. UV radiation (UVR) exposure remains the most preventable environmental risk factor for these cancers. Aside from sun avoidance, sunscreens remain our best protection. UVR directly damages DNA and cause indirect cellular damage through the creation of reactive oxygen species, the sum of which leads to cutaneous immunosuppression and a tumorigenic milieu. The current generation of sunscreens protect from UVR through two main mechanisms: absorption and deflection. In the US, new Food and Drug Association rules require sunscreen manufacturers to evaluate their products not only on sun protection factor but also on broad spectrum UVA protection by the end of 2013. New labeling requirements will also be instituted. The American Academy of Dermatology and the American Academy of Pediatrics have provided specific recommendations for proper sun protection and sunscreen usage. Plant polyphenols such as those isolated from green tea, pomegranate, and grape seed remain an interesting avenue of research as additives to sunscreens or stand-alone products that appear to modulate the immunosuppressive effects of UVR on the skin. Additionally, although UVR induces endogenous cutaneous production of vitamin D, its damaging effects overshadow this positive benefit, especially in light of the ease of achieving recommended amounts of vitamin D through diet and supplementation. PMID:25207382

  1. Viewpoint on the current status of researches on sepsis

    Directory of Open Access Journals (Sweden)

    Zheng-guo WANG

    2012-11-01

    Full Text Available Sepsis is a common complication after severe trauma and burn, and also one of the main causes of death. Recently, although some new progresses were seen in antibiotic therapy, the mortality of sepsis is still on the rise, and the death rate as a result of sepsis is higher than a total of that of prostate cancer, breast cancer and AIDS. Therefore, sepsis has obviously become one of the serious ailments threatening human health. The present paper introduced the international definition of sepsis, severe sepsis and septic shock, the current researches on diagnosis and therapy, and proposed that we should not only pay attention to pathogenesis and treatment, but also to sepsis prevention in sepsis researches, and we should try to find out the breakthrough in the interaction and dynamic balance between human being and pathogenic factors. Researches on the strategies to revert strong toxicity of infectious agents to non-toxic or weak pathogenic factors, and to conduct further research concerning biological characteristics of microorganisms and mechanism of drug resistance in order to render them to lose the drug resistance ability, or to increase its sensitivity to the drugs. The above suggested approaches might form the future strategies for preventing and controlling sepsis.

  2. A Survey of the Status of Awareness of Lymphedema in Breast Cancer Patients in Busan-Gyeongnam, Korea

    OpenAIRE

    Choi, Jong Kyoung; Kim, Hui Dong; Sim, Young Joo; Kim, Ghi Chan; Kim, Dong Kyu; Yu, Byeng Chul; Park, Si-Sung; Jeong, Ho Joong

    2015-01-01

    Objective To support the establishment of lymphedema education plans and the actual practice of education by investigating the current lymphedema awareness status of Korean breast cancer patients. Methods cross-sectional population survey was conducted in 116 breast cancer patients in the Busan-Gyeongnam area. The survey included questions regarding demographic characteristics, breast cancer-related lymphedema (BCRL) risk factors, and characteristics and treatments of the disease. Some of the...

  3. Current Status of Gyroklystron Research at the University of Maryland

    Science.gov (United States)

    Gouveia, E. S.; Lawson, W.; Hogan, B.; Bharathan, K.; Granatstein, V. L.

    2003-12-01

    At the University of Maryland, we have been developing high-power coaxial gyroklystrons. Our present work is focused on the development of a 17.136 GHz four-cavity frequency-doubling gyroklystron amplifier. This device will then be used to drive a high gradient linear accelerator structure recently developed by the Haimson Corporation. Our work has been afflicted by many technical challenges, most arising from thermal imperfections in the custom-made high current emitter of our electron gun. In our latest experimental run, instabilities were detected in the input cavity of our amplifier tube. These instabilities appear when the beam pitch ratio (α) is approximately 1, thus impeding our search of domains with higher α values (note that the circuit was designed to operate at α=1.4). In order to remedy this problem, we have radically redesigned the input cavity, changing both its geometry and Q factor. The new input cavity has been fabricated and cold-tested. It will soon undergo hot-test in the next run of experimental studies of the circuit, which will commence after an upgrade of our vacuum system. Here we present the current status of this research.

  4. Current Status of Gyroklystron Research at the University of Maryland

    International Nuclear Information System (INIS)

    At the University of Maryland, we have been developing high-power coaxial gyroklystrons. Our present work is focused on the development of a 17.136 GHz four-cavity frequency-doubling gyroklystron amplifier. This device will then be used to drive a high gradient linear accelerator structure recently developed by the Haimson Corporation. Our work has been afflicted by many technical challenges, most arising from thermal imperfections in the custom-made high current emitter of our electron gun. In our latest experimental run, instabilities were detected in the input cavity of our amplifier tube. These instabilities appear when the beam pitch ratio (α) is approximately 1, thus impeding our search of domains with higher α values (note that the circuit was designed to operate at α=1.4). In order to remedy this problem, we have radically redesigned the input cavity, changing both its geometry and Q factor. The new input cavity has been fabricated and cold-tested. It will soon undergo hot-test in the next run of experimental studies of the circuit, which will commence after an upgrade of our vacuum system. Here we present the current status of this research

  5. Current Status of Pd- Reference Electrode Development Work

    International Nuclear Information System (INIS)

    Accurate and stable in-core reference electrodes are needed in long-term corrosion potential measurements when water chemistry effects on corrosion of construction materials under radiation fields are studied. The experimental difficulties of measuring ECP inside the reactor pressure vessel are basically related to the high pressure, high temperature environments, which give significant problems connected with bringing electrochemical information across the pressure boundaries. Additionally, the sensors have to withstand exposure to high radiation and neutron flux. Currently, the most widely used in-core reference electrodes are either internal silver/silver chloride electrodes or zirconia membrane based pH sensors. A novel approach is to use a cathodically charged palladium (Pd) hydrogen electrode. This type of sensor is a suitable reference electrode for in-core corrosion potential measurements in constant pH solutions, because the potential determining components (H2,H+) are stable over the temperatures of interest and do not contaminate the measurement environment. In addition, the mechanisms of hydrogen reactions on palladium and platinum (Pt) surfaces have been extensively studied and are now reasonably well understood. A new Pd reference electrode has been tested in an out-of-core test loop in Halden. The electrode was installed into the flow through cell containing external pressure balanced silver/silver chloride reference electrodes, a high temperature conductivity sensor and a temperature probe. This report discusses the current status of the in-core Pd reference electrode development work being performed at the OECD Halden Project. (author)

  6. Current Status and Research into Overcoming Limitations of Capsule Endoscopy.

    Science.gov (United States)

    Kwack, Won Gun; Lim, Yun Jeong

    2016-01-01

    Endoscopic investigation has a critical role in the diagnosis and treatment of gastrointestinal (GI) diseases. Since 2001, capsule endoscopy (CE) has been available for small-bowel exploration and is under continuous development. During the past decade, CE has achieved impressive improvements in areas such as miniaturization, resolution, and battery life. As a result, CE is currently a first-line tool for the investigation of the small bowel in obscure gastrointestinal bleeding and is a useful alternative to wired enteroscopy. Nevertheless, CE still has several limitations, such as incomplete examination and limited diagnostic and therapeutic capabilities. To resolve these problems, many groups have suggested several models (e.g., controlled CO2 insufflation system, magnetic navigation system, mobile robotic platform, tagging and biopsy equipment, and targeted drug-delivery system), which are in development. In the near future, new technological advances will improve the capabilities of CE and broaden its spectrum of applications not only for the small bowel but also for the colon, stomach, and esophagus. The purpose of this review is to introduce the current status of CE and to review the ongoing development of solutions to address its limitations. PMID:26855917

  7. Radio Astronomy in Malaysia: Current Status and Outreach Activities

    Science.gov (United States)

    Hashim, N.; Abidin, Z. Z.; Ibrahim, U. F. S. U.; Umar, R.; Hassan, M. S. R.; Rosli, Z.; Hamidi, Z. S.; Ibrahim, Z. A.

    2011-12-01

    In this paper, we will present the current status of radio astronomical research and outreach in Malaysia. We will also present a short history of our research group, which is currently the only radio astronomical facility in Malaysia. Our group is called the Radio Cosmology Research Lab and was established in 2005 by Dr Zamri Zainal Abidin and Prof Dr Zainol Abidin Ibrahim. We will discuss the future plans for this group including our keen interest in being part of a more global network of radio astronomers. We are already an active member of the South-East Asia Astronomy Network (SEAAN) and aims to have a radio astronomical facility in order to join the Global Very Long Baseline Interferometer (VLBI) as well becoming a research hub for the future Square Kilometer Array (SKA) project. We will also present some of the scientific goals of our group including providing a platform for radio astronomers to be able to do observations of weak and high red-shifted radio objects such as galaxy clusters and supernovae.

  8. Current status of Horonobe URL project in construction phase

    International Nuclear Information System (INIS)

    The Horonobe URL project has been pursued by JAEA (Japan Atomic Energy Agency) to establish and demonstrate site characterization methodologies, engineering technologies, and safety assessment methodologies for HLW geological disposal in relevant geological environment with sedimentary rock and saline groundwater distributing in the Horonobe area, Hokkaido, Japan. In the Horonobe URL project, surface-based investigation phase (Phase I) has already completed in the year 2005, and then construction phase (Phase II) has initiated in the same year. Currently, construction of the underground facilities such as shafts/galleries which were designed in Phase I, investigations of the geological environment in the excavated shafts/galleries and confirmation of applicability of engineering technologies has been alternately carried out as Phase II activities of the project. During the construction so far, monitoring for the construction safety such as convergence measurements, tunnel wall observation, sampling of groundwater and rock, investigations for evaluating excavation damaged/disturbed zone (EDZ/EdZ) along shafts/galleries were carried out. In addition, a shotcrete construction test and a grout injection test by using low alkaline cement material were carried in the horizontal galleries. In this paper, status of the URL construction and research activities mentioned above are outlined as the current achievement of the Horonobe URL project. (author)

  9. IAA multilingual space dictionary, current status and future prospects

    Science.gov (United States)

    Yoshimitsu, Tetsuo; McKenna-Lawlor, Susan; Candel, Danielle; Ninomiya, Keiken; Contant, Jean-Michel

    2015-12-01

    Terminology is a key issue for a better understanding among people using various languages. Since 1986, when the International Academy of Astronautics (IAA) multilingual terminology database committee on astronautics was formed, the committee and its successor IAA study groups on the IAA multilingual space dictionary have made a continuous effort to construct a multilingual dictionary database on astronautical terms. In 2002, the dictionary was computerized using a database server and some recent internet technologies. The database is accessible from all over the world via the internet. You can search for terms at your home and office using a web browser installed on the computer with an internet connection. Since then, the number of terms and languages included in the database has increased. The current version includes about 3500 terms in 22 languages. The flexibility of the database enables the addition and the revision of new terms without much effort. The computerization has also demonstrated another possibility to utilize the database. When total of four paper books about the multilingual space terminology were published on the 50th anniversary of IAA in 2010, one of the lexicon books was edited by a computer program which accessed to the database. In this paper, the authors present the current status of the IAA multilingual database as well as the future possibilities on the utilization of the database.

  10. Personal dosimetric monitoring in Ukraine: current status and further development

    International Nuclear Information System (INIS)

    Presently Ukraine has mixed system for dosimetric monitoring. Nuclear power plants and some major nuclear facilities have their own dosimetry services, which are responsible for regular dosimetric monitoring of workers. Rest of occupationally exposed persons is monitored by dosimetry laboratories affiliated to the territorial authorities for sanitary and epidemiology supervision. In 2002-2003 Ukrainian Ministry of Health performed survey of the status of dosimetric monitoring and inventory of critical groups requiring such monitoring. Dosimetry services in Ukraine cover about 38,000 occupationally exposed workers, including 9,100 medical professionals, 16,400 employees of 5 nuclear power plants and ca.12,400 workers dealing with other sources of occupational exposure (industry, research). Territorial dosimetry services operate in 13 of 24 regions of Ukraine, using DTU-01 manual TLD readers produced with one exception in 1988-1990. The coverage of critical groups by dosimetric monitoring is variable and ranges from 38% to 100% depending on the region. Personnel of nuclear power plants (about 16,400 workers) is monitored by their own dosimetry services achieving absolute coverage of the main staff and temporary workers. Current inadequate status of dosimetric monitoring infrastructure in Ukraine demands an urgent elaboration of the united state system for monitoring and recording of individual doses. The proposed plan would allows to bring dosimetry infrastructure in Ukraine to the modern state which would be compatible with existing and future European and international radiation protection networks. Unitary structure of Ukraine, strong administrative command and good communications between regions of the country are positive factors in favour of efficient implementation of the proposed plan. Deficiencies are associated with limited funding of this effort. (authors)

  11. Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics.

    Science.gov (United States)

    Kim, Mi-Gyeong; Kim, Dongyoon; Suh, Soo-Kyung; Park, Zewon; Choi, Min Joung; Oh, Yu-Kyoung

    2016-04-01

    Chimeric antigen receptor-modified T cells (CAR-T) have emerged as a new modality for cancer immunotherapy due to their potent efficacy against terminal cancers. CAR-Ts are reported to exert higher efficacy than monoclonal antibodies and antibody-drug conjugates, and act via mechanisms distinct from T cell receptor-engineered T cells. These cells are constructed by transducing genes encoding fusion proteins of cancer antigen-recognizing single-chain Fv linked to intracellular signaling domains of T cell receptors. CAR-Ts are classified as first-, second- and third-generation, depending on the intracellular signaling domain number of T cell receptors. This review covers the current status of CAR-T research, including basic proof-of-concept investigations at the cell and animal levels. Currently ongoing clinical trials of CAR-T worldwide are additionally discussed. Owing to the lack of existing approved products, several unresolved concerns remain with regard to safety, efficacy and manufacturing of CAR-T, as well as quality control issues. In particular, the cytokine release syndrome is the major side-effect impeding the successful development of CAR-T in clinical trials. Here, we have addressed the challenges and regulatory perspectives of CAR-T therapy. PMID:26895243

  12. The current status and future perspectives of the combined chemo-radiotherapy for locoregionally advanced squamous cell head and neck cancer%局部或区域晚期头颈鳞癌放化疗联合治疗现状和展望

    Institute of Scientific and Technical Information of China (English)

    李志勇; 张艳清; 郑艳群; 朱步东

    2013-01-01

    头颈部鳞状细胞癌的全身治疗包括细胞毒药物治疗(简称化疗)、靶向治疗和支持治疗;而局部治疗主要包括放射治疗和手术。放化疗联合是局部晚期或区域晚期头颈部鳞癌主要治疗模式,包括同步化放疗、诱导化疗、序贯化放疗。本文综述了原发于口腔、口咽、下咽、喉的鳞癌的化放疗联合治疗现状和进展。%The systemic treatments of locoregionally advanced squamous cell head and neck cancer include cytotoxic therapy (referred to chemotherapy), targeted therapies and supportive care, in addition to local therapy consisted of surgery and/or radiation therapy (RT). Approaches combining chemotherapy and radiation therapy is primarily treatment modalities in patients with locoregionally advanced head and neck cancer, comprising of concurrent chemoradiotherapy, induction chemotherapy and sequential chemoradiotherapy. This article reviews the current status and progress in the combined chemo-radiotherapy approaches to patients with locoregionally advanced head and neck cancer arising in the oral cavity, oropharynx, hypopharynx, and larynx.

  13. Relaxation: its effect on the nutritional status and performance status of clients with cancer.

    Science.gov (United States)

    Campbell, D F; Dixon, J K; Sanderford, L D; Denicola, M A

    1984-02-01

    Relaxation was used to promote normal food consumption patterns among persons with cancer. As part of a larger study, 22 persons with cancer were randomly assigned to receive instruction and reinforcement in a relaxation technique to be used preprandially. The relaxation procedure included four components: (a) deep abdominal breathing, (b) tensing and relaxing of various body parts, (c) relaxation by autosuggestion, and (d) voluntary image control. Twelve clients complied with relaxation instructions in part, and 10 did not. Among compliers, 75% experienced desirable weight change over a six-week period. Performance status, measured by the Karnofsky scale, improved for 33% and worsened for 17% over eight weeks. Research has shown relaxation to be an effective measure in relation to pain, hypertension, and other conditions. These preliminary results now suggest that relaxation may also be effective in treating the eating problems of the person with cancer, leading to improvement in weight and performance status. PMID:6363490

  14. Current Research and Management of Ovarian Cancer in China

    Institute of Scientific and Technical Information of China (English)

    GUMeijiao; SHIWei

    2002-01-01

    Ovarian cancer is ne of the most lethal malignant tumors in China,represents the third most common cancer after cervical cancer and endometrial cancer,and the first leading cause of death from hynaecological cancers.Due to the lack of effective screening strategies and the absence of symptoms in early-stage of disease,over 70% of patients present at an advanced stage.Despite the advances in surgical techniques and conventional chemotheraphy,the prognosis of ovarian cancer has not been improved significantly,and indeed the long-term survival for patients with advanced disease does not exceed 20%.The aetiology of ovarian cancer temains poorly understood.In China,the major focus of research is to clarify the mechanism underlying ovarian cancer,develop more effective life-saving diagnostic and therapeutic measures,and undertake more population-based studies.This article summarizes current research,diagnosis and management of ovarian cancer in China.

  15. Current status and future prospects on nuclear industry in Korea

    International Nuclear Information System (INIS)

    It is ny great pleasure to have this chance of speaking at twenty-first KAIF/KNS Annual Conference, with the subject of the current status and future prospects of nuclear industry in Korea. As you all know, since the start of operation in Obninsk, the former Soviet Union, on June 26th, 1954, nuclear generation in the world has expanded continuously for the past 50 years. In 1973, when the first oil crisis hit the world, there were 147 nuclear power plants in operation, supplying only 0.8% of the world energy demand. About 30 years later, by the end of last year, 443 plants were in operation in 32 countries, supplying about 16% of the world power demand. Nuclear power generation is greatly contributing to the energy security of many countries and preservation of global environments. Recently, countries all over the world are becoming aware of the values and importance of nuclear energy which can help respond to energy crises caused by a sharp rise in oil prices and protect the earth from global warming. Due to its high energy density and ability to secure fuel supply at a lower cost, in addition to its cleanliness resulting from almost no emission of greenhouse gases, nuclear power generation is the practical alternative for energy security and the prevention of global warming. However, in the rapidly changing 21st century, the nuclear industries of the world, as well as Korea, are facing more challenges than ever before. The political and social disputes on nuclear generation are continuing while we all are facing urgent challenges, including the concerns about the safety of nuclear generation, procuring site to build nuclear power plants, and the improvement of competitiveness. Please allow me to remind you that it is very important for the world's nuclear societies to cooperate together in order to overcome diverse difficulties along our path and to contribute to the development of mankind and preservation of natural environments with nuclear power as a

  16. Gastric carcinoma in China: Current status and future perspectives (Review)

    OpenAIRE

    Zhu, Xiaodong; Li, Jin

    2010-01-01

    Gastric cancer is one of the most frequently occurring cancers in China, with an estimated 380,000 new cases each year, accounting for more than 40% of the worldwide annual cancer incidence. There is geographical clustering of the distribution of gastric cancer in China, with most of the high-risk areas being rural. D2 resection is the standard lymphadenectomy for curative resection in China, but more extensive lymphadenectomy is conducted for selected patients. Perioperative chemotherapy, po...

  17. 腹腔镜结直肠癌手术的应用现状与进展%Current status of and advance in laparoscopic surgery for colorectal cancer

    Institute of Scientific and Technical Information of China (English)

    郑民华

    2008-01-01

    Laparoscopic surgery for colorectal cancer has the advantages of minimal impairment of gastrointestinal and pulmonary function, less immunosuppression and shorter hospital stay, which had been appoved by evidence-based medicine. With the development of concepts and techniques of minimally invasive surgery, the combination of laparoscope and endoscope in the treatment of colorectal cancer has attracted surgeons' attention, and some conventional surgery techniques of colorectal-anal anastomosis have been adopted during laparoscopic colorectal resection, which make ultra-low anastomosis feasible. The aspects mentioned above will promote the further development of laparoscopic surgery for colorectal cancer.

  18. Recent developments and current status of air kerma standards

    International Nuclear Information System (INIS)

    -rays and since 1975 for medium-energy x-rays and 60Co-γ radiation the results represent an invaluable database which can be regarded as an indicator of the status of the air kerma standards operated worldwide. Consequently, this database and the reports of the NMIs to the CCRI(I) meetings which take place periodically every two years were used for the current status report as an essential source of information. Because different techniques are used to measure the air kerma rate of kilovoltage x-rays and 137Cs- and 60Co-γ radiation this status report is divided in this two parts. Undoubtedly, the most important new development was the re-evaluation of several correction factors required for cavity ionization chamber standards. However, there were also interesting developments using Monte Carlo techniques and spectrometry for the determination of x-ray quality dependent correction factors of FACs

  19. Current Status of the DPOSS Effort at Caltech

    Science.gov (United States)

    Odewahn, S. C.

    1998-05-01

    We discuss the current status of a three-color survey of fields of the digitized Second Palomar Observatory Sky Survey (DPOSS). Eventually, the DPOSS catalogs will be released to the astronomical community. The final catalog will contain an estimated minimum of 50,000,000 (50 million) galaxies, and over 2,000,000,000 (2 billion) stars, down to the equivalent blue limiting magnitude of 22., and with star-galaxy classifications accurate to 90% or better down to the equivalent blue magnitude of 21. An important addition is a program to collect extensive CCD calibration data in the Gunn gri system with the Palomar 60". This represents a considerable advance over other, currently existing optical sky surveys based on large-format photographic plates. A great variety of scientific projects should become possible using this major data set, including the following: studies of galaxy clustering and of the large-scale structure in the low-redshift universe, as tests of structure formation models; galaxy counts at moderate depth, as a function of magnitudes, colors, and morphology, to be used in tests of galaxy evolution over the past few Gigayears; a search for high redshift (z > 4) quasars, and active galactic nuclei at lower redshifts; mass optical identifications of radio, IR, and x-ray sources; generation of objectively defined catalogs of clusters and groups of galaxies; a search for previously unknown sparse globular clusters and dwarf spheroidal galaxies; cataloging of low surface brightness galaxies; a search for objects with peculiar colors or variability; and many others. In particular, we review efforts to perform automatic galaxy classification using artificial neural network image classifiers. This powerful technique is used to map a multivariate photometric parameter space to the revised Hubble system of galaxy classification. We present a new morphological classification approach using Fourier image models to identify barred and ringed spiral systems.

  20. The current status of orbital experiments for UHECR studies

    Science.gov (United States)

    Panasyuk, M. I.; Casolino, M.; Garipov, G. K.; Ebisuzaki, T.; Gorodetzky, P.; Khrenov, B. A.; Klimov, P. A.; Morozenko, V. S.; Sakaki, N.; Saprykin, O. A.; Sharakin, S. A.; Takizawa, Y.; Tkachev, L. G.; Yashin, I. V.; Zotov, M. Yu

    2015-08-01

    Two types of orbital detectors of extreme energy cosmic rays are being developed nowadays: (i) TUS and KLYPVE with reflecting optical systems (mirrors) and (ii) JEM-EUSO with high- transmittance Fresnel lenses. They will cover much larger areas than existing ground-based arrays and almost uniformly monitor the celestial sphere. The TUS detector is the pioneering mission developed in SINP MSU in cooperation with several Russian and foreign institutions. It has relatively small field of view (±4.5°), which corresponds to a ground area of 6.4 • 103 km2. The telescope consists of a Fresnel-type mirror-concentrator (∼ 2 m2) and a photo receiver (a matrix of 16 x 16 photomultiplier tubes). It is to be deployed on the Lomonosov satellite, and is currently at the final stage of preflight tests. Recently, SINP MSU began the KLYPVE project to be installed on board of the Russian segment of the ISS. The optical system of this detector contains a larger primary mirror (10 m2), which allows decreasing the energy threshold. The total effective field of view will be at least ±14° to exceed the annual exposure of the existing ground-based experiments. Several configurations of the detector are being currently considered. Finally, JEM-EUSO is a wide field of view (±30°) detector. The optics is composed of two curved double-sided Fresnel lenses with 2.65 m external diameter, a precision diffractive middle lens and a pupil. The ultraviolet photons are focused onto the focal surface, which consists of nearly 5000 multi-anode photomultipliers. It is developed by a large international collaboration. All three orbital detectors have multi-purpose character due to continuous monitoring of various atmospheric phenomena. The present status of development of the TUS and KLYPVE missions is reported, and a brief comparison of the projects with JEM-EUSO is given.

  1. The JT-60SA Cryoplant Current Design Status

    Science.gov (United States)

    Henry, D.; Michel, F.; Roussel, P.; Reynaud, P.; Journeaux, J. Y.; Maréchal, J. L.; Balaguer, D.; Roux, C.; Matsukawa, M.; Yoshida, K.

    2008-03-01

    In the framework of the ITER Broader Approach, CEA is carrying out the procurement of the Cryogenic System to the JA-EU Satellite Tokamak JT-60SA, which should be operated in Japan at JAEA, Naka in 2014. According to the Conceptual Design Report, JT-60SA is to operate for periods of at least 6 months per year, with major shutdown periods in between for maintenance and further installation upgrades. For this operation scenario, the cryoplant and the cryodistribution have to cope with different heat loads which depend on the different JT-60SA operating states. The cryoplant consists of one 4.5 K refrigerator and one 80 K helium loop, each pre-cooled by LN2. These cryogenic subsystems have to operate simultaneously in order to remove the heat loads from the superconducting magnets, 80 K shields and the divertor cryopumps. The first part of this study is based on the Process Flow Diagram (PFD) and presents the current design status of the JT-60SA cryogenic system. The second part is dedicated to the analysis of the cryoplant normal operation modes including the regeneration mode of the divertor cryopumps. Thanks to this analysis, the architecture of the present PFD is proposed in order to match the technical specifications of the cryoplant with the JT-60SA operation requirements.

  2. Solar Power – Current Status, Challenges and Policies in India

    Directory of Open Access Journals (Sweden)

    Rachit S

    2016-06-01

    Full Text Available The demand for energy is growing day by day in the whole world. The Conventional energy sources like coal and petroleum are limited. Renewable energy resources will play an important role in the future. India is situated in sunny belt India is endowed with vast solar energy potential. Government of India had launched Jawaharlal Nehru National Solar Mission (JNNSM in 2009. The target was to start Grid connected Solar Projects of 20 GW by 2022. In May 2015 government increases the target to 100 GW by 2022. This paper provides an overview on solar energy in India. It reviews the current status of solar energy in terms of existing capacity, along with historical trends of solar energy. The paper also focuses on the technical and economical barriers and challenges for development and utilization of solar energy technology. The paper reviews existing government act and regulatory policies to support solar energy development in India. Indicating how these policies are helping in achieving their goals. Finally, a review based on of the future target of solarenergy supply has been presented.

  3. Current status and scientific capabilities of the Rosetta lander payload

    Science.gov (United States)

    Biele, J.; Ulamec, S.; Feuerbacher, B.; Rosenbauer, H.; Mugnuolo, R.; Moura, D.; Bibring, J. P.

    ESA's cornerstone mission "ROSETTA" to comet 46P/Wirtanen will bring a 100 kg Lander (provided by an international European consortium) with a scientific payload of about 27 kg to the surface of the comet's nucleus. After a first scientific sequence it will operate for a considerable fraction of the cometary orbit around the sun (between 3 AU and 2 AU). The Lander is an autonomous spacecraft, powered with solar cells and using the ROSETTA Orbiter as a telemetry relais to Earth. The main scientific objectives are the in-situ investigation of the chemical, elemental, isotopic and mineralogical composition of the comet, study of the physical properties of the surface material, analyze the internal structure of the nucleus, observe temporal variations (day/night cycle, approach to sun), study the relationship between the comet and the interplanetary matter and provide ground reference data for Orbiter instruments. Ten experiments with a number of sub-experiments are foreseen to fulfil these objectives. In this paper we present the current status of the instrumental development and the scientific capabilities of each of the experiments.

  4. High-density matter: current status and future challenges

    Science.gov (United States)

    Stone, J. R.

    2015-05-01

    There are many fascinating processes in the Universe which we observe in more and more in detail thanks to increasingly sophisticated technology. One of the most interesting phenomena is the life cycle of stars, their birth, evolution and death. If the stars are massive enough, they end their lives in the core-collapse supernova explosion, the one of the most violent events in the Universe. As the result, the densest objects in the Universe, neutron stars and/or black holes are created. Naturally, the physical basis of these events should be understood in line with observation. The current status of our knowledge of processes in the life of stars is far from adequate for their true understanding. We show that although many models have been constructed their detailed ability to describe observations is limited or non-existent. Furthermore the general failure of all models means that we cannot tell which are heading in the right direction. A possible way forward in modeling of high-density matter is outlined, exemplified by the quark-meson-coupling model (QMC). This model has a natural explanation for the saturation of nuclear forces and depends on very few adjustable parameters, strongly constrained by the underlying physics. Latest QMC results for compact objects and finite nuclei are presented.

  5. Current status and future trends of medical physics in Mexico

    International Nuclear Information System (INIS)

    Medical Physics is an area that applies the principles of physics to medicine, particularly in the prevention, diagnosis and treatment of diseases using ionizing and nonionizing radiation. The main attractive of medical physics is that it has a direct impact on the quality and safety of medical care in humans; this social component with direct implications for the population is of high value for Mexico. This paper describes the concepts of medical physics, trends and the current status of this discipline as a profession, which is directly related to the efforts of clinical research. It is also described what is, in my opinion, the future of medical physics in Mexico, emphasizing the fact that this field requires a substantial boost from universities and hospitals to recruit highly qualified young medical physicists and the support from government agencies such as Secretaria de Salud, Instituto Mexicano del Seguro Social and Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado through clinical research projects that allow the necessary evolution of medical physics into the hospital setting

  6. Collagen Cross-Linking: Current Status and Future Directions

    Directory of Open Access Journals (Sweden)

    Marine Hovakimyan

    2012-01-01

    Full Text Available Collagen cross-linking (CXL using UVA light and riboflavin (vitamin B2 was introduced as a clinical application to stabilize the cornea by inducing cross-links within and between collagen fibers. CXL has been investigated extensively and has been shown clinically to arrest the progression of keratoconic or post-LASIK ectasia. With its minimal cost, simplicity, and proven positive clinical outcome, CXL can be regarded as a useful approach to reduce the number of penetrating keratoplasties performed. Small case series have also indicated that CXL is beneficial in corneal edema by reducing stromal swelling behavior and in keratitis by inhibiting pathogen growth. Despite these encouraging results, CXL remains a relatively new method that is potentially associated with complications. Aspects such as side effects and recurrence rates have still to be elucidated. In light of the growing interest in CXL, our paper summarizes present knowledge about this promising approach. We have intentionally endeavored to include the more relevant studies from the recent literature to provide an overview of the current status of CXL.

  7. Medical telerobotic systems: current status and future trends.

    Science.gov (United States)

    Avgousti, Sotiris; Christoforou, Eftychios G; Panayides, Andreas S; Voskarides, Sotos; Novales, Cyril; Nouaille, Laurence; Pattichis, Constantinos S; Vieyres, Pierre

    2016-01-01

    Teleoperated medical robotic systems allow procedures such as surgeries, treatments, and diagnoses to be conducted across short or long distances while utilizing wired and/or wireless communication networks. This study presents a systematic review of the relevant literature between the years 2004 and 2015, focusing on medical teleoperated robotic systems which have witnessed tremendous growth over the examined period. A thorough insight of telerobotics systems discussing design concepts, enabling technologies (namely robotic manipulation, telecommunications, and vision systems), and potential applications in clinical practice is provided, while existing limitations and future trends are also highlighted. A representative paradigm of the short-distance case is the da Vinci Surgical System which is described in order to highlight relevant issues. The long-distance telerobotics concept is exemplified through a case study on diagnostic ultrasound scanning. Moreover, the present review provides a classification into short- and long-distance telerobotic systems, depending on the distance from which they are operated. Telerobotic systems are further categorized with respect to their application field. For the reviewed systems are also examined their engineering characteristics and the employed robotics technology. The current status of the field, its significance, the potential, as well as the challenges that lie ahead are thoroughly discussed. PMID:27520552

  8. The current status of radiological protection infraestructures in Tanzania

    International Nuclear Information System (INIS)

    Without adequate and sustainable radiation protection infrastructure, the benefits associated with safe use of nuclear technology and atomic energy might be jeopardized. In the United Republic of Tanzania, the Atomic Energy Act No. 7 of 2003 established the Tanzania Atomic Energy Commission as sole regulatory body responsible for regulating and controlling the safe and peaceful utilization of nuclear technology in the country. The Atomic Energy (Protection from ionizing radiation) Regulations, 2004 further specifies practices designed to ensure that unnecessary exposure of persons to ionizing radiation is avoided, that all exposures are kept as low as reasonably achievable and that all the dose limits specified in the radiation protection standards are not exceeded. This is achieved through the systems of notification, authorizations through registration and licensing, safety and security of radiation sources as well as regulatory inspections and enforcements. These activities are performed by the Commission with operational funds allocated by the Government of Tanzania. The Commission further provides other services namely individual monitoring; calibration services; education and training to radiation workers, public as well as law enforcers; and safe management of radioactive waste. Despite such achievement, still there are a lot to be done in order to strengthen the radiation protection infrastructure in Tanzania. These include issues such as gaps in our legislations, regulations and guidance, security of sources, enforcement of laws, etc. This paper describes and discusses the current status of the regulatory control activities and radiation protection services provided by the Commission and suggestions for further improvement of radiological protection infrastructure in Tanzania. (author)

  9. The current status of percutaneous vertebroplasty in Canada

    Energy Technology Data Exchange (ETDEWEB)

    Heffernan, E.J.; O' Sullivan, P.J.; Alkubaidan, F.O.; Heran, M.K.S.; Legiehn, G.M.; Munk, P.L. [Dept. of Radiology, Vancouver General Hospital, Univ. of British Columbia, Vancouver, British Columbia (Canada)], E-mail: ejheffernan@eircom.net

    2008-04-15

    To provide an overview of the current status of percutaneous vertebroplasty (PVP) practice in Canada, including the preprocedure work up operative technique and follow-up practice of physicians performing the procedure in this county. Questionnaires were emailed to 31 institutions performing percutaneous vertebroplasty across Canada. Twenty-three (74.2%) completed surveys were returned, representing data from 1,516 vertebroplasties performed by 66 radiologists and surgeons. Preoperative routine imaging and screening practice varies widely. The majority of respondents perform PVP under conscious sedation; however, an anaesthetist is present in only 22% of institutions. Biplane fluoroscopy is used in 43.5% of practices. The preference for unipedicular or bipedicular injection varies: in 7 institutions, a unipedicular approach is used in at least 80% of cases. Patients receive a follow-up by the screening physician in 65.2% of institutions. There were 4 complications requiring treatment. Venous and intradiscal extravasation rates were 20.8% and 25.3%, respectively; however, the vast majority of these were clinically insignificant. PVP complication rates reported in our Canadian survey compare favourably with those in the published literature. The number of PVPs performed annually in the institutions surveyed appears small, relative to the figures from the United States. The prevalence of osteoporosis and incidence of vertebral compression fractures in Canada is increasing as the population ages, and demand for PVP is likely to rise significantly in the coming years. (author)

  10. Current Status of Manufacturing Hazardous Waste in Shanghai

    Institute of Scientific and Technical Information of China (English)

    Liu Changqing; Zhang Jiangshan; Zhao Youcai

    2007-01-01

    It is difficult to manage the manufacturing hazardous waste(MHW)whichis generated from a huge amount of complicated sources and causes very serious pollution.Therefore more and more attention has been paid to MHW pollution.shanghai,as an industrial and economic center and an intemational metropolis in China,has a vast industrial system spanning a multitude of sectors,which generates MHW not only in a huge magnitude but also in a large variety of types from complicated sourrces,resulting in severe pollution.In 2003,the production of MHW in Shanghai is about 3.96 x 10ton,involving 33 indices.Most of MHW in Shanghai is treated and disposed of,but a significant portion is not handled properly and effectively.This paper carries out in-field investigation on the current status of MHW production and treat ment in Shanghai,and puts forward scientific proposals that Shanghai should facilitate cleaner production and minimize haz ardous waste;strictly enforce hazardous waste registration system, strengthen monitoring the certified enterprises;strengthen intent disposal center construction and realize hazardous waste reclamation;accelerate establishing tlle technical criteria and the management policy,promote the research and development on the treatment and disposal technology,and strengthen information management,thus realizing integrated management on MHW pollution.

  11. Current status and prospects for development of thermometry

    International Nuclear Information System (INIS)

    The paper deals with results of an analysis carried out at the VNIIM with the purpose to ascertain the current status of thermometry as well as to make an attempt to determine a line of development of this field of measurements in future. The analysis was based on a survey of 150 industrial enterprises and scientific organizations. The results of the survey showed that during two last decades the accuracy of measuring instruments used in science and industry was increased almost tenfold. However, advances in the improvement of temperature measuring instruments were achieved not owing to new principles of designing thermometers, but due to rapid development of electronics, which allowed to solve the problem of accurate measurements of resistance and electromotive force and automatize measurement information processing. In most cases the contemporary measuring instruments perfectly meet the requirements to the measurement accuracy claimed by the enterprises surveyed and are provided with a necessary metrological assurance. Although there is a general understanding of the necessity to use the thermodynamic scale rather than the conditional one, we have no objective evidence with regard to how close we have to bring the international scale used in our everyday practice to the thermodynamic scale and what will be a benefit for development of science and industry. Increasing the accuracy of national standards does not affect, as a rule, the accuracy of temperature measurements in industry and scientific research since the main contribution to a total measurement error is made by components caused by an improper measurement procedure

  12. Current Status and Tasks in Development of Cable Recycling Technology

    Science.gov (United States)

    Ezure, Takashi; Goto, Kazuhiko

    This paper shows current status and tasks in development of cable recycling technology and it’s items to be solved. Electric cable recycle system has been activated especially for copper conductor recycle in Japan. Previously removed cable coverings materials were mainly land filled. But landfill capacity is decreased and limited in recent years, at the same time, recycle technology was highly developed. A cable recycle technology has 4 tasks. (1) Applying new high efficiency separation system instead of electrostatic and gravity methods to classify mixed various kind of plastics materials including recently developed ecological material (ex PE, PVC, Rubber), (2) Removing heavy metal, especially lead from PVC material, (3) Treatment of optical glass fiber core, which has possibility going to be harmful micro particles, and (4) Establishment of social recycle system for electric wire and cable. Taking action for these tasks shall be proceeded under environmentally sensitive technology together with local government, user, manufacturer, and waste-disposal company on cost performance basis.

  13. Neural synchrony in cortical networks: history, concept and current status

    Directory of Open Access Journals (Sweden)

    Peter Uhlhaas

    2009-07-01

    Full Text Available Following the discovery of context-dependent synchronization of oscillatory neuronal responses in the visual system, the role of neural synchrony in cortical networks has been expanded to provide a general mechanism for the coordination of distributed neural activity patterns. In the current paper, we present an update of the status of this hypothesis through summarizing recent results from our laboratory that suggest important new insights regarding the mechanisms, function and relevance of this phenomenon. In the first part, we present recent results derived from animal experiments and mathematical simulations that provide novel explanations and mechanisms for zero and nero-zero phase lag synchronization. In the second part, we shall discuss the role of neural synchrony for expectancy during perceptual organization and its role in conscious experience. This will be followed by evidence that indicates that in addition to supporting conscious cognition, neural synchrony is abnormal in major brain disorders, such as schizophrenia and autism spectrum disorders. We conclude this paper with suggestions for further research as well as with critical issues that need to be addressed in future studies.

  14. The UPM high temperature solar collector current status

    International Nuclear Information System (INIS)

    The high temperature solar energy research at Universiti Putra Malaysia (UPM) is an attempt to study the merits of the fixed aperture optics collector for the equatorial region using the concept of the fixed mirror distributed focus (FMDF). The general objective is to look for an alternative source of clean energy and a practical method of converting this energy to usable form for the projected industrialisation program of the country. The FMDF uses a stationary hemisphere bowl to capture the solar irradiance. The UPM bowl has a rim angle of 120 0 with radius of curvature of 27.9 m. This corresponds to an aperture diameter of 48 m and submerges 5.1 m in the ground. The bowl will later be tiled with 2446 square meters of mirror to form a spherical shape. And therefore will be able to collect about 1 MW of solar irradiance at the conical focus formed along the direction of the radius (high concentrated region) which then can be harnessed by different means. In this paper, we will report the current status and future works of the project, under construction at the site. We anticipate that the project will be completed and operated by the year 2000. (Author)

  15. Current status and future trends of medical physics in Mexico

    Science.gov (United States)

    Azorin Nieto, J.

    2015-01-01

    Medical Physics is an area that applies the principles of physics to medicine, particularly in the prevention, diagnosis and treatment of diseases using ionizing and nonionizing radiation. The main attractive of medical physics is that it has a direct impact on the quality and safety of medical care in humans; this social component with direct implications for the population is of high value for Mexico. This paper describes the concepts of medical physics, trends and the current status of this discipline as a profession, which is directly related to the efforts of clinical research. It is also described what is, in my opinion, the future of medical physics in Mexico, emphasizing the fact that this field requires a substantial boost from universities and hospitals to recruit highly qualified young medical physicists and the support from government agencies such as Secretaria de Salud, Instituto Mexicano del Seguro Social and Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado through clinical research projects that allow the necessary evolution of medical physics into the hospital setting.

  16. Chinese Soybean Industry:Current Status and Outlook

    Institute of Scientific and Technical Information of China (English)

    DachuanLiu; ShaojunTian

    2002-01-01

    This paper focus on the soybean resources and their industry development in China.Due to the high demand in domestic market,it is necessary to expand the cultivation area and improve the production yields.Meanwhile,to increase the export of soybeans from overseas is also important.China has a long history in producing traditional soybean foods.After recent fifty years,the development of Chinese soybean industry has reached to a reasonable level.The current status of Chinese soybean industry has been included in the paper.It has been expected that in next five years,there will be a rapid increase in the processing of soybeans;it will become more reasonable in the scale and distribution of soybean oil factories.Emphasis will be put on the improvement of the functionalities of soybean products.Different kinds of functional soybean foods,especially the soybean proteins for particular uses will be developed by the use of modification technologies.Concern is also given to the multi-utilization of soybean resources,which not only covers the extraction of oil from soybean seeds and the processing of protein products from the meal;but also includes the recovery of the natural phyto-chemicals from soybeans which could then be exploited to novel products with more profits.

  17. Radiation processing in India. Current status and future program

    International Nuclear Information System (INIS)

    Radiation processing is an alternative to conventional methods such as thermal and chemical processing in many industrial applications. In India, this technology has found extensive applications in area of healthcare, agriculture, food preservation, industry and environment. Both gamma radiation and electron beam accelerators are being utilized for this purpose. Presently, 6 commercial gamma irradiators housing about 1.5 million curie Co-60 and an annual turnover of over US$ 2 million and 3 commercial electron beam (EB) accelerators with installed capacity of 185 kW are commercially operating in India. Five demonstration plants housing a total of 0.5 million curie Co-60 have been set up to assess the techno-commercial viability of the processes such as radiation vulcanization of natural rubber latex, decontamination of spices, hygienization of sewage sludge, shelf-life extension of onions. The new areas being explored include use of electron beam treated pulp for viscose-rayon process, radiation processed 'hydrogel' burn/wound dressings and radiation processing of natural polymers. In the present paper, the current status of this program, especially the recent developments and future direction of radiation processing technology in India is reviewed. (author)

  18. Radiation processing in India: Current status and future programme

    International Nuclear Information System (INIS)

    Radiation processing is an alternative to conventional methods such as thermal and chemical processing in many industrial applications. In India, this technology has found extensive applications in area of healthcare, agriculture, food preservation, industry and environment. Both gamma radiation and electron beam accelerators are being utilized for this purpose. Presently, six commercial Co-60 gamma irradiators and three commercial electron beam (EB) accelerators with installed capacity of 185 kW are commercially operating in India. Five demonstration plants housing a total of 18.5x107 GBq Co-60 have been set up to assess the techno-commercial viability of the processes such as radiation vulcanization of natural rubber latex, decontamination of spices, hygienization of sewage sludge, shelf-life extension of onions. The new areas being explored include use of electron beam treated pulp for viscose-rayon process, radiation processed 'hydrogel' burn/would dressings and radiation processing of natural polymers. In the present paper, the current status of this program, especially the recent developments and future direction of radiation processing technology in India is reviewed. (author)

  19. CURRENT STATUS, CHALLENGES AND OPPORTUNITIES OF RABBIT PRODUCTION IN BOTSWANA

    Directory of Open Access Journals (Sweden)

    J.C. MOREKI

    2012-03-01

    Full Text Available This review highlights the current status of rabbit production, challenges facing the industry and opportunities available. Rabbit farming in Botswana is in its infancy and the rabbit population is estimated to be less than 1000. However, this value is a gross underestimate due to poor monitoring by government extension services. In Botswana, rabbits are mainly kept in the backyards, indicating that intensive systems have not yet been developed. Rabbits have small body size, short gestation period, high reproductive potential, rapid growth rate and ability to utilize forages. Compared to beef, chicken, mutton, chevon and chicken, rabbit meat has low cholesterol, high protein and low fat contents. Rabbit production can be integrated into small farming systems, with the rabbits being fed on crop residues, weeds, poultry droppings, and kitchen and garden wastes. The manure can be used to fertilize soils. The major challenges in rabbit production are inadequacy of breeding stock, inadequate rabbit feeds, poor management (feeding, housing and health care, lack of research support, lack of technical support from extension services, lack of access to credit and inadequate supply of equipment. The major opportunity available to the rearers is that the market is vast due to the small rabbit population in the country. The attributes of rabbits suggest that rabbit farming is likely to play an important role in nutrition, poverty alleviation and food security, especially in countries with higher unemployment levels and HIV/AIDS prevalence rates such as Botswana.

  20. Thorium-based nuclear fuel: current status and perspectives

    International Nuclear Information System (INIS)

    Until the present time considerable efforts have already been made in the area of fabrication, utilization and reprocessing of Th-based fuels for different types of reactors, namely: by FRG and USA - for HTRs; FRG and Brazil, Italy - for LWRs; India - for HWRs and FBRs. Basic research of thorium fuels and thorium fuel cycles are also being undertaken by Australia, Canada, China, France, FRG, Romania, USSR and other countries. Main emphasis has been given to the utilization of thorium fuels in once-through nuclear fuel cycles, but in some projects closed thorium-uranium or thorium-plutonium fuel cycles are also considered. The purpose of the Technical Committee on the Utilization of Thorium-Based Nuclear Fuel: Current Status and Perspective was to review the world thorium resources, incentives for further exploration, obtained experience in the utilization of Th-based fuels in different types of reactors, basic research, fabrication and reprocessing of Th-based fuels. As a result of the panel discussion the recommendations on future Agency activities and list of major worldwide activities in the area of Th-based fuel were developed. A separate abstract was prepared for each of the 9 papers in this proceedings series

  1. Computational modeling of cardiac hemodynamics: Current status and future outlook

    Science.gov (United States)

    Mittal, Rajat; Seo, Jung Hee; Vedula, Vijay; Choi, Young J.; Liu, Hang; Huang, H. Howie; Jain, Saurabh; Younes, Laurent; Abraham, Theodore; George, Richard T.

    2016-01-01

    The proliferation of four-dimensional imaging technologies, increasing computational speeds, improved simulation algorithms, and the widespread availability of powerful computing platforms is enabling simulations of cardiac hemodynamics with unprecedented speed and fidelity. Since cardiovascular disease is intimately linked to cardiovascular hemodynamics, accurate assessment of the patient's hemodynamic state is critical for the diagnosis and treatment of heart disease. Unfortunately, while a variety of invasive and non-invasive approaches for measuring cardiac hemodynamics are in widespread use, they still only provide an incomplete picture of the hemodynamic state of a patient. In this context, computational modeling of cardiac hemodynamics presents as a powerful non-invasive modality that can fill this information gap, and significantly impact the diagnosis as well as the treatment of cardiac disease. This article reviews the current status of this field as well as the emerging trends and challenges in cardiovascular health, computing, modeling and simulation and that are expected to play a key role in its future development. Some recent advances in modeling and simulations of cardiac flow are described by using examples from our own work as well as the research of other groups.

  2. Bonded permanent magnets: Current status and future opportunities (invited)

    Science.gov (United States)

    Ormerod, John; Constantinides, Steve

    1997-04-01

    Permanent magnets play a vital role in modern society as a component in a wide range of devices utilized by many industries and consumers. In 1995, the world production of permanent magnets was estimated to be valued at 3.6 billion and growing at an annual rate of 12%. Bonded permanent magnets are the fastest growing segment of this market. Bonded magnet technology enables a wide variety of magnetic powders to be combined with several polymer and binder systems to produce magnetic components utilizing several processing options. In this article, we review the development of bonded magnet technology. The major classes of magnetic powders, binder systems, and processing technologies are described. Recent developments in magnetic material grades, e.g., anisotropic NdFeB, rare earth lean NdFeB, SmFe(N,C) are outlined. The current status of processing and binder options aimed at increasing the upper application temperature limit of these materials is highlighted. Finally, the improvements and future opportunities for bonded magnets are discussed.

  3. High-density matter: current status and future challenges

    Directory of Open Access Journals (Sweden)

    Stone J. R.

    2015-01-01

    Full Text Available There are many fascinating processes in the Universe which we observe in more and more in detail thanks to increasingly sophisticated technology. One of the most interesting phenomena is the life cycle of stars, their birth, evolution and death. If the stars are massive enough, they end their lives in the core-collapse supernova explosion, the one of the most violent events in the Universe. As the result, the densest objects in the Universe, neutron stars and/or black holes are created. Naturally, the physical basis of these events should be understood in line with observation. The current status of our knowledge of processes in the life of stars is far from adequate for their true understanding. We show that although many models have been constructed their detailed ability to describe observations is limited or non-existent. Furthermore the general failure of all models means that we cannot tell which are heading in the right direction. A possible way forward in modeling of high-density matter is outlined, exemplified by the quark-meson-coupling model (QMC. This model has a natural explanation for the saturation of nuclear forces and depends on very few adjustable parameters, strongly constrained by the underlying physics. Latest QMC results for compact objects and finite nuclei are presented.

  4. The ALICE DAQ Current Status and Future Challenges

    CERN Document Server

    Röhrich, D; Villalobos Baillie, O; Dénes, E; Eged, B; Sulyán, J; Kiss, T; Meggyesi, Z; Soos, C; Vissy, B; Tarján, D; Tóth, N; Novák, I; Csató, P; Rubin, G; Arregui, M; Carena, W; Chapeland, S; Divià, R; Schossmaier, K; Van de Vyvre, P; Vascotto, Alessandro; Stock, Reinhard; Rademakers, F; Lindenstruth, V; Skaali, B

    2001-01-01

    Proposal of abstract for CHEP2000The ALICE DAQ system has been designed to support an aggregate eventr building bandwidth of up to 2.5 GByte/s and a storage capability o fup to 1.25 GByte/s to mass storage.A general framework called the ALICE Data Acquisition Test Environment (DATE) system has been developed as a basis for prototyping the components of the DAQ. DATE supports a wide spectrum of configurations from simple systems to more complex systems with multiple detectors and multiple event builders.Prototypes of several key components of the ALICE DAQ have been developed and integrated with the DATE system, such as the ALICE Detector Data Link, the online data monitoring from ROOT and the interface to the Mass Storage systems. Combined tests of several of these components are pursued during the ALICE Data Challenges.The architecture of the ALICE DAQ system will be presented together with the current status of the different prototypes. The recent addition of a Transition Radiation Detector (TRD) to ALICE h...

  5. Management of reprocessed uranium. Current status and future prospects

    International Nuclear Information System (INIS)

    There is worldwide interest in developing advanced and innovative technologies for nuclear fuel cycles, minimizing waste and environmental impacts. As of the beginning of 2003, about 171000 tonnes heavy metal spent nuclear fuel is in storage, while smaller amounts have been reprocessed. In several countries, including France, India, Japan and the Russian Federation, spent fuel has been viewed as a national energy resource. Some countries hold reprocessed uranium as the result of their commercial reprocessing service contracts for reprocessing the spent fuel of others. Reprocessed uranium has a potential value for recycling either directly or after appropriate treatment. This report analyses the existing options, approaches and developments in the management of reprocessed uranium. It includes the technical issues involved in managing reprocessed uranium which are RepU arisings, storage, chemical conversion, re-enrichment, fuel fabrication, transport, reactor irradiation, subsequent reprocessing and disposal options, as well as assessment of holistic environmental impacts. The objective of this document is to overview the information on the current status and future trends in the management of RepU and to identify major issues to be considered for future projects

  6. Current Status of Carl Sagan Observatory in Mexico

    Science.gov (United States)

    Sanchez-Ibarra, A.

    The current status of Observatory "Carl Sagan" (OCS) of University of Sonora is presented. This project was born in 1996 focused to build a small solar-stellar observatory completely operated by remote control. The observatory will be at "Cerro Azul", a 2480 m peak in one of the best regions in the world for astronomical observation, at the Sonora-Arizona desert. The OCS, with three 16 cm solar telescopes and a 55 cm stellar telescope is one of the cheapest observatories, valuated in US200,000 Added to its scientific goals to study solar coronal holes and Supernovae Type 1A, the OCS has a strong educative and cultural program in Astronomy to all levels. At the end of 2001, we started the Program "Constelacion", to build small planetariums through all the countries with a cost of only US80,000. Also, the webcast system for transmission of the solar observations from the prototype OCS at the campus, was expanded to webcast educational programs in Astronomy since July of this year, including courses and diplomats for Latin American people. All of these advances are exposed here.

  7. The Current Status and Future Prospects for the GRACE Mission

    Science.gov (United States)

    Tapley, Byron; Flechtner, Frank; Watkins, Michael; Bettadpur, Srinivas; Boening, Carmen

    2016-04-01

    The twin satellites of the Gravity Recovery and Climate Experiment (GRACE) were launched on March 17, 2002 and have operated for over 13 years. The mission objectives are to sense the spatial and temporal variations of the Earth's mass through its effects on the gravity field at the GRACE satellite altitude. The major cause of the time varying mass is water motion and the GRACE mission has provided a continuous decade long measurement sequences which characterizes the seasonal cycle of mass transport between the oceans, land, cryosphere and atmosphere; its inter-annual variability; and the climate driven secular, or long period, mass transport signals. In 2012, the RLO5 solution, based on a complete reanalysis of the mission data, data release, was initiated. The monthly solutions from this effort were released in mid-2013 with the mean fields following in 2014 and 2015. The mission is entering the final phases of operations. The current mission operations strategy emphasizes extending the mission lifetime to achieve mission overlap with the GRACE Follow On Mission. This presentation will review the mission status and the projections for mission lifetime, summarize plans for the RL 06 data re-analysis, describe the issues that influence the operations philosophy and discuss the impact the operations may have on the scientific data products.

  8. Current Immunotherapeutic Approaches in Pancreatic Cancer

    Directory of Open Access Journals (Sweden)

    Shigeo Koido

    2011-01-01

    Full Text Available Pancreatic cancer is a highly aggressive and notoriously difficult to treat. As the vast majority of patients are diagnosed at advanced stage of the disease, only a small population is curative by surgical resection. Although gemcitabine-based chemotherapy is typically offered as standard of care, most patients do not survive longer than 6 months. Thus, new therapeutic approaches are needed. Pancreatic cancer cells that develop gemcitabine resistance would still be suitable targets for immunotherapy. Therefore, one promising treatment approach may be immunotherapy that is designed to target pancreatic-cancer-associated antigens. In this paper, we detail recent work in immunotherapy and the advances in concept of combination therapy of immunotherapy and chemotherapy. We offer our perspective on how to increase the clinical efficacy of immunotherapies for pancreatic cancer.

  9. Current Immunotherapeutic Approaches in Pancreatic Cancer

    OpenAIRE

    Jianlin Gong; Shigeo Koido; Hisao Tajiri; Hideo Komita; Masaki Ito; Kan Uchiyama; Kenichi Satoh; Keisuke Nagatsuma; Hiroshi Matsudaira; Toyokazu Yukawa; Shunichi Odahara; Jimi Mitobe; Yoshihisa Namiki; Shintaro Tsukinaga; Akitaka Takahara

    2011-01-01

    Pancreatic cancer is a highly aggressive and notoriously difficult to treat. As the vast majority of patients are diagnosed at advanced stage of the disease, only a small population is curative by surgical resection. Although gemcitabine-based chemotherapy is typically offered as standard of care, most patients do not survive longer than 6 months. Thus, new therapeutic approaches are needed. Pancreatic cancer cells that develop gemcitabine resistance would still be suitable targets for immuno...

  10. Exercise after breast cancer treatment: current perspectives

    OpenAIRE

    Dieli-Conwright CM; Orozco BZ

    2015-01-01

    Christina M Dieli-Conwright, Breanna Z Orozco Division of Biokinesiology and Physical Therapy, Women's Health and Exercise Laboratory, University of Southern California, Los Angeles, CA, USA Abstract: Over the past 2 decades, great strides have been made in the field of exercise-oncology research, particularly with breast cancer. This area of research is particularly important since there are >2.8 million breast cancer survivors who are in need of an intervention that can offs...

  11. Diet and colorectal cancer risk: current views

    Directory of Open Access Journals (Sweden)

    A. Giacosa, M. Rondanelli, H. Cena, F. Frascio, M.J. Hill

    2007-03-01

    Full Text Available SUMMARY Large bowel cancer (CRC is amongst the most common cancers in North America, Australasia and western Europe. The major risk factors of CRC are genetic and dietary. Evidence regarding genetic polymorphisms which may influence the metabolism of nutrients thought to be important in the aetiology of CRC and colorectal adenomatous polyps is discussed. At present, the strongest evidence of genenutrient interaction in relation to CRC is for folate and genetic variants associated with differences in metabolism of folate. Significant trends of increasing CRC risk with increasing intake emerged for total energy, bread and pasta, cakes and desserts, and refined sugar have been observed in recent Italian studies. Most vegetables, including pulses, were inversely associated with CRC. Among macronutrients, a high intake of starch and saturated fat seemed to lead to an increased risk of cancer. High intakes of polyunsaturated fatty acids (chiefly derived from olive oil and seed oils showed a marginal inverse association with CRC. In the present paper the relation between meat consumption and cancer risk is reviewed showing that there is little evidence to support this relationship. Key words: cancer risk, colorectal cancer, diet, energy intake, genetic polymorphism, prevention, physical activity

  12. Current Controversies in Lung Cancer Staging.

    Science.gov (United States)

    Carter, Brett W; Godoy, Myrna C B; Wu, Carol C; Erasmus, Jeremy J; Truong, Mylene T

    2016-07-01

    Lung cancer remains the leading cause of cancer-related mortality in the United States, and accurate staging of disease plays an important role in the formulation of treatment strategies and optimization of patient outcomes. The International Association for the Study of Lung Cancer has recently proposed changes to the upcoming eighth edition of the tumor, node, and metastasis (TNM-8) staging system used for lung cancer. This revised classification is based on significant differences in patient survival identified on analysis of a new large international database of lung cancer cases. Key changes include: further modifications to the T descriptors based on 1 cm increments in tumor size; grouping of tumors resulting in partial or complete lung atelectasis/pneumonitis; grouping of tumors involving a main bronchus with respect to distance from the carina; reassignment of diaphragmatic invasion; elimination of mediastinal pleural invasion as a descriptor; and further subdivision of metastatic disease into distinct descriptors based on the number of extrathoracic metastases and involved organs. Because of these changes, several new stage groups have been developed, and others have shifted. Although TNM-8 represents continued improvement upon modifications previously made to the staging system, reflecting an evolving understanding of tumor behavior and patient management, several limitations and unaddressed issues persist. Understanding the proposed revisions to TNM-8 and awareness of key limitations and potential controversial issues still unaddressed will allow radiologists to accurately stage patients with lung cancer and optimize treatment decisions. PMID:27306388

  13. An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status.

    Science.gov (United States)

    Sun, Lei; Quan, Xiao-Qing; Yu, Shiying

    2015-01-01

    Recently, an international consensus diagnostic criterion for cancer cachexia was proposed. The aim of the study is to assess the prevalence of cachexia in patients with advanced cancer and to assess the current status of the diagnosis and management of cancer cachexia. A total of 390 patients with advanced cancer were included. There were 140 patients with cachexia and the prevalence was 35.9%. The prevalence was highest in pancreatic cancer (88.9%), followed by gastric cancer (76.5%) and esophageal cancer (52.9%). Sixty-three patients with cancer cachexia have CT scans available for muscle mass evaluation and 98.4% were sarcopenic. Cachectic patients have a significantly lower overall quality of life and a higher symptom burden. According to oncology physicians, only 33 patients were considered to have cancer cachexia. The false negative rate amounted to 76.4%. The positive rate was related to the body mass index and Eastern Cooperative Oncology Group performance status of the patients. There were few types of pharmacological approaches for cancer cachexia and more than half of cachectic patients did not receive any anticachexia treatment. These results indicate that the prevalence of cachexia in advanced cancer patients was high. However, cancer cachexia was rarely recognized and clinical management for cancer cachexia was very inadequate. PMID:26317149

  14. The current status of robot-assisted radical prostatectomy

    Institute of Scientific and Technical Information of China (English)

    Prokar Dasgupta; Roger S.Kirby

    2009-01-01

    Robot-assisted radical prostatectomy (RARP) is a rapidly evolving technique for the treatment of localized prostate cancer.In the United States,over 65% of radical prostatectomies are robot-assisted,although the acceptance of this technology in Europe and the rest of the world has been somewhat slower.This article reviews the current literature on RARP with regard to oncological,continence and potency outcomes-the so-called 'trifecta'.Preliminary data appear to show an advantage of RARP over open prostatectomy,with reduced blood loss,decreased pain,early mobilization,shorter hospital stay and lower margin rates.Most studies show good postoperative continence and potency with RARP;however,this needs to be viewed in the context of the paucity of randomized data available in the literature.There is no definitive evidence to show an advantage over standard laparoscopy,but the fact that this technique has reached parity with laparoscopy within 5 years is encouraging.Finally,evolving techniques of single-port robotic prostatectomy,laserguided robotics,catheter-free prostatectomy and image-guided robotics are discussed.

  15. Nanotechnology in neurology: Genesis, current status, and future prospects

    Directory of Open Access Journals (Sweden)

    Paurush Ambesh

    2015-01-01

    Full Text Available Nanotechnology is a promising, novel field of technological development. There is great potential in research and clinical applications for neurological diseases. Here we chronicle the inception of nanotechnology, discuss its integration with neurology, and highlight the challenges in current application. Some of the problems involving practical use of neuronanotechnology are direct biological toxicity, visualization of the nanodevice, and the short life expectancy of nanomachinery. Neuron cell therapy is an upcoming field for the treatment of challenging problems in neurology. Peptide nanofibers based on amphiphilic molecules have been developed that can autoregulate their structure depending on the conditions of the surrounding milieu. Such frameworks are promising for serving as drug delivery systems or communication bridges between damaged neurons. For common disabling diseases such as Alzheimer′s disease (AD, Parkinson′s disease (PD, amyotrophic lateral sclerosis (ALS, and multiple sclerosis (MS, recent developments have seen revolutionary nanotech-based novelties, which are discussed here in detail. Bioimaging integrated with nanoneuromedicine has opened up new doors for cancer and infection therapeutics.

  16. Current relevance of hypoxia in head and neck cancer

    OpenAIRE

    Bredell, Marius G; Ernst, Jutta; El-Kochairi, Ilhem; Dahlem, Yuliya; Ikenberg, Kristian; Schumann, Desiree M.

    2016-01-01

    Head and Neck cancer (HNC) is a complex mix of cancers and one of the more common cancers with a relatively poor prognosis. One of the factors that may assist us in predicting survival and allow us to adjust our treatment strategies is the presence of tumor hypoxia. In this overview we aim to evaluate the current evidence and potential clinical relevance of tumor hypoxia in head and neck cancer according to an extensive search of current literature. An abundance of evidence and often contradi...

  17. HER2 status and disparities in luminal breast cancers.

    Science.gov (United States)

    Holowatyj, Andreana N; Ruterbusch, Julie J; Ratnam, Manohar; Gorski, David H; Cote, Michele L

    2016-08-01

    National Comprehensive Care Network guidelines for adjuvant treatment of invasive breast cancer are based on HER2 and hormone receptor (HR) status, where HR+ disease encompasses all estrogen receptor (ER)+ and/or progesterone receptor (PR)+ tumors. We sought to explore clinical and demographic differences among patients with HR+ breast cancer subtypes, and the role of HER2 status, age, race/ethnicity, and socioeconomic status (SES) in disease risk. We evaluated breast cancer subtype distribution, defined by HR and HER2 status, using patient clinical, demographic, and socioeconomic characteristics. Differences in HR categories by demographic and tumor characteristics were examined using chi-squared tests. Multinomial logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) to quantify associations between breast cancer HR status and demographic factors. We found that differences in HR+ (ER-/PR+ vs. ER+/PR- or ER+/PR+) tumor biology are likely clinically significant and may play a role in breast cancer, regardless of HER2 status. While clinical and patient characteristics differed within each luminal subtype, we found disparities in SES only among Luminal A (HR+/HER2-) tumors. Among HR+/HER2- cases, we observed that ER-/PR+ patients tend to live in areas of higher poverty (OR = 1.20, 95% CI = 1.03-1.40) and are 70% more likely to be aged 50 years or older. However, this pattern was not found in women with Luminal B (HR+/HER2+) disease (Poverty OR = 0.98, 95% CI = 0.76-1.27; Age OR = 1.01, 95% CI = 0.81-1.26). Racial/ethnic disparities among non-Hispanic black and Hispanic women persisted across HR+/HER2- cases compared to non-Hispanic white women. Our findings suggest that while race/ethnicity and SES are correlated, each plays an independent role in contributing to disease among Luminal A tumors. Further study is needed to investigate how tumor biology, race/ethnicity, and socioeconomic disparities among HR+/HER2

  18. Total oxidant/antioxidant status in sera of patients with thyroid cancers

    OpenAIRE

    Wang, Dong; Feng, Jia-fu; Zeng, Ping; Yang, Yun-Hong; Luo, Jun; Yang, Yu-Wei

    2011-01-01

    Oxidative stress is considered to be involved in the pathophysiology of all cancers. In order to evaluate the total oxidant/antioxidant status in patients with thyroid cancer and to investigate the relationship between oxidative stress parameters and serum thyroid profiles among thyroid cancer patients and various controls, we determined oxidative status including total antioxidant status (TAS) and total oxidant status (TOS) and calculation of oxidative stress index (OSI) in sera in 82 thyroi...

  19. Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?

    Institute of Scientific and Technical Information of China (English)

    Guo-Yan Liu; Wei Zhang

    2012-01-01

    In Western countries,the mutation status of the BRCA1 and BRCA2 genes is commonly determined for genetic counseling among members of families with a history of breast or ovarian cancer,especially for women of the Ashkenazi Jewish ethnicity.Recent studies in the Cancer Genome Atlas project have demonstrated that BRCA2 mutation carriers are more responsive to platinum-based chemotherapy among high-grade serous ovarian cancer patients.Thus,in Western countries,the mutation status of BRCA1 and BRCA2 is recognized to have an important value with which to assess cancer risk and therapeutic response.However,very limited studies of BRCA1 and BRCA2 mutations and their implications for counseling and therapeutic prediction have been conducted in China.Therefore,a potentially important genetic test that is technically simple has not benefited Chinese women with an increased risk of breast or ovarian cancer.This article summarizes the current progress in the study of BRCA1/2 mutation in China and recommends an increased effort in applying advances in genetic testing to the clinical management of Chinese patients with ovarian cancer.

  20. Current status of fast reactors and future plans in India

    International Nuclear Information System (INIS)

    In the Indian energy scenario projections for the future, the nuclear power through fast reactors is expected to play an important role of ∼ 20% of total installed capacity by 2052. Successful operation of 40 MWt/13 MWe capacity Fast Breeder Test Reactor(FBTR) since 1985, strong R and D executed in multidisciplinary domain backed up by manufacturing technology and construction of 500 MWe Prototype Fast Breeder Reactor (PFBR) based on indigenous design have provided high confidence on the success of sodium cooled fast reactor technology. PFBR is a pool type MoX fuelled reactor designed with 2 primary sodium pumps, 2 secondary loops, 8 single wall integrated once through steam generators, and a rectangular containment. PFBR is presently under advanced stage of construction. Beyond PFBR, it is planned to construct 6 more FBRs of 500 MWe capacity each. Towards this, a systematic road map has been drawn for improved economy and enhanced safety through a number of measures. Road map for necessary R and D and manufacturing technology has been well detailed. The major features incorporated are twin unit concept, plant life increased to 60 years in comparison to 40 years for PFBR, reduction in number of steam generators from 8 to 6, reduction in special steel specific weight requirements, integrated primary sodium purification, enhanced reliability of shutdown systems, enhanced diversity in decay heat removal systems, enhanced in-service inspection, and compact plant layout. Beyond 2025, a series of 1000 MWe capacity metallic fuel with higher breeding potential are planned. R and D activities have been systematically formulated for metallic fuel development of both sodium bonded and mechanical bonded design. The paper addresses the highlights of current operating experience of FBTR and its life extension, construction status of PFBR, and design features of future sodium cooled fast reactors in India. (author)

  1. CURRENT STATUS OF INDIVIDUAL DOSIMETRIC MONITORING IN UKRAINE.

    Science.gov (United States)

    Chumak, V; Deniachenko, N; Makarovska, O; Mihailescu, L-C; Prykhodko, A; Voloskyi, V; Vanhavere, F

    2016-09-01

    About 50 000 workers are being occupationally exposed to radiation in Ukraine. Individual dosimetric monitoring (IDM) is provided by 77 dosimetry services and laboratories of very different scale with a number of monitored workers ranging from several persons to ∼9000. In the present work, the current status of personal dosimetry in Ukraine was studied. The First National Intercomparison (FNI) of the IDM labs was accompanied by a survey of the laboratory operation in terms of coverage, types of dosimetry provided, instrumentation and methodologies used, metrological support, data recording, etc. Totally, 34 laboratories responded to the FNI call, and 18 services with 19 different personal dosimetry systems took part in the intercomparison exercise providing 24 dosimeters each for blind irradiation to photons of 6 different qualities (ISO N-series X-rays, S-Cs and S-Co sources) in a dose range of 5-60 mSv. Performance of the dosimetry labs was evaluated according to ISO 14146 criteria of matching trumpet curves with H0 = 0.2 mSv. The test revealed that 8 of the 19 systems meet ISO 14146 criteria in full, 5 other labs show marginal performance and 6 laboratories demonstrated catastrophic quality of dosimetric results. Altogether, 18 participating labs provide dosimetric monitoring to 37 477 workers (about three-fourths of all occupationally exposed workers), usually on monthly (nuclear industry) or quarterly (rest of applications) basis. Of this number, 20 664 persons (55 %) receive completely adequate individual monitoring, and the number of personnel receiving IDM of inadequate quality counts 3054 persons. PMID:26979804

  2. Analysis on Current Status and Plights of Translational Medicine

    Institute of Scientific and Technical Information of China (English)

    ZHAO Jin-wen; QIAN Feng

    2015-01-01

    Translational medicine, which is a new concept appearing in the field of international medical health in the past three or four years, forms a discipline of the system medicine (including systematic pathology, diagnosis and comprehensive treatment as well as pharmacology, etc) synchronizing with personalized medicine and predictable medicine. It is a branch of medical research trying to build a better bridge between the basic studies and the clinical medical treatment. It can promote the predicative, prognostic and personalized medicines by the evaluation and application of molecular markers, the individual therapies based on molecular subtypes and the evaluation and predication of therapeutic responses and prognosis. And its purpose is to build a direct connection between basic research and clinical practice so as to transform the knowledge and achievements of basic research into new therapeutic methods in clinic, which can be used to serve the clinic and solve clinical problems. Nevertheless, the study on translational medicine is limited, and there are few review articles about the progress of translational medicine in English. With the development of innovative and new technology, the therapeutic methods become more accurate and diverse, and the translational medicine will make outstanding advances and provide more space for the future treatment of various diseases so as to better serve the clinical practices and the patients. In addition, except the outstanding achievements, there are still multiple plights in the translational medicine research. Therefore, this study aimed to review the current status and the present problems in translational medicine, hoping to expand the study outcomes in China to the whole world.

  3. CURRENT STATUS AND POLICY IMPLICATIONS FOR FOSTERING SOCIAL ENTREPRENEUR

    Directory of Open Access Journals (Sweden)

    Yoon-Doo Kim

    2012-01-01

    Full Text Available In this study, problems in current status of social entrepreneurs in Korea were examined and further policy issues for them were suggested as well. For the methodology, the study analyzed the drawbacks and policy implication of fostering social entrepreneurs through Focus Group Interview (FGI on analysis of present condition of incubating social entrepreneur and programs for it. First, it should escape from personnel expense-centered one and convert to ecosystem-centered or division-centered project in the direction of the government for fostering social entrepreneurs, putting emphasis on follow-up management and evaluation. Second, it must suggest a standard model for social entrepreneur promotion project. In other words, the projects with low performance should be reduced and education models appropriate for new circumstances and changes must be adopted through not only programs standardized in divisions, categories and local provinces, but also appointing expert instructors and project evaluation. Third, it’s necessary to propose specific guideline for detailed education operation according to education trainee and objectives of social entrepreneur. Fourth, it is needed to have more various contents development and distribution by strengthening support for specialized foundation, management and case studies related to fostering social entrepreneurs. Finally, it is even more required to spread awareness on social economics relating to programs for fostering social entrepreneur. With the long-term perspective, it is needed to render policy and specialization for fostering Korean-model social entrepreneurs, which is able to raise competent social entrepreneurs suitable for each stage of growth such as sourcing, incubation and launching social entrepreneurs.

  4. Genomic resources in fruit plants: an assessment of current status.

    Science.gov (United States)

    Rai, Manoj K; Shekhawat, N S

    2015-01-01

    The availability of many genomic resources such as genome sequences, functional genomics resources including microarrays and RNA-seq, sufficient numbers of molecular markers, express sequence tags (ESTs) and high-density genetic maps is causing a rapid acceleration of genetics and genomic research of many fruit plants. This is leading to an increase in our knowledge of the genes that are linked to many horticultural and agronomically important traits. Recently, some progress has also been made on the identification and functional analysis of miRNAs in some fruit plants. This is one of the most active research fields in plant sciences. The last decade has witnessed development of genomic resources in many fruit plants such as apple, banana, citrus, grapes, papaya, pears, strawberry etc.; however, many of them are still not being exploited. Furthermore, owing to lack of resources, infrastructure and research facilities in many lesser-developed countries, development of genomic resources in many underutilized or less-studied fruit crops, which grow in these countries, is limited. Thus, research emphasis should be given to those fruit crops for which genomic resources are relatively scarce. The development of genomic databases of these less-studied fruit crops will enable biotechnologists to identify target genes that underlie key horticultural and agronomical traits. This review presents an overview of the current status of the development of genomic resources in fruit plants with the main emphasis being on genome sequencing, EST resources, functional genomics resources including microarray and RNA-seq, identification of quantitative trait loci and construction of genetic maps as well as efforts made on the identification and functional analysis of miRNAs in fruit plants. PMID:24649925

  5. Current status of the nuclear matter incompressibility coefficient

    International Nuclear Information System (INIS)

    We review the current status of the incompressibility coefficient of symmetric nuclear matter, Knm, as deduced from experimental data on excitation cross section, σ(E), of the isoscalar giant monopole resonance (ISGMR) and the isoscalar giant dipole resonance (ISGDR), by inelastic α-particle scattering, using the nonrelativistic and relativistic mean-field based random phase approximation (RPA). We will discuss the following problems: (1) Self-consistent (non-relativistic) Hartree-Fock (HF)-based RPA calculations and the need to carry out detailed and accurate calculations of the strength function distributions, S(E), and the transition densities, pt, of the isoscalar giant resonance within the HF-RPA theory. We will present results of our investigation concerning, (i) the consequences of violation of self-consistency in common applications of HF-based RPA on S(E) and p, of isoscalar giant resonances, and (ii) the effects of the spurious state mixing (SSM) on properties of the ISGDR. (2) The relation between the strength function S(E) and the excitation cross section a(E) of the isoscalar giant resonances (the ISGMR and the ISGDR, in particular) obtained by alpha-scattering. Here we present results of accurate microscopic calculations for S(E) and for σ(E), obtained within the folding-model distorted-wave-Born approximation with transition densities pt(r ) obtained from HF-RPA calculations. We provide an explanation for the discrepancy between theory and experiment concerning S(E) of the ISGDR. (3) The apparent discrepancy of about 20 % in the value of Knm as predicted by the relativistic and the non-relativistic models. Our investigation suggests that this discrepancy is mainly due to the different values of the symmetry energy coefficient employed in the relativistic and the non-relativistic models

  6. EDIBLE VACCINES FROM GM CROPS: CURRENT STATUS AND FUTURE SCOPE

    Directory of Open Access Journals (Sweden)

    Doshi V

    2013-06-01

    take “food” rather than “drugs” when we are ill. This review attempts to discuss the current status and future of this new preventive modality.

  7. Current status and future of utilization in research reactors

    International Nuclear Information System (INIS)

    In research reactors of Japan Atomic Energy Research Institute (JAERI), JRR-3 was upgraded (so called JRR-3M) with irradiation facilities and neutron beam experimental facilities. Particularly the new supply of cold neutrons brings to a great increase of fields of utilization in research reactors of JAERI. In JRR-4, it is planned to reduce the fuel enrichment and to renew several utilization facilities in several years. JRR-2 will be shut down also in several years because of its superannuation. On the other hand most research reactors of other institutes in Japan have faced with their superannuation and the difficulties of refurbishment or upgrading as well as new construction because of the changes of environmental condition such as urbanization of their surroundings. The research reactors in JAERI will play more important role for research and development using neutrons in future than past and present. Therefore the investigation was made in order to catch the needs for utilization of research reactors. The results of this investigation show that there are many research institutes which hope to utilize research reactors in accordance with the increase of available fields such as research of high polymer, biology, industrial materials and components, and contribution to environmental investigation by using neutron scattering, neutron radiography and activation analysis. This means that the research reactor utilization will be able to contribute to general scientific fields as well as utilization for research and development of nuclear energy which have been popular as utilization of research reactors. In this presentation, the current status of utilization of research reactors in JAERI and utilization fields of research reactors expected in future based on the investigation are described. It is also discussed what is important for the utilization to use effectively the research reactors in JAERI. (author)

  8. Current Status of Soil-transmitted Nematode Infection in China

    Institute of Scientific and Technical Information of China (English)

    YING-DAN CHEN; LIN-HUA TANG; LONG-QI XU

    2008-01-01

    Objective To Carry out national surveys for ascertaining the current status and trends of soil-transmitted nematode infections in China,providing scientific basis for forther developing control strategies.Methods In 1988-1992(hereinafter abbreriated as "survey in 1990"),a stratified cluster random sampling method was used in the survey.In 2001-2004(hereinafter abbreriated as "survey in 2003"),in order to compare with the survey in 1990,two-characteristic stratified cluster random sampling method was used and 687 investigation spots were sampled from the 2848 spots selected in the survey in 1990.Kato-Katz thick smear method was used to examine the eggs of soil-transmitted nematodes in fecal samples. Results The prevalence rates were 53.6% and 19.6% for soil-transmitted nematodes,14.6%and 6.120% for hookworms,44.6% and 12.7% for Ascaris lumbricoides,17.4% and 4.630% for Trichuris trichiura in survey 1990 and survey 2003,respectively.The prevalence rates of soil-transmitted nematodes were higher in 13 provinces than the average level in China in the survey in 1990.and higher in 8 provinces than the average level in the survey in 2003.The prevalence of hookworms,Ascaris lumbricoides,Trichurls trichiura and the overall prevalence of soft-transmitted nematodes were higher in females than in males.It is estimated from the results of survey in 2003 that the number of persons with soil-transmitted nematode infections in the country is about 129 million,less than that in the survey in 1990. Conclusion The prevalence of soil-transmitted nematodes has declined considerably but is still relatively high in some provinces and autonomous regions.Control activities and socioeconomic development may have contributed to the decreased prevalence.

  9. 20 CFR 404.120 - How we determine currently insured status.

    Science.gov (United States)

    2010-04-01

    ... 20 Employees' Benefits 2 2010-04-01 2010-04-01 false How we determine currently insured status... § 404.120 How we determine currently insured status. (a) What the period is for determining currently... not counted as part of the 13-quarter period. We do not count as part of the 13-quarter period...

  10. 21 CFR 210.1 - Status of current good manufacturing practice regulations.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 4 2010-04-01 2010-04-01 false Status of current good manufacturing practice... SERVICES (CONTINUED) DRUGS: GENERAL CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL § 210.1 Status of current good manufacturing practice...

  11. Race/Ethnicity, Gender, Weight Status, and Colorectal Cancer Screening

    Directory of Open Access Journals (Sweden)

    Heather Bittner Fagan

    2011-01-01

    The literature on colorectal cancer (CRC screening is contradictory regarding the impact of weight status on CRC screening. This study was intended to determine if CRC screening rates among 2005 National Health Interview Survey (NHIS respondent racial/ethnic and gender subgroups were influenced by weight status. Methods. Univariable and multivariable logistic regression analyses were performed to determine if CRC screening use differed significantly among obese, overweight, and normal-weight individuals in race/ethnic and gender subgroups. Results. Multivariable analyses showed that CRC screening rates did not differ significantly for individuals within these subgroups who were obese or overweight as compared to their normal-weight peers. Conclusion. Weight status does not contribute to disparities in CRC screening in race/ethnicity and gender subgroups.

  12. Current management of locally recurrent rectal cancer

    DEFF Research Database (Denmark)

    Nielsen, Mette Bak; Laurberg, Søren; Holm, Thorbjörn

    2011-01-01

    ABSTRACT Objective: A review of the literature was undertaken to provide an overview of the surgical management of locally recurrent rectal cancer (LRRC) after the introduction of total mesorectal excision (TME). Method: A systematic literature search was undertaken using PubMed, Embase, Web of...

  13. Policies for second generation biofuels: current status and future challenges

    Energy Technology Data Exchange (ETDEWEB)

    Egger, Haakan; Greaker, Mads; Potter, Emily

    2011-07-01

    Current state-of-the-art knowledge concludes that green house gas (GHG) emissions must be controlled and reduced within the next 30-40 years. The transport sector contributes almost a fifth of the current global emissions, and its share is likely to increase in the future. The US and a number of European countries have therefore introduced various support schemes for research and development (RandD) of low emission fuels that can potentially replace the current fossil fuels. One such alternative is biofuels. The advantage of biofuels are that it is easy to introduce into the transport sector. On the other hand, recent research papers question whether the supply of feedstock is sufficient, and to what extent biofuels lead to GHG emission reductions. This report reviews the current status of second generation biofuels. Second generation biofuels are made from cellulose, which according to our survey of the literature, is in more abundant supply than the first generation biofuels feedstocks. Furthermore, it seems to have the potential to reduce GHG emissions from the transport sector without leading to devastating land use changes, which recent critique has held against first generation biofuels. Given that governments have decided to support RandD of low emission fuels, we ask the following questions: Should second generation biofuels receive RandD support to the same extent as other low emission fuels like hydrogen? How should support schemes for second generation biofuels be designed? Second generation biofuels can be divided according to the production process into thermo-chemical and bio-chemical. With respect to the thermo-chemical process the potential for cost reductions seems to be low. On the other hand, ethanol made from cellulose using the biochemical conversion process is far from a ripe technology. Expert reports point to several potential technological breakthroughs which may reduce costs substantially. Hence, cellulosic ethanol, should receive direct

  14. Current status on performance of CT colonography and clinical indications

    International Nuclear Information System (INIS)

    CT colonography (CTC) is a robust and reliable imaging test of the colon. Accuracy for the detection of colorectal cancer (CRC) is as high as conventional colonoscopy (CC). Identification of polyp is size dependent, with large lesions (≥10 mm) accurately detected and small lesions (6–9 mm) identified with moderate to good sensitivity. Recent studies show good sensitivity for the identification of nonpolypoid (flat) lesions as well. Current CTC indications include the evaluation of patients who had undergone a previous incomplete CC or those who are unfit for CC (elderly and frail individuals, patients with underlying severe clinical conditions, or with contraindication to sedation). CTC can also be efficiently used in the assessment of diverticular disease (excluding patients with acute diverticulitis, where the exam should be postponed), before laparoscopic surgery for CRC (to have an accurate localization of the lesion), in the evaluation of colonic involvement in the case of deep pelvic endometriosis (replacing barium enema). CTC is also a safe procedure in patients with colostomy. For CRC screening, CTC should be considered an opportunistic screening test (not available for population, or mass screening) to be offered to asymptomatic average-risk individuals, of both genders, starting at age 50. The use in individuals with positive family history should be discussed with the patient first. Absolute contraindication is to propose CTC for surveillance of genetic syndromes and chronic inflammatory bowel diseases (in particular, ulcerative colitis). The use of CTC in the follow-up after surgery for CRC is achieving interesting evidences despite the fact that literature data are still relatively weak in terms of numerosity of the studied populations. In patients who underwent previous polypectomy CTC cannot be recommended as first test because debate is still open. It is desirable that in the future CTC would be the first-line and only diagnostic test for

  15. Current status on performance of CT colonography and clinical indications

    Energy Technology Data Exchange (ETDEWEB)

    Laghi, Andrea, E-mail: andrea.laghi@uniroma1.it [Department of Radiological Sciences, Oncology and Pathology Sapienza – Università di Roma, Polo Pontino, I.C.O.T. Hospital, Via Franco Faggiana 43, 04100 Latina (Italy); Rengo, Marco [Department of Radiological Sciences, Oncology and Pathology Sapienza – Università di Roma, Polo Pontino, I.C.O.T. Hospital, Via Franco Faggiana 43, 04100 Latina (Italy); Graser, Anno [InstitutfürKlinische Radiologie, Klinikumder Ludwig-Maximilians-Universität München, Campus Großhadern, Marchioninistr. 15, 81377 München (Germany); Iafrate, Franco [Department of Radiological Sciences, Oncology and Pathology Sapienza – Università di Roma, Policlinico Umberto I, Viale Regina Elena 324, 00161 Rome (Italy)

    2013-08-15

    CT colonography (CTC) is a robust and reliable imaging test of the colon. Accuracy for the detection of colorectal cancer (CRC) is as high as conventional colonoscopy (CC). Identification of polyp is size dependent, with large lesions (≥10 mm) accurately detected and small lesions (6–9 mm) identified with moderate to good sensitivity. Recent studies show good sensitivity for the identification of nonpolypoid (flat) lesions as well. Current CTC indications include the evaluation of patients who had undergone a previous incomplete CC or those who are unfit for CC (elderly and frail individuals, patients with underlying severe clinical conditions, or with contraindication to sedation). CTC can also be efficiently used in the assessment of diverticular disease (excluding patients with acute diverticulitis, where the exam should be postponed), before laparoscopic surgery for CRC (to have an accurate localization of the lesion), in the evaluation of colonic involvement in the case of deep pelvic endometriosis (replacing barium enema). CTC is also a safe procedure in patients with colostomy. For CRC screening, CTC should be considered an opportunistic screening test (not available for population, or mass screening) to be offered to asymptomatic average-risk individuals, of both genders, starting at age 50. The use in individuals with positive family history should be discussed with the patient first. Absolute contraindication is to propose CTC for surveillance of genetic syndromes and chronic inflammatory bowel diseases (in particular, ulcerative colitis). The use of CTC in the follow-up after surgery for CRC is achieving interesting evidences despite the fact that literature data are still relatively weak in terms of numerosity of the studied populations. In patients who underwent previous polypectomy CTC cannot be recommended as first test because debate is still open. It is desirable that in the future CTC would be the first-line and only diagnostic test for

  16. Current status of education and training in medical physics in developing and developed countries

    International Nuclear Information System (INIS)

    Significant resources are allocated for applying Medical Physics to health care. State-of-the-art technological developments have made this discipline valuable in early diagnosis and treatment of many diseases, particularly cancer. The current challenge is the dire need of harmonizing the standards of practice, including equipment, quality assurance, safety, education and training in Medical Physics across various countries. With experiences gained from the successes and failures in this field, standards of practice have evolved in the developed as well as the developing countries, but at different rates. Considerations of cost-benefit and priorities have led to increased gap in these standards of practice. In this presentation, the status of the education and training component of selected countries representing the two domains will be discussed. Possible causes, as well as the means adopted by the national and international organisations to bridge the gaps, will also be a part of the discussion. Suggestions for future improvements will be offered for consideration

  17. Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis

    Institute of Scientific and Technical Information of China (English)

    2008-01-01

    This article is to offer a concise review on the use of cytoreductive surgery (CRS) plus intraperitoneal hyperthermic chemotherapy (IPHC) for the treatment of peritoneal carcinomatosis (PC). Traditionally, PC was treated with systemic chemotherapy alone with very poor response and a median survival of less than 6 mo. With the establishment of several phase studies, a new trend has been developed toward the use of CRS plus IPHC as a standard method for treating selected patients with PC, in whom sufficient cytoreduction could be achieved. In spite of the need for more high quality phase studies, there is now a consensus among many surgical oncology experts throughout the world about the use of this new treatment strategy as standard care for colorectal cancer patients with PC. This review summarizes the current status and possible progress in future.

  18. Assessment of the current status of basic nuclear data compilations

    International Nuclear Information System (INIS)

    Topics discussed include: the status of mass-chain evaluations, remote terminal access, other US Nuclear Data Network publications, formats and procedures subcommittee report, keyword follow-up (Phys. Rev. C), and atomic data and nuclear data tables

  19. Current Status and Prediction on Development of PE Market

    Institute of Scientific and Technical Information of China (English)

    Yu Jiao

    2003-01-01

    This article comprehensively analyzes the status of market demand/supply and import/export volumes of PE in the world and in China, and predicts the future development trends in the fields of PE production and consumption.

  20. The current status of utilization of research reactors in China

    International Nuclear Information System (INIS)

    Seminars on utilization of research reactors were held to enhance experience exchanging among institutes and universities in China. The status of CARR (China Advanced Research Reactor) project is briefly described. The progress in BNCT program in China is introduced. (author)

  1. Total antioxidant status in women with breast cancer

    International Nuclear Information System (INIS)

    Objective: To measure the concentration of total antioxidant status (TAS) in women with breast cancer. Methodology: This is a case control study conducted in Al-Salam Hospital and Department of Pharmacology in Mosul Medical College. Twenty women having histologically confirmed breast cancer and twenty age-matched healthy volunteer women participated in the study. Serum total antioxidant status (TAS) was measured in both groups. Results: Mean TAS of the patient group (0.91 +- 0.32 mmol/l) was significantly lower (P<0.001) than that of the control group (1.82 +- 0.14 mmol/l). Conclusion: The present study demonstrated that women with breast cancer have a low level of TAS as compared to those of healthy women. It further emphasizes the growing concern that oxidative damage may occur in those patients that exhaust the antioxidant defense of the body leading to a low levels of TAS. Administration of antioxidant supplements such as a combination of vitamins A, C and E are necessary in women at high risk of developing breast cancer or after surgery or with anticancer drugs. (author)

  2. Socioeconomic status and patterns of care in lung cancer

    International Nuclear Information System (INIS)

    This retrospective study aims to explore any associations between socioeconomic factors and lung cancer management and outcome in the Australian setting. The study population consisted of patients newly diagnosed with lung cancer in 1996 who were living in the Northern Sydney Area Health Service (NSAHS) or South Western Sydney Area Health Service (SWSAHS). These two Area Health Services differ in socioeconomic profiles based on socioeconomic indexes for areas (SEIFA), median income, education level and unemployment rate. Data on patient demographics, tumour characteristics, management details, recurrence and survival were collected, and the patterns of care were analysed. Socioeconomic status indicators of the two Area Health Services were imputed from the Australian Bureau of Statistics data. There were 270 and 256 new cases of lung cancer identified in NSAHS and SWSAHS respectively. Patients in NSAHS were slightly older (median age 73 versus 68 years) and there was less male predominance. The stage distributions and performance status of the two cohorts were similar. There were no significant differences in the utilisation rates of different treatment modalities between the two areas: radiotherapy (54% in NSAHS and 55% in SWSAHS), chemotherapy (34% and 25%), surgery (26% and 21%) and no treatment (22% and 25%). The 5-year overall survival was slightly in favour of NSAHS (10.5% and 7.4%), but did not reach statistical significance. Despite differences in socioeconomic profiles between the two area health services, patients with lung cancer had similar patterns of care and survival

  3. Optimal breast cancer screening strategies for older women: current perspectives

    Directory of Open Access Journals (Sweden)

    Braithwaite D

    2016-02-01

    Full Text Available Dejana Braithwaite,1 Joshua Demb,1 Louise M Henderson2 1Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, 2Department of Radiology, University of North Carolina, Chapel Hill, NC, USA Abstract: Breast cancer is a major cause of cancer-related deaths among older women, aged 65 years or older. Screening mammography has been shown to be effective in reducing breast cancer mortality in women aged 50–74 years but not among those aged 75 years or older. Given the large heterogeneity in comorbidity status and life expectancy among older women, controversy remains over screening mammography in this population. Diminished life expectancy with aging may decrease the potential screening benefit and increase the risk of harms. In this review, we summarize the evidence on screening mammography utilization, performance, and outcomes and highlight evidence gaps. Optimizing the screening strategy will involve separating older women who will benefit from screening from those who will not benefit by using information on comorbidity status and life expectancy. This review has identified areas related to screening mammography in older women that warrant additional research, including the need to evaluate emerging screening technologies, such as tomosynthesis among older women and precision cancer screening. In the absence of randomized controlled trials, the benefits and harms of continued screening mammography in older women need to be estimated using both population-based cohort data and simulation models. Keywords: aging, breast cancer, precision cancer screening

  4. Staging Lung Cancer: Current Controversies and Strategies

    OpenAIRE

    Riyad Karmy-Jones; Hyland, Robert H.; Lewis, Joseph W; Paul Kvale

    1997-01-01

    A consistent approach to staging is required for the rational management of lung cancer. This paper was prepared at the request of the Standards Committee of the Canadian Thoracic Society, and reviews and discusses the relative merits of the available methods of staging. Whichever methods are chosen by a particular institution, the following points must be stressed. No patient can be considered automatically "unresectable" when chest radiography and/ or computed tomography demonstrate adenopa...

  5. Indus-2 Synchrotron Radiation Source: current status and utilization

    International Nuclear Information System (INIS)

    Indus Synchrotron Radiation complex at Raja Ramanna Centre for Advanced Technology at Indore, India houses two synchrotron radiation sources: Indus-1 and Indus-2. Indus-1 is a 450 MeV source emitting in VUV/ soft x-ray region and operating at 100 mA since 1999. Indus-2 is designed for 2.5 GeV, 300 mA operation and is operating at 2 GeV and 100 mA since March 2010 in 24x7 mode and a beam lifetime of about 22 hrs has been achieved. Operation at 2.5 GeV and 100 mA has recently been demonstrated with the addition of in-house developed solid state RF amplifiers. Indus-2 can accommodate 21 bending magnet (BM) and 5 insertion device (ID) beamlines. Sixteen BM beamlines have been planned and six BM beamlines namely i) Angle Dispersive XRD ii) Energy dispersive XRD iii) Energy dispersive EXAFS iv) Soft and deep x-ray lithography v) X-ray fluorescence micro-probe and vi) X-ray photoelectron spectroscopy beamlines have been commissioned. These are being used by researchers from different universities, national institutes and laboratories for carrying out several investigations. Two more beamlines namely 'Grazing incidence x-ray scattering' and 'Protein crystallography' are nearing commissioning. A number of materials research related problems have been investigated using these beamlines and several papers have already been published. Here we will report on the current status of the source, details of the beamlines already operational, beamlines to be commissioned soon and several up-gradation schemes that are being planned. Five IDs consisting of two soft x-ray planar undulators, one superconducting wavelength shifter / wiggler, one APPLE II soft x-ray helical undulator and one hard x-ray undulator will be installed during the next few years. Three new ID based beamli-nes for Atomic and Molecular physics, Angle integrated / Angle resolved PES and Magnetic Circular Dichroism experiments will be commissioned.

  6. Current Status of the New Antiepileptic Drugs in Chronic Pain

    Science.gov (United States)

    Sidhu, Harpreet S.; Sadhotra, Akshay

    2016-01-01

    Antiepileptic drugs (AEDs) are extensively used worldwide to treat a wide range of disorders other than epilepsy, such as neuropathic pain, migraine, and bipolar disorder. Due to this situation more than 20 new third-generation AEDs have been introduced in the market recently. The future design of new AEDs must also have potential to help in the non-epileptic disorders. The wide acceptance of second generation AEDs for the management of various non-epileptic disorders has caused the emergence of generics in the market. The wide use of approved AEDs outside epilepsy is based on both economic and scientific reasons. Bipolar disorders, migraine prophylaxis, fibromyalgia, and neuropathic pain represent the most attractive indication expansion opportunities for anticonvulsant developers, providing blockbuster revenues. Strong growth in non-epilepsy conditions will see Pfizer’s Lyrica become the market leading brand by 2018. In this review, we mainly focus on the current status of new AEDs in the treatment of chronic pain and migraine prophylaxis. AEDs have a strong analgesic potential and this is demonstrated by the wide use of carbamazepine in trigeminal neuralgia and sodium valproate in migraine prophylaxis. At present, data on the new AEDs for non-epileptic conditions are inconclusive. Not all AEDs are effective in the management of neuropathic pain and migraine. Only those AEDs whose mechanisms of action are match with pathophysiology of the disease, have potential to show efficacy in non-epileptic disorder. For this better understanding of the pathophysiology of the disease and mechanisms of action of new AEDs are essential requirement before initiating pre-clinical and clinical trials. Many new AEDs show good results in the animal model and open-label studies but fail to provide strong evidence at randomized, placebo-controlled trials. The final decision regarding the clinical efficacy of the particular AEDs in a specific non-epileptic disorder should be

  7. Oilfield microseismic monitoring - current status, challenges and opportunties

    Science.gov (United States)

    Jupe, A.

    2011-12-01

    Over the last 5-10 years microearthquake (microseismic) imaging has become an important diagnostic technique in the hydrocarbons industry. It is most commonly used for the 3D time-lapse imaging of fracture system development during high-pressure and flowrate hydraulic-fracturing operations, where it is commonly referred to as "frac-mapping". The technique has also seen less wide-spread, but increasing, usage in the long-term monitoring of primary-recovery (ie pressure depletion), the injection of water/steam/gas for secondary-recovery and also for subsurface disposal/storage (eg water/drill-cuttings/H2S/CO2). A significant turning point for microseismic monitoring was the successful imaging of the complex fracturing resulting from the stimulation of the Barnet Shale, Fort Worth Basin, Texas. Microseismic imaging was quickly recognized as the only technology that could provide detailed spatial-temporal information on the fracturing process, and significantly aided the development of sophisticated horizontal well completions. The commercial value of microseismic derived fracture properties, such as growth direction, height and length, has subsequently been recognized in shale and coal-seam gas developments throughout North America, and the rest of the world. The initial uptake and early development of this geophysical technology is however somewhat unusual in that it was largely driven by reservoir engineers, and is typically applied in non-ideal geophysical (wellsite) conditions, and also necessitates near real-time processing and interpretation. The geophysical problems typically faced in frac-mapping include limited network geometry, relatively poor data quality (due to small event magnitudes and ambient noise), automated processing requirements, velocity model uncertainty and incomplete geomechanical understanding of the source mechanism. Nonetheless it is an important and widely used technique. The paper considers the current status of microseismic monitoring in

  8. Chemopreventive Herbal Anti-Oxidants: Current Status and Future Perspectives

    OpenAIRE

    Patel, Rachana; Garg, Rachana; Erande, Suvarna; B. Maru, Girish

    2007-01-01

    Cancer chemoprevention is fast becoming a lucrative approach for controlling cancer. Carcinogenesis being a complex multi-step, multi-factorial process, a number of chemopreventive interventions can be employed. These strategies are generally directed against two broad events of carcinogenesis viz., initiation and promotion/progression. Anti-initiation interventions principally involve inhibition of carcinogen activation, scavenging of free radicals and reactive carcinogen metabolites along w...

  9. Weight status and body image perceptions in adolescents: current perspectives.

    Science.gov (United States)

    Voelker, Dana K; Reel, Justine J; Greenleaf, Christy

    2015-01-01

    Adolescence represents a pivotal stage in the development of positive or negative body image. Many influences exist during the teen years including transitions (eg, puberty) that affect one's body shape, weight status, and appearance. Weight status exists along a spectrum between being obese (ie, where one's body weight is in the 95th percentile for age and gender) to being underweight. Salient influences on body image include the media, which can target adolescents, and peers who help shape beliefs about the perceived body ideal. Internalization of and pressures to conform to these socially prescribed body ideals help to explain associations between weight status and body image. The concepts of fat talk and weight-related bullying during adolescence greatly contribute to an overemphasis on body weight and appearance as well as the development of negative body perceptions and dissatisfaction surrounding specific body parts. This article provides an overview of the significance of adolescent development in shaping body image, the relationship between body image and adolescent weight status, and the consequences of having a negative body image during adolescence (ie, disordered eating, eating disorders, and dysfunctional exercise). Practical implications for promoting a healthy weight status and positive body image among adolescents will be discussed. PMID:26347007

  10. MELiSSA Food Characterization general approach and current status

    Science.gov (United States)

    Weihreter, Martin; Chaerle, Laury; Secco, Benjamin; Molders, Katrien; van der Straeten, Dominique; Duliere, Eric; Pieters, Serge; Maclean, Heather; Dochain, Denis; Quinet, Muriel; Lutts, Stanley; Graham, Thomas; Stasiak, Michael; Rondeau Vuk, Theresa; Zheng, Youbin; Dixon, Mike; Laniau, Martine; Larreture, Alain; Timsit, Michel; Aronne, Giovanna; Barbieri, Giancarlo; Buonomo, Roberta; Veronica; Paradiso, Roberta; de Pascale, Stafania; Galbiati, Massimo; Troia, A. R.; Nobili, Matteo; Bucchieri, Lorenzo; Page, Valérie; Feller, Urs; Lasseur, Christophe

    . Available MELiSSA closed environment crop growth data were used to develop a first photosynthetic model representing the basic carbon fixation mechanisms. This model will be further elaborated in the course of this study to predict yield, oxygen production and transpi-ration. As an ultimate goal the model is intended to simulate the composition of the different plant organs (root, shoot, fruit/seed or tuber) for each crop under various conditions. For the validation of this model an extensive amount of data sets are needed. Current plant growth bench test setups will provide part of the required data. To gain more precise and detailed datasets, a highly closed plant growth chamber (Plant Characterization Unit, PCU) is under development. The PCU will provide accurate mass balances for carbon, water, oxygen and other elements with statistical reliability. This reliability is achieved through a high degree of closure and environment homogeneity. The PCU will also provide data for the above described plant characterization studies. The general work approach, the current status and future steps will be illustrated.

  11. Assessment of the current status of basic nuclear data compilations

    International Nuclear Information System (INIS)

    The Panel on Basic Nuclear Data Compilations met at the National Nuclear Data Center at Brookhaven National Laboratory (BNL). All 7 panel members were present, together with 17 other individuals with various responsibilities and interests in the US Nuclear Data Network (USNDN). Status reports were presented to the panel by the five US evaluation centers, located at Brookhaven (BNL), Idaho Falls (INEL), Berkeley (LBL), Oak Ridge (ORNL), and the University of Pennsylvania. The reports from the centers outlined the status of their mass chain evaluations and of a number of other projects related to this work; these areas are discussed in more detail in this report

  12. [Development of antituberculous drugs: current status and future prospects].

    Science.gov (United States)

    Tomioka, Haruaki; Namba, Kenji

    2006-12-01

    and drug regimens for anti-TB chemotherapy. There are a number of difficulties in drug-design for the development of new drug formulations with increased potential for antimycobacterial effects, excellent pharmacokinetics, and tolerability. It should be emphasized that the most urgent goal of chemotherapy of TB and MAC infections, especially that associated with HIV infection, is to develop highly active, low-cost drugs which can be used not only in industrialized countries but also in developing countries, since the incidences of AIDS-associated intractable TB and MAC infections are rapidly increasing in the latter. We strongly wish a great advance of fundametal and practical studies in developing such kinds of new anti-TB drugs in the near future. 1. Prospects for non-clinical or clinical development of new antituberculous drugs in relation to corporate strategy: Kenji NAMBA (New Product Research Laboratories I, Daiichi Pharmaceutical Co., Ltd.) Tuberculosis (TB) remains one of the deadliest threats to public health. No new anti-TB drugs have been brought into the clinic in the past 40 years. Current non-clinical works with progressed technology and Global Alliance for TB Drug Development, a non-profit organization established in 2000, accelerate research and development of faster-acting anti-TB compounds. We reviewed the status of new types of compounds which are being developed as anti-TB drug, such as diarylquinoline (TMC 207), nitroimidazole (PA-824 and OPC-67683), and moxifloxacin (MFLX). We also discussed the best clinical development plans for new-TB drugs in relation to corporate strategy. 2. Exploring novel drug targets through the chemical genomics approach and its possible application to the development of anti-tuberculosis drugs: Yorimasa SUWA (Reverse Proteomics Research Institute Co., Ltd.), Yohji SUZUKI (Teijin Ltd.) Recently, chemical genomics approach has been focused as an emerging technology for the drug discovery. In advance to a very large scale

  13. Gastric carcinoma in China: Current status and future perspectives (Review)

    Science.gov (United States)

    ZHU, XIAODONG; LI, JIN

    2010-01-01

    Gastric cancer is one of the most frequently occurring cancers in China, with an estimated 380,000 new cases each year, accounting for more than 40% of the worldwide annual cancer incidence. There is geographical clustering of the distribution of gastric cancer in China, with most of the high-risk areas being rural. D2 resection is the standard lymphadenectomy for curative resection in China, but more extensive lymphadenectomy is conducted for selected patients. Perioperative chemotherapy, postoperative chemotherapy or chemoradiotherapy can be combined with surgery. It remains uncertain which option is best, but if surgery is insufficient, adjuvant chemoradiotherapy is recommended. In the palliative setting, although there is no standard first-line chemotherapy, regimens based on taxane, oxaliplatin or capecitabine, or the epirubicin, cisplatin, 5-fluorouracil regimen and its modifications are the most common options selected by Chinese oncologists. Several studies to evaluate target therapy are ongoing, but it is too early to draw any conclusions. However, the development of target therapy is likely to become a milestone in the treatment of gastric cancer. PMID:22966316

  14. ACRF Instrumentation Status: New, Current, and Future - February 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-03-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  15. ACRF Instrumentation Status: New, Current, and Future - March 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-04-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  16. ACRF Instrumentation Status: New, Current, and Future May 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-05-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  17. ACRF Instrumentation Status: New, Current, and Future June 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-06-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  18. ACRF Instrumentation Status: New, Current, and Future October 2006

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2006-10-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  19. Current status of Russian Evaluated Neutron Data Libraries

    International Nuclear Information System (INIS)

    The status of Russian Evaluated Data Libraries is discussed. The last modifications of the BROND-2 files and their relations to the additional files of the FOND library and the ABBN-90 group constants are considered. The main characteristics of new libraries for the photoneutron data, dosimetry and activation reaction cross sections and transmutation cross sections for intermediate energies are described briefly. (author)

  20. Current status of the Mallard population in the Nordic countries

    DEFF Research Database (Denmark)

    Dalby, Lars; Söderquist, Pär; Clausen, Preben; Christensen, Thomas Kjær; Elmberg, Johan; Fox, Anthony David; Holmqvist, Niklas; Lehikoinen, Aleksi; Lindström, Åke; Nilsson, Leif; Pöysä, Hannu; Sigfússon, Arnór Þórir; Svenning, J.-C.

    Dabbling ducks (Anas ssp.) are cornerstone species in wetland bird communities and yet in many cases we lack sufficient data to judge the conservation status of the flyway population. In a first step to remedy this we here compile all available data on Mallard in the Nordic countries. We find...

  1. ACRF Instrumentation Status: New, Current, and Future February 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-02-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development

  2. ACRF Instrumentation Status: New, Current, and Future March 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-03-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  3. ACRF Instrumentation Status: New, Current, and Future January 2007

    Energy Technology Data Exchange (ETDEWEB)

    Liljegren, JC

    2007-01-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  4. ACRF Instrumentation Status: New, Current, and Future May 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-04-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  5. ACRF Instrumentation Status: New, Current, and Future July 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-07-01

    The purpose of this report is to provide a concise but comprehensive overview of ACRF instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) SBIR instrument development.

  6. Current status on marine litter indicators in Nordic waters

    DEFF Research Database (Denmark)

    Strand, Jakob; Tairova, Zhanna; Magnusson, Kerstin;

    Status for project on Marine litter in the Nordic waters. This includes a review of Nordic studies on marine litter indicators. Various studies as part of either research or existing monitoring have provided information on occurrence of marine litter in Nordic waters from Baltic Sea to the Arctic....

  7. Gastric cancer in Africa: current management and outcomes.

    Science.gov (United States)

    Asombang, Akwi W; Rahman, Rubayat; Ibdah, Jamal A

    2014-04-14

    Gastric cancer is the fourth most common cancer and second most common cause of cancer death worldwide. Globally, gastric cancer poses a significant public health burden - both economically and socially. In 2008, the economic burden from premature cancer deaths and disability was $895 billion and gastric cancer was the second highest cancer responsible for healthy life lost. With the expected increase in cancer deaths and non-communicable diseases, these costs are expected to rise and impact patient care. World Health Organization, estimates a 15% increase in non-communicable disease worldwide, with more than 20% increase occurring in Africa between 2010 and 2020. Mali, West Africa, is ranked 15(th) highest incidence of gastric cancer worldwide at a rate of 20.3/100000, yet very scarce published data evaluating etiology, prevention or management exist. It is understood that risk factors of gastric cancer are multifactorial and include infectious agents (Helicobacter pylori, Epstein-Barr virus), genetic, dietary, and environmental factors (alcohol, smoking). Interestingly, African patients with gastric cancer are younger, in their 3(rd)-4(th) decade, and present at a late stage of the disease. There is sparse data regarding gastric cancer in Africa due to lack of data collection and under-reporting, which impacts incidence and mortality rates. Currently, GLOBOCAN, an International Agency for Research on Cancer resource, is the most comprehensive available resource allowing comparison between nations. In resource limited settings, with already restricted healthcare funding, data is needed to establish programs in Africa that increase gastric cancer awareness, curtail the economic burden, and improve patient management and survival outcomes. PMID:24833842

  8. Weight status and body image perceptions in adolescents: current perspectives

    Directory of Open Access Journals (Sweden)

    Voelker DK

    2015-08-01

    Full Text Available Dana K Voelker,1 Justine J Reel,2 Christy Greenleaf3 1West Virginia University, College of Physical Activity and Sport Sciences, Morgantown, WV, 2University of North Carolina Wilmington, College of Health and Human Services, Wilmington, NC, 3University of Wisconsin–Milwaukee, College of Health Sciences, Milwaukee, WI, USA Abstract: Adolescence represents a pivotal stage in the development of positive or negative body image. Many influences exist during the teen years including transitions (eg, puberty that affect one’s body shape, weight status, and appearance. Weight status exists along a spectrum between being obese (ie, where one’s body weight is in the 95th percentile for age and gender to being underweight. Salient influences on body image include the media, which can target adolescents, and peers who help shape beliefs about the perceived body ideal. Internalization of and pressures to conform to these socially prescribed body ideals help to explain associations between weight status and body image. The concepts of fat talk and weight-related bullying during adolescence greatly contribute to an overemphasis on body weight and appearance as well as the development of negative body perceptions and dissatisfaction surrounding specific body parts. This article provides an overview of the significance of adolescent development in shaping body image, the relationship between body image and adolescent weight status, and the consequences of having a negative body image during adolescence (ie, disordered eating, eating disorders, and dysfunctional exercise. Practical implications for promoting a healthy weight status and positive body image among adolescents will be discussed. Keywords: adolescence, eating disorders, obesity, bullying, puberty, physical activity

  9. KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine | Office of Cancer Genomics

    Science.gov (United States)

    Decitabine, a cancer therapeutic that inhibits DNA methylation, produces variable antitumor response rates in patients with solid tumors that might be leveraged clinically with identification of a predictive biomarker. In this study, we profiled the response of human ovarian, melanoma, and breast cancer cells treated with decitabine, finding that RAS/MEK/ERK pathway activation and DNMT1 expression correlated with cytotoxic activity. Further, we showed that KRAS genomic status predicted decitabine sensitivity in low-grade and high-grade serous ovarian cancer cells.

  10. Status of hypo fractionated radiotherapy in breast cancer

    International Nuclear Information System (INIS)

    It has been assumed that in the case of a majority of tumours hypo fractionation radiotherapy is of limited value because it negatively affected the ratio of curability to late adverse effects. However, there now exists data to suggest that hypo fractionation may be advisory in breast cancer. The author presents a number of recently published and currently ongoing trials, which may provide evidence for the use of hypo fractionated radiotherapy in breast cancer patients. The possible implications for primary breast cancer are that modest increase in fraction size combined with reduction in treatment time may translate into worthwhile gains in tumour control, without enhanced late normal tissue injuries. This may affect future decision-making in the course of radiotherapy for breast cancer if the ongoing trials are confirmatory. (author)

  11. The current status and future directions of myxoma virus, a master in immune evasion.

    Science.gov (United States)

    Spiesschaert, Bart; McFadden, Grant; Hermans, Katleen; Nauwynck, Hans; Van de Walle, Gerlinde R

    2011-01-01

    Myxoma virus (MYXV) gained importance throughout the twentieth century because of the use of the highly virulent Standard Laboratory Strain (SLS) by the Australian government in the attempt to control the feral Australian population of Oryctolagus cuniculus (European rabbit) and the subsequent illegal release of MYXV in Europe. In the European rabbit, MYXV causes a disease with an exceedingly high mortality rate, named myxomatosis, which is passively transmitted by biting arthropod vectors. MYXV still has a great impact on European rabbit populations around the world. In contrast, only a single cutaneous lesion, restricted to the point of inoculation, is seen in its natural long-term host, the South-American Sylvilagus brasiliensis and the North-American S. Bachmani. Apart from being detrimental for European rabbits, however, MYXV has also become of interest in human medicine in the last two decades for two reasons. Firstly, due to the strong immune suppressing effects of certain MYXV proteins, several secreted virus-encoded immunomodulators (e.g. Serp-1) are being developed to treat systemic inflammatory syndromes such as cardiovascular disease in humans. Secondly, due to the inherent ability of MYXV to infect a broad spectrum of human cancer cells, the live virus is also being developed as an oncolytic virotherapeutic to treat human cancer. In this review, an update will be given on the current status of MYXV in rabbits as well as its potential in human medicine in the twenty-first century. PMID:21658227

  12. Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives.

    Science.gov (United States)

    Yamada, Kiyofumi; Nabeshima, Toshitaka

    2015-01-01

    To improve the adherence to and knowledge about pharmacotherapy in outpatients and to maximize the efficacy and minimize the adverse drug events, the first pharmacist-managed clinic (PMC) in Japan was established for anticoagulation therapy at Nagoya University Hospital in 2000. Since then, various PMCs such as for asthma/chronic obstructive pulmonary disease, Alzheimer's disease, hypercholesterolemia, chronic hepatitis C, cancer chemotherapy, palliative care, chronic kidney disease, and continuous ambulatory peritoneal dialysis have been established and expanded to many hospitals in Japan. Accumulating evidences suggest that PMCs have some beneficial effects on patients' adherence to and knowledge about their pharmacotherapy as well as the clinical outcome, besides being cost-effective. Notably, PMCs for cancer chemotherapy have been approved as a new medical service in hospitals in 2014, which is covered by the universal health coverage in Japan. In this review article, the current status of PMCs for patient education and counseling in Japan and their impact on pharmaceutical care and management are critically reviewed. Furthermore, future perspectives on PMCs are discussed. PMID:26819713

  13. ACRF Instrumentation Status: New, Current, and Future - May 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-05-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  14. ACRF Instrumentation Status: New, Current, and Future - October 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-10-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  15. ACRF Instrumentation Status: New, Current, and Future - July 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-07-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  16. ACRF Instrumentation Status: New, Current, and Future - April 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-05-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  17. ACRF Instrumentation Status: New, Current, and Future - January 2009

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2009-03-02

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  18. ACRF Instrumentation Status: New, Current, and Future - December 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2009-01-15

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  19. ACRF Instrumentation Status: New, Current, and Future - September 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-10-15

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  20. ACRF Instrumentation Status: New, Current, and Future - November 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-12-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  1. ACRF Instrumentation Status: New, Current, and Future - June 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-07-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  2. ACRF Instrumentation Status: New, Current, and Future - August 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-09-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  3. ACRF Instrumentation Status: New, Current, and Future September 2006

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2006-09-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development. New information is highlighted in blue text.

  4. ACRF Instrumentation Status: New, Current, and Future February 2009

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2009-02-15

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  5. ACRF Instrumentation Status: New, Current, and Future March 2009

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2009-03-15

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  6. ACRF Instrumentation Status: New, Current, and Future July 2006

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2006-07-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development. New information is highlighted in blue text.

  7. ACRF Instrumentation Status: New, Current, and Future August 2006

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2006-08-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development. New information is highlighted in blue text.

  8. Current Status & Development Trend of VSAT Market in China

    Institute of Scientific and Technical Information of China (English)

    Xu Nutu

    2006-01-01

    @@ 1. General Status of VSAT Market Development in China 1)Development History Development in China The history of the application of satellite communication in China is not too long and it was dated from the early seventies of the 20th century. In 1973, approved by Chinese government,Ministry of Posts and Telecommunications purchased satellite earth equipment from foreign country and constructed 3 stations in Shanghai and Beijing.

  9. Review and current status of hepatobiliary imaging agents

    International Nuclear Information System (INIS)

    This review will outline aspects of the normal hepatobiliary anatomy and physiology relevant to an understanding of cholescintigraphy and discuss factors of hepatobiliary diseases which impact on the design of new hepatobiliary radiopharmaceuticals. The synthesis, pharmacokinetics, and structure-distribution relationship of the existing /sup 99m/Tc hepatobiliary agents will be compared, and the clinical status of present cholescintigraphic agents will be summarized. Future trends in the design and use of hepatobiliary tracers will be presented

  10. Current status of the near surface repository in Romania

    International Nuclear Information System (INIS)

    The radioactive waste management at the Cernavoda NPP is based on collection, pretreatment and storage of all solid wastes. The disposal of operational and decommissioning wastes has been evaluated, based on the results of a research and development programme. A near surface disposal facility was selected and a siting process was implemented. The status of this project and its prospective are discussed in the paper. (author)

  11. The current status of the U.S. MTBE industry

    International Nuclear Information System (INIS)

    This paper reviews the status of the MTBE industry from its beginnings as a result of the Clean Air Act Amendments and the need for the use of oxygenates in non-attainment areas. During 1990--93 three world scale merchant plants were constructed and in 1994 two more were brought on stream. The paper tabulates reasons why MTBE gained the lion's share of the oxygenates market. Finally the paper discusses the problems that now plague the industry and their causes

  12. Assessment of the current status of basic nuclear data compilations

    International Nuclear Information System (INIS)

    The Panel on Basic Nuclear Data Compilations met on April 6, 1979, to review the present status of nuclear data compilations. The following topics are addressed in this report: A-chain situation; ENSDF, Nuclear Structure Reference Files, and Recent References; Handbook of the Nuclides; and charged particle nuclear data. The panel made 13 recommendations, probably the most forceful being its recommendation against the use of data from unreferenced journals in ENSDF. 1 table

  13. Current status of Chinese nuclear power industry and technology

    International Nuclear Information System (INIS)

    China has been carrying out active international cooperation aiming to be a country where is to be an economical super power and an advanced country in nuclear power technology by the year early 2000, and China also has begun to be recognized as the largest potential market for the construction of nuclear power plants(NPPs) expecting to construct more than thirty nuclear power units by the year 2020. China has advanced technology in the basic nuclear science including liquid metal breeder reactor technology, nuclear material, medium and small size power plants, and isotope production technology, and also China has complete nuclear fuel cycle technology. However, China still has low NPP technology. Therefore, it is expected that China may have complementary cooperative relationship with China, it is expected that Korea may have an access to the advanced Chinese nuclear science technology, and may have a good opportunity to explore the Chinese market actively exporting excellent Korean NPP technology, and further may have a good position to the neighboring Asian countries' NPP markets. From this perspective, general Chinese social status, major nuclear R and D activity status, and correct NPP and technology status have been analyzed in this report, and this report is expected to be a useful resource for cooperating with China in future. 10 tabs., 6 figs., 16 refs. (Author)

  14. Tiagabine: efficacy and safety in partial seizures – current status

    Directory of Open Access Journals (Sweden)

    Jürgen Bauer

    2008-09-01

    Full Text Available Jürgen Bauer, Déirdre Cooper-MahkornDepartment of Epileptology, Bonn University Hospital, GermanyAbstract: Tiagabine hydrochloride (TGB is a selective gamma-aminobutyric acid (GABA reuptake inhibitor. TGB is effective as an add-on medication in adults and children 12 years and older in the treatment of partial seizures. Results of nonrandomized add-on trials with TGB show treatment success with seizure reduction of at least 50% in 33% to 46% of patients. In newly diagnosed patients with partial epilepsy, TGB monotherapy was as effective as carbamazepine. Comedication with TGB elevates the risk of nonconvulsive status (7.8% vs 2.7% without TGB. The most common side effects include dizziness/lightheadedness, asthenia/lack of energy and somnolence. TGB has no negative effects on cognition; it does not increase the risk of fractures or rash. TGB may interfere with color perception. TGB presents an intermediate risk for depression in patients with epilepsy (approximately 4%. Regarding the risk of overdose, 96–680 mg TGB (mean 224 mg caused seizures or coma. TGB is an antiepileptic drug exhibiting a specific anticonvulsive mechanism of action, the efficacy of which is relatively low when used in comedication. Critical side effects, such as the induction of nonconvulsive status epilepticus, further limit its use.Keywords: epilepsy, tiagabine, antiepileptic drugs, status epilepticus, pharmacotherapy

  15. Current major cancer targets for nanoparticle systems.

    Science.gov (United States)

    Wesselinova, Diana

    2011-02-01

    This review presents some common features of nanoparticles - activity, toxicity and biological activity. Humans are exposed to tiny particles via dust storms, volcanic ash, and other natural processes and the body systems are well adapted to protect from these potentially harmful intruders. Technological advancement has also changed the character of particulate pollution, increasing the proportion of nanometer-sized particles - "nanoparticles" and expanding the variety of chemical compositions. Studies have shown a strong correlation between particulate air pollution levels, respiratory and cardiovascular diseases, various cancers, and mortality. Adverse effects of nanoparticles on human health depend on individual factors such as genetics and existing disease, as well as exposure, and nanoparticle chemistry, size, shape, agglomeration state, and electromagnetic properties. The key to understand the toxicity of nanoparticles is their size, smaller than cells and cellular organelles, which allows them to penetrate these basic biological structures, disrupting their normal function. Examples of toxic effects include tissue inflammation, and altered cellular redox balance toward oxidation, causing abnormal function or cell death. Some of these materials have desirable characteristics for industrial applications, as nanostructured materials often exhibit beneficial properties, from UV absorbance in sunscreen to oil-less lubrication of motors. In the sense of the huge surrounding positive and negative influence of known and unknown NP-impacts it seems very important to understand and forecast the processes in the body, due to the interaction between these two sides - organism. How nanoparticles can be used as drug delivery systems and imaging devices to increase the efficacy per dose of therapeutic or imaging contrast agents; how nanoparticles will be further developed to improve their functionality in cancer treatment and imaging? How reacts the immune system of the

  16. Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients.

    Directory of Open Access Journals (Sweden)

    Hellmuth A Meyer

    Full Text Available Selenium (Se is an essential trace element for selenoprotein biosynthesis. Selenoproteins have been implicated in cancer risk and tumor development. Selenoprotein P (SePP serves as the major Se transport protein in blood and as reliable biomarker of Se status in marginally supplied individuals. Among the different malignancies, renal cancer is characterized by a high mortality rate. In this study, we aimed to analyze the Se status in renal cell cancer (RCC patients and whether it correlates to cancer-specific mortality. To this end, serum samples of RCC patients (n = 41 and controls (n = 21 were retrospectively analyzed. Serum Se and SePP concentrations were measured by X-ray fluorescence and an immunoassay, respectively. Clinical and survival data were compared to serum Se and SePP concentrations as markers of Se status by receiver operating characteristic (ROC curve and Kaplan-Meier and Cox regression analyses. In our patients, higher tumor grade and tumor stage at diagnosis correlated to lower SePP and Se concentrations. Kaplan-Meier analyses indicated that low Se status at diagnosis (SePP<2.4 mg/l, bottom tertile of patient group was associated with a poor 5-year survival rate of 20% only. We conclude that SePP and Se concentrations are of prognostic value in RCC and may serve as additional diagnostic biomarkers identifying a Se deficit in kidney cancer patients potentially affecting therapy regimen. As poor Se status was indicative of high mortality odds, we speculate that an adjuvant Se supplementation of Se-deficient RCC patients might be beneficial in order to stabilize their selenoprotein expression hopefully prolonging their survival. However, this assumption needs to be rigorously tested in prospective clinical trials.

  17. Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients.

    Science.gov (United States)

    Meyer, Hellmuth A; Endermann, Tobias; Stephan, Carsten; Stoedter, Mette; Behrends, Thomas; Wolff, Ingmar; Jung, Klaus; Schomburg, Lutz

    2012-01-01

    Selenium (Se) is an essential trace element for selenoprotein biosynthesis. Selenoproteins have been implicated in cancer risk and tumor development. Selenoprotein P (SePP) serves as the major Se transport protein in blood and as reliable biomarker of Se status in marginally supplied individuals. Among the different malignancies, renal cancer is characterized by a high mortality rate. In this study, we aimed to analyze the Se status in renal cell cancer (RCC) patients and whether it correlates to cancer-specific mortality. To this end, serum samples of RCC patients (n = 41) and controls (n = 21) were retrospectively analyzed. Serum Se and SePP concentrations were measured by X-ray fluorescence and an immunoassay, respectively. Clinical and survival data were compared to serum Se and SePP concentrations as markers of Se status by receiver operating characteristic (ROC) curve and Kaplan-Meier and Cox regression analyses. In our patients, higher tumor grade and tumor stage at diagnosis correlated to lower SePP and Se concentrations. Kaplan-Meier analyses indicated that low Se status at diagnosis (SePP<2.4 mg/l, bottom tertile of patient group) was associated with a poor 5-year survival rate of 20% only. We conclude that SePP and Se concentrations are of prognostic value in RCC and may serve as additional diagnostic biomarkers identifying a Se deficit in kidney cancer patients potentially affecting therapy regimen. As poor Se status was indicative of high mortality odds, we speculate that an adjuvant Se supplementation of Se-deficient RCC patients might be beneficial in order to stabilize their selenoprotein expression hopefully prolonging their survival. However, this assumption needs to be rigorously tested in prospective clinical trials. PMID:23056383

  18. Breast cancer. Current approach in the treatment

    International Nuclear Information System (INIS)

    Of 115 women who had surgery for a malignant breast tumor proven by biopsy at the Department of General Surgery, Hospital 'Jose Ramon Lopez Tabrane' of Matanzas during the period January 2007 to May 2008 a study was conducted observational, analytical (study cohort) and using certain variables, with the aim of analyzing the behavior of this disease in our environment. Data were collected from medical records of patients admitted a breast lump in that period and files Statistics and Provincial Hospital Pathology 'Jose Ramon Lopez Tabrane'. The percentage method was applied to the description found in our sample, expressing the results in tabular form, with the objective facilitate their interpretation. The most affected age range between 65 and 74, but followed very near the range between 55 and 64. The most frequent clinical stage II, followed by the III. The left breast has proven to be most affected in outer quadrant exceeded. Veronesi conservative technique was the most used in our study. We recommend promoting breast self-examination and use of media We recommend promoting breast self-examination and use of media such as mammography as a method of early diagnosis of breast cancer and the creation of a file to the technical assessment conservative based on the survival and the immediate and mediate complications of this technique, and the best instruction in family practice clinical diagnosis of breast diseases and specialized inter consultation. (Author)

  19. Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives

    International Nuclear Information System (INIS)

    Intravesical instillation of bacillus Calmette Guérin (BCG) for the treatment of urothelial carcinoma (UC) of the bladder is based on the BCG-induced immune response, which eradicates and prevents bladder cancer. The results of recent studies have suggested that not only major histocompatibility complex (MHC)-nonrestricted immune cells such as natural killer cells, macrophages, neutrophils, etc., but also MHC-restricted CD8+ T cells play an important role and are one of the main effectors in this therapy. Better understanding of the mechanism of BCG immunotherapy supports the idea that active immunotherapy through its augmented T cell response can have great potential for the treatment of advanced UC. In this review, progress in immunotherapy for UC is discussed based on data from basic, translational and clinical studies. We also review the escape mechanism of cancer cells from the immune system, and down-regulation of MHC class I molecules

  20. Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives

    Energy Technology Data Exchange (ETDEWEB)

    Kitamura, Hiroshi, E-mail: hkitamu@sapmed.ac.jp; Tsukamoto, Taiji [Department of Urology, Sapporo Medical University School of Medicine, South 1 West 16, Chuo-ku, Sapporo 060-8543 (Japan)

    2011-07-29

    Intravesical instillation of bacillus Calmette Guérin (BCG) for the treatment of urothelial carcinoma (UC) of the bladder is based on the BCG-induced immune response, which eradicates and prevents bladder cancer. The results of recent studies have suggested that not only major histocompatibility complex (MHC)-nonrestricted immune cells such as natural killer cells, macrophages, neutrophils, etc., but also MHC-restricted CD8{sup +} T cells play an important role and are one of the main effectors in this therapy. Better understanding of the mechanism of BCG immunotherapy supports the idea that active immunotherapy through its augmented T cell response can have great potential for the treatment of advanced UC. In this review, progress in immunotherapy for UC is discussed based on data from basic, translational and clinical studies. We also review the escape mechanism of cancer cells from the immune system, and down-regulation of MHC class I molecules.

  1. Mouse Tumor Biology Database (MTB): enhancements and current status

    OpenAIRE

    Bult, Carol J.; Krupke, Debra M.; Sundberg, John P.; Eppig, Janan T.

    2000-01-01

    The Mouse Tumor Biology Database (MTB) is a Web-based resource that provides access to information on tumor frequency and latency, genetics and pathology in genetically defined mice (transgenics, targeted mutations and inbred strains). MTB is designed to serve as an information resource for cancer genetics researchers who use the laboratory mouse as a model system for understanding human disease processes. Data in MTB are obtained from the primary scientific literature and direct submissions ...

  2. Microbiological aspects of biofuel production: Current status and future directions

    Directory of Open Access Journals (Sweden)

    Mostafa S. Elshahed

    2010-04-01

    Full Text Available Biofuel research is currently an area of immense interest due to the increase in global energy demand by emerging economies and the recent increases in global oil prices. Multiple approaches are currently being researched for the use of microorganisms in the production of various biofuel (e.g. alcohols, hydrogen, biodiesel, and biogas from multiple starting materials. This review provides a brief overview on the research currently underway on laboratory and industrial scales in the area of biofuels, with specific emphasis on the economic viability of various approaches currently being utilized.

  3. Current and emerging treatments for pancreatic cancer.

    Science.gov (United States)

    Regine, W F; John, W J; Mohiuddin, M

    1997-10-01

    The worldwide annual pancreatic cancer death rate equals its estimated annual incidence. Surgery has been considered the only curative modality for this disease, but only 5 to 15% of patients are candidates for potentially curative resection. Evidence that postoperative adjuvant treatment improves outcome has been limited to a single randomised trial of a well tolerated split-course chemoradiation regimen. More intensive regimens have since been developed and are associated with, at best, a modest improvement in patient outcome. The potentially significant morbidity associated with pancreaticoduodenectomy, which can compromise the delivery of postoperative adjuvant chemoradiation, has led to the development of preoperative adjuvant ('neoadjuvant') chemoradiation in these patients. Although experience suggests that such an approach is feasible, its ultimate impact awaits further evaluation. Combined modality therapy has produced the most promising results in patients with unresectable or locally advanced disease. However, only modest improvements in median survival and minimal increases in long term survival have so far been achieved. This observation has encouraged many investigators to devise innovative methods of delivering therapy, including radioisotope implantation and intraoperative radiation therapy (IORT). Combined modality therapy with radioisotope implantation appears to have the greatest potential for improving local control and survival in these patients. IORT may be associated with lower morbidity than radioisotope implantation, but its impact may be limited by the radiobiological disadvantage associated with single dose boost therapy. Although new radiosensitising drugs are being tested, the problem of distant metastasis remains significant. New chemotherapeutic agents such as gemcitabine appear to have the potential to produce better results than those achieved over the last 35 years with fluorouracil. Investigations into the optimal integration of

  4. Current status and prospects of U.S. nuclear industry

    International Nuclear Information System (INIS)

    The status of the U.S. nuclear enterprise is considered followed by a summary of the advanced light water reactor program. Several selected national policy issues are discussed which include high level nuclear waste management, disposition of excess weapons plutonium, and economic deregulation and competition. A summary of the following three technical issues: (1) plant aging and license renewal, (2) regulatory guidance being developed for digital instrumentation and control systems in nuclear power plants, and (3) risk-informed performance based regulation is provided. A rather philosophical perspective on the topic of safety and compliance is also provided

  5. Current Status and Challenges in Wind Energy Assessment

    DEFF Research Database (Denmark)

    Gryning, Sven-Erik; Badger, Jake; Hahmann, Andrea N.;

    2014-01-01

    Here we discuss the status and challenges in the development of atlases for the assessment of the regional and global wind resources. The text more specifically describes a methodology that is under development at DTU Wind Energy in Denmark. As the wind assessment is based on mesoscale modelling......, some of the specific challenges in mesoscale modelling for wind energy purposes are discussed such as wind profiles and long-term statistics of the wind speed time series. Solutions to these challenges will help secure an economic and effective deployment of wind energy....

  6. The proton ''spin contents'': Current status ampersand perspectives

    International Nuclear Information System (INIS)

    The present status of the phenomenological and theoretical interpretation of the EMC result on the polarized deep elastic scattering is reviewed. We focus our discussion on the possibility of a significant gluonic contribution to the proton spin via the axial anomaly. We contrast the variant perspectives on this question: the viewpoint that stresses the interpretation in terms of the parton distributions vs the one that concentrates on the matrix elements of local operators. Some remarks concerning the validity of OZI rule for the strange quark are also included. 53 refs

  7. CURRENT STATUS OF ADVACATE PROCESS FOR FLUE GAS DESULFURIZATION

    Science.gov (United States)

    The following report discusses current bench- and pilot-plant advances in preparation of ADVAnced siliCATE (ADVACATE) calcium silicate sorbentsfor flue gas desulfurization. It also discusses current bench- and pilot-plant advances in sorbent preparation. Fly ash was ground in a l...

  8. Medicinal Use of Cannabis: History and Current Status

    Directory of Open Access Journals (Sweden)

    Harold Kalant

    2001-01-01

    Full Text Available OBJECTIVE: To provide an overview of the history and pharmacology of cannabis in relation to current scientific knowledge concerning actual and potential therapeutic uses of cannabis preparations and pure cannabinoids.

  9. CURRENT STATUS AND POTENTIAL FOR PRIMARY ACL REPAIR

    OpenAIRE

    Murray, Martha M.

    2009-01-01

    ACL rupture occurs in hundreds of thousands active adolescents and young adults each year. Despite current treatment, post-traumatic osteoarthritis following these injuries is commonplace within a decade of injury in these young patients. Thus, there is widespread clinical and scientific interest in improving patient outcomes and preventing osteoarthritis. The current emphasis on the removal of the torn ACL and subsequent replacement with a tendon graft (ACL reconstruction) stems from adheren...

  10. International tourism demand in Macedonia: Current status and estimation

    OpenAIRE

    Biljana Petrevska

    2013-01-01

    The paper aims to investigate current international tourism demand in Macedonia, as well as to make an attempt to forecast it in a short-term horizon by 2014. For this purpose, the past and current patterns are based on stylized facts obtained from secondary data spreading over a sample period from 2000-2011. Furthermore, the estimation of future trends is based on Box-Jenkins methodology. Several alternative specifications were introduced and upon the outcomes of standard indicators for accu...

  11. Status and Advances of RGD Molecular Imaging in Lung Cancer

    Directory of Open Access Journals (Sweden)

    Ning YUE

    2014-12-01

    Full Text Available Lung cancer has been one of the most common and the highest mortality rates malignant tumors at home and abroad. Sustained angiogenesis was not only the characteristic of malignant tumors, but also the foundation of tumor proliferation, invasion, recurrence and metastasis, it was also one of the hot spots of treatments in lung cancer biology currently. Integrins played an important part in tumor angiogenesis. Arg-Gly-Asp (RGD peptides could combine with integrins specifically, and the application of radionuclide-labeled RGD molecular probes enabled imaging of tumor blood vessels to reflect its changes. The lung cancer imaging of RGD peptides at home and abroad in recent years was reviewed in this article.

  12. The MiMeS Project: Overview and Current Status

    CERN Document Server

    Wade, G A; Bohlender, D A; Bouret, J -C; Cohen, D; Duez, V; Gagné, M; Grunhut, J; Henrichs, H F; Hill, N; Kochukhov, O; Mathis, S; Neiner, C; Oksala, M; Owocki, S; Petit, V; Shultz, M; Rivinius, T; Townsend, R; Vink, J S

    2010-01-01

    The Magnetism in Massive Stars (MiMeS) Project is a consensus collaboration among many of the foremost international researchers of the physics of hot, massive stars, with the basic aim of understanding the origin, evolution and impact of magnetic fields in these objects. At the time of writing, MiMeS Large Programs have acquired over 950 high-resolution polarised spectra of about 150 individual stars with spectral types from B5-O4, discovering new magnetic fields in a dozen hot, massive stars. The quality of this spectral and magnetic mat\\'eriel is very high, and the Collaboration is keen to connect with colleagues capable of exploiting the data in new or unforeseen ways. In this paper we review the structure of the MiMeS observing programs and report the status of observations, data modeling and development of related theory.

  13. Current Status of the GRACE Follow-On Mission

    Science.gov (United States)

    Watkins, Michael; Flechtner, Frank; Webb, Frank; Landerer, Felix; Grunwald, Ludwig

    2016-04-01

    The GRACE Follow-On Mission has now advanced to the Assembly and Test Phase with the delivery of essentially all satellite subsystems and science instruments. As of the time of this abstract submission, the team continues to plan launch in 2017. The project team is conducting tests of satellite and instrument operation and performance and putting together updated simulations of expected performance on-orbit, including intersatellite ranging (both microwave and laser), accelerometer, thermal variability and deformation, and other errors. In addition, all required ground analysis software of the Science Data System is in development and testing at JPL, The UTCSR, and GFZ, in preparation for fully integrated end-to-end (international) testing from Level-1 through Level-3 data in the coming year. In this presentation, we will provide the detailed status of project integration and test, the latest simulations of science performance, and schedule for remaining project milestones.

  14. Current status of a low-energy photon transport benchmark

    International Nuclear Information System (INIS)

    The scattered-energy spectra of monochronized synchrotron-radiation photons toward 90 deg C by samples (C, Cu, Pb) were measured using high-purity Ge detectors. The incident photons were in a linearly polarised beam of 20, 30 and 40 keV. To investigate the validity of the EGS4 code regarding photon transport in the keV region, we performed systematic comparisons of measurements and EGS4. EGS4 calculations were performed in default status and with improvements of low-energy photon transport (linearly polarised photon scattering, Doppler broadening, L-X and K-X). The measurement and calculations were compared in absolute values. Both the intensity and the shape of the peaks were compared. EGS4 calculations with improvements in low-energy photon transport agreed well with the measurements. (authors)

  15. HappyFace - current status and future development plans

    International Nuclear Information System (INIS)

    The HappyFace Project is a meta-monitoring tool, which is allow to monitor the Grid sites of the Worldwide LHC Computing Grid (WLCG). It can also be used for any (complex) computing system, e.g. local or distributed computing resources. HappyFace provides fast access to all relevant monitoring sites and gets a complete overview about the status of all available sites on one page. It has an automatic querying system, a lot of testing modules can be plugged in and also the ability to design and add new modules is available. The project had been written in Python and PHP, but in the 3rd version of HappyFace the source code is fully migrated to Python and the web output uses only HTML templates, which makes it simpler.

  16. Targeting to the hair follicles: current status and potential.

    Science.gov (United States)

    Wosicka, Hanna; Cal, Krzysztof

    2010-02-01

    The pilosebaceous unit is a complex structure that undergoes a specific growth cycle and comprises a few important drug targeting sites. For example, drugs can be targeted to the bulge region with stem cells or to the sebaceous glands. Interest in pilosebaceous units is directed towards their utilization as reservoirs for localized therapy and also as a transport pathway for systemic drug delivery. Improved investigative methods, such as differential stripping, are being developed in order to determine follicular penetration. This article reviews relevant aspects of effective follicle-targeting formulations and delivery systems as well as the activity status of hair follicles, and variations in follicle size and distribution throughout various body regions. Each of these factors strongly affects follicular permeation. We provide examples of improved penetration of particle-based formulations and of a size-dependent manner of follicular penetration. Contradictions are also discussed, indicating the need for detailed future investigations. PMID:20060268

  17. DNA barcoding to fishes: current status and future directions.

    Science.gov (United States)

    Bhattacharya, Manojit; Sharma, Ashish Ranjan; Patra, Bidhan Chandra; Sharma, Garima; Seo, Eun-Min; Nam, Ju-Suk; Chakraborty, Chiranjib; Lee, Sang-Soo

    2016-07-01

    DNA barcoding appears to be a promising approach for taxonomic identification, characterization, and discovery of newer species, facilitating biodiversity studies. It helps researchers to appreciate genetic and evolutionary associations by collection of molecular, morphological, and distributional data. Fish DNA barcoding, based on the sequencing of a uniform area of Cytochrome C Oxidase type I (COI) gene, has received significant interest as an accurate tool for species identification, authentication, and phylogenetic analysis. The aim of this review article was to investigate recent global status, approaches, and future direction of DNA barcoding in fisheries sectors. We have tried to highlight its possible impacts, complications, and validation issues at species levels for biodiversity analysis. Moreover, an effort has been put forward to understand issues related to various marker genes associated with barcode process as primer sequences and have concluded barcode promotion as an indispensable tool of molecular biology for the development of taxonomic support systems. PMID:26057011

  18. Filtered neutron beams at the FMRB - review and current status

    International Nuclear Information System (INIS)

    A review is presented of our experience with filtered neutron beams installed in beam tubes of the Research and Measurement Reactor Braunschweig since 1976: Desing of the filters and measurement of the beam parameters are reported and an outline of the research work done with the beams is given. The present status of the irradiation facility, which consists of 5 beams (144 keV, 24.5 keV, 2 keV, 0.2 keV and thermal neutrons), is described in some detail to allow understanding of the physical as well as the technical prerequisites for performing calibrations of neutron measuring instruments. An appendix contains the actual beam parameters. (orig.)

  19. Captive breeding of pangolins: current status, problems and future prospects.

    Science.gov (United States)

    Hua, Liushuai; Gong, Shiping; Wang, Fumin; Li, Weiye; Ge, Yan; Li, Xiaonan; Hou, Fanghui

    2015-01-01

    Pangolins are unique placental mammals with eight species existing in the world, which have adapted to a highly specialized diet of ants and termites, and are of significance in the control of forest termite disaster. Besides their ecological value, pangolins are extremely important economic animals with the value as medicine and food. At present, illegal hunting and habitat destruction have drastically decreased the wild population of pangolins, pushing them to the edge of extinction. Captive breeding is an important way to protect these species, but because of pangolin's specialized behaviors and high dependence on natural ecosystem, there still exist many technical barriers to successful captive breeding programs. In this paper, based on the literatures and our practical experience, we reviewed the status and existing problems in captive breeding of pangolins, including four aspects, the naturalistic habitat, dietary husbandry, reproduction and disease control. Some recommendations are presented for effective captive breeding and protection of pangolins. PMID:26155072

  20. Small modular reactors: current status, economic aspects and licensing

    Energy Technology Data Exchange (ETDEWEB)

    Zimbron E, E. [Instituto Tecnologico de Estudios Superiores de Monterrey, Campus Santa Fe, Av. Carlos Lazo No. 100, Santa Fe, 01389 Mexico D. F. (Mexico); Puente E, F., E-mail: erick.zimbron@gmail.com [ININ, Direccion de Investigacion Cientifica, Carretera Mexico-Toluca s/n, 52750 Ocoyoacac, Estado de Mexico (Mexico)

    2014-10-15

    Interest for nuclear energy had resurgence since the beginning of the new century. This was a consequence of the new world conditions and needs: increasing energy demands (mainly from developing countries), awareness of the importance of energetic security and the necessity of limiting carbon emissions. In this nuclear boom, Small Modular Reactors (SMRs) develop and start to consolidate as a viable option for the present energy market. Their modular characteristics, lower initial capital cost, passive safety features and their niche applications, situate them as a technology with various advantages. The following study will present and analysis that will help to comprehend the SMRs present status. Information will show planned reactors, reactors in construction and in operation, advantages and challenges of their implementation, relevant economic aspects and important licensing factors that need to be highlighted. The analysis showed that the SMR technology is still in an initial stage that could reach and important development point in the next ten years. In this period, many of the reactors that are in design stage or that are through their licensing process might be constructed and could be getting ready for a commercial status. On the other hand, it has been observed that there are two main economic factors that need to be considered for any SMRs implementation project. First, the costs (initial, operation, maintenance, fuel and decommissioning) and second their possible niche market applications. Additionally, it has been noted that the licensing process is one of the greatest challenges for SMR general development. Licensing is mainly related to topic such as Emergency Planning Zone, first-of-a-kind engineering, passive safety features, proliferation resistance, multiple module designs and staffing. Previous information will serve as a base for carrying out a feasibility assessment analysis for SMR in Mexico. This part will be the last section of the project